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Inflammatory pain is a debilitating condition that can occur following tissue injury or
inflammation and results in touch evoked pain (allodynia), exaggerated pain
(hyperalgesia) and spontaneous pain, yet the neural plasticity underlying these
symptoms is not fully understood. However, it is known that lamina I neurokinin 1
receptor expressing (NK1R+) spinal cord output neurons are crucial for the
manifestation of inflammatory pain. There is also evidence that the afferent input to
and the postsynaptic response of these neurons may be altered in inflammatory pain,
which could be relevant for inflammatory pain hypersensitivity. Therefore, the aim of
this thesis was to study inflammatory pain spinal plasticity mechanisms by
investigating the synaptic input to lamina I NK1R+ neurons. In ex vivo spinal cord
and dorsal root preparations from the rat, electrophysiological techniques were used
to assess inflammation-induced changes in and pharmacological manipulation of the
primary afferent drive to lamina I NK1R+ neurons.
The excitatory input to lamina I NK1R+ neurons was examined and it was found that
inflammation did not alter the relative distribution of the type of primary afferent
input received and did not potentiate monosynaptic Aδ- or monosynaptic C-fibre
input, the predominant input to these neurons. Spontaneous excitatory input was
significantly elevated in the subset of neurons that received monosynaptic Aδ-fibre
input only, regardless of inflammation.
It has recently been shown that the chemerin receptor 23 (ChemR23) represents a
novel inflammatory pain target, whereby ChemR23 agonists can decrease
inflammatory pain hypersensitivity, by a mechanism that involves the attenuation of
potentiated spinal cord responses. This study has found that the ChemR23 agonist,
chemerin, attenuated capsaicin potentiation of excitatory input to lamina I NK1R+
neurons and significantly reduced monosynaptic C-fibre input to a subset of these
neurons in inflammatory pain. However, chemerin was without effect in
non-potentiated conditions.
In exploring potential inflammatory pain spinal plasticity mechanisms, I have
investigated a phenomenon called activity-dependent slowing (ADS), whereby
repetitive stimulation of C-fibres at frequencies of 1Hz or above results in a
progressive slowing of action potential conduction velocity, which manifests as a
progressive increase in response latency. This is proposed to limit nociceptive input to
the spinal cord, thus regulating plasticity. Results demonstrate that inflammation
ii
iii
significantly attenuated C-fibre ADS in isolated dorsal roots. Furthermore, ADS in
monosynaptic C-fibre input to lamina I NK1R+ neurons was significantly reduced in
inflammatory pain, which could facilitate nociceptive drive to these key spinal cord
output neurons and promote inflammatory pain spinal cord plasticity.
In conclusion, the major novel findings of this thesis are firstly, that chemerin can
attenuate primary afferent input to lamina I NK1R+ neurons in potentiated conditions,
which supports recent studies that suggest ChemR23 is a potential target for the
development of new analgesics. Secondly, it was discovered that ADS in
monosynaptic C-fibre inputs to lamina I NK1R+ neurons is altered in inflammatory
pain, which could be relevant for inflammatory pain spinal plasticity. The findings
presented in this thesis could contribute to the development of novel inflammatory
pain treatments.
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Chapter 1
General Introduction
1.1 Pain and nociception
The International Association for the Study of Pain (IASP) defines pain as “an
unpleasant sensory and emotional experience associated with actual or potential tissue
damage, or described in terms of such damage” (IASP Taskforce on Taxonomy 1994).
Nociception is the term given to the process by which noxious stimuli, including
thermal, mechanical and chemical stimuli, are detected and transduced into neural
signals (Sherrington 1906). Acute pain resulting from noxious stimuli that causes, or
has the potential to cause, actual tissue damage can be considered to be an adaptive
sensation, in that it can elicit reflex withdrawal responses, thus removing the tissue
from the noxious stimuli, while the associated unpleasant sensation is instrumental in
learning to avoid potentially harmful situations (Latremoliere & Woolf 2009, Scholz
& Woolf 2002).
Chronic pain is defined by The British Pain Society as “continuous, long-term pain of
more than 12 weeks or after the time that healing would have been thought to have
occurred in pain after trauma or surgery” (British Pain Society 2013). Chronic pain
can be broadly divided into inflammatory pain, which results from tissue injury or
inflammation, and neuropathic pain, which arises following injury to the peripheral
and/or central nervous system. Both inflammatory and neuropathic pain features the
characteristic symptoms of spontaneous pain, hyperalgesia, where responses to
noxious stimuli are exaggerated and allodynia, where painful sensations result from
normally innocuous stimuli such as light touch (figure 1.1). Following tissue injury,
these symptoms can play an adaptive role, in that they can evoke behaviours that will
protect the site of injury and aid healing by preventing further harm and/or infection.
However, these advantageous properties are lost if symptoms persist after injured
1
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tissue has healed, which can result in detrimental consequences for patients quality of
life (Basbaum et al. 2009, Latremoliere & Woolf 2009, Scholz & Woolf 2002,
Torsney & Fleetwood-Walker 2012).
A 2003 survey of over 46,000 adults, from 15 European countries and Israel, found
that 19% of responders suffered from chronic pain, with the average duration of
chronic pain being 7 years (Breivik et al. 2006). Furthermore, 64% of chronic pain
suffers described the treatment of their pain as inadequate at times. In addition to
these consequences on patients quality of life, chronic pain imposes a substantial
financial burden upon society, with the UK costs for back pain in 1998 being
estimated at £6.65 billion (Maniadakis & Gray 2000), while a more recent study has
estimated the back pain costs to Germany at e 48.96 billion (Wenig et al. 2009).
Many analgesics that are currently used for the treatment of chronic pain lack
efficacy, exhibit undesirable side effects or have the potential for abuse, therefore one
of the key challenges in pain research is the development of new efficacious drugs
that lack these disadvantages (Scholz & Woolf 2002, Woolf 2010).
This chapter will provide an overview of the neurobiology of pain perception and the
mechanisms underlying chronic pain. This will include describing the peripheral and
central organisation of the somatosensory nervous system, the changes that occur
within peripheral (‘peripheral sensitisation’) and central (‘central sensitisation’)
sensory circuits following injury, that can give rise to chronic pain, with a particular
emphasis on central sensitisation. The main focus of this chapter will be the
involvement of lamina I neurokinin 1 receptor expressing (NK1R+) projection
neurons in central sensitisation mechanisms and their crucial role in chronic pain
conditions. This will provide the background information for the aims of this thesis,
which are detailed at the end of this chapter.



















Figure 1.1: Perception of sensory stimuli. Under normal conditions innocuous stimuli are
perceived as touch, while noxious stimuli give rise to the unpleasant sensation of pain.
However, chronic pain conditions, which result from injury, are characterised by the
symptoms of allodynia (touch-evoked pain), hyperalgesia (exaggerated pain) and
spontaneous pain.
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1.2 Primary afferent neurons
Primary sensory neurons of the somatosensory nervous system detect, transduce and
transmit sensory information from the peripheral and visceral tissues to the dorsal
horn of the spinal cord. The cell bodies of primary afferents that innervate the body
are found within the dorsal root ganglia (DRG), while those innervating the face are
contained within the trigeminal ganglia (TG). Primary sensory neurons are known as
pseudo-unipolar neurons, in that the axons emerge from the DRG and bifurcate to
form a peripheral branch that innervates tissue and viscera and a central branch
(dorsal root) which forms synapses with second order neurons within the dorsal horn
(Basbaum et al. 2009, Smith & Lewin 2009). Synaptic transmission between the
primary afferents and dorsal horn neurons is excitatory. The excitatory
neurotransmitter glutamate, is released from the central terminals of primary sensory
neurons and acts upon postsynaptic ionotropic (AMPA, NMDA, kainate) and
metabotropic (mGluR) glutamate receptors present on second order neurons (Larsson
2009, Larsson & Broman 2011, Latremoliere & Woolf 2009, Liu & Salter 2010). The
primary afferent neurons are divided into three groups, based upon anatomical and
functional properties (table 1.1), Aβ-fibres, Aδ-fibres and C-fibres and these can be
further subdivided into nociceptors or non-nociceptors (Smith & Lewin 2009).
Furthermore, Aβ-, Aδ- and C-fibres are known to display distinct termination
patterns in the dorsal horn of the spinal cord (Todd 2010) (figure 1.2).
Fibre Myelination Diameter (µm) Conduction velocity (m/s)
Aβ myelinated >10 5.5 – 8.8
Aδ myelinated 2 – 6 1.6 – 5.5
C unmyelinated 0.4 – 1.2 0.5 – 0.9
Table 1.1: Characteristics of primary afferent fibres. Diameters taken from Millan 1999.
Conduction velocity values, recorded in juvenille rats, taken from Nakatsuka et al. 2000
1.2.1 Aβ-fibres
Aβ-fibres are thick diameter, heavily myelinated fibres and as such display the fastest
conduction velocity of the primary afferent fibres (5.5–8.8m/s) (Nakatsuka et al.
2000). The peripheral terminals of Aβ-fibres are associated with specialised sensory
complexes such as Merkel’s discs or with hair follicles (Smith & Lewin 2009). Most
Aβ-fibres convey low-threshold innocuous stimuli such as brush and light touch,
although there is evidence that some Aβ-fibres may be involved in the transmission of
noxious information (Djouhri & Lawson 2004). The central terminals of Aβ-fibres
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are predominantly found in lamina IIi-V in the dorsal horn of the spinal cord (Todd
2010) (figure 1.2).
1.2.2 Aδ-fibres
Aδ-fibres are thinly myelinated, medium diameter fibres with conduction velocities
ranging between 1.6–5.5m/s (Nakatsuka et al. 2000). While these fibres are
myelinated, they terminate in the skin as free nerve endings, following the loss of
their myelin sheath (Smith & Lewin 2009). The majority of Aδ-fibres are classified as
nociceptors and respond to intense (high-threshold) mechanical, thermal and
chemical stimuli. A subset of Aδ-fibres transmit non-nociceptive information
resulting from the slow movement of hair and are termed D-hair afferents (Lewin &
Moshourab 2004). Aδ-fibre nociceptors primarily terminate in the lamina I region of
the dorsal horn, while non-nociceptive D-hair afferents terminate in lamina IIi/III
(Todd 2010) (figure 1.2).
1.2.3 C-fibres
C-fibres are small diameter, unmyelinated fibres and as such display the slowest
conduction velocity of the primary sensory afferents (0.5–0.9m/s) (Nakatsuka et al.
2000). The peripheral branch of C-fibres terminate in the skin as free nerve endings
(Smith & Lewin 2009). As with Aδ-fibres, the majority of C-fibres can be categorised
as nociceptors, on the basis that they are activated by intense (high-threshold) thermal,
mechanical or chemical stimuli. C-fibres can respond to a single stimuli, e.g. heat
only, or to multiple stimuli, with the latter being termed polymodal, a classification to
which the majority of C-fibres fall into (Basbaum et al. 2009). It should be recognised
that not all C-fibres are nociceptors. A group of unmyelinated low threshold
mechanoreceptors (C-LTMRs) have been shown to mediate pleasant touch (Löken
et al. 2009, Olausson et al. 2008), while C-LTMRs which express the vesicular
glutamate transporter 3 (VGLUT3) may play a role in mediating mechanical allodynia
in inflammatory and neuropathic pain conditions (Seal et al. 2009). Some C-fibres are
also known to response to innocuous thermal stimuli only (Hunt & Mantyh 2001).
C-fibres can also be classified on a neurochemical basis into peptidergic and
non-peptidergic C-fibres. Peptidergic C-fibres contain the peptides, substance P (SP)
and calcitonin gene related peptide (CGRP), while non-peptidergic neurons can be
identified by their ability to bind isolectin-B4 (IB4) (Basbaum et al. 2009, Woolf &
CHAPTER 1: GENERAL INTRODUCTION 6
Ma 2007). The central terminals of C-fibres are largely restricted to lamina I/II, with
peptidergic C-fibres terminating in lamina I/IIo and most non-peptidergic in lamina II
(Todd 2010) (figure 1.2).
1.3 Transduction of sensory information by primary
afferent fibres
A plethora of ion channels and receptors, which are expressed on primary afferent
fibres, are involved in the peripheral transduction of sensory information and the
generation of action potentials (Hu, Milenkovic & Lewin 2006, Smith & Lewin 2009,
Woolf & Ma 2007). Transduction occurs when stimuli activate ion channels or
receptors present on the peripheral terminals of nociceptors, which drives the influx of
Na+ and Ca2+ through ion channels, leading to depolarisation of the terminals, which
if the depolarisation is of large enough amplitude and duration will result in action
potential firing and propagation along the afferent fibre towards the central nervous
system (CNS).
1.3.1 Transducer receptors / channels
Transduction of thermal stimuli
Perhaps the best known transducer receptor for thermal stimuli is the noxious heat
(>43◦C) / capsaicin sensitive transient receptor potential subtype vanilloid 1
(TRPV1) channel, as first identified by Caterina et al. (1997). The TRPV1 channel is
essential for the detection and transduction of noxious thermal stimuli, in that
knockout mice lacking this channel show deficiencies in their responses to acute
intense heat and fail to develop thermal hypersensitivity in the complete Freund’s
adjuvant (CFA) inflammatory pain model, but display normal thermal hypersensitivity
following nerve injury (Caterina et al. 2000). However, Davis et al. (2000) found that
the responses to acute noxious thermal stimuli were not altered TRPV1 knockout
mice, although they did fail to develop thermal hypersensitivity following
carrageenan hindpaw injection.
Subsequently a number of other transient receptor potential (TRP) channels have been
identified that play a role in the detection of various temperatures including; transient
receptor potential subtype ankyryn 1 (TRPA1) (<17◦C), transient receptor potential
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subtype vanilloid 2 (TRPV2) (>52◦C), transient receptor potential subtype vanilloid 3
(TRPV3) (33-39◦C), transient receptor potential subtype vanilloid 4 (TRPV4)
(27-34◦C) and transient receptor potential subtype melastatin 8 (TRPM8) (8-28◦C)
(Wu et al. 2010).
Transduction of mechanical stimuli
The precise channel(s) responsible for the transduction of mechanical stimuli is
currently not clear (Hu, Milenkovic & Lewin 2006, Woolf & Ma 2007), however a
number of candidates have been suggested including; TRPA1 (Kwan et al. 2006,
2009), TRPV4 (Alessandri-Haber et al. 2006), acid-sensitive ion channels (ASICs)
(Price et al. 2001), the stretch-activated channels, transient receptor potential subtype
canonical 1 (TRPC1) and transient receptor potential subtype canonical 6 (TRPC6)
(Alessandri-Haber et al. 2009) and recently Piezo channels (Coste et al. 2010).
Transduction of chemical stimuli
Chemical stimuli can be detected and transduced by a number of TRP channels
present on the peripheral terminals of nociceptors, including TRPV1 (capsaicin, H+),
TRPA1 (mustard oil, cinnamaldehyde, allicin, wasabi, acrolein, cadmium) and
TRPM8 (menthol, icilin, eucalyptol) (Miura et al. 2013, Wu et al. 2010). Interestingly
TRPA1 can also be activated by formalin and is therefore thought to mediate
nociceptive responses in the formalin pain test (McNamara et al. 2007). ASICs are
also involved in the detection of chemical (H+) stimuli (White et al. 2010).
1.3.2 Voltage-gated sodium channels
Voltage-gated sodium channel (Nav) channels allow the rapid influx of Na+ into
neurons, which drives the depolarising upstroke of action potentials and as such they
play a crucial role in the initiation and propagation of action potentials (Catterall
2000, Catterall et al. 2005). Nav channels are therefore essential for the transmission
of sensory information, by primary sensory neurons, from the periphery to the dorsal
horn of the spinal cord (Gold & Gebhart 2010, Liu & Wood 2011). Nav channels are
heteromultimers, made up of an α-subunit and β-subunits. The larger α-subunit is
essential and sufficient to produce a functional channel, while the smaller auxiliary
β-subunits confer different functional attributes to the channels, such as the
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biophysical properties and channel trafficking and anchoring (Catterall 2000, Catterall
et al. 2005). There are a total of nine different Nav subtypes, named Nav1.1–Nav1.9.
Adult rodent DRG neurons are known to express up to five Nav channel subtypes,
Nav1.1, Nav1.6–Nav1.9 (Dib-Hajj et al. 2009, 2010). Nav1.3 is embryonically
expressed in DRG neurons, but undetectable in the naı̈ve adult (Waxman et al. 1994).
The expression of Nav1.7–Nav1.9 is largely restricted to the peripheral nervous
system. Nav1.8 is widely considered to be predominantly restricted to C-fibre
nociceptors (Abrahamsen et al. 2008, Akopian et al. 1996, Amaya et al. 2000,
Novakovic et al. 1998), however recent evidence suggests that there is also a large
population of Nav1.8-expressing A-fibres, that are likely to include myelinated low
threshold mechanoreceptors (Shields et al. 2012).
A number of genetic studies have highlighted the importance of Nav channels in pain.
Loss of function mutations in the SCN9A gene, which encodes Nav1.7, are known to
result in congenital insensitivity to pain in humans (Ahmad et al. 2007, Cox et al.
2006, Drenth & Waxman 2007), while gain of function mutations are known to
underly the painful conditions; primary erythermalgia and paroxysmal extreme pain
disorder (Drenth & Waxman 2007, Fertleman et al. 2006, Yang et al. 2004).
Furthermore, nociceptor-specific Nav1.7 knockout mice show a reduction in
sensitivity towards acute noxious mechanical and noxious thermal stimuli and fail to
develop hypersensitivity in inflammatory pain models (Nassar et al. 2004). Similarly,
Nav1.8 global knockout mice display altered thresholds to noxious mechanical and
noxious thermal stimuli and the development of inflammatory pain hypersensitivity is
delayed (Akopian et al. 1999). Nav1.9 global knockout mice, while exhibiting normal
responses to acute noxious mechanical or noxious thermal stimuli, show deficiencies
in the development of thermal, but not mechanical, hypersensitivity in inflammatory
pain models. (Amaya et al. 2006, Priest et al. 2005). However, the development of
neuropathic pain hypersensitivity in these Nav1.9 knockout mice is no different from
controls.
1.4 Peripheral sensitisation
In inflammatory pain, tissue injury or inflammation can result in an increase in the
excitability of the peripheral endings of primary afferent fibres, with this
hypersensitivity being termed peripheral sensitisation (Latremoliere & Woolf 2009,
Woolf & Ma 2007). Peripheral sensitisation is driven by the release of a number of
inflammatory mediators from damaged tissue and/or immune cells, including;
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bradykinin, prostaglandins, adenosine triphosphate (ATP), 5-hydroxytryptamine
(5-HT), tumor necrosis factor-α (TNF-α), nerve growth factor (NGF), H+,
interleukin-1β (IL-1β), interleukin-6 (IL-6) and proinflammatory cytokines (Gold &
Gebhart 2010, Nicol & Vasko 2007, Oh et al. 2001, Sommer & Kress 2004, Stein
et al. 2009, Woolf & Ma 2007). These mediators act on their corresponding receptors,
that are expressed on primary afferents, to directly activate or modulate the activity of
ion-channels and receptors that play a crucial role in the transduction of nociceptive
signals (Basbaum et al. 2009, Bhave & Gereau 2004, Binshtok et al. 2008, Cheng &
Ji 2008, Hucho & Levine 2007, Nicol & Vasko 2007). These changes can occur
relatively fast, with timescales of minutes, through the activation of intracellular
cascades, including protein kinase A (PKA), protein kinase C (PKC), extracellular
signal-regulated kinase (ERK) and p38, which in particular can sensitise Nav and
TRP channels via their phosphorylation (Basbaum et al. 2009, Cheng & Ji 2008, Jin
& Gereau 2006, Varga et al. 2006, Woolf & Ma 2007). These rapid changes allow the
somatosensory nervous system to dynamically respond to injury. Longer-term
changes in excitability can be driven by changes in gene expression, which can
increase the expression of key transducers, such as TRP and Nav channels and of
pronociceptive neuropeptides, such as SP (Basbaum et al. 2009, Ji et al. 2002, Woolf
& Ma 2007). Ultimately these changes act to increase the excitability of the primary
afferent fibres through reducing activation thresholds, increasing spontaneous activity
and enhancing evoked responses. This increase in excitability and spontaneous
activity in primary afferent fibres is thought to be a crucial driver of central
sensitisation. Peripheral sensitisation is thought to underlie thermal hyperalgesia and
hypersensitivity in the zone of injured tissue (primary hyperalgesia), with central
sensitisation being largely responsible for mechanical hypersensitivity and
hypersensitivity in uninjured tissue surrounding the zone of injured tissue (secondary
hyperalgesia) (Lewin et al. 2004).
1.5 Dorsal horn organisation
The dorsal horn of the spinal cord has been subdivided into a number of cell layers,
denoted lamina I through to VI, with laminae VII to X comprising the ventral horn
(Rexed 1952) (figure 1.2). The dorsal horn is broadly divided into the superficial
laminae, which is comprised of laminae I and II and the deep lamina, containing
laminae III to VI.
The superficial lamina predominantly receives input from nociceptive primary
CHAPTER 1: GENERAL INTRODUCTION 10
afferent Aδ- and C-fibres and as such plays a crucial role in the central processing of
nociceptive information (Todd 2010). Lamina I, alternatively known as the marginal
layer, is composed of populations of interneurons and projection neurons. The
majority (∼80%) of these lamina I projection neurons express the receptor for SP, the
neurokinin 1 receptor (NK1R) (Al-Khater et al. 2008, Marshall et al. 1996, Spike
et al. 2003, Todd 2010). These lamina I NK1R+ projection neurons play an essential
role in the manifestation of chronic pain (Nichols et al. 1999) and are discussed in
greater depth later in this chapter. Lamina II, which is subdivided into inner (IIi) and
outer (IIo) layers, principally contains excitatory (glutamatergic) and inhibitory
(γ-aminobutyric acid (GABA)ergic and/or glycinergic) interneurons. The termination
of primary afferent input to the superficial dorsal horn shows a distinct pattern (Todd
2010) (figure 1.2). Peptidergic C-fibres terminate largely in lamina I and IIo, while the
majority of non-peptidergic C-fibres target lamina II (Lorenzo et al. 2008), although a
small population of non-peptidergic C-fibres form synapses in lamina I (Saeed &
Ribeiro-da Silva 2012). Aδ-fibre nociceptors predominantly terminate in lamina I
(Light & Perl 1979), whereas a population of peptidergic Aδ-fibres target lamina I
and IIo (Lawson et al. 1997). Aδ- and some Aβ-fibre hair follicle afferents have been
shown to target lamina IIi (Brown et al. 1981, Light & Perl 1979).
The deep dorsal horn contains both interneurons and projection neurons, with
interneurons accounting for the majority of lamina III neurons (Todd 2010). Of the
lamina III inhibitory interneurons, GABA immunoreactive neurons account for
∼40% of all cells (Polgár et al. 2003). While glycine is found in many lamina III
neurons, this is typically in GABAergic neurons and very few inhibitory interneurons
contain glycine only (Polgár et al. 2003, Todd & Sullivan 1990). There is a lack of a
reliable way in which to identify excitatory interneurons (Todd 2010), however many
lamina III, as well as lamina I/II, excitatory interneurons are know to express
vesicular glutamate transporter 2 (VGLUT2) (Maxwell et al. 2007, Todd et al. 2003,
Yasaka et al. 2010). There are also a subgroup of protein kinase Cγ (PKCγ)
expressing excitatory interneurons that are found in lamina III, and also lamina IIi
(Polgár et al. 1999), some of which receive afferent input from myelinated
low-threshold mechano-sensitive fibres (Hughes et al. 2003, Neumann et al. 2008).
The number of projection neurons in the deep dorsal horn, which are found
throughout lamina III-VI, are much less compared to lamina I. Of these projection
neurons there are two subgroups that expresses the NK1R, one of which features large
dendrites, that reach as far as lamina I (Bleazard et al. 1994, Littlewood et al. 1995,
Naim et al. 1997, Sakamoto et al. 1999). These lamina III-IV NK1R+ neurons are
targeted by SP-containing C-fibres (Naim et al. 1997, Sakamoto et al. 1999) and are
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know to be activated by noxious stimuli (Doyle & Hunt 1999, Mantyh et al. 1995,
Polgár et al. 2007). The other subgroup of lamina III-IV NK1R+ neurons, have a
smaller dendritic tree, although their function is unclear as they do not respond to
noxious stimuli (Doyle & Hunt 1999, Mantyh et al. 1995). Torsney & MacDermott
(2006) demonstrated that lamina III NK1R+ neurons predominantly receive
monosynaptic Aβ-fibre input, which likely reflects this population of neurons with
restricted dendritic trees. The deep dorsal horn is largely targeted by both Aβ-fibres,
which transmit information relating to innocuous stimuli and Aδ-fibre hair follicle
afferents (Brown et al. 1981, Light & Perl 1979) (figure 1.2.)



























Figure 1.2: Laminar arrangement of the dorsal horn and the termination pattern of
primary afferent input. Diagram based upon a traverse section from the lumbar (L4)
region of the spinal cord. Adapted from Todd 2010.
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1.6 Lamina I neurokinin 1 receptor expressing spinal cord
projection neurons
Spinal cord projection neurons are concentrated in the lamina I region of the dorsal
horn, with a smaller proportion being found in lamina III-VI (Al-Khater et al. 2008,
Marshall et al. 1996, Spike et al. 2003, Todd 2010, Todd et al. 2000). In lamina II,
projection neurons are scarce. The axons of many projection neurons, including those
in lamina I, cross the midline and ascend to the brain in the contralateral white matter,
where they target areas in the brainstem and thalamus. The pathways formed by the
lamina I projection neurons in particular have been well characterised using both
retrograde (Almarestani et al. 2007, Hylden et al. 1989, Lima & Coimbra 1988, Lima
et al. 1991, Spike et al. 2003, Todd et al. 2000) and anterograde (Bernard et al. 1995,
Gauriau & Bernard 2004, Slugg & Light 1994) tracing techniques. In the lamina I
region of the dorsal horn, projection neurons have been shown to account for ∼5% of
all neurons, of which ∼80% express the NK1R (Al-Khater et al. 2008, Spike et al.
2003, Todd et al. 2000). Most neurons only project contralaterally, but ∼25% have
bilateral projections (Spike et al. 2003, Todd 2010). The majority of lamina I
projection neurons target the parabrachial area (PB) (∼95%, figure 1.3), with smaller
proportions projecting to the periaquducal gray matter (PAG) (∼30%) and thalamus
(<5%), with some neurons targeting multiple sites (Spike et al. 2003, Todd 2010).



















Figure 1.3: Lamina I NK1R+ neuron projections. Lamina I NK1R+ neurons receive
monosynaptic input from both C-fibre and Aδ-fibre nociceptors (Torsney 2011, Torsney &
MacDermott 2006). The axons of many of these neurons cross the midline and project to
the brain in the lateral white matter tracts, where the main targets include the
parabrachial area (PB), periaquducal gray matter (PAG) and thalamus (percentages
shown in figure). The PB projections target areas in the limbic system, such as the
hypothalamus and amygdala and plays a role in mediating the emotional and affective
aspects of pain. The thalamic projections target areas within the ‘pain matrix’, such as
the somatosensory cortex and anterior cingulate cortex and are involved in the
discriminative aspects of pain. There are descending inhibitory and excitatory inputs
from the limbic system that project to the dorsal horn, via the PAG and rostral
ventromedial medulla (RVM), that play an essential role in controlling dorsal horn
excitability. Adapted from Basbaum et al. 2009, D’Mello & Dickenson 2008, Todd 2010,
values from Todd 2010.
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Functional-anatomical studies have demonstrated that lamina I NK1R+ neurons
process nociceptive information, as evidenced by NK1R internalisation in response to
hindpaw capsaicin injection (Mantyh et al. 1995) and c-Fos expression induced by
noxious heat, noxious cold, hindpaw formalin injection, mustard oil (topical or
injection) and sciatic nerve crush injury (Doyle & Hunt 1999, Todd et al. 2002, 2005).
Electrophysiological investigations have shown that lamina I NK1R+ neurons
predominantly receive monosynaptic input from C-fibre nociceptors and to a lesser
extent Aδ-fibres (Ruscheweyh et al. 2004, Torsney 2011, Torsney & MacDermott
2006), which includes heat / capsaicin-sensitive nociceptors (Labrakakis &
MacDermott 2003, Tong & MacDermott 2006). Anatomical studies have shown that
the C-fibre input to these neurons is comprised of peptidergic (Hwang et al. 2003,
Todd et al. 2002) and to a lesser extent non-peptidergic afferents (Saeed & Ribeiro-da
Silva 2012).
Selective ablation of NK1R+ neurons, by intrathecal administration of the cytotoxin,
saporin, conjugated to SP (SP-SAP), which significantly reduces the number of
NK1R+ neurons in lamina I/III (Mantyh et al. 1997), attenuates central sensitisation
(Khasabov et al. 2002, Mantyh et al. 1997) and reduces hyperalgesia and allodynia in
a number of animal models of inflammatory and neuropathic pain (Mantyh et al.
1997, Nichols et al. 1999, Suzuki et al. 2002). However, acute pain responses remain
intact, whereby there are no differences in baseline responses to thermal and
mechanical stimuli and the first phase of the formalin test is unaltered between
control and SP-SAP treated rats (Mantyh et al. 1997, Nichols et al. 1999). These
findings provide compelling evidence that these lamina I NK1R+ neurons play a
unique role in the manifestation of chronic pain.
1.6.1 The neurokinin 1 receptor
The NK1R is a G-protein coupled receptor (GPCR) which, along with the neurokinin
2 and neurokinin 3 receptors, belongs to the family of tachykinin receptors (Łazarczyk
et al. 2007, Maggi 1995). Expression of the NK1R is greatest in the lamina I region of
the dorsal horn (Abbadie et al. 1996, Mantyh et al. 1997). Overall in lamina I the
NK1R is found on ∼45% of all neurons (Todd et al. 1998), this includes both NK1R+
projection neurons (∼5% of all neurons) (Spike et al. 2003) and a population of likely
interneurons (Todd et al. 2005), that display weak NK1R immunoreactivity
(Cheunsuang & Morris 2000). In lamina II, NK1R expression is limited (Abbadie
et al. 1997, Bleazard et al. 1994, Brown et al. 1995), while ∼11% of lamina III and
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∼28% of lamina IV neurons show NK1R immunoreactivity (Todd et al. 1998).
NK1R immunoreactivity has been shown to be increased in the dorsal horn in the
CFA inflammatory pain model (Abbadie et al. 1996), specifically in the lamina I/II
region (Abbadie et al. 1997, Honor et al. 1999), but levels are unchanged following
hindpaw formalin or carrageenan injection (Honor et al. 1999). Nerve injury is also
reported to increase the dorsal horn expression of the NK1R (Abbadie et al. 1996).
Moreover, NK1R mRNA is elevated in the CFA and formalin pain models (McCarson
& Krause 1994, Schäfer et al. 1993). The CFA-induced enhancement of NK1R
expression is not due to the novel expression of NK1Rs in those neurons that do not
express the receptor in control conditions (Abbadie et al. 1997, Honor et al. 1999).
The binding of SP to the NK1R results in receptor internalisation, with NK1R
internalisation having been demonstrated in the dorsal horn following noxious
mechanical, thermal and chemical (capsaicin) stimulation (Abbadie et al. 1997,
Honor et al. 1999, Mantyh et al. 1995, Marvizón et al. 2003). An overview of NK1R
internalisation in the superficial dorsal horn, produced by numerous stimuli, in both
control and chronic pain models, is provided in table 1.2. In control conditions, in the
absence of stimulation, NK1R internalisation is undetectable, while electrical
activation of Aβ-fibres and innocuous stimuli do not cause internalisation (Allen et al.
1999, Honor et al. 1999, Hughes et al. 2007). However, electrical stimulation of Aδ-
or C-fibres and noxious mechanical or thermal stimuli are able to drive internalisation
in the superficial lamina (Abbadie et al. 1997, Allen et al. 1999, Honor et al. 1999).
Notably NK1R internalisation is largely restricted to lamina I, which is unsurprising
given the limited number of NK1R+ neurons in lamina II (Abbadie et al. 1997,
Bleazard et al. 1994, Brown et al. 1995). Internalisation of NK1Rs is significantly
increased in the formalin and carrageenan models, without further stimulation,
although in the carrageenan model this response is small and only detectable 10
minutes following injection, but is not evident 3 hours after injection (Honor et al.
1999). In CFA inflammation, although CFA by itself does not result in NK1R
internalisation in the superficial lamina, the degree of internalisation in response to
noxious mechanical and thermal stimuli is enhanced, while innocuous mechanical
stimuli can novelly drive internalisation (Abbadie et al. 1997, Honor et al. 1999).
Likewise, there is an enhanced response to electrical stimulation of Aδ-fibres
following CFA inflammation, in that there is a greater proportion of neurons
displaying NK1R internalisation (Allen et al. 1999). However, no novel or enhanced
NK1R internalisation is evident in the superficial laminae following electrical
stimulation of Aβ- or C-fibres, respectively, although C-fibre stimulation results in
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Model Stimulus NK1R Reference
Internalisation
Control
no stimulus no 3,4
electrical (Aβ) no 2,4
electrical (Aδ) yes 2
electrical (C) yes 2,4
innocuous mechanical no 1,3
noxious mechanical yes 1,3
noxious thermal yes 1
CFA
no stimulus no 2,3
electrical (Aβ) no 2
electrical (Aδ) increased 2
electrical (C) no change 2
innocuous mechanical increased 1,3
noxious mechanical increased 1,3
noxious thermal increased 1
Carrageenan
no stimulus yes† 3
innocuous mechanical increased 3
noxious mechanical increased 3
Formalin no stimulus yes 3
CFA polyarthritis no stimulus no 3
Nerve transection
no stimulus no 2
electrical (Aβ) no 2
electrical (Aδ) increased 2
electrical (C) no change 2
CCI electrical (Aβ) no 4
SNI electrical (Aβ) no 4
Table 1.2: Comparison of NK1R internalisation in the superficial laminae of the spinal
cord in different chonic pain models. ‘Increased’ and ’no change’ refers to the response
when compared to control. † small degree of internalisation detectable for a short time
following injection. References: 1; Abbadie et al. 1997, 2; Allen et al. 1999, 3; Honor
et al. 1999, 4; Hughes et al. 2007.
increased internalisation in the deep dorsal horn. In a similar manner, sciatic nerve
transection does not alter the response to Aβ- or C-fibre stimulation, while there is an
elevated number of neurons displaying internalisation in response to Aδ-fibre
activation (Allen et al. 1999). Aβ-fibre stimulation in the chronic constriction injury
(CCI) and spared nerve injury (SNI) neuropathic pain models, as in control
conditions, does not result in NK1R internalisation (Hughes et al. 2007).
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1.6.2 Lamina III/IV neurokinin 1 receptor expressing spinal cord
projection neurons
It should also be noted that there is also a population of NK1R+ projection neurons
found in the lamina III/VI region of the dorsal horn. These neurons can be subdivided
into two groups bases on morphological and functional differences.
One subgroup has been shown to have long dorsally directed dendrites that penetrate
the superficial laminae (Bleazard et al. 1994, Littlewood et al. 1995, Naim et al. 1997,
Sakamoto et al. 1999). These neurons are known to target similar sites in the
brainstem and thalamus as the lamina I NK1R+ neurons (Al-Khater et al. 2008,
Al-Khater & Todd 2009, Todd 2010, Todd et al. 2000) and may also project to areas
in the forebrain, indicating possible roles in alertness and motor aspects of pain
(Gauriau & Bernard 2004). Anatomical studies have shown that this subgroup are
targeted by SP-containing C-fibre afferents, mainly onto their distal dendrites in
lamina I/IIo, but also onto their proximal dendrites in lamina IIi/III (Naim et al. 1997,
Sakamoto et al. 1999). However, contacts with non-peptidergic C-fibres (Sakamoto
et al. 1999) and A-fibres (Naim et al. 1998) are limited. There is also evidence that
these lamina III/IV NK1R+ neurons process nociceptive information, in that they
demonstrate NK1R internalisation and ERK phosphorylation in response to noxious
thermal, mechanical and chemical (formalin / capsaicin) stimuli (Mantyh et al. 1995,
Polgár et al. 2007) and increased c-Fos expression in the formalin inflammatory pain
model (Doyle & Hunt 1999).
The second subgroup of lamina III/IV NK1R+ neurons have a more restricted
dendritic arbour and their function is uncertain, given they do not display NK1R
internalisation or c-Fos expression in response to noxious stimuli (Doyle & Hunt
1999, Mantyh et al. 1995).
Electrophysiological studies in spinal cord slices have shown that lamina III/IV
NK1R+ neurons receive minimal input from monosynaptic Aδ- or monosynaptic
C-fibre nociceptors, with the majority of input (70%) arising from monosynaptic
Aβ-fibres (Torsney & MacDermott 2006). However, this lack of monosynaptic input
from Aδ- or C-fibres could reflect that the lamina III/IV NK1R+ neurons that Torsney
& MacDermott (2006) recorded from belonged to the subgroup of neurons that have
restricted dendritic arbours. Furthermore, the authors suggest that the methods used to
prepare spinal cord slices for these investigations may have resulted in the loss of
afferent input to the neurons and/or a reduction in the dendritic tree, which could also
account for the lack of monosynaptic Aδ- or C-fibre input to these lamina III/IV
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NK1R+ neurons.
1.7 Central sensitisation
Central sensitisation is a process whereby plasticity in the processing of sensory
information within nociceptive pathways in the CNS leads to altered processing of
nociceptive information and an enhancement of responses (Latremoliere & Woolf
2009, Woolf 1983). While peripheral sensitisation is thought to underly thermal
hypersensitivity and primary hyperalgesia, central sensitisation is considered
responsible for mediating mechanical hypersensitivity and secondary hyperalgesia
(Lewin et al. 2004). Following tissue injury, novel spontaneous activity in C-fibre
nociceptors drives changes in the dorsal horn of the spinal cord which results in spinal
cord hyperexcitability / central sensitisation (Woolf 1983). This spinal cord
hyperexcitability then enables Aβ- and Aδ-fibres to access nociceptive circuits that
allows them to mediate mechanical allodynia and mechanical hyperalgesia,
respectively (Latremoliere & Woolf 2009, Treede & Magerl 2000). However, it
should be noted that the exact spinal cord circuitry that is involved in this process is
not fully understood.
Central sensitisation was first described in 1983 by Clifford Woolf (Woolf 1983).
Using electrophysiological recordings from rat α-motorneuron efferents to measure
the flexion withdrawal reflex as a proxy of spinal cord nociceptive processing, it was
discovered that repetitive noxious stimulation of the hindpaw, which was sufficient to
cause inflammation, resulted in a long lasting hypersensitivity. This hypersensitivity
following noxious stimulation was characterised by the following; there was an
increase in novel spontaneous firing in the α-motorneurons, an enlargement of
receptive fields and a reduction in activation thresholds, whereby responses could now
be evoked by innocuous stimuli. Three key experiments were performed to confirm
that these changes were due to changes in the central, as opposed to peripheral,
processing of noxious information:
1. Selective electrical activation of Aβ-fibres, which in control conditions was
without effect, was able to evoke responses in the α-motorneurons following
noxious stimulation of the hindpaw.
2. Peripheral nerve block, by application of local anaesthetic (2% xylocaine) to
the injured hindpaw, did not reverse the expansion of the receptive fields.
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3. In the absence of peripheral injury, brief low-frequency electrical stimulation of
C-fibres was sufficient to elicit the changes seen following noxious hindpaw
stimulation.
What these findings elegantly show is that activation of C-fibre nociceptors drives
plasticity in the dorsal horn of the spinal cord that enables low-threshold afferents to
activate nociceptive pathways and enables these pathways to be activated by stimuli
outwith the area of injury (secondary hyperalgesia). Subsequent studies have
provided evidence that the activity of dorsal horn neurons is altered in a similar
manner to the changes seen in α-motorneurons (Dougherty & Willis 1992, Lin et al.
1999, Woolf & King 1990). Interestingly, central sensitisation has also been shown to
occur in higher centres in the rat, such as the amygdala (Neugebauer & Li 2003,
Neugebauer et al. 2003), thalamus (Dostrovsky & Guilbaud 1990) and anterior
cingulate cortex (Wei & Zhuo 2001), while human and rat neuroimaging studies
suggest changes indicative of central sensitisation occur in the prefrontal cortex, PAG,
PB and superior colliculus (Maihöfner et al. 2010, Mohr et al. 2008, Moylan Governo
et al. 2006, Peyron et al. 2000, Shih et al. 2008).
While Woolf (1983) demonstrated that central sensitisation was driven by noxious
thermal stimulation and repetitive electrical activation of C-fibres, subsequent studies
have shown that central sensitisation can also be induced by capsaicin activation of
TRPV1 channels (LaMotte et al. 1991, Lin et al. 1999), or by the injection of mustard
oil (Woolf & King 1990, Woolf & Thompson 1991) or formalin, which both activate
TRPA1 channels (Jordt et al. 2004, McNamara et al. 2007). The key properties of
noxious stimuli that are required for the induction of central sensitisation are that it
must be intense, repeated and sustained (Latremoliere & Woolf 2009). Furthermore,
while actual tissue damage is not essential, the noxious stimulation that follows tissue
damage in most cases will lead to central sensitisation.
The importance of C-fibre activity in driving inflammatory pain hypersensitivity has
been further confirmed by Abrahamsen et al. (2008) using a genetic strategy. The
cre-lox system was used to selectively destroy Nav1.8 expressing neurons, which
includes both C- and A-fibres (Shields et al. 2012). In these mice, there was a loss of
>85% of peripherin and 13% of neurofilament 200 (NF200) expressing neurons
(Abrahamsen et al. 2008), signifying the loss of the majority of C-fibres (Goldstein
et al. 1991) and and some A-fibres (Perry et al. 1991), respectively. These mice failed
to develop thermal or mechanical hypersensitivity in the CFA inflammatory pain
model and did not display thermal hypersensitivity following hindpaw carrageenan or
NGF injections. Furthermore, the second phase of the formalin test was abolished in
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these mice. However, the development of mechanical and thermal hypersensitivity
was unaltered following nerve injury, which demonstrates that Nav1.8 expressing
C-fibres are crucially required for inflammatory, but not neuropathic pain. However,
one cannot rule out potential developmental changes in the circuitry of the dorsal horn
in these animals, given that neonatal destruction of C-fibres is known to delay or
prevent many developmental processes in the dorsal horn (Fitzgerald 2005), which
could contribute to the phenotype of these mice.
1.8 Mechanisms of central sensitisation
Central sensitisation is known to involve two distinct phases, a
transcription-independent early phase and a transcription-dependent late phase
(Latremoliere & Woolf 2009, Woolf & Salter 2000). The early phase is largely driven
by rapid changes in the activity of glutamate receptors and ion channels, via
phosphorylation, while in the late phase altered gene expression can lead to long
lasting changes in the expression of a large number of ion channels and receptors.
Central sensitisation lacks a single underlying mechanism and is instead considered to
be a multifaceted phenomenon where the processing of somatosensory information is
altered (Latremoliere & Woolf 2009). There are a number of disparate processes that
are known to occur in the dorsal horn of the spinal cord that can result in increased
excitability, reduced inhibition or alterations in sensory input, which in turn can give
rise to the symptoms of allodynia, hyperalgesia and spontaneous pain.
One of the key players in central sensitisation is the ionotropic glutamatergic
N-methyl-D-aspartate receptor (NMDAR). Under naı̈ve conditions, NMDARs play a
minimal role in fast excitatory transmission, due to the Mg2+ block at the channel
pore at resting membrane potential (Mayer et al. 1984) (figure 1.4A). However,
repetitive or high-frequency firing of C-fibres, which drives the presynaptic release of
glutamate, SP and CGRP (figure 1.4B), results in a sustained depolarisation of the
membrane which is sufficient to remove the Mg2+ block and leads to slow excitatory
postsynaptic potentials (EPSPs), with a duration of tens of milliseconds. The removal
of the Mg2+ block greatly enhances synaptic transmission and permits the influx of
Ca2+ into the neuron, that can drive a number of intracelluar signalling pathways that
are involved in central sensitisation (Latremoliere & Woolf 2009). One of the first
indicators that NMDARs play a crucial role in central sensitisation was provided by
Woolf & Thompson (1991), who demonstrated that the application of the NMDAR
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antagonists, MK-801 or D-CCP, at concentrations that were without effect on baseline
responses, prevented the induction of and reversed the hyperexcitability associated
with central sensitisation.
SP, which is co-released from peptidergic C-fibre nociceptors along with glutamate
(figure 1.4B), is also known to play a key role in the development of central
sensitisation (Liu & Sandkühler 1997, Ma & Woolf 1995, Willis 2002). The binding
of SP to its corresponding receptor, the NK1R, results in a long-lasting depolarisation
of postsynaptic neurons in the dorsal horn (Henry 1976, Randić & Miletić 1977),
which can act to enhance the temporal summation of C-fibre-evoked responses
(Dougherty & Willis 1991, Xu et al. 1992) and the activation of a number of
intracellular signalling pathways that are important in central sensitisation, such as
PKA, PKC and ERK (figure 1.4C). The involvement of SP–NK1R signalling in
central sensitisation was first described by Ma & Woolf (1995), who demonstrated,
using electrophysiological recordings from α-motorneurons, that intrathecal
application of substance P methy ester (SPME), a NK1R agonist, resulted in central
sensitisation, which manifested as an increase in spontaneous activity, decrease in
mechanical activation thresholds and an enhancement in the response to innocuous
mechanical stimuli. Pre-treatment with the NK1R antagonist, RP67580, prevented the
reduction in mechanical activation threshold and the facilitation of touch-evoked
responses following SPME application, C-fibre stimulation or mustard oil application,
the latter two being known to drive central sensitisation (Woolf 1983, Woolf & King
1990, Woolf & Thompson 1991). Interestingly, once central sensitisation was
established, RP6780 did not reverse it (Ma & Woolf 1995). Further studies have
shown that RP67580 can prevent the long-lasting potentiation of C-fibre evoked field
potentials in the dorsal horn, but is without effect upon established potentiated
responses (Liu & Sandkühler 1997). Therefore, SP can be considered to play a crucial
role in the development, but not maintenance, of central sensitisation.
Other effectors that play an important role in central sensitisation include CGRP,
bradykinin and brain-derived neurotrophic factor (BDNF). CGRP enhances the effects
of SP (Woolf & Wiesenfeld-Hallin 1986) and via its actions upon CGRP1 receptors,
which are expressed on postsynaptic neurons in the dorsal horn, can activate PKA and
PKC (Sun et al. 2003, 2004). PKA, PKC, as well as ERK can also be activated via the
actions of bradykinin (Kohno et al. 2008), which is spinally produced during intense
nociceptive stimulation, acting upon the bradykinin B2 receptor, which is present on
spinal neurons (Chapman & Dickenson 1992, Wang et al. 2005). BDNF acts as both a
synaptic modulator and a neurotrophic factor and is produced by nociceptors, where
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its activity-dependent release into the dorsal horn (Balkowiec & Katz 2000, Zhou &
Rush 1996) can drive central sensitisation through the activation of PKC and ERK
(Kawasaki et al. 2004, Pezet et al. 2002, Slack et al. 2005, 2004, Zhao et al. 2006) and
the facilitation of NMDAR-mediated C-fibre-evoked responses (Kerr et al. 1999),
through its actions upon the tyrosine receptor kinase B (TrkB). Interestingly,
nociceptor-derived BDNF has been shown to regulate inflammatory, but not
neuropathic pain (Zhao et al. 2006). A summary of the intracellular signalling
pathways that are important in central sensitisation is provided in figure 1.4C.
A key driver of the changes that arise during central sensitisation is an increase in
intracellular Ca2+ in postsynaptic neurons. This increase in intracellular Ca2+ occurs
through the entry of Ca2+ into the neuron, predominantly via NMDARs (Latremoliere
& Woolf 2009), but also through Ca2+-permeable
α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs)
(Larsson & Broman 2008, Luo et al. 2008, Vikman et al. 2008) and voltage-gated
calcium channels (VGCCs) (Coderre & Melzack 1992, Woolf & Salter 2000).
Release of Ca2+ from intracellular stores, following the activation of various
metabotropic receptors can also contribute to this rise in intracellular Ca2+ (Guo et al.
2004, Luo et al. 2008). The increase in intracellular Ca2+ results in the activation of a
number of kinases which can act to enhance the efficiency of synaptic transmission.
PKA, PKC and calcium/calmodulin-dependent protein kinase II (CaMKII) act to
phosphorylate AMPARs (Carvalho et al. 2000, Larsson & Broman 2011), while PKA,
PKC as well as the tyrosine kinases, Syc and Fyn phosphorylate NMDARs (Chen &
Roche 2007, Guo et al. 2002, Larsson & Broman 2011). The phosphorylation of
AMPARs and NMDARs acts to enhance synaptic transmission in a number of ways.
Phosphorylation of the carboxyl tail of AMPAR subunits at serine-threonine residues
acts to increase channel conductance and open probability, alter the expression of
AMPAR subunits at the postsynaptic membrane and regulate aspects of long-term
potentiation (LTP) (Larsson & Broman 2011, Lee 2006, Liu & Salter 2010).
Likewise, NMDAR phosphorylation can alter receptor function by modulating
NMDAR-mediated currents, increasing the open time and open probability of the
channel and regulating the trafficking of subunits to the plasma membrane (Larsson &
Broman 2011, Lee 2006, Liu & Salter 2010). PKA, PKC and CaMKII also activate
ERK, through its phosphorylation (figure 1.4C), which can enhance the excitability of
the postsynaptic neurons by reducing inhibitory K+ currents as a result of the
ERK-mediated phosphorylation of voltage-gated potassium channels (Kvs) (Hu,
Carrasquillo, Karim, Jung, Nerbonne, Schwarz & Gereau 2006, Hu & Gereau 2003,
Hu et al. 2003). Furthermore, ERK, PKA and CaMKII can drive the insertion of
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Figure 1.4: Synapse between central terminal of a nociceptor and a lamina I dorsal horn
neuron. A Diagram of a synapse between the central terminal of a nociceptor and a
lamina I dorsal horn neuron under naı̈ve conditions. In this situation the pore of NMDARs
are blocked by Mg2+ (denoted by black dot). B During nociceptive input, the central
terminals of nociceptors release a number of neurotransmitters including; glutamate, that
acts upon AMPARs, NMDARs (with Mg2+ removed due to depolarisation of the
postsynaptic neuron) and mGluRs. Substance P, CGRP and BDNF are also
presynaptically released and bind to NK1, CGRP1 and TrkB receptors, respectively.
Spinally produced bradykinin can also activate bradykinin B2 receptors. C The binding of
these neurotransmitter to their postsynaptic receptors results in the activation of a
number of intracellular signalling pathways which play a key role in central sensitisation.
Adapted from Latremoliere & Woolf 2009.
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1.8.1 Increased excitability in central sensitisation
Synaptic transmission between primary afferent neurons and second-order neurons in
the dorsal horn is excitatory, involving the release of glutamate from the central
terminals of primary afferents, which acts upon ionotropic glutamate receptors
(AMPAR, NMDAR and kainate receptors (KARs)) and a number of mGluRs
(Larsson 2009, Larsson & Broman 2011, Latremoliere & Woolf 2009, Liu & Salter
2010). One of the key mechanisms underlying central sensitisation that occurs in the
early phase is the increase in the activity and expression of postsynaptic AMPARs and
NMDARs, that results from receptor phosphorylation and the insertion of receptors
into the postsynaptic membrane (Ji et al. 2003, Latremoliere & Woolf 2009, Liu &
Salter 2010).
NMDA receptors
NMDARs are tetrameric, non-selective cation-permeable channels that are composed
of two essential GluN1 subunits along with two regulatory GluN2 (GluN2A,
GluN2B, GluN2C or GluN2D) or two GluN3 (GluN3A or GluN3B) subunits
(Nakanishi 1992, Paoletti & Neyton 2007). The subunit composition of NMDARs is
crucial in dictating the functional characteristics of the receptor, such as ligand
affinity, channel conductance and kinetics (Cull-Candy & Leszkiewicz 2004). For
example, the presence of GluN2A or GluN2B subunits results in NMDARs that have
greater sensitivity to Mg2+, than those containing GluN2C or GluN2D subunits
(Kuner & Schoepfer 1996, Monyer et al. 1994).
Anatomical studies have shown that the GluN1 subunit is present throughout the
dorsal horn of the spinal cord. GluN2A is most intensely expressed in laminae III-IV,
with only limited expression in laminae I/II, while the opposite is true for the
expression of GluN2B, where there the expression is high in laminae I/II, but weak in
lamina III-IV (Nagy et al. 2004a). Additional studies show that GluN1 and
GluN2A/B mRNA shows a comparable expression pattern in the dorsal horn,
although mRNA for GluN2C/D was undetectable using these methods (Shibata et al.
1999, Watanabe et al. 1994).
Using a combined electrophysiological / pharmacological approach, it has been
shown that NMDARs that contain GluN2A/B and GluN2C/D subunits are
functionally expressed on lamina I NK1R+ neurons (Tong et al. 2008). In addition,
lamina I NK1R+ neurons express a greater percentage of NMDARs that contain
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GluN2C/D subunits than lamina I neurons lacking the NK1R. Functional expression
of NMDARs that contain GluN2A/B and GluN2C/D subunits has also been shown in
lamina II GABAergic inhibitory interneurons, while lamina II presumed excitatory
interneurons predominantly express receptors containing GluN2A/B subunits
(Shiokawa et al. 2010).
In the CCI neuropathic pain model, the expression of GluN1 and GluN2B, but not
GluN2A, is increased in the dorsal horn ipsilateral to the injury (Wilson et al. 2005).
Western blot analysis shows that CFA inflammation causes the sustained
phosphorylation of GluN2B, but not GluN2A, subunits in the lumbar dorsal horn
(Guo et al. 2002). Carrageenan inflammation causes the phosphorylation of GluN1,
but not GluN2A or GluN2B, subunits, without altering the overall levels of expression
(Caudle et al. 2005).
AMPA receptors
AMPARs play a crucial role in both acute and chronic pain (Dickenson et al. 1997,
Garry & Fleetwood-Walker 2004). AMPARs (along with KARs) are responsible for
mediating fast synaptic transmission between primary afferents and second order
neurons in the dorsal horn, whereby the presynaptic release of glutamate from the
central terminals of primary afferents activates postsynaptic dorsal horn AMPARs,
resulting in fast EPSPs with durations in the order of milliseconds (Yoshimura &
Jessell 1990, Yoshimura & Nishi 1992).
AMPARs are hetromeric or homomeric tetramers that are assembled from a
combination of four subunits, GluA1, GluA2, GluA3 or GluA4 and these subunits can
be modified via RNA editing and alternative splicing (Hollmann & Heinemann 1994,
Seeburg & Hartner 2003). The cation permeability of AMPARs is dependent upon the
subunit composition (Hollmann et al. 1991, Sommer et al. 1990, 1991). In particular
the Ca2+ permeability of AMPARs is regulated by the GluA2 subunit, whereby only
those channels that lack the GluA2 subunit are permeable to Ca2+ (Burnashev et al.
1992, Hollmann et al. 1991).
In the dorsal horn of the spinal cord, all four AMPAR subunits have been detected
(Engelman et al. 1999, Henley et al. 1993, Kerr et al. 1998, Nagy et al. 2004b, Polgár
et al. 2008, Todd et al. 2009, Tölle et al. 1993). Synaptic expression of GluA1 and
GluA2 subunits is widespread throughout the dorsal horn, but with greater
immunoreactivity seen in lamina I/II. Furthermore, most AMPARs contain the GluA2
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subunit (Nagy et al. 2004b, Polgár et al. 2008). GluA3 and GluA4 subunits are
strongly expressed in lamina III-VI, but show weak expression in lamina I/II.
The Ca2+-permeable AMPAR antagonist, synthetic Joro spider toxin (JSTX), has
been shown to attenuate secondary mechanical hyperalgesia and secondary
mechanical allodynia following gastrocnemius incision (Pogatzki et al. 2003) and
first-degree burn injury (Jones & Sorkin 2004), respectively. GluA2 knockout mice,
in which there is an enhancement of Ca2+-permeable AMPARs, show enhanced
hypersensitivity in CFA inflammation and following hindpaw formalin and capsaicin
injection (Hartmann et al. 2004). While GluA1 knockout mice, where
Ca2+-impermeable AMPARs are enhanced, do not show an increase in ERK
phosphorylation, which is considered a marker of central sensitisation (Ji et al. 1999,
Karim et al. 2001), in response to C-fibre stimulation (Hartmann et al. 2004),
indicating that a reduction in Ca2+-permeable AMPARs correlates with a reduction in
measures of spinal cord potentiation. These data indicate that Ca2+-permeable
AMPARs play a key role in central sensitisation.
1.8.2 Disrupted spinal cord inhibition in central sensitisation
There is evidence that altered inhibitory tone in the dorsal horn may play a role in the
development of central sensitisation in inflammatory pain (Müller et al. 2003,
Zeilhofer & Zeilhofer 2008). Nociceptive processing in the dorsal horn of the spinal
cord is known to be influenced by spinal inhibition, in that pharmacologically
mimicking disrupted inhibition in naı̈ve animals, by spinal application of the glycine
receptor (GlyR) antagonist, strychnine, or the GABAA receptor (GABAAR)
antagonist, bicuculline, results in the development of allodynia-like responses
(Sherman & Loomis 1996, Sorkin & Puig 1996, Yaksh 1989). Studies have shown
that following nerve injury there is a significant reduction in levels of
immunoreactivity for GABA (Eaton et al. 1998, Ibuki et al. 1997) and its synthesising
enzyme, glutamic acid decarboxylase (GAD) (Eaton et al. 1998, Moore et al. 2002),
in the dorsal horn of the spinal cord, which may arise due to the death of GABAergic
interneurons (Scholz et al. 2005). However, these findings are disputed by others who
report that there is no loss of dorsal horn neurons following nerve injury (Polgár et al.
2004, 2005) and no change in GABA, vesicular GABA transporter or GABAAR
immunoreactivity (Polgár & Todd 2008). GABAAR expression has also been shown
to be increased in the CCI neuropathic pain model (Moore et al. 2002).
There is also electrophysiological evidence that spinal cord inhibition is reduced in
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chronic pain conditions. GlyR-mediated miniature inhibitory postsynaptic current
(mIPSC) frequency was found to be significantly reduced in the CFA inflammatory
pain model (Müller et al. 2003), while GABAAR-mediated mIPSC frequency is
attenuated and the number of neurons displaying no evoked inhibitory postsynaptic
currents (eIPSCs) is increased in neuropathic pain models (Moore et al. 2002). It is
also reported that inhibitory inputs in the lamina I region of the dorsal horn may
actually become excitatory following nerve injury, whereby downregulation of the
potassium-chloride exporter (KCC2), which normally maintains Cl– homeostasis,
results in a disruption of the anion reversal potential (Eanion), transforming inhibitory
hyperpolarising inputs into excitatory depolarising inputs (Coull et al. 2005, 2003).
This disruption of Eanion has subsequently been shown to be driven by the release of
BDNF from activated spinal microglia (Coull et al. 2005).
1.8.3 Altered sensory input to the spinal cord
Heterosynaptic facilitation of sensory input
Heterosynaptic facilitation, where stimulation of one group of synapses results in the
augmented activity in other unstimulated synapses, normally via the sensitisation of
the whole neuron, is a key component of central sensitisation (Latremoliere & Woolf
2009). Since the discovery of central sensitisation it has been clear that heterosynaptic
facilitation plays a crucial role in this process. Woolf (1983) demonstrated that
repetitive activity in one group of primary afferents (C-fibres) enabled a different
group (Aβ-fibres) to novelly drive nociceptive spinal cord circuits. Furthermore, the
expansion of receptive fields seen following nociceptive stimulation was unaffected
by peripheral administration of the local anaesthetic, xylocaine, indicating that
stimulation of one group of primary afferents drove central changes leading to the
recruitment of a different group of afferents from outwith the area of tissue injury. It
is widely considered that heterosynaptic facilitation plays an essential role in the
development of inflammatory and neuropathic pain hypersensitivity, whereby
repetitive activity in C-fibre nociceptors drives spinal cord hyperexcitability that
enables Aβ- and Aδ-fibre afferents to access circuits by which they mediate allodynia
and hyperalgesia, respectively (Latremoliere & Woolf 2009, Treede & Magerl 2000).
However, while heterosynaptic potentiation is a crucial feature of central
sensitisation, the underlying changes that occur in the circuitry of the dorsal horn are
not well understood.
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Homosynaptic facilitation of sensory input
Another facilitatory mechanism that has been proposed to be involved in central
sensitisation is that of homosynaptic potentiation (Sandkühler 2010), where
stimulation results in the potentiation of only those synapses that are stimulated.
While heterosynaptic facilitatory mechanisms are considered to be responsible for
secondary hyperalgesia and allodynia, homosynaptic potentiation by its very nature
can only be involved in primary hyperalgesia (Latremoliere & Woolf 2009).
One method of altered excitatory input to the dorsal horn that has been proposed is
the homosynaptic facilitation of C-fibre input, which acts to amplify nociceptive
inputs and thus provides a potential mechanism for hyperalgesia. Some authors
consider this potentiation to be analogous to LTP, as is typically involved in learning
and memory in the cortex, since this C-fibre potentiation shares many of the same
characteristics as cortical LTP (Ruscheweyh et al. 2011, Sandkühler 2010). However,
the use of LTP is regarded inaccurate by others, due to unique differences in the
underlying mechanisms, duration and purpose of central sensitisation compared to
cortical LTP (Latremoliere & Woolf 2010).
High-frequency stimulation (HFS) (100Hz) of C-fibres significantly potentiates
C-fibre-evoked field potentials in the superficial dorsal horn, which indicates
summation of largely monosynaptically evoked postsynaptic currents (Liu &
Sandkühler 1997). Interestingly, the induction of this potentiation was found to be
NK1R-dependent, in that application of RP 67580, an NK1R antagonist, prevented
the initiation of potentiation, but did not reverse established potentiation. Further
evidence can be considered to support the view that homosynaptic C-fibre
potentiation may be a feature of central sensitisation. In intact rats, nerve injury
resulting from transection or crush (Zhang et al. 2004, Zhou et al. 2010) and hindpaw
capsaicin or formalin injection (Ikeda et al. 2006) results in a potentiation of
C-fibre-evoked field potentials in the superficial dorsal horn, that is comparable to that
seen following electrical stimulation. While stimulation protocols similar to those
used to induce long-lasting potentiation of C-fibre responses in intact rats and ex vivo
tissue preparations, enhances pain perception in humans (Klein et al. 2004, 2008).
However, these human studies cannot provide direct evidence for homosynaptic
potentiation of C-fibre input, as that can only be obtained by measuring synaptic
strength. Moreover, in these human studies mechanical allodynia in areas outwith the
stimulated zone was reported, which strongly suggests heterosynaptic facilitatory
mechanisms were involved in these responses.
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1.8.4 Non-synaptic mechanisms of central sensitisation
Neuron-glia interactions
In recent years it has become clear that interactions between neurons and glial cells,
namely microglia and astrocytes, in the spinal cord play an important role in the
development and maintenance of central sensitisation in neuropathic and
inflammatory pain.
Microglia In response to tissue or nerve injury, microglia undergo the process of
microgliosis, in which a number of complex changes occur that result in microglia
entering an ‘activated’ state (Ren & Dubner 2010, Taves et al. 2013, Tsuda et al.
2013). The activation of microglia is prominent in neuropathic pain models (Beggs &
Salter 2006, 2007, Calvo & Bennett 2012), with nerve injury being associated with an
increase in the number and density of spinal microglia, driven by proliferation and
migration of microglia (Beggs & Salter 2007, Taves et al. 2013). However, in
inflammatory pain this response is less apparent (Clark et al. 2007, Honore et al.
2000, Lin et al. 2007). Typically the activated state of microglia is determined by a
morphological change in the cell from ramified to amoeboid (Streit et al. 1999).
Microglia activation is driven by the release of neurotransmitters and
neuromodulators, such as glutamate, CGRP, SP, ATP, BDNF and IL-6, from the
presynaptic terminals of primary afferent fibres, which in addition to acting upon
receptors on the postsynaptic terminal also act on receptors present on microglia (Ren
& Dubner 2010). Activated microglia can release a number of mediators that can act
to modulate spinal cord excitability, including BDNF, TNF-α and IL-1β as well as
other proinflammatory cytokines and chemokines (Kavelaars et al. 2011, Kawasaki
et al. 2008, Scholz & Woolf 2007), although the release of these mediators may occur
in the absence of morphological changes (Taves et al. 2013). Notably, administration
of minocycline, a specific microglia inhibitor, can significantly attenuate behavioural
hypersenstivity in neuropathic (Guasti et al. 2009, Osikowicz et al. 2009, Pabreja
et al. 2011, Pu et al. 2013) and inflammatory pain models (Bastos et al. 2013, Li et al.
2010).
One mechanism by which microglial activation can modulate the central processing
of pain that has become apparent in recent years is by altering inhibitory tone in the
dorsal horn in neuropathic pain conditions (Coull et al. 2005, Ferrini & De Koninck
2013). This microgial mediated disinhibition occurs as a result of ATP activation of
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P2X4 receptors expressed on spinal cord microglia, which drives the release of BDNF
from these microglia. This BDNF release, acting via TrkB, downregulates KCC2
activity, which normally maintains Cl– homeostasis, resulting in a disruption of
Eanion. This in turn leads to diminished GABAAR / GlyR mediated inhibition and the
transformation of inhibitory hyperpolarising currents into excitatory depolarising
currents (Coull et al. 2005).
Astrocytes As with microglia, astrocytes in the spinal cord can become activated
following a noxious stimulus, although it should be noted that unlike microglia,
astrocytes are not quiescent under normal conditions and ‘activation’ in this context
refers to a state of enhanced function (Cao & Zhang 2008, Dong & Benveniste 2001,
Watkins & Maier 2003). This activation is typically associated with a morphological
change, whereby astrocytes display a hypertrophied soma with thick processes, in
addition to displaying increased expression of the astrocyte marker, glial fibrillary
acidic protein (GFAP) (Cao & Zhang 2008, Raghavendra et al. 2003, Watkins &
Maier 2003). Astrocytes play a key role in maintaining glutamate homeostasis, in that
they are responsible for the uptake of the majority of extrasynaptic glutamate through
the glutamate transporter-1 (GLT-1) (McMahon & Malcangio 2009, Tanaka et al.
1997), with injury induced downregulation of GLT-1 resulting in a disruption of
glutamate homeostasis (Ren & Dubner 2010). In response to an increase in
intracellular Ca2+, astrocytes can release glutamate and D-serine, which can modulate
central sensitisation via actions on synaptic and extrasynaptic NMDARs, respectively
(McMahon & Malcangio 2009, Ren & Dubner 2010). Activated astrocytes are also
known to release a number of chemokines and cytokines, including IL-1β, IL-6 and
TNF-α (Dong & Benveniste 2001), which are known to play a key role in central
sensitisation (Kawasaki et al. 2008).
Astrocytes are highly connected via gap junctions, therefore increases in intracellular
Ca2+ concentration can lead to signalling throughout the astrocyte network, via a
‘Ca2+ wave’, enabling long-range signalling (McMahon & Malcangio 2009, Wu et al.
2012a). Interestingly, expression of the gap junction protein connexin-43 is increased
in the brainstem following facial nerve injury, indicating greater connectivity between
astrocytes and a possible facilitation of Ca2+ signalling (Rohlmann et al. 1994).
Further evidence that gap junctions play a role in chronic pain hypersensitivity is
provided by the finding that intrathecal administration of carbenoxolone, which acts
to reversibly decouple gap junctions, at a low dose abolished ‘mirror-image’
mechanical allodynia in the contralateral hindpaw in the CCI and sciatic inflammatory
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neuropathy (SIN) models, while a higher dose bilaterally reversed mechanical
allodynia. Carbenoxolone also abolishes thermal hyperalgesia, contralaterally at low
dose and bilaterally at high dose, in the CCI model (Spataro et al. 2004). Similarly,
carbenoxolone has also been shown to attenuate hypersensitivity in the formalin test
(Qin et al. 2006) and in mustard oil-induced hypersensitivity (Chiang et al. 2010).
1.9 Lamina I neurokinin 1 receptor expressing projection
neurons and central sensitisation
Lamina I NK1R+ neurons are essential for the manifestation of inflammatory pain
(Nichols et al. 1999), therefore it is unsurprising that many of the mechanisms of
central sensitisation discussed above have been investigated in the context of these
neurons.
1.9.1 Lamina I neurokinin 1 receptor expressing neurons are at the
origin of a spinal-bulbo-spinal loop
Studies show that lamina I NK1R+ neurons are at the origin of a spinal-bulbo-spinal
loop, that controls excitability in the dorsal horn (Suzuki et al. 2002). Projections
from the PB, which the majority of lamina I NK1R+ neurons target (Spike et al. 2003,
Todd 2010), terminate in brain areas, including the amygdala and hypothalamus, that
are implicated in the emotional and autonomic components of pain (Bernard et al.
1993, Bernard & Bandler 1998, Bester et al. 1997, Fulwiler & Saper 1984, Hunt
2000). Projections from the hypothalamus and amygdala, target the PAG, which in
turn projects to the rostral ventromedial medulla (RVM), with both excitatory and
inhibitory monoaminergic pathways descending from the RVM to the spinal cord,
thus closing the loop (Bernard & Bandler 1998, D’Mello & Dickenson 2008,
Heinricher et al. 2009, Hunt 2000, Urban & Gebhart 1999) (figure 1.3). Importantly,
descending serotoninergic axons have been shown to preferentially innervate lamina I
NK1R+ neurons (Polgár et al. 2002).
Disruption of the descending component of the loop provides evidence that this
spinal-bulbo-spinal loop is driven by activity in lamina I NK1R+ neurons and plays a
key role in controlling spinal cord excitability. The 5-HT3 receptor (5-HT3R) is
expressed in the superficial lamina of the dorsal horn (Laporte et al. 1996) and the
actions of 5-HT upon this receptor are known to mediate pronociceptive responses
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(Ali et al. 1996, Green et al. 2000, Zeitz et al. 2002). Blocking this serotonergic
signalling by intrathecal administration of the selective 5-HT3R antagonist,
ondansetron, attenuates the second phase of the formalin test and mechanical and
thermal hypersensitivity in the CFA inflammatory pain model (Suzuki et al. 2002).
Interestingly, the reduction in hypersensitivity seen during ondansetron treatment is
comparable to that following ablation of superficial NK1R+ neurons (SP-SAP
treatment) and ondansetron is without effect in SP-SAP-treated rats, suggesting that
these effects are mediated via NK1R+ neurons. Additional evidence shows that
depletion of endogenous 5-HT in the spinal cord, by injection of the selective 5-HT
neurotoxin, 5,7di-hydroxytryptamine, significantly reduces mechanical and cold
allodynia in rats following nerve injury (Rahman et al. 2006), further detailing the
importance of descending serotonergic input in controlling spinal cord excitability.
Electrophysiological data shows that in SP-SAP treated rats, wide dynamic range
(WDR) neurons in the deep dorsal horn display significantly reduced receptive fields,
less firing in the second phase of the formalin test and attenuated ‘wind-up’ (Suzuki
et al. 2002), where repetitive C-fibre stimulation results in enhanced action-potential
firing. While ondansetron was without effect on receptive fields and wind-up, it was
shown to reduce the number of spikes in response to mechanical and thermal
stimulation in control rats (Bee & Dickenson 2008, Suzuki et al. 2002), but not
SP-SAP treated rats (Suzuki et al. 2002), suggesting the descending serotonergic
pathways are not active in the absence of NK1R+ projection neurons. Ondansetron
also reduced the second phase of the formalin test in control rats in a manner that
mimicked the effects of SP-SAP treatment (Suzuki et al. 2002). Furthermore, spinal
depletion of 5-HT reduces the number of action potentials in response to thermal and
mechanical stimulation and decreases the receptive field sizes in WDR neurons
(Rahman et al. 2006). Similarly, ablation of RVM neurons, which are a component of
these descending pathways, reduces the number of spikes evoked by thermal,
mechanical and electrical C-fibre stimulation in both control and nerve injured rats
and attenuates wind-up and after-discharge in control rats (Bee & Dickenson 2008).
Data from human neuroimaging studies provides additional evidence that activity in
brain areas known to be involved in descending inhibitory pathways correlates with a
modulation of pain (Tracey 2008, 2010). Tracey et al. (2002) demonstrated, using
functional magnetic resonance imaging (fMRI) in health human participants, that
when subjects were instructed to either focus on or distract themselves from a noxious
thermal stimuli, pain intensity ratings were significantly reduced during ‘distraction’,
with this condition also exhibiting increased PAG activation. Furthermore, the
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magnitude of the increase in this PAG activation was predictive of the change in the
perception of pain. This finding has been supported by further evidence that when
subjects are distracted, by performing the Stroop-test, they report lower pain scores
following a noxious insult, which correlated with greater PAG activation in fMRI
measurements (Valet et al. 2004).
1.9.2 Increased excitability in lamina I neurokinin 1 receptor
expressing neurons
As discussed previously in this chapter, enhanced activity and expression of
postsynaptic AMPARs and NMDARs plays a significant role in central sensitisation
(Ji et al. 2003, Latremoliere & Woolf 2009, Liu & Salter 2010). This altered AMPAR
and NMDAR expression / activity has been described in lamina I NK1R+ neurons.
The AMPAR subtypes that are responsible for mediating synaptic transmission
between primary afferent fibres and lamina I NK1R+ neurons include a mixture of
those that contain or lack the GluA2 subunit, as revealed by calculating the
rectification index of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
(AMPA) evoked excitatory postsynaptic currents (eEPSCs) and the ability of the
Ca2+-permeable AMPAR antagonist, JSTX, to reduce the amplitude of
AMPA-mediated eEPSCs (Tong & MacDermott 2006). Anatomical studies using the
kainate-induced cobalt uptake technique have also indicated the presence of
Ca2+-permeable AMPARs in lamina I NK1R+ neurons (Engelman et al. 1999).
Interestingly, in CFA inflammation, AMPA eEPSCs in lamina I NK1R+ neurons
showed greater inward rectification and enhanced sensitivity to
1-naphthylacetylspermine (a JSTX analogue), indicating an increase in the
contribution of Ca2+-permeable AMPARs (Vikman et al. 2008). As Ca2+-permeable
AMPARs play a key role in central sensitisation (Hartmann et al. 2004, Jones &
Sorkin 2004, Pogatzki et al. 2003), this increase in Ca2+-permeable AMPARs seen in
lamina I NK1R+ neurons in inflammation (Vikman et al. 2008) could play a role in
the development of inflammatory pain hypersensitivity.
Using a combined electrophysiological / pharmacological approach, it has been
shown that NMDARs that contain GluN2A/B and GluN2C/D subunits are
functionally expressed on lamina I NK1R+ neurons (Tong et al. 2008). In addition,
lamina I NK1R+ neurons express a greater percentage of NMDARs that contain
GluN2C/D subunits than lamina I neurons lacking the NK1R. Application of the
non-competitive GluN2B antagonist, CP-101,606, reduces the peak amplitude of
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NMDAR-mediated eEPSCs in lamina I NK1R+ neurons, with this antagonist effect
being significantly attenuated in CFA inflammation (Vikman et al. 2008).
Furthermore, CFA significantly reduces the rectification index of NMDAR-mediated
eEPSCs, suggesting the N-methyl-D-aspartate (NMDA) current in inflammation
displays a reduction in Mg2+ sensitivity. It is suggested that this reduced Mg2+
sensitivity could result in enhanced NMDAR-mediated synaptic transmission in the
dorsal horn during inflammatory pain and play a role in central sensitisation (Vikman
et al. 2008).
1.9.3 Lamina I neurokinin 1 receptor expressing neurons and disrupted
inhibition
The effect of disrupted inhibition, which has been implicated in chronic pain
hypersensitivity (Coull et al. 2005, 2003, Müller et al. 2003, Sherman & Loomis
1996, Sorkin & Puig 1996, Yaksh 1989, Zeilhofer & Zeilhofer 2008), upon the
synaptic input to lamina I NK1R+ neurons has been investigated. Pharmacologically
mimicking disrupted inhibition in an ex vivo spinal cord slice preparation, by
application of the GABAAR and GlyR antagonists, bicuculline and strychnine,
respectively, unmasks novel and enhanced polysynaptic Aβ- and polysynaptic
Aδ-fibre input to these neurons (Torsney & MacDermott 2006). These novel and
enhanced inputs are NMDAR-dependent, in that application of the NMDAR
antagonist, D-(-)-2-Amino-5-phosphonopentanoic acid (D-APV), blocks the
appearance of novel A-fibre inputs and the enhancement of A-fibre eEPSCs during
disinhibition. Although it should be noted that while these polysynaptic inputs are
NMDAR-dependent, they are blocked by the AMPAR antagonist,
2,3-dihydroxy-6-nitro-7-sulfonyl-benzo[f]quinoxaline (NBQX), indicating they are
not driven solely by NMDARs. The authors propose that in control conditions some
or all of the excitatory interneurons that mediate this polysynaptic input receive
inhibitory input, which could comprise tonic and/or afferent-driven inhibition
(Narikawa et al. 2000). This inhibition is proposed to hyperpolarise these
interneurons, preventing the removal of the Mg2+ block from NMDARs and given
that this pathway is NMDAR-dependent this prevents the transmission of novel
A-fibre input via these excitatory interneurons to lamina I NK1R+ neurons. It is
proposed that in chronic pain states these novel polysynaptic inputs would be revealed
as a result of reduced inhibition (Müller et al. 2003, Zeilhofer & Zeilhofer 2008) or
inhibition that has become excitatory (Coull et al. 2005, 2003). These novel
polysynaptic A-fibre inputs, which are largely polysynaptic Aβ-fibre inputs, that are
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unmasked during disinhibition could provide a pathway that allows innocuous
information, which is conveyed by Aβ-fibres, to drive ‘nociceptive-specific’ neurons
in the dorsal horn and thus presents a potential mechanism by which allodynia is
mediated. Furthermore, the enhanced polysynaptic Aδ-fibre input may provide
additional high-threshold input and therefore could contribute to hyperalgesia.
However, further research suggests that the unveiling of this polysynaptic Aβ-fibre
input may not be relevant in the case of inflammatory pain (Torsney 2011), but may
be more relevant for neuropathic pain (discussed below).
In vivo single unit recordings from lamina I projection neurons in the rat show that
normally these neurons only respond to noxious pinch. However, following
peripheral nerve injury these neurons now respond to innocuous touch and brush
stimuli and show enhanced responses to pinch (Keller et al. 2007). Interestingly, these
responses could be mimicked in naı̈ve rats by the application of bicuculline, which
suggests that the novel and enhanced A-fibre inputs to lamina I NK1R+ neurons that
are revealed when local spinal cord inhibition is diminished (Torsney & MacDermott
2006) could play a role in the mediation of mechanical allodynia in neuropathic pain.
1.9.4 Heterosynaptic facilitation of synaptic input to lamina I
neurokinin 1 receptor expressing neurons
Heterosynaptic facilitation, which is a crucial component of central sensitisation
(Latremoliere & Woolf 2009), of the synaptic input to lamina I NK1R+ neurons has
been demonstrated in the CFA inflammatory pain model, using patch-clamp
electrophysiology in an ex vivo spinal cord preparation (Torsney 2011). In control
tissue these neurons predominantly receive monosynaptic C-fibre input, with a
smaller proportion receiving monosynaptic Aδ-fibre input. However, following CFA
inflammation there is a significant change in the relative distribution of the type of
primary afferent input received and specifically the incidence of monosynaptic
Aδ-fibre input is increased 2-fold, without any change in the incidence of
monosynaptic C-fibre input. Moreover, a proportion of control neurons, which lacked
conventional monosynaptic Aδ-fibre input, received inputs from monosynaptic
Aδ-fibres that formed ‘silent’ (pure-NMDA) synapses. In addition, the amplitude of
monosynaptic Aδ-fibre eEPSCs was found to be significantly potentiated in a subset
of neurons that received monosynaptic Aδ-fibre only input.
This increase in the incidence of and potentiation of monosynaptic Aδ-fibre input to
lamina I NK1R+ neurons is interesting for a number of reasons. Punctate mechanical
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hyperalgesia is known to be mediated by a subset of capsaicin-insensitive Aδ-fibres
(Fuchs et al. 2000, Magerl et al. 2001, Ziegler et al. 1999), while secondary, and
possibly also primary, mechanical hyperalgesia is recognised to be centrally mediated
(Klede et al. 2003, Klein et al. 2008, Lewin et al. 2004). As such, the novel
monosynaptic Aδ-fibre inputs that are revealed during inflammation could mediate
mechanical hyperalgesia, with the unmasking of these inputs, possibly through the
‘activation’ of Aδ-fibre silent synapses, forming part of the central process by which
mechanical hyperalgesia is established.
1.9.5 Homosynaptic facilitation of synaptic input to lamina I neurokinin
1 receptor expressing neurons
Several studies by Jürgen Sankühler’s group have investigated homosynaptic
potentiation of the monosynaptic C-fibre input to lamina I SP-responsive,
retrogradely labelled projection neurons, which are presumably NK1R+ projection
neurons. Electrical HFS (100Hz) and low-frequency stimulation (LFS) (2Hz) of
monosynaptic C-fibre input to lamina I projection neurons induces long-lasting
potentiation of C-fibre eEPSCs in these neurons (Ikeda et al. 2003, 2006). However,
this effect is dependent on which subpopulation, defined on the basis of the region to
which they project, of neurons involved. Specifically, those neurons that project to the
PB are potentiated by HFS but not LFS, while those projecting to the PAG are
potentiated by LFS, but not HFS. Furthermore, this potentiation is a Ca2+ dependent
process, which requires the co-activation of NK1Rs, NMDARs and T-type VGCCs.
The potentiation of C-fibre eEPSCs appears to be specific to lamina I projection
neurons, as these HFS and LFS protocols do not induce potentiation in unidentified
dorsal horn neurons. It is known that C-fibre nociceptors mediate inflammatory pain
hypersensitivity (Abrahamsen et al. 2008), therefore this homosynaptic potentiation
of the C-fibre input to lamina I projection neurons, which are known to be essential
for the manifestation of inflammatory pain (Nichols et al. 1999), could be involved in
the development of inflammatory pain hypersensitivity.
1.10 Summary
Inflammatory pain is a debilitating condition, which imposes substantial human and
financial costs upon society (Basbaum et al. 2009, Breivik et al. 2006, Latremoliere &
Woolf 2009, Maniadakis & Gray 2000, Scholz & Woolf 2002, Torsney &
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Fleetwood-Walker 2012, Wenig et al. 2009). There is a pressing need for more
efficacious inflammatory pain treatments, that are free from the undesirable side
effects which beset many current analgesics (Scholz & Woolf 2002, Woolf 2010).
The characteristic symptoms of inflammatory pain; hyperalgesia, allodynia and
spontaneous pain, arise largely as a result of altered central processing of nociceptive
information, driven by central sensitisation (Latremoliere & Woolf 2009). However,
the neuronal plasticity that underlies these changes is not fully understood. Lamina I
NK1R+ neurons are known to be essential for the manifestation of inflammatory pain
(Nichols et al. 1999) and there is compelling evidence that the primary afferent input
to and the postsynaptic responses of these neurons are altered in inflammatory pain
(Ikeda et al. 2006, Torsney 2011, Torsney & MacDermott 2006), which could be
relevant for inflammatory pain hypersensitivity. Gaining a greater understanding of
spinal cord inflammatory pain plasticity is therefore crucial to further our knowledge
of the underlying mechanisms of this condition and to inform the development of
novel inflammatory pain treatment strategies.
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1.11 Thesis aims and hypotheses
The experiments presented in this thesis were designed to investigate spinal cord
plasticity in inflammatory pain. Given recent evidence that synaptic input to lamina I
NK1R+ neurons, which are crucial for the manifestation of inflammatory pain
(Nichols et al. 1999), is altered following inflammation (Torsney 2011) or when the
monosynaptic C-fibre input to these neurons is electrically stimulated to mimic the
firing pattern seen during inflammation (Ikeda et al. 2006), both
inflammation-induced changes in and pharmacological modulation of the primary
afferent input to these neurons in the CFA inflammatory pain model were investigated
to address the following aims and hypotheses.
Aims
• Chapter 2: Assess the impact of inflammatory pain on the type of primary
afferent input received by and the spontaneous excitatory drive to lamina I
NK1R+ neurons.
• Chapter 3: Investigate the ability of chemerin, an agonist of the novel
inflammatory pain target, the chemerin receptor 23 (ChemR23), to modulate
primary afferent input to lamina I NK1R+ neurons.
• Chapter 4: Evaluate inflammation-induced changes in the phenomenon of
activity-dependent slowing (ADS) in primary afferent input to lamina I NK1R+
neurons.
Hypotheses
• Chapter 2: CFA inflammation will alter the relative distribution of the type of
primary afferent input that lamina I NK1R+ neurons receive.
• Chapter 3: The ChemR23 agonist, chemerin, will attenuate the capsaicin
potentiation of synaptic input to lamina I NK1R+ neurons and monosynaptic
C-fibre input to a subset of these neurons in CFA inflammation.
• Chapter 4: ADS in isolated dorsal roots and in the monosynaptic C-fibre input
to lamina I NK1R+ neurons will be altered in CFA inflammation, which could
have functional consequences for the activity of these neurons.
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The individual aims and hypotheses are discussed in greater detail in the
corresponding chapters.
Chapter 2
Synaptic input to lamina I neurokinin 1
receptor expressing neurons in
inflammatory pain
2.1 Introduction
2.1.1 Effects of inflammation on primary afferent fibres
The Aβ-, Aδ- and C-fibre primary afferent components of dorsal roots can be defined
based on activation threshold and conduction velocity (Nakatsuka et al. 2000, 1999,
Park et al. 1999, Torsney 2011). Previous studies have established that the complete
Freund’s adjuvant (CFA) inflammatory pain model does not alter activation threshold,
conduction velocity or amplitude of Aβ-, Aδ- or C-fibres in isolated dorsal roots,
using both intracellular recordings from individual dorsal root ganglia (DRG) neurons
(Nakatsuka et al. 1999) and extracellular population recordings (Baba et al. 1999,
Torsney 2011). Differences exist in the electrically evoked properties of dorsal roots
isolated from adult and juvenile rats, namely juveniles exhibit significantly increased
activation thresholds and reduced conduction velocity for all primary afferent fibre
types, presumably due to increased myelination and/or fibre diameter in adult rats
(Nakatsuka et al. 2000, Park et al. 1999). Notably, CFA inflammation has no effect on
these properties of dorsal roots in both adults (Baba et al. 1999, Nakatsuka et al.
1999) and juveniles (Torsney 2011).
A major focus of this thesis is to investigate the spinal mechanisms of inflammatory
pain, by examining the synaptic inputs to lamina I neurokinin 1 receptor expressing
(NK1R+) neurons. It is therefore important to verify that the electrical stimulation
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intensities used in previous studies (Nakatsuka et al. 2000, Torsney 2011, Torsney &
MacDermott 2006) to activate the different primary afferent fibre types are
appropriate. Furthermore, it is important to confirm that inflammation does not alter
the electrically evoked properties of isolated rat dorsal roots to ensure that, where
dorsal root evoked excitatory postsynaptic currents (eEPSCs) are recorded, any
changes resulting from CFA inflammation presented here can be attributed to central
rather than peripheral changes.
2.1.2 Altered patterns of synaptic input to lamina I neurokinin 1
receptor expressing neurons in inflammatory pain
Under naı̈ve conditions, lamina I NK1R+ neurons predominantly receive
monosynaptic C- and/or monosynaptic Aδ-fibre input, with a smaller proportion
receiving monosynaptic Aβ-fibre or purely polysynaptic input (Torsney 2011,
Torsney & MacDermott 2006). Following peripheral inflammation there is a loss of
inhibition in the dorsal horn of the spinal cord (Müller et al. 2003, Zeilhofer &
Zeilhofer 2008). Pharmacologically mimicking this disrupted inhibition by applying
the glycine receptor (GlyR) and GABAA receptor (GABAAR) antagonists strychnine
and bicuculline, respectively, reveals novel and enhanced polysynaptic A-fibre input
to lamina I NK1R+ neurons (Torsney & MacDermott 2006). This increased A-fibre
input to lamina I NK1R+ neurons is largely the result of novel polysynaptic Aβ-fibre
input (figure 2.1A), thereby unveiling a pathway that enables low-threshold (touch)
input to access ‘nociceptive specific’ neurons and thus provides a potential model for
the development of allodynia. Interestingly, a similar facilitation of polysynaptic
Aβ-fibre input has also been reported in unidentified lamina II neurons (Baba et al.
1999). This increased polysynaptic Aβ-fibre input to lamina I NK1R+ neurons does
not appear to be implicated in inflammatory pain (Torsney 2011), but may be relevant
in neuropathic pain (Keller et al. 2007), where spinal cord disinhibition is a dominant
feature (Costigan et al. 2009).
Following CFA inflammation, monosynaptic Aδ-fibre input to lamina I NK1R+
neurons is significantly increased by around two fold, without any change in the
incidence of monosynaptic Aβ- or monosynaptic C-fibre input. Furthermore,
monosynaptic Aδ-fibres were shown to form pure-N-methyl-D-aspartate (NMDA) or
‘silent’ synapses with a portion of control cells that were classified as lacking
conventional monosynaptic Aδ-fibre input, but which typically received polysynaptic
A-fibre input (figure 2.1B). It is proposed that the ‘activation’ of these silent synapses
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could account for the novel monosynaptic Aδ-fibre inputs observed following CFA
inflammation and form part of the mechanism responsible for mechanical

























Figure 2.1: Changes in synaptic input to lamina I NK1R+ neurons. A Left: in control
conditions lamina I NK1R+ neurons typically receive input from monosynaptic Aδ- and/or
monosynaptic C-fibres. Right: pharmacologically mimicking disinhibition reveals a novel
polysynaptic Aβ-fibre pathway to these neurons, adapted from Torsney & MacDermott
2006. B Top: in control conditions a subset of lamina I NK1R+ neurons which do not
receive conventional monosynaptic Aδ-fibre input, receive input from monosynaptic
Aδ-fibre silent synapses. Bottom: following CFA inflammation lamina I NK1R+ neurons
receive novel monosynaptic Aδ-fibre input, which may result from the activation of these
silent synapses, adapted from Torsney 2011
This increased monosynaptic Aδ-fibre drive to lamina I NK1R+ neurons is interesting
for the following reasons. A subset of capsaicin-insensitive Aδ-fibres have been
shown to mediate punctate mechanical hyperalgesia (Fuchs et al. 2000, Magerl et al.
2001, Ziegler et al. 1999) and secondary mechanical hyperalgesia and potentially also
primary mechanical hyperalgesia has been established to be a centrally mediated
process (Klede et al. 2003, Klein et al. 2008, Lewin et al. 2004). Therefore, these
novel Aδ-fibre inputs to these neurons during inflammation could potentially mediate
mechanical hyperalgesia, with the unmasking of these inputs being part of central
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processes involved in establishing mechanical hyperalgesia.
2.1.3 Potentiation of synaptic inputs to lamina I neurokinin 1 receptor
expressing neurons in inflammatory pain
C-fibre potentiation
A number of studies have investigated ways in which monosynaptic C-fibre input to
lamina I NK1R+ neurons may be potentiated, which could have implications for the
development of allodynia and hyperalgesia. The effect of high-frequency stimulation
(HFS) and low-frequency stimulation (LFS) of monosynaptic C-fibre input to lamina
I projection neurons, identified by retrograde labelling and that were substance P (SP)
responsive and thus likely to be NK1R+ neurons, has been assessed (Ikeda et al.
2003, 2006). HFS (100Hz) of monosynaptic C-fibre input to a subset of these neurons
that project to the parabrachial area (PB) produces homosynaptic potentiation of
C-fibre eEPSCs (Ikeda et al. 2003). Furthermore, this potentiation was demonstrated
to be a Ca2+ dependent process, which is reliant on neurokinin 1 receptor (NK1R),
N-methyl-D-aspartate receptor (NMDAR) and T-type voltage-gated calcium channel
(VGCC) co-activation. Incidentally, this phenomenon occurred only in these
projection neurons and the stimulation protocol was without effect in unidentified
spinal cord neurons. However, the physiological relevance of this finding is
questionable due to the fact that stimulation of C-fibres in this manner does not reflect
the continuous low-frequency firing patterns observed in inflammatory pain (Djouhri
et al. 2006, Puig & Sorkin 1996, Xiao & Bennett 2007). Furthermore, increasing the
C-fibre stimulation frequency correlates with a reduction in the ability of these fibres
to repetitively fire action potentials (Nakatsuka et al. 2000), so the degree to which
C-fibres can sustain action potential firing when stimulated at 100Hz is debatable.
Subsequent investigation into this phenomenon revealed that LFS (2Hz), that more
closely mimics the spontaneous C-fibre firing pattern seen during inflammation,
resulted in homosynaptic potentiation of C-fibre eEPSCs in a subset of neurons that
project to the periaquducal gray matter (PAG) (Ikeda et al. 2006). As with HFS, LFS
potentiation was dependent on the concurrent activation of NMDARs, NK1Rs and
T-type VGCCs and was Ca2+-dependent. In summary, as detailed above it was shown
that different lamina I NK1R+ neuron subpopulations respond differently to identical
stimulation protocols. While HFS of C-fibre inputs potentiates C-fibre synapses onto
PB projecting neurons, it is without effect on those projecting to the PAG
(figure 2.2A) (Ikeda et al. 2003, 2006). Conversely, LFS of C-fibres has no effect in
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PB projecting neurons, but potentiates C-fibre synapses onto PAG projecting neurons
(figure 2.2B) (Ikeda et al. 2006). It is worth noting that C-fibre activity is essential for
the development of inflammatory pain (Abrahamsen et al. 2008), therefore this
C-fibre potentiation could play a crucial role in the development of inflammatory
hypersensitivity. However, potentiation of C-fibre synapses onto these neurons does
not appear to occur following CFA inflammation (Torsney 2011). As C-fibre eEPSCs
are the focus of several investigations in later chapters of this thesis, it was important
to establish whether these C-fibre synapses onto lamina I NK1R+ neurons are
potentiated following CFA inflammation in these particular studies.
A-fibre potentiation
Unlike monosynaptic C-fibre input to lamina I projection neurons, in vitro LFS of
monosynaptic A-fibre inputs on to PAG projecting neurons, at C-fibre intensity, does
not potentiate eEPSCs (Ikeda et al. 2006). However, following CFA inflammation
monosynaptic Aδ-fibre input to a subset of lamina I NK1R+ neurons that received
only Aδ-fibre input displayed a significantly increased eEPSC amplitude (Torsney
2011). Aδ-fibre eEPSCs were used in experimental protocols in later chapters,
therefore it was important to establish whether this Aδ-fibre potentiation was present
in the data presented here.
Monosynaptic Aβ-fibre input to lamina I NK1R+ neurons has been shown to be
minimal (Torsney 2011, Torsney & MacDermott 2006). Polysynaptic Aβ-fibre input
to lamina I NK1R+ neurons is predicted to be enhanced under conditions of
disinhibition (Torsney & MacDermott 2006), however this does not appear to be the
case in CFA inflammation (Torsney 2011).














Figure 2.2: Repetitive electrical stimulation of C-fibre input to lamina I NK1R+ projection
neurons potentiates eEPSCs in different subsets, depending on stimulation frequency. A
Stimulation of C-fibre inputs to NK1R+ neurons at high frequency (100Hz) has no effect
on PAG projecting neurons (top), but potentiates eEPSCs in those that project to the PB
(bottom) (Ikeda et al. 2003, 2006). B Low frequency stimulation of C-fibre inputs to the
subset of lamina I NK1R+ neurons that project to the periaquducal gray matter (PAG)
causes a long lasting potentiation of eEPSCs (top), however is without effect in neurons
projecting to the parabrachial area (PB, bottom) (Ikeda et al. 2006).
2.1.4 Spontaneous excitatory input to lamina I NK1R+ neurons
The evidence presented above suggests that evoked excitatory input to lamina I
NK1R+ neurons is likely to be potentiated following inflammation (Ikeda et al. 2006,
Torsney 2011). Others have studied the effects of inflammation on spontaneous
excitatory input to lamina II neurons, with conflicting results. CFA inflammation is
reported to significantly increase spontaneous excitatory postsynaptic current
CHAPTER 2: SYNAPTIC INPUT TO NK1R+ NEURONS 47
(sEPSC) frequency and amplitude (Park et al. 2011), however others have
demonstrated CFA is without effect (Lappin et al. 2006). It is not known whether
spontaneous excitatory input to lamina I NK1R+ neurons is altered in inflammation.
Given that these neurons play such a crucial role in the manifestation of inflammatory
pain (Nichols et al. 1999), it is important to establish whether the spontaneous input
they receive is altered in inflammation. It is known that different lamina II neuronal
subtypes show different levels of altered spontaneous excitatory input in neuropathic
pain (Balasubramanyan et al. 2006). Given that the pattern of primary afferent input
to lamina I NK1R+ neurons is likely to be altered in inflammation (Torsney 2011), it
is of interest to determine whether spontaneous excitatory input to these neurons
varies with the type of input received.
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2.2 Chapter aims and hypotheses
The experiments presented in this chapter were conducted to determine the changes in
primary afferent input to lamina I NK1R+ neurons following CFA inflammation and
to address the following aims and hypotheses.
Aims
1. Confirm that CFA inflammation does not alter the electrical activation
threshold, conduction velocity or amplitude of Aβ-, Aδ- and C-fibre compound
action potentials recorded in isolated dorsal roots.
2. Verify the appropriate electrical stimulation intensities required to activate the
different primary afferent fibre types for use in patch-clamp studies of synaptic
input to lamina I NK1R+ neurons.
3. Confirm the previously reported increased incidence and potentiation of
monosynaptic Aδ-fibre input to lamina I NK1R+ neurons during inflammation.
4. Determine whether potentiation of C-fibre synapses with lamina I NK1R+
neurons occurs during CFA inflammation.
5. Investigate the spontaneous excitatory input to lamina I NK1R+ neurons and
determine whether this is altered by CFA inflammation and/or the type of
primary afferent input a neuron receives.
Hypotheses
1. CFA inflammation will not alter the electrical activation thresholds, conduction
velocity or amplitude of Aβ-, Aδ- and C-fibre compound action potentials
recorded in isolated dorsal roots.
2. The appropriate electrical stimulation intensities for activation of different
primary afferent components, for use in subsequent patch-clamp studies, will be
in agreement with stimulation intensities reported in previous studies
(Nakatsuka et al. 2000, Torsney 2011, Torsney & MacDermott 2006).
3. The incidence of monosynaptic Aδ-fibre input to lamina I NK1R+ neurons will
be significantly increased following CFA inflammation.
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4. CFA inflammation will not result in potentiation of monosynaptic C-fibre input
to lamina I NK1R+ neurons.
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2.3 Methods
2.3.1 Animals
All procedures were carried out in accordance with the UK Animals (Scientific
Procedures) Act 1986, and the International Association for the Study of Pain (IASP)
ethical guidelines for animal research (Zimmermann 1983). Juvenile Sprague Dawley
rats of both sexes, aged approximately postnatal day 21 (P21), that were bred within
and obtained from the University of Edinburgh Biological Research Resources were
used in all experiments. Animals were housed in cages at 21◦C and 55% relative
humidity, with a 12h light-dark cycle. Food and water were provided ad libitum.
Importantly, previous studies have shown that juvenile rats of this age develop
inflammation-induced behavioural hypersensitivity and spinal cord hyperexcitability
that is comparable to adult rats (Torsney 2011, Torsney & Fitzgerald 2002)
2.3.2 Complete Freunds’s adjuvant inflammatory pain model
The CFA inflammatory pain model is a commonly used experimental model of
persistent inflammatory pain (Ren & Dubner 1999). CFA contains heat attenuated
mycobacterium tuberculosis suspended in a mineral oil. CFA injection provokes an
immune response and when injected subcutaneously into the plantar surface of a rats
paw it causes localised tissue inflammation and oedema (Nakatsuka et al. 1999, Xiao
& Bennett 2007). About 24 hours following injection, rats develop a persistent
mechanical and thermal hypersensitivity, in both adults (Lin et al. 2007, Nakatsuka
et al. 1999, Raghavendra et al. 2004, Xiao & Bennett 2007) and juveniles (Torsney
2011).
In these studies, CFA was injected into the plantar surface of the left hindpaw
(0.5mg/ml, 1µl/g body weight, Sigma, figure 2.3) under brief isoflurane anaesthesia.
Injections were performed 2-6 days (∼P18) prior to electrophysiological recordings
at ∼P21 (Torsney 2011). Control rats were untreated.
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Figure 2.3: CFA hindpaw injection, showing location of CFA injection.
2.3.3 Isolated dorsal root electrophysiology
Isolated dorsal root preparation
Isolated dorsal roots were prepared using previously established methods (Bardoni
et al. 2004, Labrakakis et al. 2003, Lee et al. 2002, Torsney 2011). Control untreated
or CFA treated rats, aged ∼P21 were anaesthetised with isoflurane and decapitated.
Spinal cords with dorsal roots attached were removed and placed in ice-cold
dissection solution that was continuously bubbled with 95% O2 / 5% CO2. Lumbar
(L4/5) dorsal roots, with DRGs removed, were cut near to the dorsal root entry zone
and placed in oxygenated recovery solution for 1 hour at 37◦C and were then
maintained at room temperature prior to recording. In the case of CFA treated
animals, dorsal roots from the inflamed (left) side only were prepared. It was not
always possible to retain DRGs, therefore to ensure all preparations were comparable,
any DRGs were removed. Dorsal roots of comparable length were used in both
groups (control: 4.4 ± 0.3mm, CFA: 4.2 ± 0.2mm, P=0.761, unpaired t-test).
Dorsal roots were transferred to the recording chamber of an upright microscope
(Zeiss Axiokop II) and continually perfused with oxygenated Krebs solution at a rate
of 1-2ml/min at room temperature. The composition of the Krebs solution was as
follows (in mM); 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 26 NaHCO3, 25 glucose, 1
MgCl2, 2 CaCl2, pH 7.4. A high Mg
2+, low Ca2+ Krebs solution was used minimise
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excitotoxic damage during the dissection and recovery. To further minimise
excitotoxicity during dissection, the ionotropic glutamate receptor antagonist,
kynurenic acid, was added to the dissection solution. The recovery solution was
composed of the following (in mM); 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 26 NaHCO3,
25 glucose, 6 MgCl2, 1.5 CaCl2, pH 7.4. The composition of the dissection solution
was as follows (in mM); 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 26 NaHCO3, 25 glucose,
6 MgCl2, 1.5 CaCl2, 1 kynurenic acid, pH 7.4. All chemicals were obtained from
Sigma.
Compound action potential electrophysiology
Compound action potential (CAP) recordings were used to evaluate the influence of
CFA inflammation on the electrically evoked properties of isolated dorsal roots.
Recordings were made using glass suction electrodes placed at either end of the
dorsal root, one for stimulating and the other for recording (Figure 2.4) (Baba et al.
1999, Bardoni et al. 2004, Labrakakis et al. 2003, Lee et al. 2002, Torsney 2011).
Dorsal roots were electrically stimulated 10 times at a frequency of 0.2Hz and a
stimulus duration of 0.1ms, with an ISO-Flex Stimulus Isolator (A.M.P.I. Intracel). To
determine the activation threshold for each primary afferent component, stimulation
intensities were increased in a stepwise manner as follows (in µA): 1, 2, 3, 4, 5, 7.5,
10, 15, 20, 25, 30-100 (in 10µA steps) and 150-500 (in 50µA steps) (Nakatsuka et al.
2000, Torsney 2011). Data were acquired and recorded using a Cygnus ER-1
differential amplifier (Cygnus Technologies Inc.) and pClamp 10 software (Molecular
Devices).
The main components of the CAPs were differentiated as fast (Aβ), medium (Aδ) and
slow (C) conducting components, with each displaying a characteristic triphasic
(positive-negative-positive) response (figure 2.6B). Small intermediate components
were occasionally observed, as has been reported previous (Géranton et al. 2009,
Torsney 2011), however these were not analysed. The data from roots in which the
identity of any of the three components was ambiguous were excluded from analysis.
Activation threshold was defined as the lowest stimulation intensity at which the
negative component of the triphasic response was first clearly identifiable (figure 2.5).
Amplitude and conduction velocity were measured from averaged traces (average of
10 traces) at stimulation intensities of 20, 100 and 500µA for Aβ-, Aδ- and C-fibre
components, respectively, as these were the intensities selected to activate these fibre
types in subsequent dorsal root eEPSC experiments, as described in section 2.4.1.
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Amplitude was measured as the distance between the positive and negative peak of
the response (figure 2.6B). In the case of Aδ- and C-fibres, typically the second
positive peak was chosen, as the first positive peak sometimes overlapped with the
previous component (example in figure 2.6A), despite using dorsal roots that were as
long as possible. The latency between the stimulus artefact and the negative peak of
the triphasic response (figure 2.6A) and the distance between the recording and
stimulating electrodes (dorsal root length) were measured and conduction velocity










Figure 2.4: Compound action potential recording set-up.











































Figure 2.5: Identification of primary afferent activation thresholds. Examples of
identification of activation thresholds for Aβ- (A), Aδ- (B) and C-fibres (C) in isolated
dorsal roots. Activation thresholds were defined as the stimulation intensity at which the
negative peak of the triphasic response is first clearly identifiable, indicated on the traces
by arrows. The stimulus artefact is highlighted in A by the grey box. In B the first positive
peak of the Aδ-fibre response is shown overlapping with the second positive peak of the
Aβ-fibre response. Numbers to left of traces indicate stimulation intensity used. All traces
shown are an average of 10 traces.




























Figure 2.6: Examples of how compound action potential latency and amplitude was
measured. A Response latency was measured as the time between the stimulus artefact
and the negative peak of the triphasic response. This example indicates the latency for
the C-fibre component. The negative peaks of the Aβ-, Aδ- and C-fibre components are
indicated by arrows. B Example trace shows C-fibre component from A (denoted by
box), where the negative and 2 positive peaks of the triphasic response can be clearly
seen. Amplitude was measured as the difference between the negative and second
positive peak. Traces shown are an average of 10 traces.
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2.3.4 Spinal cord slice electrophysiology
Spinal cord slice preparation
Spinal cord slices with dorsal roots attached were prepared using previously
established methods (Bardoni et al. 2000, 2004, Nakatsuka et al. 1999, Tong et al.
2008, Tong & MacDermott 2006, Torsney 2011, Torsney & MacDermott 2006).
Spinal cords were removed from control or CFA treated rats and placed in ice-cold
dissection solution in the manner detailed in section 2.3.3. Following removal of the
ventral roots, DRGs, dura mater and arachnoid membrane, the lumbar (L4/5) spinal
cord was embedded in 3% low-melting-point agar (Invitrogen) and transverse slices
(350µm) with dorsal roots attached (left side only in CFA tissue) were cut using a
vibrating blade microtome (Intracell) and placed in oxygenated recovery solution for
1 hour at 37◦C. Slices were then incubated with tetramethylrhodamine conjugated
substance P (TMR-SP) (Enzo Life Sciences), as described below and were then kept
in recovery solution at room temperature prior to use (Labrakakis & MacDermott
2003, Torsney 2011, Torsney & MacDermott 2006). Slices were transferred to the
recording chamber of an upright microscope (Zeiss Axiokop II) equipped with
infrared-differential interference contrast (ir-DIC) (Hamamatsu) for
electrophysiological recordings and fluorescence (Cairn Research) for identification
of TMR-SP labelled (TMR-SP+) neurons. Slices were fully submerged and held in
place with a small weight made of sliver wire (Harvard Apparatus) and continually
perfused with oxygenated Krebs solution at a flow rate of 1-2ml/min at room
temperature.
Neurokinin 1 receptor expressing neuron identification
To enable the targeting of lamina I NK1R+ neurons for electrophysiological
investigation, neurons were pre-labelled with a fluorescent SP ligand, as has been
reported elsewhere (Labrakakis & MacDermott 2003, Takazawa & MacDermott
2010, Tong et al. 2008, Tong & MacDermott 2006, Torsney 2011, Torsney &
MacDermott 2006). After spinal cord slices had been cut and placed in oxygenated
recovery solution for 1 hour at 37◦C, as described above, slices were incubated in
35nM TMR-SP, in oxygenated recovery solution, for 30 minutes at room
temperature. Following incubation in TMR-SP, slices were kept in oxygenated
recovery solution at room temperature prior to use. This method for pre-identification
of lamina I NK1R+ neurons is regarded to have minimal impact on the synaptic
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responses of these neurons. TMR-SP is one of the least biologically active of the
fluorescent SP conjugates, as evidenced by the fact it does not alter neuronal M-type
K+ currents at nM concentrations or elevate Ca2+ in Chinese hamster ovary cells that
express the NK1R (Bennett & Simmons 2001). Importantly, TMR-SP has also been
shown to have no effect on the synaptic responses of lamina I NK1R+ neurons (Tong
& MacDermott 2006). While it is reported that ∼45% of lamina I neurons display
NK1R immunoreactivity (Todd et al. 1998) and only ∼5% of all lamina I neurons are
projection neurons, the majority of which express the NK1R (Spike et al. 2003), it is
argued that TMR-SP labelling will preferentially label lamina I NK1R+ projection
neurons (Torsney & MacDermott 2006). TMR-SP labelling in the spinal cord slice
preparation labels a small proportion of neurons in the lamina I region, far less than
45% (Torsney & MacDermott 2006). Given that the majority of lamina I NK1R+
projection neurons display moderate to strong levels of NK1R immunoreactivity
(Spike et al. 2003), it is argued that TMR-SP labelling is more likely to identify these
projection neurons (Torsney & MacDermott 2006) as opposed to the population of
likely interneurons that display weak NK1R immunoreactivity (Cheunsuang &
Morris 2000, Todd et al. 2005).
Patch-clamp electrophysiology
Whole-cell patch-clamp recordings were made from TMR-SP+ / presumptive NK1R+
neurons in the lamina I region of the dorsal horn. A suction electrode was used to
electrically stimulate the dorsal root and activate primary afferent inputs (figures 2.7
& 2.8A). The lamina I region was identified visually as the thin area between the
white matter and lamina II, the latter being easily distinguished as a translucent band
across the dorsal horn. Furthermore, in lamina II there are very few projection
neurons (Todd 2010) and limited numbers of NK1R+ neurons (Bleazard et al. 1994,
Brown et al. 1995). To confirm that the recorded neurons were located in lamina I,
images, using a X5 objective, showing the dorsal horn and position of the recording
electrode were obtained (figure 2.8A).
Patch electrodes, with a tip resistance of 4–6MΩ when filled with intracellular
solution, were pulled from thick wall borosilicate glass (GC150F-7.5, Harvard
Apparatus) using a Flaming/Brown model P-97 microelectrode puller (Sutter
Instruments). The composition of the intracellular solution used in all eEPSC and
sEPSC recordings is as follows (in mM): 120 Cs-methylsulfonate, 10
Na-methylsulfonate, 10 ethylene glycol tetraacetic acid (EGTA), 1 CaCl2, 10
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4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 5
2(triethylamino)-N-(2,6-dimethylphenyl) acetamine chloride (QX-314-Cl), 5
Mg-ATP, pH adjusted to 7.2 with CsOH, osmolarity ∼290mOsm. In addition, 1µM
Alexa Fluor 488 hydrazide was added to the recording pipette. This filled the neuron
recorded from and confirms it was the targeted TMR-SP+ neuron (figure 2.8B). All
chemicals were obtained from Sigma, except from EGTA (Fluka), QX-314-Cl
(Alomone Labs) and Alexa Fluor 488 (Molecular Probes). All recordings were made
at a holding potential of -70mV, which is the anion reversal potential (Eanion) in
lamina I neurons (Coull et al. 2003) and as such blocks inhibitory inputs on to these
neurons. This enables the study of excitatory input without the influence of inhibition.
It is important to note that while the Eanion is developmentally regulated, lamina I
neurons in rats of the age used in these studies display an Eanion comparable to adults
(Cordero-Erausquin et al. 2005). Junction potential was corrected prior to recording.
Data were recorded and acquired with an Axopatch 200B amplifier and pClamp 10
software (Molecular Devices). Data were filtered at 5kHz and digitised at 10kHz.
Cells were excluded if any of the following criteria were met: access resistance
>25MΩ; holding current >100pA or <-100pA; membrane resistance <300MΩ.
Membrane resistance was monitored by measuring current responses to a -20mV
voltage step.







L4/L5 Spinal Cord Slice with Dorsal Root attached
-.012
Figure 2.7: Patch-clamp electrophysiology recording set-up.
2.3.5 Primary afferent input characterisation
Synaptic input to lamina I NK1R+ neurons was characterised in tissue isolated from
control and CFA treated rats to confirm the previously reported alterations seen
following inflammation (Torsney 2011). To characterise input the dorsal root was
stimulated three times at low frequency (0.05Hz), with a stimulus duration of 0.1ms at
intensities of 20, 100 and 500µA to activate Aβ-, Aδ- and C-fibre inputs respectively.
At this stimulation frequency, both monosynaptic and polysynaptic primary afferent
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input displays a stable latency, therefore responses which were stable and thus time
locked with the stimulus were classified as ‘evoked’. Whereas responses that lacked
stability and were thus unconnected with the stimulus were considered ‘spontaneous’
(Nakatsuka et al. 2000, Torsney 2011, Torsney & MacDermott 2006). The
monosynaptic / polysynaptic nature of stable afferent input was determined in the
manner previously reported (Nakatsuka et al. 2000, Torsney 2011, Torsney &
MacDermott 2006). The dorsal root was stimulated 20 times, with a stimulus duration
of 0.1ms at the intensities and frequencies detailed below in table 2.1.




Table 2.1: Stimulation parameters used to determine the monosynaptic / polysynaptic
nature of primary afferent input to lamina I NK1R+ neurons
These frequencies were selected because action potential firing fails in Aδ- and
C-fibres at stimulation frequencies >2Hz and >1Hz, respectively, while Aβ-fibres
show no failures at frequencies of up to 20Hz (Nakatsuka et al. 2000). Therefore, if
frequencies greater than these were used, it would have been impossible to
differentiate between synaptic failures and a failure of action potential firing in the
primary afferent inputs. A-fibre eEPSCs were classified as monosynaptic if there was
an absence of synaptic failures and a stable latency (≤2ms) and polysynaptic where
synaptic failures occurred and/or latency variability was >2ms. C-fibre eEPSCs were
classified as monosynaptic if no synaptic failures occurred, regardless of latency
variability, with the presence of synaptic failures indicating a polysynaptic input
(Nakatsuka et al. 2000, Torsney 2011, Torsney & MacDermott 2006). Neurons that
received both monosynaptic and polysynaptic input were classified on the basis of the
monosynaptic input only, while those that received only polysynaptic input were
classified as polysynaptic only, regardless of whether this was polysynaptic Aβ-, Aδ-
or C-fibre input. Neurons that displayed no input in response to dorsal root
stimulation were excluded as it was impossible to be certain that these neurons
received no input, it being most likely that the input was cut in the process of
preparing the spinal cord slices.
The amplitude of monosynaptic responses was determined by measuring the
difference between baseline and the negative peak of the response (figure 2.15A). The
latency between the stimulus artefact and the onset of the monosynaptic response was
measured (figure 2.15C), as was the distance between the stimulating electrode and
the point at where the dorsal root entered the dorsal horn and estimated conduction
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velocity calculated using equation (a). This method of determining conduction
velocity provides an imperfect estimate, as it ignores the portion of the conduction
pathway within the spinal cord and does not take into account the synaptic delay.
However, as the primary afferent inputs have such different conduction velocities
(Géranton et al. 2009, Nakatsuka et al. 2000, Torsney 2011), this measure is still
informative. The amplitude and estimated conduction velocity of inputs were









Figure 2.8: Spinal cord slice and lamina I NK1R+ neuron images. A ir-DIC image of
spinal cord slice preparation employed to record dorsal root eEPSCs in lamina I NK1R+
neurons. B Identification of a lamina I NK1R+ neuron using TMR-SP labelling. Neuron
visualised with TMR-SP fluorescence (left panel), ir-DIC (middle panel) and filled with
Alexa Fluor 488 hydrazide (right panel)
2.3.6 Spontaneous excitatory input
Spontaneous excitatory input to lamina I NK1R+ neurons was investigated to
determine if this was altered by CFA inflammation and/or whether the type of
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synaptic input received was predictive of the level of excitatory drive to these
neurons. Patch-clamp electrophysiology (as described in section 2.3.4) was used to
record sEPSCs in neurons, from tissue isolated from control or CFA treated rats. At
least 5 minutes after establishing whole-cell configuration, sEPSCs were recorded for
5 minutes prior to characterising the input received, to avoid any potential influence
from the characterisation stimulation protocol used. Recordings were made at a
holding potential of -70mV which, is the Eanion in these neurons (Coull et al. 2003),
therefore no inhibitory blockers were required to block direct inhibitory inputs.
The influence of primary afferent input type on sEPSCs was assessed only in neurons
that received monosynaptic input. Neurons receiving polysynaptic input were not
included in this analysis as it was not possible to be certain that these neurons truly
lacked monosynaptic input, as monosynaptic input could had been severed in the
process of preparing spinal cord slices. To confirm that sEPSCs recorded in lamina I
NK1R+ neurons are mediated by α-amino-3-hydroxy-5-methyl-4-isoxazole propionic
acid (AMPA) and NMDA receptors, in a subset of cells the AMPA and NMDA
antagonists 2,3-dihydroxy-6-nitro-7-sulfonyl-benzo[f]quinoxaline (NBQX) (10µM,
Abcam), and D-(-)-2-Amino-5-phosphonopentanoic acid (D-APV) (30µM, Abcam),
respectively, were bath applied for 13 minutes.
Mini Analysis software (Synaptosoft Inc.) was used to analyse sEPSCs. To assess the
influence of CFA inflammation / input received on sEPSCs, the final 2 minutes of the
recording were analysed. Where NBQX / D-APV was applied, the final 2 minutes
prior to drug application and the final 2 minutes of drug application were analysed.
sEPSC events were automatically detected by the software and were then accepted or
rejected following further visual examination.
2.3.7 Statistical analysis
All data were assessed for normality using D’Agostino & Pearson omnibus normality
tests, to establish whether it was appropriate to use parametric or non-parametric
statistical tests, or whether data should be transformed prior to performing parametric
tests.
CAP data were analysed using 2-way repeated measures ANOVA. The amplitude data
were log transformed prior to analysis. Recording location and the overall pattern of
primary afferent input, in spinal cord slice eEPSC experiments was assessed using the
Chi-squared test. Changes in the incidence of individual input types were evaluated
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using Fischer’s exact test. 2-way ANOVA was performed on rank transformed
estimated conduction velocity and amplitude data. The influence of CFA
inflammation on sEPSC frequency and amplitude within the overall neuronal
population was statistically analysed using a Mann Whitney U-test. Statistical
analysis of the effect of CFA and input type on sEPSC frequency and amplitude in
cells that received monosynaptic primary afferent input were performed using 2-way
ANOVA followed by Tukey’s multiple comparison post-tests on log transformed data.
All data are presented as mean ± standard error of the mean (SEM). All statistical
analysis was performed using Prism 6 (Graphpad Software).
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2.4 Results
2.4.1 Electrophysiological properties of isolated dorsal roots
To confirm that CFA inflammation does not alter the activation threshold, conduction
velocity or amplitude of Aβ- Aδ- and C-fibres (Baba et al. 1999, Nakatsuka et al.
1999, Torsney 2011) and verify the appropriate electrical stimulation intensities to
activate these components in subsequent eEPSC studies, CAPs were recorded from
dorsal roots isolated from control and CFA treated rats. It is well established that the
three different primary afferent components can be distinguished on the basis of
threshold (Aβ < Aδ < C) and conduction velocity (Aβ > Aδ > C) (Meyer et al.
2005), as illustrated in example figure 2.9A. At Aβ-fibre stimulation intensity (20µA)
only a single component with a characteristic triphasic response is visible and as this
is the first component following the stimulus artefact, and thus the fastest conducting,
this can be considered to be the Aβ-fibre component. When the stimulation intensity
is increased to Aδ- and C-fibre strength (100 & 500µA respectively) a second (Aδ)
and then third (C) slower component becomes identifiable. The activation threshold
was significantly different between Aβ- Aδ- and C-fibres (P<0.0001, 2-way repeated
measures ANOVA), however CFA inflammation was without effect (P=0.422, 2-way
repeated measures ANOVA, figure 2.9B, table 2.2) and there was no interaction
between these factors (P=0.826, 2-way repeated measures ANOVA). These data were
used to determine the appropriate stimulation intensities to use in subsequent dorsal
root eEPSC patch-clamp studies to selectively activate the different primary afferent
inputs. Stimulation intensities which were above that required to activate the
component of interest, but which did not activate any higher threshold components
(e.g. activated all Aβ- but no Aδ-fibres) were selected. Therefore, 20, 100 and 500µA
were chosen to activate Aβ-, Aδ- and C-fibre components respectively (as detailed in
section 2.3.5). Conduction velocity of the primary afferent components was
significantly altered by fibre type, but unaffected by CFA inflammation, with no
interaction between these factors (P<0.0001, P=0.979 & P=0.688, respectively,
2-way repeated measures ANOVA, figure 2.9C, table 2.2). Similarly, fibre type
significantly altered the response amplitude, but CFA was without effect and there
was no interaction (P<0.0001, P=0.465 & P=0.432, respectively, 2-way repeated
measures ANOVA on log transformed data, table 2.2).













































































Figure 2.9: CFA inflammation does not alter activation thresholds or conduction velocity
of primary afferents. A Example traces from control dorsal roots, left shows low
magnification, right shows magnified portion of trace, as indicated by box on left trace,
average of 10 traces shown, arrows denote negative peak of ’triphasic’ component.
Stimulation intensities used were: Aβ-fibre (top); 20µA, Aδ-fibre (middle); 100µA, C-fibre
(bottom); 500µA. B Electrical activation thresholds for Aβ-, Aδ- and C-fibres recorded
from dorsal roots isolated from control and CFA treated rats. There was a significant
effect of fibre type (P<0.0001), but no significant effect of CFA (P=0.422) on activation
threshold. There was no interaction between these factors (P=0.826) Dotted lines
indicate the dorsal root stimulation intensities to be employed in subsequent patch-clamp
eEPSC studies to selectively activate the different fibre types. C Conduction velocities for
Aβ-, Aδ- and C-fibre components. CFA inflammation had no effect (P=0.979), while fibre
type significantly affected conduction velocity (P<0.0001), with this effect being
independent of CFA (P=0.688). All statistics: 2-way repeated measures ANOVA, n=13 in
all groups.
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Threshold (pA) Conduction Amplitude (mV)
velocity (m/s)
Control Aβ 7.73 ± 0.64 4.83 ± 0.39 1.52 ± 0.23
Aδ 38.85 ± 2.78 0.90 ± 0.10 0.10 ± 0.02
C 238.46 ± 12.85 0.19 ± 0.01 0.11 ± 0.02
CFA Aβ 6.04 ± 0.57 5.00 ± 0.27 2.34 ± 0.42
Aδ 34.62 ± 2.80 0.74 ± 0.07 0.10 ± 0.02
C 226.92 ± 15.62 0.20 ± 0.01 0.14 ± 0.03
Table 2.2: Electrically evoked properties of isolated dorsal roots. Activation threshold,
conduction velocity and amplitude of Aβ-, Aδ- and C-fibre components recorded from
dorsal roots isolated from control of CFA treated rats. All values shown as mean ± SEM,
all groups n=13.
2.4.2 Effect of inflammation on primary afferent input to lamina I
neurokinin 1 receptor expressing neurons
To confirm the previously reported increased incidence of monosynaptic Aδ-fibre
input to lamina I NK1R+ neurons seen during inflammation (Torsney 2011) and
determine whether monosynaptic C-fibre input to these neurons is potentiated in
inflammatory pain, patch-clamp recordings were made from lamina I NK1R+ neurons
pre-labelled with TMR-SP.
The location of the lamina I NK1R+ neurons targeted for patch-clamp recordings was
analysed to ensure that recordings were made from comparable anatomical locations
in tissue isolated from control and CFA treated rats. Primary afferent input was
characterised in neurons situated predominantly in the middle region of the dorsal
horn, with smaller proportions in medial and lateral regions (as defined in
figure 2.10A). This result could reflect the fact that the central portion of lamina I is
thicker and displays more dense NK1R immunoreactivity (Todd et al. 1998). The
overall pattern of cell location showed no difference between control and CFA groups
(P=0.320, Chi-squared, 2.10B).
























Figure 2.10: Location of patch clamp recordings. A Image of dorsal horn showing
definition of medial, middle and lateral regions. B Patch clamp recordings were made
predominantly in the middle region of lamina I of the dorsal horn, with a smaller
proportion in the medial and lateral regions. There was no significant difference in the
pattern of recording location between control and CFA tissue, P=0.320 (Chi-squared).
Control n=61, CFA n=91. Actual sample sizes in parentheses.
Primary afferent input to lamina 1 NK1R+ neurons was classified on the basis of the
monosynaptic input they received, regardless of whether they received additional
polysynaptic input, as follows. Neurons with only polysynaptic input were classified
as ‘polysynaptic only’:
• ‘C’ = monosynaptic C-fibre only
• ‘Aδ’ = monosynaptic Aδ-fibre only
• ‘Aδ + C’ = monosynaptic Aδ-fibre with monosynaptic C-fibre
• ‘Aβ’ = monosynaptic Aβ-fibre only
CHAPTER 2: SYNAPTIC INPUT TO NK1R+ NEURONS 68
• ‘Aβ + C’ = monosynaptic Aβ-fibre with monosynaptic C-fibre
• ‘Aβ + Aδ’ = monosynaptic Aβ-fibre with monosynaptic Aδ-fibre
• ‘Aβ + Aδ + C’ = monosynaptic Aβ-fibre with monosynaptic Aδ-fibre and
monosynaptic C-fibre
• ‘Polysynaptic only’ = polysynaptic only
Example traces in figures 2.11 and 2.12 show lamina I NK1R+ neurons that receive:
2.11A; monosynaptic C-fibre only input, 2.11B; monosynaptic Aδ-fibre with
monosynaptic C-fibre and a small polysynaptic Aβ-fibre input, 2.12A; monosynaptic
Aδ-fibre only input, although this example also has a small polysynaptic Aβ- and
polysynaptic C-fibre input, 2.12B; monosynaptic Aβ-fibre only input. In these
example traces it can be seen that these monosynaptic inputs do not show failures
when stimulated at high frequency and exhibit stable latencies. Figure 2.13 shows an
example of a neuron that receives polysynaptic only input, where there is clear
evidence of failures and a large latency variability. Overall, CFA inflammation did not
alter the pattern of input that lamina I NK1R+ neurons received (P=0.507,
Chi-squared test, figure 2.14). In spinal slices isolated from control and CFA treated
animals, the predominant input type was monosynaptic C-fibre, with almost three
quarters of all neurons receiving this type of input. In addition, neurons received
smaller but similar proportions of monosynaptic Aδ-fibre and polysynaptic input. The
incidence of monosynaptic Aδ- or monosynaptic C-fibre, or polysynaptic input was
not affected by CFA inflammation (all: P>0.05, Fischer’s exact test). However, CFA
inflammation resulted in a 5 fold increase in neurons that received monosynaptic
Aβ-fibre input, although this did not reach statistical significance (P=0.051, Fischer’s
exact test).
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low frequency (0.05Hz) high frequency
monosynaptic Aδ-fibre & monosynaptic C-fibre
Figure 2.11: Monosynaptic primary afferent input to lamina I NK1R+ neurons. Examples
of characterisation of synaptic input to lamina I NK1R+ neurons: A CFA neuron with
monosynaptic C-fibre input, B control neuron with both monosynaptic Aδ- &
monosynaptic C-fibre input. Left traces show example of eepsc using low frequency
(0.05Hz) stimulation at Aβ- (20µA), Aδ- (100µA) and C-fibre (500µA) stimulation
intensities, average of 3 traces shown. Right traces show example of eEPSCs using high
frequency stimulation (20µA / 20Hz, 100µA / 2Hz, 500µA / 1Hz), 20 superimposed
traces shown.

































Figure 2.12: Monosynaptic primary afferent input to lamina I NK1R+ neurons. Examples
of characterisation of synaptic input to lamina I NK1R+ neurons: A CFA neuron with
monosynaptic Aδ-fibre input and a small polysynaptic Aβ-fibre input, B CFA neuron with
Aβ- input. Left traces show example of eEPSCs recorded during low frequency (0.05Hz)
stimulation at Aβ- (20µA), Aδ- (100µA) and C-fibre (500µA) stimulation intensities,
average of 3 traces shown. Right traces show example of eEPSCs using high frequency
stimulation (20µA / 20Hz, 100µA / 2Hz, 500µA / 1Hz), 20 superimposed traces shown.















Figure 2.13: Polysynaptic primary afferent input to lamina I NK1R+ neurons. Example of
characterisation of synaptic input to a control lamina I NK1R+ neuron that received
polysynaptic input. Left traces show example of eEPCSs using low frequency (0.05Hz)
stimulation at Aβ- (20µA), Aδ- (100µA) and C-fibre (500µA) stimulation intensities,
average of 3 traces shown. Right traces show example of eEPSCs using high frequency
stimulation (20µA / 20Hz, 100µA / 2Hz, 500µA / 1Hz), 20 superimposed traces shown.
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Figure 2.14: CFA inflammation increases the incidence of monosynaptic Aβ-fibre, but
not monosynaptic Aδ- or monosynaptic C-fibre input to lamina I NK1R+ neurons. CFA
inflammation had no impact on the overall pattern of input received by lamina I NK1R+
neurons (P=0.507, Chi-squared). The incidence of monosynaptic Aβ-fibre input was
increased following CFA inflammation, however this just failed to reach significance
(P=0.051, Fischer’s exact test). CFA inflammation did not not alter the incidence of
monosynaptic Aδ- or C-fibre, or polysynaptic input (all P>0.05, Fischer’s exact test).
Control n=61, CFA n=91. Actual sample sizes in parentheses
CFA inflammation did not alter the peak amplitude of monosynaptic Aδ- or
monosynaptic C-fibre inputs, regardless of whether neurons received Aδ-fibre only,
both Aδ- & C-fibre or C-fibre only input (P=0.388, 2-way ANOVA on rank
transformed data, figure 2.15B). Amplitude was not significantly difference between
input types and there was no interaction between CFA and input type P=0.999 &
P=0.217, respectively, 2-way ANOVA on rank transformed data). Neurons that
received Aδ-fibre inputs are displayed as two groups, depending on whether C-fibre
input was also received, because it has previously been shown that monosynaptic
Aδ-fibre inputs are potentiated following inflammation in those neurons which receive
Aδ-fibre only input, but not Aδ- with C-fibre input (Torsney 2011). The amplitude of
monosynaptic C-fibre inputs was not altered by CFA inflammation, regardless of
whether Aδ-fibre input was also received and there was no interaction between these
factors (P=0.386, P=0.103 & P=0.168, respectively, 2-way ANOVA, data not shown).
The estimated conduction velocity of Aδ-fibre inputs was significantly greater than
C-fibre inputs (P<0.0001, 2-way ANOVA on rank transformed data, figure 2.15D) as
would be expected. CFA inflammation did not alter conduction velocity and there was
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no interaction between input type and CFA (P=0.937 & P=0.723, respectively, 2-way
ANOVA on rank transformed data). Aβ-fibre inputs displayed similar amplitudes to
Aδ- and C-fibres but faster conduction velocities (table 2.3), however these were not
statistically analysed due to the small sample size in the control group. Occasionally
there was an overlapping of components that made it difficult to analyse peak
amplitude and/or estimated conduction velocity, in such cases that parameter was
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Figure 2.15: Amplitude and estimated conduction velocity of monosynaptic input to
lamina I NK1R+ neurons is not altered by CFA inflammation. A Example of how peak
eEPSC amplitude was measured. B Both input type and CFA inflammation had no
significant effect on eEPSC peak amplitude and there was no interaction between these
factors (P=0.099, P=0.388 & P=0.217, respectively). C The response latency, used to
calculate estimated conduction velocity, was measured as the time between the stimulus
artefact and the onset of the monosynaptic eEPSC response. D Conduction velocity was
significantly altered by input type (P<0.0001), but was unaffected by CFA inflammation
(P=0.937). There was no significant interaction between input type and CFA (P=0.723).
All statistics: 2-way ANOVA on rank transformed data, sample sizes indicated by
numbers on bars.
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Conduction Amplitude (pA)
Velocity (m/s)
Control Aβ 2.21 (1) -1272.60 (1)
Aδ 1.28 ± 0.17 (18) -875.92 ± 209.68 (19)
C 0.31 ± 0.03 (48) -858.14 ± 118.05 (48)
CFA Aβ 1.68 ± 0.17 (10) -917.36 ± 378.91 (10)
Aδ 1.24 ± 0.12 (26) -957.45 ± 226.93 (25)
C 0.31 ± 0.03 (71) -864.83 ± 84.56 (69)
Table 2.3: Amplitude and estimated conduction velocity of monosynaptic Aβ-, Aδ- and
C-fibre inputs to lamina I NK1R+ neurons in tissue isolated from control and CFA treated
rats. All values shown as mean ± SEM, sample sizes in parentheses.
2.4.3 Spontaneous excitatory input to lamina I neurokinin 1 receptor
expressing neurons
To assess whether the spontaneous excitatory input to lamina I NK1R+ neurons was
altered by CFA inflammation and/or the type of primary afferent input a neuron
receives, sEPSCs were recorded from pre-labelled lamina I NK1R+ neurons is tissue
isolated from control or CFA treated rats. Figure 2.16A shows example sEPSC traces
recorded in neurons receiving monosynaptic: Aδ-fibre only, Aδ- & C-fibre and
C-fibre only input, in tissue from both control (Aδ only) and CFA treated rats (Aδ &
C, C only). CFA inflammation did not influence sEPSC frequency (P=0.460, 2-way
ANOVA on log transformed data), but frequency was significantly altered by input
type (P=0.002, 2-way ANOVA on log transformed data). There was no significant
interaction between inflammation and input type (P=0.745, 2-way ANOVA on log
transformed data). Post-hoc analysis revealed that neurons receiving monosynaptic
Aδ-fibre only input displayed significantly greater sEPSC frequency that those
receiving C-fibre only input (P<0.01, 2-way ANOVA on log transformed data,
Tukey’s multiple comparison post-test, figure 2.16B). Both input type and CFA
inflammation were without effect on sEPSC amplitude, and there was no interaction
between these two factors (P=0.512, P=0.444 & P=0.950, respectively, 2-way
ANOVA on log transformed data, figure 2.16C). In the overall population of neurons,
CFA inflammation did not influence sEPSC frequency or amplitude (P=0.661 and
P=0.159, respectively, Mann Whitney, table 2.4). The addition of NBQX and D-APV,
to tissue isolated from both control and CFA treated rats, abolished sEPSC events, as
shown in the representative traces in figure 2.17A. NBQX and D-APV reduced
sEPSC frequency from 1.61 ± 0.67Hz to 0 ± 0Hz (figure 2.17B), while sEPSC
amplitude was reduced from 31.46 ± 5.20pA to 0 ± 0pA (figure 2.17C).
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Aδ (control)Aδ & C (CFA)C (CFA)
Figure 2.16: Lamina I NK1R+ neuron sEPSC frequency, but not amplitude, is altered by
primary afferent input type. A Example sEPSC traces from cells receiving monosynaptic
C-fibre (left), Aδ & C-fibre (middle) and Aδ-fibre (right) input. B The frequency of sEPSCs
was significantly altered by input type (P=0.002). Cells with monosynaptic Aδ only input
showed significantly higher frequency that those with C-fibre input (P<0.01). CFA
inflammation was without effect on sEPSC frequency (P=0.460) and there was no
interaction between input type and CFA (P=0.745). C Input type and CFA inflammation
had no significant effect on sEPSC amplitude (P=0.515 & P=0.444, respectively) and
there was no interaction between these factors (P=0.950). All stats = 2-way ANOVA on
log transformed data, followed by Tukey’s multiple comparison post-test ∗∗P<0.01.
Sample sizes indicated by numbers on bars.
CHAPTER 2: SYNAPTIC INPUT TO NK1R+ NEURONS 76
Frequency (Hz) Amplitude (pA) n=
Control Aδ 9.76 ± 3.80 33.37 ± 2.63 6
Aδ & C 4.39 ± 1.56 35.91 ± 2.32 9
C 3.69 ± 0.99 34.72 ± 1.57 28
Aβ† 17.07 35.14 1
Poly 4.38 ± 1.56 34.83 ± 3.37 7
Overall 4.89 ± 0.84 34.80 ± 1.08 51
CFA Aδ 10.74 ± 4.39 33.80 ± 2.63 5
Aδ & C 6.91 ± 2.31 37.77 ± 2.15 9
C 3.07 ± 0.54 36.60 ± 1.39 33
Aβ‡ 5.06 ± 1.21 43.86 ± 3.75 9
Poly 2.65 ± 3.20 32.49 ± 1.90 17
Overall 4.21 ± 0.57 36.49 ± 1.01 73
Table 2.4: sEPSC frequency and amplitude values recorded in lamina I NK1R+ neurons
in tissue isolated from control and CFA treated rats. CFA did not alter the overall
frequency (P=0.661) or amplitude (P=0.159) of sEPSCs, Mann Whitney. All values
shown as mean ± SEM. † Includes monosynaptic Aβ- & C-fibre. ‡ Includes
monosynaptic Aβ-fibre only; Aβ- & Aδ-; Aβ- & C-; Aβ- & Aδ- & C-fibre.
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Baseline NBQX / D-APV
A
Figure 2.17: sEPSCs are blocked by NBQX + D-APV. A Representative sEPSC traces
recorded in a lamina I NK1R+ neuron, in tissue isolated from a CFA treated rat, in the
absence (left) and presence of the AMPA and NMDA antagonists, NBQX and D-APV,
respectively (right). Application of NBQX and D-APV blocked sEPSC events, as seen in
the frequency (B) and amplitude (C) data. All groups n=4 (control n=2, CFA n=2).
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2.5 Discussion
2.5.1 Electrically evoked responses of primary afferent fibres in
isolated dorsal roots
CAP recordings in isolated dorsal roots established that activation threshold,
conduction velocity and response amplitude for Aβ-, Aδ- and C-fibres were not
affected by CFA inflammation, which confirms the findings of earlier studies in
juvenile (Torsney 2011) and adult rats (Baba et al. 1999, Nakatsuka et al. 1999).
Therefore, identical stimulation parameters can be used to electrically activate
primary afferent inputs in dorsal root eEPSC studies in tissue isolated from control
and CFA treated rats. Importantly, the conduction velocity values reported here are
comparable to those described in other studies where extracellular CAP recordings
were performed in ex vivo tissue (Daniele & MacDermott 2009, Géranton et al. 2009,
Labrakakis et al. 2003, Torsney 2011), which can be considered to further confirm the
identity of the afferent components examined in this study.
From these data, stimulation intensities of 20, 100 and 500µA were selected to
activate Aβ-, Aδ- and C-fibre inputs, respectively, in dorsal root eEPSC studies.
These intensities are largely in agreement with published studies (Nakatsuka et al.
2000, Torsney 2011, Torsney & MacDermott 2006), however a slightly lower
intensity was chosen to activate Aβ-fibres, 20µA versus 25µA. The reason for this
choice is that in 2 dorsal roots recorded here, the activation threshold for Aδ-fibres
was 25µA. Therefore, to avoid potentially misidentifying Aδ-fibre input as Aβ-fibre
input, this lower intensity was selected.
It could be argued that the method of determining the activation threshold of the
primary afferent components was subjective as it relied upon the investigator to
determine when the negative peak of the triphasic response was first clearly
identifiable based upon a visual inspection of the resulting traces. As extracellular
population recordings, these were reliant on the simultaneous activation of a critical
mass of afferents for response detection. Response amplitude varies with stimulation
intensity, as more or less afferents are activated and so activation thresholds are not a
clear all or nothing response. However, the activation thresholds reported here are
comparable to published values obtained by intracellular recording from individual
neurons (Nakatsuka et al. 2000), where these issues do not exist. This can be
considered to support the findings reported here.
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2.5.2 Synaptic input to lamina I neurokinin 1 receptor expressing
neurons in inflammatory pain
The overall pattern of synaptic input to lamina I NK1R+ neurons was unaltered by
CFA inflammation, as was the incidence of monosynaptic Aδ- and/or monosynaptic
C-fibre and polysynaptic input. The incidence of monosynaptic Aβ-fibre input was
increased, although this did not reach a level of statistical significance. These findings
do not confirm previous work that reports that the overall pattern of input is
significantly altered and specifically that the incidence of monosynaptic Aδ-fibre
input is increased following inflammation (Torsney 2011). It is unclear why these
previous findings were not replicated in the results presented here.
In the experiments presented here a stimulation intensity of 20µA was employed to
activate Aβ-fibre inputs, as an intensity of 25µA was found to be the Aδ-fibre
activation threshold in a few cases in CAP recordings. In the work that established
that the incidence of monosynaptic Aδ-fibre input to lamina I NK1R+ neurons is
increased in CFA inflammation, a stimulation intensity of 25µA was used to activate
Aβ-fibre inputs (Torsney 2011). This finding is unlikely to be influenced due to
misidentification of inputs resulting from using an Aβ-fibre stimulation intensity of
25µA. If monosynaptic Aδ-fibre inputs were wrongly identified as Aβ-fibre, arguably
a corresponding increase in the incidence of monosynaptic Aβ-fibre input would be
expected, although this was not the case. Any Aδ-fibres identified at a stimulation
intensity of 25µA would have been stimulated at 20Hz to determine their
monosynaptic / polysynaptic nature. As Aδ-fibres fail to fire action potentials at
frequencies of >2Hz (Nakatsuka et al. 2000), this is highly likely to have lead to
failures and thus any misidentified Aδ-fibre inputs would likely have been classed as
polysynaptic Aβ-fibre. Notably, polysynaptic Aβ-fibre input was not altered by CFA
inflammation (Torsney 2011).
One possibility is that the previously described increased incidence of monosynaptic
Aδ-fibre input (Torsney 2011) occurs in a subpopulation of lamina I NK1R+ neurons
and that this present study did not include enough of that subpopulation for the effect
to be detected. There is evidence that different lamina I NK1R+ subpopulations may
receive different types of input and respond differently to identical patterns of
stimulation. Lamina I projection neurons that target the PB have a greater incidence
of monosynaptic Aδ-fibre input than those that target the PAG (9% versus 2%)
(Ruscheweyh et al. 2004), however it is unknown whether this is altered following
inflammation. As previously discussed, electrical stimulation of C-fibre inputs to
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these neurons drives synaptic plasticity, with the outcome depending on the neuronal
subpopulation involved (Ikeda et al. 2006), so clearly different subpopulations have
the capacity to respond differently to the same input. The extent to which altered
C-fibre responses impact upon Aδ-fibre inputs is unclear. However, it is proposed that
C-fibre activity drives spinal cord hyperexcitability, which in turn allows A-fibres
access to circuits, that enable them to mediate hyperalgesia and allodynia
(Latremoliere & Woolf 2009, Treede & Magerl 2000), thereby providing a potential
mechanism by which altered C-fibre activity in a particular neuronal subpopulation
could impact upon the Aδ-fibre input in those neurons. The method used here and
elsewhere (Torsney 2011) for identifying lamina I NK1R+ neurons does not enable
the identification of subpopulations so it is not possible to conclude whether this
could account for the differences in input pattern reported.
Different lamina I NK1R+ neuron subpopulations are known to display different
levels of NK1R immunoreactivity, specifically neurons that project to the PAG show
lower NK1R expression (Spike et al. 2003). Incidentally, this PAG projecting
subpopulation also receive a lower incidence of monosynaptic Aδ-fibre input than
those projecting to the PB (Ruscheweyh et al. 2004). The TMR-SP used to identify
lamina I NK1R+ neurons in this study was obtain from a different supplier than has
been used in previous reports (Torsney 2011). Therefore, the failure to replicate the
previously reported increase in the incidence of monosynaptic Aδ-fibre input to
lamina I NK1R+ neurons in inflammation (Torsney 2011) could be due to differences
in the sensitivity of the TMR-SP used. For example, a reduction in TMR-SP
sensitivity could have resulted in the preferential targeting of neuronal subpopulations
that display greater NK1R immunoreactivity. If the inflammation induced increase in
the incidence of monosynaptic Aδ-fibre input to lamina I NK1R+ neurons (Torsney
2011) occurs in a specific neuronal subpopulation, then a change in TMR-SP
sensitivity could have altered the proportion of that subpopulation in the data
presented here.
The possibility of addressing the hypothesis that changes in input pattern are a
subpopulation specific process are restricted with current techniques for identifying
lamina I NK1R+ neurons. While TMR-SP labelling of neurons (Labrakakis &
MacDermott 2003, Torsney 2011, Torsney & MacDermott 2006), ensures the neuron
recorded from expresses the NK1R, it does not identify subpopulations. Retrograde
labelling of neurons, as used by others (Ikeda et al. 2003, 2006, Ruscheweyh et al.
2004), identifies subpopulations, however only ∼80% of lamina I projection neurons
display NK1R immunoreactivity (Al-Khater et al. 2008, Spike et al. 2003, Todd et al.
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2000) so this approach will include data from non-NK1R+ neurons. However, one
approach that has been used to negate this possibility is to confirm whether retrograde
labelled neurons respond to application of SP (Ikeda et al. 2003, 2006). Although, it
should be recognised that retrograde labelling of spinal cord neurons is a more time
consuming and invasive procedure.
One potential approach to overcome these limitations would be to use genetic
labelling techniques. Such approaches have already been employed to dissect
different populations of peripheral (Cavanaugh et al. 2011, Li et al. 2011, Takashima
et al. 2010) and central (Cavanaugh et al. 2011, Mesnage et al. 2011, Nowak et al.
2011, Paul et al. 2012, Torsney et al. 2006, Zeilhofer et al. 2005) sensory neurons. A
transgenic mouse model that expresses the human NK1R with a green fluorescent
protein (GFP) marker gene has been developed (Vasiliou et al. 2007). However, the
utility of such a model is questionable as the expression pattern of GFP expressing
neurons is not comparable with the NK1R+ neuron pattern established by numerous
groups (Al-Khater et al. 2008, Brown et al. 1995, Mantyh et al. 1997, Spike et al.
2003, Todd 2010, Todd et al. 2000). Furthermore, this transgenic model (Vasiliou
et al. 2007) does not identify subpopulations of these neurons. To date no other study
has applied genetic labelling approaches to study the different lamina I NK1R+
neuron subpopulations.
The increased monosynaptic Aβ-fibre input to lamina I NK1R+ neurons reported
here just failed to reach a level of statistical significance and there is conflicting
evidence to support this finding. Previous studies that have examined the synaptic
input to lamina I NK1R+ neurons have shown there to be minimal monosynaptic
Aβ-fibre input to these neurons in both control and inflamed conditions (Torsney
2011, Torsney & MacDermott 2006). Normally, light touch / brush stimulation of the
hindpaw does not result in NK1R internalisation in lamina I neurons, however
following CFA inflammation and after the initial CFA-induced NK1R internalisation
has subsided, the same stimuli now cause NK1R internalisation (Abbadie et al. 1997,
Honor et al. 1999). This effect is thought to be mediated by a phenotypic switch in
Aβ-fibres, whereby there is novel SP expression in these fibres in inflammation
(Neumann et al. 1996) as opposed to novel monosynaptic Aβ-fibre input.
Furthermore, electrical stimulation of the sciatic nerve at Aβ-fibre strength fails to
evoke NK1R internalisation in lamina I neurons regardless of inflammation (Allen
et al. 1999). Incidentally, NK1R internalisation in response to electrical stimulation of
Aδ-fibres (Allen et al. 1999) and noxious mechanical stimuli (Abbadie et al. 1997,
Honor et al. 1999), which is known to be Aδ-fibre mediated (Treede & Magerl 2000),
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is increased following CFA inflammation. This can be considered to support the
previously reported finding that the incidence of Aδ-fibre input to lamina I NK1R+
neurons is increased in CFA inflammation (Torsney 2011). Following nerve injury
Aβ-fibres sprout dorsally into lamina I (Woolf et al. 1992, 1995) which could form
the basis of novel monosynaptic Aβ-fibre input. However, there is limited evidence
that this sprouting occurs in inflammation (Ma & Tian 2002) and this finding has been
strongly disputed by others (Hughes et al. 2003, Shehab et al. 2003, Tong et al. 1999),
so collateral sprouting is unlikely to account for the increase in Aβ-fibre input
reported here.
Under control conditions a portion of lamina I NK1R+ neurons which do not receive
conventional monosynaptic Aδ-fibre input, receive monosynaptic Aδ-fibre input
which forms pure-NMDA or ‘silent’ synapses (Torsney 2011). It is suggested that
inflammation results in the activation of these synapses, presumably through
α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR)
insertion into the post-synaptic membrane and provides a possible mechanism for the
unveiling of novel monosynaptic Aδ-fibre inputs, which could be relevant for
mechanical hyperalgesia (Torsney 2011). However, limited evidence was found for
the existence of silent monosynaptic Aβ-fibre input to lamina I NK1R+ neurons
(Torsney, unpublished data). Furthermore, while other studies provide clear evidence
for the presence of silent synapses in the dorsal horn (Baba et al. 2000, Bardoni et al.
1998, Jung et al. 2005, Li & Zhuo 1998), none of these studies identify the pre- or
post-synaptic populations involved. However, it is possible that these reported silent
synapses were formed with Aβ-fibres, as the minimum stimulation protocol used by
these studies to identify silent synapses enables the identification of silent synapses
with low-threshold afferents only (Baba et al. 2000, Bardoni et al. 1998, Li & Zhuo
1998). The existence of silent synapses in the dorsal horn of the spinal cord has
recently been disputed (Yasaka et al. 2009). However, as part of the silent synapse
identification protocol, presynaptic stimulation was paired with depolarisation of the
postsynaptic neuron to confirm the pharmacological inhibition of inhibitory
postsynaptic currents (IPSCs) (Yasaka et al. 2009). This pairing protocol has been
reported to drive AMPAR expression at silent synapses (Durand et al. 1996, Isaac
et al. 1995, Liao et al. 1995). Therefore, this finding is inconclusive as the protocol
used to identify silent synapses may have unintentionally altered any silent synapses
(Yasaka et al. 2009). In summary, if the novel monosynaptic Aβ-fibre input reported
here is a real effect, the mechanism by which these inputs are unmasked is unclear.
Inflammation did not result in any alteration in the amplitude of monosynaptic inputs
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to lamina I NK1R+ neurons. This finding does not confirm the previously reported
CFA induced potentiation of monosynaptic Aδ-fibre input amplitude, in neurons
which receive monosynaptic Aδ-fibre only input (Torsney 2011). However, the failure
of this study to detect novel monosynaptic Aδ-fibre input following inflammation
could account for this difference. This suggests that the increased incidence of
monosynaptic Aδ-fibre input following inflammation is correlated with this amplitude
potentiation (Torsney 2011). Therefore, it could be argued that the novel Aδ-fibre
inputs that are unmasked during inflammation display higher amplitudes than those
that are functional in control conditions. As such it is possible that the novel inputs
are responsible for the increased Aδ-fibre eEPSC amplitude, as opposed to there
being a potentiation of synapses which are functional in control conditions.
Furthermore, in vitro electrical stimulation of Aδ-fibre inputs to these neurons in
tissue isolated from control rats does not result in potentiation (Ikeda et al. 2006),
which could be considered to support this postulate.
It has been demonstrated that in vitro electrical stimulation of monosynaptic C-fibre
input on to lamina I NK1R+ neurons, to mimic the firing pattern seen during
peripheral inflammation can drive potentiation at these C-fibre synapses (Ikeda et al.
2006). This previous finding is not not supported by data reported here or by others
(Torsney 2011). However, this C-fibre potentiation was only present in a subset of
neurons which project to the PAG, which account for approximately a third of these
neurons (Spike et al. 2003). This population was not specifically targeted, therefore a
failure to reveal a similar effect could reflect the fact that data were recorded from
neurons that project to other targets (Al-Khater et al. 2008, Marshall et al. 1996, Spike
et al. 2003, Todd et al. 2000). The population of neurons that project to the PAG have
been demonstrated to display lower levels of NK1R immunoreactivity (Spike et al.
2003), therefore an alternative explanation is that TMR-SP labelling may not be
sufficient for identification of this subpopulation. To address these questions, it would
be necessary to record from pre-identified lamina I NK1R+ neuronal subpopulations.
If the subset of PAG projecting neurons were incorporated in this study, the failure to
observe C-fibre potentiation could be indicative of the different timescales employed,
with recordings made minutes following artificial electrical stimulation (Ikeda et al.
2006) versus days after natural stimulation through inflammation (Torsney 2011). To
establish whether C-fibre potentiation is a feature of early inflammatory processes,
C-fibre eEPSCs could be recorded in tissue isolated from rats within a period that is
shorter than the 2 - 6 days after CFA injection used here.
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2.5.3 Spontaneous excitatory input to lamina I neurokinin 1 receptor
expressing neurons
This study has novelly examined the spontaneous excitatory input to lamina I NK1R+
neurons and investigated whether this is influenced by CFA inflammation and/or the
type of monosynaptic primary afferent input received. CFA inflammation had no
significant effect on sEPSC frequency or amplitude in the overall population of lamina
I NK1R+ neurons or when the neuronal subpopulations receiving monosynaptic Aδ-
only, Aδ- & C- or C-fibre only input are considered independently. Interestingly, the
type of monosynaptic input on to these neurons significantly predicted sEPSC
frequency, but not amplitude, with neurons that received monosynaptic Aδ-fibre only
input displaying significantly greater sEPSC frequency than those receiving
monosynaptic C-fibre only input. The effect of input type on sEPSCs was investigated
only in neurons that received monosynaptic Aδ- and/or monosynaptic C-fibre input as
it was not possible to be certain that neurons classified as having polysynaptic input
only would not have had monosynaptic input in vivo as it may have been the case that
monosynaptic input was cut in the process of the spinal cord slice preparation.
Neurons that received monosynaptic Aβ-fibre input were not analysed in this manner
as the low numbers in the control group made statistical analysis unsound.
Although the data presented here did not find any change in the incidence of
monosynaptic Aδ-fibre input to lamina I NK1R+ neurons in CFA inflammation,
previous reports have suggested CFA results in an increase in monosynaptic Aδ-fibre
input to these neurons (Torsney 2011). Given that those neurons receiving
monosynaptic Aδ-fibre input display an elevated sEPSC frequency, if previous reports
are correct and this type of input is increased in inflammation, then it could be
hypothesised that there will also be an increase in the spontaneous excitatory drive to
these neurons.
It should be recognised that sEPSCs arise from both action-potential dependent and
action-potential independent neurotransmitter release (Engelman & MacDermott
2004). Although the increased sEPSC frequency in neurons receiving monosynaptic
Aδ-fibre only input cannot be directly attributed to the Aδ-fibre input, this seems a
plausible explanation given the previously reported potentiation in neurons with this
type of input (Torsney 2011). However, it is possible that this increased excitatory
input was driven from elsewhere in the spinal cord network. Additionally, while the
neuron in which sEPSCs were recorded was clamped at the Eanion (-70mV), thus
blocking direct inhibitory inputs, it is possible that varying levels of inhibition within
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the wider spinal cord network impact differently on sEPSCs in particular subgroups
of neuron. One approach to undertake a more complete investigation into the link
between primary afferent input and spontaneous excitatory input to lamina I NK1R+
neurons, would be to record miniature excitatory postsynaptic currents (mEPSCs) in
addition to sEPSCs. Recording in tetrodotoxin (TTX) to block network activity would
enable the direct study of spontaneous neurotransmitter release from synaptic
terminals directly onto these neurons. However, this would include excitatory input
from excitatory interneurons, so would be unable to give a definitive answer to the
influence of monosynaptic primary afferent input in setting sEPSC frequency in
lamina I NK1R+ neurons.
To my knowledge this is the first study that has investigated the effect of CFA
inflammation on spontaneous excitatory input to lamina I NK1R+ neurons. Others
have studied the effects of CFA inflammation on unidentified lamina II neurons and
report no effect on sEPSCs in rat (Lappin et al. 2006), but significantly increased
frequency and amplitude in mice (Park et al. 2011). Similarly there are conflicting
reports on the effect of nerve injury on sEPSCs. No effects were found in unidentified
neurons in the lamina I/II (Spicarova et al. 2011) and IIo regions (Kohno et al. 2003).
Nerve injury has also been reported to cause changes in sEPSC frequency and/or
amplitude in lamina II neurons, although the effect was different depending upon the
action potential discharge pattern that the neuron displayed, where for example
‘tonic’ neurons show reduced sEPSC frequency while ‘phasic’ firing neurons show
increased frequency (Balasubramanyan et al. 2006).
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2.6 Conclusion
The results presented here demonstrates that CFA inflammation does not alter the
electrical activation threshold, conduction velocity or amplitude of Aβ-, Aδ- or
C-fibre components in rat dorsal roots (figure 2.9, table 2.2). These findings confirm
previous reports showing inflammation does not alter these properties in juveniles
(Torsney 2011) and adults (Baba et al. 1999, Nakatsuka et al. 1999). These findings
mean that identical parameters can be used to activate the different primary afferent
fibres in eEPSC studies performed in spinal slices with dorsal roots attached, isolated
from control and CFA treated rats. These data also confirm the stimulation intensities
used to activate Aδ- and C-fibres in previous studies (Nakatsuka et al. 2000, Torsney
2011, Torsney & MacDermott 2006). However, it was established that a slightly
lower intensity should be used to activate Aβ-fibres, to prevent potential
misidentification of primary afferent inputs.
In the data presented here, CFA inflammation did not alter the overall pattern of
primary afferent input to lamina I NK1R+ neurons or the incidence of monosynaptic
and polysynaptic inputs, apart from an increase in monosynaptic Aβ-fibre input that
did not reach statistical significance (figure 2.14). This did not replicate the
previously reported alterations in monosynaptic Aδ-fibre input to these neurons
during inflammation (Torsney 2011). Similarly, the potentiation of a subset of
monosynaptic Aδ-fibre inputs in inflammation (Torsney 2011) was not found in these
data presented here (figure 2.15, table 2.3). Inflammation did not increase C-fibre
eEPSC amplitude, which confirms that potentiation of C-fibre synapses with lamina I
NK1R+ neurons is not a feature of CFA inflammation (Torsney 2011).
These data presented here have novelly shown that CFA inflammation does not alter
sEPSC frequency or amplitude in lamina I NK1R+ neurons, either in the entire
population or when the neuronal subpopulations receiving monosynaptic Aδ- only,
Aδ- & C- or C-fibre only input are considered independently (figure 2.16, table 2.4).
Furthermore, neurons that received monosynaptic Aδ-fibre only input displayed
significantly greater sEPSC frequency that neurons receiving monosynaptic C-fibre
only input. This suggests that if the previously reported increase in the incidence of
monosynaptic Aδ-fibre input to lamina I NK1R+ neurons following inflammation
(Torsney 2011) is a genuine effect, then this could be associated with an increase in
spontaneous excitatory input to these neurons.
Chapter 3
Chemerin modulation of potentiated
primary afferent input to lamina I
neurokinin 1 receptor expressing neurons
3.1 Introduction
Many currently available treatments for inflammatory pain lack efficacy and/or exhibit
undesirable side effects (Scholz & Woolf 2002). Commonly used pharmacological
interventions for inflammatory pain include opioids and cyclooxygenase (COX)
inhibitors, however use of these drugs can result in complications. Non-selective
COX inhibitors can lead to kidney damage and gastrointestinal bleeding, while
selective COX-2 inhibitors are known to elevate the risk of cardiovascular disease
(Mattia & Coluzzi 2005, Mukherjee et al. 2001, Sommer & Birklein 2010). Opioids
often cause sedation, nausea, respiratory depression, constipation, cognitive
disturbances and in cases of long-term use can lead to addiction (Noble et al. 2010,
Sommer & Birklein 2010, Xu & Ji 2011). Development of new analgesics that are
both efficacious and lack such side effects is therefore a key challenge for pain
research. The goal of this chapter is to investigate whether chemerin, an agonist of the
chemerin receptor 23 (ChemR23), can modulate potentiated primary afferent input to
lamina I neurokinin 1 receptor expressing (NK1R+) neurons. The findings from the
studies presented here could provide insight into whether ChemR23 represents a
promising target for the development of novel inflammatory pain treatment strategies,
as recent studies have suggested (Xu et al. 2010).
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3.1.1 The use of novel lipid mediators in the treatment of inflammatory
pain
In recent years there has been a growing interest in the use of novel lipid mediators,
including lipoxins, protectins / neuroprotectins and resolvins, in the treatment of
inflammatory diseases (Recchiuti & Serhan 2012, Serhan 2010, Serhan & Chiang
2008, Serhan et al. 2008). In the case of inflammatory pain, particular attention has
been focussed on the resolvins, which includes resolvin E1 (RvE1), resolvin D1
(RvD1) and resolvin D2 (RvD2) (Ji et al. 2011, Lee 2012, Park et al. 2011, Sommer
& Birklein 2010, Xu & Ji 2011, Xu et al. 2010). Resolvins are endogenously
synthesised from the omega-3 fatty acids docosahexaenoic acid (RvD1 and RvD2)
and eicosapentaenoic acid (RvE1) (Serhan et al. 2008, 2002, Spite et al. 2009).
Interestingly, dietary intake of these omega-3 fatty acids can provide relief from
inflammatory joint pain (Goldberg & Katz 2007, Lee et al. 2012, Tokuyama &
Nakamoto 2011) and there is some evidence that omega-3 fatty acid supplements can
attenuate neuropathic pain (Ko et al. 2010) and reduce non-steroidal
anti-inflammatory drug (NSAID) intake following surgery (Maroon & Bost 2006) and
in rheumatoid arthritis (Galarraga et al. 2008). In addition to exhibiting
anti-inflammatory properties, resolvins have been shown to play a unique role in the
resolution of inflammation, which in recent years has been demonstrated to be an
active homeostatic process that is distinct from inflammation (Lawrence et al. 2002,
Serhan & Chiang 2008, Serhan et al. 2008). The pro-resolution activity of resolvins is
in contrast to many commonly used inflammatory pain treatments, such as COX-2
inhibitors and local anaesthetics, that actually inhibit key resolution processes
(Chiang et al. 2008, Gilroy et al. 1999, Schwab et al. 2007, Serhan et al. 2008). It has
been speculated that this inhibition of natural resolution may actually extend the
period of inflammatory pain (Ji et al. 2011).
Resolvins have been suggested to be a promising novel treatment for inflammatory
pain in part because they are proposed to exhibit limited side effects due to a number
of factors (Ji et al. 2011, Xu et al. 2010). As naturally occurring endogenous
mediators they are likely to be safe. These compounds are also highly potent at low
concentrations, exhibiting comparable analgesic activity to morphine and COX-2
inhibitors at much lower doses (Xu et al. 2010). The resolvins RvE1, RvD1 and
RvD2 do not alter baseline thermal or mechanical withdrawal thresholds, while RvE1
and RvD2 are without effect on the first phase of the formalin-induced pain.
Therefore, resolvins attenuate maladaptive / chronic pain but do not alter protective
acute pain responses. (Huang et al. 2011, Park et al. 2011, Xu et al. 2010).
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There is a growing body of evidence to support the use of resolvins in the treatment of
inflammatory pain, where it has been shown that resolvins have both peripheral and
central mechanisms of action (Xu et al. 2010).
Peripheral administration of RvE1 significantly reduces oedema in the carrageenan
inflammatory pain model (Xu et al. 2010). Specifically, pretreatment with RvE1
significantly reduced the carrageenan-induced increases in neutrophil infiltration and
proinflammatory cytokine and chemokine expression (Xu et al. 2010).
Central (intrathecal) administration of resolvins has been shown to be highly effective
in attenuating thermal, mechanical and chemical hypersensitivity in a number of
inflammatory and neuropathic pain models, as shown in table 3.1. The fact that
resolvins can attenuate mechanical hypersensitivity, which is known to be a centrally
mediated process (Klede et al. 2003, Lewin et al. 2004) and the second phase of
formalin-induced hypersensitivity, which is typically considered to be driven by
central sensitisation (Ji et al. 1999, Yamamoto & Yaksh 1992), indicates that resolvins
have a central mechanism of action.
The central activity of RvE1 has been investigated in relation to its effects on;
1. Tumor necrosis factor-α (TNF-α) signalling: which is crucial in centrally
mediated inflammatory pain processes (Kawasaki et al. 2008)
2. Transient receptor potential subtype vanilloid 1 (TRPV1) channels: that are
known to be essential for thermal hypersensitivity (Caterina et al. 2000, Davis
et al. 2000) and which can be sensitised by TNF-α and other inflammatory
mediators, with this sensitisation contributing to inflammatory pain (Basbaum
et al. 2009, Cheng & Ji 2008, Palazzo et al. 2012, Pingle et al. 2007).
RvE1 abolished both the capsaicin and TNF-α mediated potentiation of spontaneous
excitatory postsynaptic current (sEPSC) frequency, but not amplitude, in unidentified
lamina II spinal cord neurons (Xu et al. 2010). The authors suggest that this finding
indicates a presynaptic mechanism of action, however sEPSCs were recorded, where
network activity is not blocked by tetrodotoxin (TTX), so this cannot be concluded
from their results. These effects were further demonstrated to be mediated via
extracellular signal-regulated kinase (ERK) signalling. Inhibition of the ERK
pathway, with the mitogen-activated protein kinase kinase (MEK) inhibitors PD98059
and U0126, prevented the capsaicin potentiation of sEPSCs. RvE1 also reduced
capsaicin / TNF-α driven ERK phosphorylation (pERK) in dorsal root ganglia (DRG)
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cultures, which support a presynaptic mechanism of action (figure 3.1A) (Xu et al.
2010).
The postsynaptic effects of RvE1 have been investigated in unidentified lamina II
neurons, where it was shown that RvE1 attenuates the TNF-α-mediated potentiation
of postsynaptic N-methyl-D-aspartate (NMDA) currents and phosphorylation of ERK
(Xu et al. 2010), the latter being considered a marker of central sensitisation (Ji et al.
1999, Karim et al. 2001).
Notably, RvE1 alone did not alter sEPSCs or the phosphorylation of ERK in DRG or
dorsal horn neurons (Xu et al. 2010). Therefore, the evidence provided by Xu et al.
(2010) indicates that resolvins reduce inflammatory pain by two mechanisms;
1. By reducing the peripheral inflammatory response.













































Stimulus Model RvE1 RvD1 RvD2 Reference
Thermal
CFA X X X Park et al. 2011, Xu et al. 2010
carrageenan X X X Park et al. 2011, Xu et al. 2010
SNL X Xu et al. 2013, 2010
Mechanical
CFA X Xu et al. 2010
carrageenan X X X Abdelmoaty et al. 2011, Park et al. 2011
TNFα X Xu et al. 2010
post-operative pain X X Huang et al. 2011, Xu et al. 2010
CCI X Xu et al. 2013
SNL X Xu et al. 2013
Chemical
formalin (2nd phase) X X X Park et al. 2011, Xu et al. 2010
capsaicin (i.t.) X Xu et al. 2010
Table 3.1: Attenuation of behavioural hypersensitivity by resolvins.
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Figure 3.1: Schematic diagram of RvE1 mediated attenuation of inflammatory pain. A In
the central terminals of primary afferent fibres, RvE1 attenuates inflammatory pain
hypersensitivity via a reduction in ERK phosphorylation leading to a reduction in the
presynaptic release of glutamate. B In poststynaptic dorsal horn neurons, RvE1
attenuates inflammatory pain through the inhibition of potentiated NMDA currents by
suppressing ERK phosphorylation. Adapted from Xu et al. 2010.
Resolvins have also demonstrated an ability to regulate a number of transient receptor
potential (TRP) channels, including TRPV1, transient receptor potential subtype
vanilloid 3 (TRPV3), transient receptor potential subtype vanilloid 4 (TRPV4) and
transient receptor potential subtype ankyryn 1 (TRPA1) (Bang et al. 2012, 2010, Park
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et al. 2011). Notably, these channels are known to be involved in the inflammatory
pain response (Alessandri-Haber et al. 2005, Basbaum et al. 2009, Caterina et al.
2000, Davis et al. 2000, Mandadi & Roufogalis 2008, McMahon & Wood 2006). A
list of TRP channels that are inhibited by resolvins is shown in table 3.2. All resolvins
were shown to be particularly potent inhibitors of these TRP channels and highly
active at low nM concentrations. Interestingly, RvE1 was reported to inhibit TRPV1
channels to a much greater extent than the commonly used TRPV1 antagonist
AMG9810, with an IC50 of 1nM versus 163nM for AMG9810 (Park et al. 2011). The
exact mechanisms by which resolvins inhibit TRP channels is not well understood.
However, current evidence suggests that the resolvin inhibition of TRP channels is
mediated via G-protein coupled receptors (GPCRs) as opposed to direct interactions
with the channels (Ji et al. 2011, Park et al. 2011, Xu et al. 2010). Specifically, the
RvE1 mediated inhibition of TRPV1 is thought to result from RvE1 acting via the
GPCR, ChemR23 (also known as chemokine receptor-like 1 (CMKLR1)) to inhibit
the phosphorylation of ERK and presynaptic release of glutamate (Xu et al. 2010). It
is also worth noting that the omega-3 fatty acid, resolvin precursors, have been
reported to modulate the activity of TRP channels (Leonelli et al. 2011).
Channel RvE1 RvD1 RvD2 17R-RvD1 Reference
TRPV1 X X Park et al. 2011, Xu et al. 2010
TRPV3 X X Bang et al. 2012, 2010
TRPV4 X Bang et al. 2010
TRPA1 X X Bang et al. 2010, Park et al. 2011
Table 3.2: Inhibition of TRP channels by resolvins.
The evidence discussed above strongly suggests that resolvins, particularly RvE1, are
effective at attenuating inflammatory pain through a mechanism whereby potentiated
spinal cord responses are normalised. However, these findings were made in
unidentified lamina II neurons, so it is unclear which neuronal subtypes are involved.
Lamina I NK1R+ neurons are known to be essential for the development of
inflammatory pain (Nichols et al. 1999), which is driven by C-fibres (Abrahamsen
et al. 2008), some of which may be potentiated in inflammation (Ikeda et al. 2006).
Therefore, it is possible that some of the effects of the resolvins could be mediated
through an attenuation of potentiated primary afferent input to these key spinal cord
output neurons.
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3.1.2 ChemR23 as a potential target for the treatment of inflammatory
pain
RvE1 has been reported to act through the Gαi coupled GPCR, ChemR23 (Arita et al.
2005). This finding has been disputed as the result has not been replicated by other
groups (Bondue et al. 2011). However, the ability of RvE1 to attenuate hyperalgesia
in the carrageenan and formalin pain models was abolished by application of the Gαi
inhibitor, pertussis toxin (PTX) and ChemR23 siRNA, with PTX also blocking the
RvE1 attenuation of potentiated spinal cord responses (Xu et al. 2010). Therefore,
ChemR23 clearly plays a role in mediating the RvE1 attenuation of inflammatory
pain responses and represents a potential target for the development of novel
inflammatory pain treatments.
ChemR23 is largely expressed in adipocytes (Bozaoglu et al. 2007, Goralski et al.
2007, Huang et al. 2010, Roh et al. 2007) and immune cells including monocytes,
macrophages, dendritic cells, microglia and natural killer cells (Bondue et al. 2011,
Graham et al. 2009, Luangsay et al. 2009, Parolini et al. 2007, Samson et al. 1998,
Vermi et al. 2005). While the expression data for ChemR23 in pain pathways is not
comprehensive, anatomical studies have demonstrated that ChemR23 is expressed
both peripherally in DRG cell bodies and centrally in the central terminals of primary
afferent fibres and also in spinal cord neurons (Xu et al. 2010). Further evidence from
microarray studies corroborates that ChemR23 mRNA is expressed in DRG neurons
and in the dorsal horn (Abdelmoaty et al. 2011, Rodriguez Parkitna et al. 2006).
However, as these were microarray studies of DRG tissue it is not possible to attribute
ChemR23 expression level changes to any particular subpopulation of DRG neurons.
ChemR23 mRNA expression is not altered in DRG or spinal cord neurons following
complete Freund’s adjuvant (CFA) inflammation (Rodriguez Parkitna et al. 2006), but
is increased in dorsal horn neurons by carrageenan inflammation (Abdelmoaty et al.
2011) and nerve injury (Rodriguez Parkitna et al. 2006). Almost a third of all DRG
neurons express ChemR23 and there is a large degree of co-expression between
ChemR23 and TRPV1, with 61% of TRPV1 expressing (TRPV1+) DRG neurons
also expressing ChemR23 (Xu et al. 2010). In the superficial lamina of the dorsal
horn, ChemR23 is expressed on substance P (SP) containing axon terminals (Xu et al.
2010). These findings are particularly interesting for the following reasons. The
majority of C-fibres and some Aδ-fibres express TRPV1 (Amaya et al. 2003,
Kobayashi et al. 2005, Michael & Priestley 1999, Yu et al. 2008), while around a half
of C-fibres and a fifth of Aδ-fibres contain SP (Lawson et al. 1997, 1993, McCarthy &
Lawson 1989). Lamina I NK1R+ neurons receive monosynaptic input from C- and
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Aδ-fibres (Torsney 2011, Torsney & MacDermott 2006), that are known to include
TRPV1+ (Hwang et al. 2003, Labrakakis & MacDermott 2003, Tong & MacDermott
2006) and SP containing (Hwang et al. 2003, Todd et al. 2002) inputs. Therefore,
given the co-expression of ChemR23 with TRPV1 and SP (Xu et al. 2010) it is
possible that lamina I NK1R+ neurons will receive input from primary afferents that
express ChemR23. Therefore, it is hypothesised that ChemR23 is likely to be
functionally expressed on primary afferent input to lamina I NK1R+ neurons and that
activation of these ChemR23 receptors could attenuate potentiated primary afferent
input to these key spinal cord output neurons that are crucial for the manifestation of
inflammatory pain (Nichols et al. 1999).
Chemerin
The peptide chemerin has been identified as the natural ChemR23 ligand (Meder et al.
2003, Wittamer et al. 2003). It is currently unclear which cell types are responsible
for the endogenous production and release of chemerin, however endothelial cells,
keratinocytes, chondrocytes, platelets and osteoclasts have been proposed as possible
sources (Berg et al. 2010, Bondue et al. 2011, Du et al. 2009, Luangsay et al. 2009,
Nagpal et al. 1997, Vermi et al. 2005). Chemerin plays a key role in a number of
physiological processes including adipocyte generation and metabolism (Goralski
et al. 2007) and the chemotaxis of macrophages and dendritic cells (Wittamer et al.
2003). The role of endogenous chemerin in the modulation of inflammatory pain is
currently unknown. However, like RvE1, chemerin application has been shown to
significantly reduce the second phase of formalin-induced pain and inhibit the
capsaicin potentiation of spinal cord responses (Xu et al. 2010). It is therefore
possible that chemerin activation of ChemR23 receptors could attenuate primary
afferent input to a subset of lamina I NK1R+ neurons.
3.1.3 Summary
The evidence discussed above demonstrates that activation of ChemR23 with the
agonists chemerin and RvE1 can attenuate the behavioural hypersensitivity associated
with inflammatory pain, by a mechanism that involves the normalisation of
potentiated spinal cord responses. Furthermore, ChemR23 is expressed on TRPV1+
and SP containing primary afferents (Xu et al. 2010). Lamina I NK1R+ neurons are
essential for the manifestation of inflammatory pain (Nichols et al. 1999) and some of
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the monosynaptic C- and monosynaptic Aδ-fibre input they receive may be
potentiated in inflammation (Ikeda et al. 2006, Torsney 2011). In addition, these
neurons are known to receive input from TRPV1+ and SP containing afferents
(Hwang et al. 2003, Labrakakis & MacDermott 2003, Todd et al. 2002, Tong &
MacDermott 2006). Therefore, it is hypothesised that ChemR23 is likely to be
functionally expressed on a subset of inputs to these neurons. ChemR23-mediated
analgesia could in part be due to a normalisation of potentiated monosynaptic C-
and/or monosynaptic Aδ-fibre excitatory input to these neurons. As such, the
application of chemerin could attenuate primary afferent input to a subset of these
neurons in inflammatory pain. Notably, RvE1 is not commercially available, therefore
it was not possible to investigate the effect of this compound upon primary afferent
input to lamina I NK1R+ neurons.
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3.2 Chapter aims and hypotheses
The experiments presented in this chapter were performed to determine whether
chemerin, an agonist of the novel inflammatory pain target ChemR23 (Xu et al.
2010), can attenuate potentiated primary afferent input to lamina I NK1R+ neurons
and to address the aims and hypotheses detailed below.
Aims
1. Using miniature excitatory postsynaptic current (mEPSC) recordings, establish
whether the ChemR23 agonist, chemerin, modulates excitatory input to lamina
I NK1R+ neurons in non-potentiated conditions.
2. Determine whether chemerin can attenuate the capsaicin potentiation of
primary afferent input to these neurons, as measured using mEPSC recordings.
3. Ascertain whether ChemR23 is functionally expressed on monosynaptic C-
and/or monosynaptic Aδ-fibre input to lamina I NK1R+ neurons, using dorsal
root evoked excitatory postsynaptic current (eEPSC) recordings.
4. By employing dorsal root eEPSC recordings, investigate the ability of chemerin
to modulate monosynaptic C- and/or monosynaptic Aδ-fibre input to these
neurons and establish whether chemerin effects are dependent upon CFA
inflammation.
Hypotheses
1. In non-potentiated conditions, chemerin will not alter mEPSCs in lamina I
NK1R+ neurons.
2. Chemerin will attenuate the capsaicin potentiation of mEPSCs in lamina I
NK1R+ neurons.
3. ChemR23 will be functionally expressed on a subset of monosynaptic C-fibre
and to a lesser extent a subset of monosynaptic Aδ-fibre input, to lamina I
NK1R+ neurons.
4. In CFA inflammation, chemerin will attenuate monosynaptic C-fibre input to a
subset of lamina I NK1R+ neurons and to a lesser extent will attenuate
monosynaptic Aδ-fibre input to a subset of these neurons.
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3.3 Methods
3.3.1 Animals
As described in section 2.3.1.
3.3.2 Complete Freunds’s adjuvant inflammation
As described in section 2.3.2.
3.3.3 Capsaicin potentiation
Spinal cord slice preparation
Spinal cords were removed from control rats only and spinal cord slices were made as
described in section 2.3.4, except all dorsal roots were removed prior to embedding
the spinal cord in agar.
Miniature excitatory postsynaptic current (mEPSC) recordings
Whole cell patch-clamp configuration, as described in section 2.3.4, was used to
record mEPSCs from NK1R+ neurons in lamina I. Bath application of 0.5µM TTX
(Alomone Labs) was used to block action potential dependent events. Inhibition was
blocked by recording at a holding potential of -70mV, which is the anion reversal
potential (Eanion) in lamina I neurons (Coull et al. 2003) and bath application of the
GABAA receptor (GABAAR) and glycine receptor (GlyR) antagonists, bicuculline
(10µM, Tocris) and strychnine (1µM, Sigma), respectively. The internal solution
composition was as follows (in mM, all Sigma); 110 K-methanesulfonate, 10 NaCl,
10 EGTA, 1 CaCl2, 10 HEPES, 5 Mg-ATP, 0.5 Na-GTP, pH adjusted to 7.2 with
KOH, osmolarity ∼290mOsm. 1µM Alexa Fluor 488 hydrazide (Molecular Probes)
was also included in the recording pipette. Junction potential was corrected prior to
recording. Data were acquired and recorded using an Axopatch 200B amplifier and
pClamp 10 software (Molecular Devices). Data were filtered at 5kHz and digitised at
10kHz. Neurons were excluded if any of the following criteria were met: access
resistance; >25MΩ, holding current; >100pA or <-100pA, membrane resistance;
<300MΩ.
CHAPTER 3: CHEMERIN MODULATION OF INPUT TO NK1R+ NEURONS 98
Capsaicin potentiation of excitatory input to lamina I neurokinin 1
receptor expressing neurons
Baseline mEPSCs were recorded for 5 minutes, following which the TRPV1 agonist,
capsaicin (1µM, Sigma) was bath applied for a further 5 minutes to pharmacologically
potentiate primary afferent input (Yang et al. 1998). TRPV1 is only found on primary
afferents in the spinal cord (Caterina et al. 1997, Cavanaugh et al. 2011, Tominaga
et al. 1998), with the majority of C- and some A-fibres expressing the channel
(Amaya et al. 2003, Kobayashi et al. 2005, Michael & Priestley 1999, Yu et al. 2008).
One study has suggested that TRPV1 may be expressed on a subset of lamina II
GABAergic interneurons (Kim et al. 2012), however this finding has not been
validated by recent studies using transgenic TRPV1 reporter mice, that clearly
demonstrate that TRPV1 is not expressed on dorsal horn neurons and is only present
in the central terminals of primary afferent fibres in the spinal cord (Cavanaugh et al.
2011). Therefore, applying capsaicin to spinal cord slices should potentiate primary
afferent input only, by increasing the release of glutamate from the central terminals
(Kim et al. 2009). Importantly, lamina I NK1R+ neurons are known to receive input
from TRPV1+ afferents (Labrakakis & MacDermott 2003). Potentiation was assessed
by comparing mEPSCs recorded at baseline and during capsaicin application. To
assess whether ChemR23 activation modulates this capsaicin potentiation,
recombinant mouse chemerin (100ng/ml, R&D Systems) was applied for 10 minutes
prior to and throughout capsaicin application, in a separate group of lamina I NK1R+
neurons. It was not possible to carry out a single neuron analysis of the chemerin
modulation of capsaicin mEPSC potentiation because capsaicin mEPSC potentiation
shows significant reductions with repeated capsaicin application (data not shown).
Therefore, separate neuronal groups were studied to assess the effect of capsaicin
alone, chemerin & capsaicin and chemerin alone. Recombinant mouse chemerin was
used because rat chemerin is not commercially available, however there is a high
degree of homology between rat and mouse chemerin and cross-species activity has
been reported (Busmann et al. 2004). Although much of the interest in targeting
ChemR23 revolves around the use of RvE1 (Ji et al. 2011, Lee 2012, Park et al. 2011,
Sommer & Birklein 2010, Xu & Ji 2011, Xu et al. 2010), this compound is not
commercially available so it was not possible to investigate its potential. The effect of
ChemR23 activation in non-potentiated conditions was similarly assessed by applying
chemerin alone. In all cases mEPSC frequency and amplitude was measured during
the final 2 minutes of baseline or drug application and were analysed using Mini
Analysis (Synaptosoft). mEPSC events were automatically detected by the software
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and were then accepted or rejected following further visual examination.
3.3.4 Inflammatory pain
Spinal cord slice preparation
Spinal cords were isolated from control and CFA treated rats and spinal slices with
dorsal roots attached were prepared as described in section 2.3.4.
Effects of chemerin application on dorsal root evoked primary afferent
input to lamina I neurokinin 1 receptor expressing neurons
To assess the ability of chemerin to modulate primary afferent input to lamina I
NK1R+ neurons in an inflammatory pain model, the effect of chemerin was assessed
on monosynaptic C- and monosynaptic Aδ-fibre eEPSCs in tissue isolated from
control and CFA treated rats.
Monosynaptic C- and monosynaptic Aδ-fibre input to lamina I NK1R+ neurons was
identified in the manner described previously in section 2.3.5. Following input
characterisation, dorsal roots were then stimulated at an intensity of 500µA, with a
stimulus duration of 0.1ms and a frequency of 0.05Hz and eEPSCs recorded. eEPSCs
were recorded for a baseline period of 10 minutes, followed by a further 15 minutes
minutes where chemerin (100ng/ml) or vehicle (Krebs only) was applied. A vehicle
control was recorded because previous observations in our laboratory have shown that
repetitive stimulation of monosynaptic C- and monosynaptic Aδ-fibres in this manner
can result in a gradual ‘run-down’ of the response (unpublished data), this can also be
observed in figure 3.5A. Therefore, by comparing chemerin data to vehicle control
this enabled the accurate determination of the amplitude changes resulting from
chemerin treatment independently from any changes that may occur due to run-down.
Peak eEPSC amplitude was measured for each sweep, as shown in figure 2.15A and
mean peak amplitude per minute was calculated. All data were normalised to minute
2, because in many neurons there was a large degree of run-down in the peak eEPSC
amplitude between minute 1 and minute 2, after which the response generally
stabilised. Neurons in which the peak amplitude could not be clearly identified were
excluded. To compare the effect of chemerin / vehicle between control and CFA
treated tissue, the amplitude change between the mean eEPSC amplitude for baseline
(10 minutes) and final 5 minutes of chemerin / vehicle application was calculated as








It was hypothesised that chemerin would modulate primary afferent input to a subset
of lamina I NK1R+ neurons, given that ChemR23 is only expressed on a subset of
TRPV1+ and a subset of SP containing afferents (Xu et al. 2010). To identify this
subgroup, linear regression analysis was performed on vehicle data to calculate 95%
prediction bands. A neuron was classified as a responder if the peak eEPSC amplitude
fell below the lower limit of the 95% prediction bands for at least the final 5 minutes
of chemerin application. To evaluate the validity of this classification method and to
assess whether responders and non-responders were two distinct subpopulations,
frequency histograms of mean peak amplitude in the final 5 minutes of chemerin /
vehicle application were plotted.
To determine the pre- / post-synaptic nature of chemerin effects, paired-pulse
recordings were conducted in a subset of neurons that received monosynaptic C-fibre
input in tissue isolated from CFA treated rats. eEPSCs were recorded in the manner
described above, however each dorsal root evoked event featured 2 stimuli given in
close succession, with an interstimulus interval of 500ms (figure 3.8A). The duration
of this interstimulus interval is longer than is typically been used in paired-pulse
recordings (Bardoni et al. 2007, Li & Baccei 2009), however stimulation of C-fibres
at frequencies of >1Hz, which is equivalent to an interstimulus interval of <1000ms,
results in failures to fire action potentials (Nakatsuka et al. 2000). Therefore, 500ms
was chosen to balance the need for the two stimuli to be given close enough so that
the second release event is influenced by the first, with the need to avoid action
potential failures. Paired-pulse ratio (PPR) was calculated for the 5 minutes prior to
(‘pre-chemerin’) and the final 5 minutes of chemerin application using the following
equation, so as to correct for misleading facilitation that can be caused by random





To examine whether the initial eEPSC amplitude was predictive of the chemerin
response, the correlation between initial amplitude at minute 2 and the amplitude
change, recorded in the final 5 minutes of chemerin application was analysed. As it
was hypothesised that chemerin would reduce potentiated inputs, this analysis was
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performed to provide insight into whether neurons that received inputs with greater
initial eEPSC amplitudes (possibly signifying potentiated inputs) displayed enhanced
chemerin responses.
3.3.5 Statistical analysis
All data were assessed for normality using D’Agostino & Pearson omnibus normality
tests, or Kolmogorov-Smirnov tests if sample sizes were insufficient to use the former,
to establish whether it was appropriate to use parametric or non-parametric statistical
tests, or whether data should be transformed prior to performing parametric tests.
Paired t-tests were used to assess changes in mEPSC frequency and amplitude
following application of chemerin alone, capsaicin alone and chemerin & capsaicin,
except for frequency following chemerin alone where a Wilcoxon test was used. To
determine whether chemerin altered the capsaicin potentiation of mEPSC frequency
or amplitude, 2-way repeated measures ANOVA, followed by Bonferroni post-tests
were used. To establish whether chemerin alone, capsaicin alone or chemerin &
capsaicin caused significant changes in the probability distribution of mEPSC
inter-event interval or amplitude within individual neurons, a 2 sample
Kolmogorov-Smirnov test was used.
The influence of time and chemerin on monosynaptic C- and monosynaptic Aδ-fibre
eEPSCs in tissue isolated from both control and CFA treated rats was assessed by
2-way repeated measures ANOVA followed by Bonferroni post-tests. The difference
in amplitude change between control and CFA groups was assessed using 2-way
ANOVA followed by Bonferroni post-tests and differences in amplitude change
between CFA vehicle, chemerin responder and chemerin non-responder groups were
analysed with 1-way ANOVA followed by Bonferroni post-tests. To determine
whether there were differences in the frequency distribution of peak amplitude in the
final 5 minutes of chemerin application between vehicle, chemerin responder and
chemerin non-responder groups, 1-way ANOVA followed by Bonferroni post-tests
were used. The effect of chemerin on PPR in neurons classified as chemerin
responders and chemerin non-responders was statistically analysed by 2-way repeated
measures ANOVA followed by Bonferroni post-tests. To assess whether there was
any correlation between initial eEPSC amplitude and the chemerin reduction in
amplitude, Pearson’s r test was used.
All data are presented as mean ± standard error of the mean (SEM). All statistical
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analysis was performed using Prism 6 (Graphpad Software).
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3.4 Results
3.4.1 Chemerin alone does not alter mEPSC frequency or amplitude in
lamina I neurokinin 1 receptor expressing neurons
To assess whether chemerin alone altered synaptic input to lamina I NK1R+ neurons,
mEPSCs were recorded in the absence (‘baseline’) and presence of chemerin.
Representative traces of baseline and chemerin recordings are shown in figure 3.2A.
Chemerin did not alter the probability distribution of inter-event intervals in 6/11
neurons. In 2/11 neurons there was a significant leftward shift, indicating shorter
inter-event intervals / increased frequency. In 3/11 neurons there was a significant
rightwards shift, indicating longer inter-event intervals / reduced frequency (all
statistics, Kolmogorov-Smirnov 2-sample test, example shown in figure 3.2B).
Overall chemerin had no significant effect on mEPSC frequency (P=0.824, Wilcoxon,
n=11, figure 3.2C). The cumulative probability distribution of mEPSC amplitude was
not altered by chemerin in 5/11 neurons, but significantly leftward shifted, indicating
reduced amplitude, in 1/11 and significantly rightward shifted, indicating increased
amplitude, in 5/11 (all statistics, Kolmogorov-Smirnov 2-sample test, example shown
in figure 3.2D). The summary data show that chemerin alone did not significantly
alter mEPSC amplitude in lamina I NK1R+ neurons (P=0.654, paired t-test, n=11,
figure 3.2E)
































































































Figure 3.2: Chemerin does not alter lamina I NK1R+ neuron mEPSC frequency or
amplitude. A Representative mEPSC traces recorded prior to (baseline, left) and during
chemerin application (right). B Example cumulative probability curve shows chemerin
does not alter the distribution of mEPSC inter-event intervals in an individual neuron
(P=0.992, 2-sample Kolmogorov-Smirnov test). C Summary data shows that chemerin
did not significantly alter mEPSC frequency (P=0.824, Wilcoxon, n=11). D Example
cumulative probability curve shows chemerin had no effect on mEPSC amplitude
distribution in an individual neuron (P=0.171, 2-sample Kolmogorov-Smirnov test). E
Summary data demonstrates that chemerin did not alter mEPSC amplitude (P=0.654,
paired t-test, n=11). Black lines in C & E denote mean ± SEM, grey points & lines show
trajectories for individual neurons.
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3.4.2 Chemerin attenuates capsaicin potentiation of primary afferent
input to lamina I neurokinin 1 receptor expressing neurons.
To determine whether chemerin could attenuate capsaicin potentiation of primary
afferent input to lamina I NK1R+ neurons, mEPSCs were recorded prior to and during
capsaicin treatment, in two populations of neurons in either the presence (n=10) or
absence (n=12) of chemerin. Figure 3.3A shows representative traces recorded in the
absence of chemerin, before (‘baseline’) and during capsaicin treatment (‘capsaicin’),
3.3D displays traces recorded in the presence of chemerin, prior to (‘chemerin’) and
during capsaicin treatment (‘chemerin & capsaicin’). Capsaicin alone resulted in a
significant leftwards shift in the distribution of inter-event intervals in 10/12 neurons,
while in 2/12 there was no effect (all statistics, Kolmogorov-Smirnov 2-sample test,
example shown in figure 3.3B). Summary data show that capsaicin alone resulted in a
large significant potentiation of mEPSC frequency (P=0.002, paired t-test, n=12,
figure 3.3C). Capsaicin applied in the presence of chemerin resulted in a significant
leftwards shift in inter-event interval distribution in 9/10 neurons, while there was no
effect in 1/10 (all statistics, Kolmogorov-Smirnov 2-sample test, example shown in
figure 3.3D). Overall, capsaicin applied in the presence of chemerin caused a
significant increase in mEPSC frequency (P=0.008, paired t-test, n=10, figure 3.3F).
When the effect of chemerin on the capsaicin potentiation was assessed, it was
discovered that capsaicin, in the presence and absence of chemerin, significantly
increased the frequency of mEPSCs (P=0.0001, 2-way repeated measures ANOVA),
however this capsaicin potentiation was significantly reduced by chemerin (P=0.031,
2-way repeated measures ANOVA, Bonferroni post-test, figure 3.3G).




































































































































Figure 3.3: Chemerin significantly attenuates the capsaicin potentiation of mEPSC
frequency in lamina I NK1R+ neurons. Representative mEPSC traces recorded before
(top) and during (bottom) capsaicin application in the absence (A) and presence (D) of
chemerin. Example cumulative probability plots from individual neurons show capsaicin
applied in the absence (B) and presence (E) of chemerin resulted in a significant
leftwards shift in the inter-event interval distribution (both P<0.0001, 2-sample
Kolmogorov-Smirnov test). Summary data show that mEPSC frequency was significantly
increased by capsaicin treatment in the absence (C, P=0.002, paired t-test, n=12) and
presence of chemerin (F, P=0.008, paired t-test, n=10). G Capsaicin significantly
increased mEPSC frequency in the presence and absence of chemerin (P=0.0001,
2-way repeated measures ANOVA), however this increase was significantly attenuated
by chemerin (P=0.031, 2-way repeated measures ANOVA, Bonferroni post-tests).
∗∗ P<0.01, ∗∗∗ P<0.001. Scale bars in A apply to D. Black lines in C & F denote mean ±
SEM, grey points & lines show trajectories for individual neurons. Error bars in G = SEM.
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Capsaicin alone caused a significant rightwards shift in mEPSC amplitude
distribution in 10/12 neurons, while in 2/12 it was without effect (all statistics,
Kolmogorov-Smirnov 2-sample test, example shown in figure 3.4A). Figure 3.4B
demonstrates that capsaicin significantly increases mEPSC amplitude in lamina I
NK1R+ neurons (P=0.0003, paired t-test, n=12). Capsaicin applied in the presence of
chemerin resulted in a significant rightwards shift in mEPSC amplitude distribution in
5/10 neurons, while in 2/10 there was a significant leftwards shift and 3/10 no change
(all statistics, Kolmogorov-Smirnov 2-sample test, example shown in figure 3.4C).
Summary data show that capsaicin applied in the presence of chemerin did not
significantly alter mEPSC amplitude (P=0.194, paired t-test, n=10, figure 3.4D).
Figure 3.4E demonstrates that capsaicin significantly potentiated mEPSC amplitude in
the presence and absence of chemerin (P=0.002, 2-way repeated measures ANOVA),
while chemerin was without effect and there was no interaction between chemerin
and capsaicin (P=0.168 & P=0.443, respectively, 2-way repeated measures ANOVA).
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Figure 3.4: Chemerin does not alter the capsaicin potentiation of mEPSC amplitude. A
Example cumulative probability plot demonstrates that in an individual neuron capsaicin
caused a significant rightward shift in the amplitude distribution, indicating an increase in
amplitude (P<0.0001, 2-sample Kolmogorov-Smirnov test). B Overall, capsaicin caused
a significant increase in mEPSC amplitude (P=0.0003, paired t-test, n=12). C Cumulative
probability plot example shows capsaicin applied in the presence of chemerin did not
alter the mEPSC amplitude distribution in an individual neuron (P=0.647, 2-sample
Kolmogorov-Smirnov test). D Capsaicin applied in the presence of chemerin did not
significantly alter mEPSC amplitude (P=0.194, paired t-test, n=10). E Capsaicin in the
presence and absence of chemerin significantly increased mEPSC amplitude (P=0.002,
2-way repeated measures ANOVA), chemerin did not significantly alter amplitude
(P=0.168, 2-way repeated measures ANOVA) and there was no interaction between
chemerin and capsaicin (P=0.443, 2-way repeated measures ANOVA). ∗∗ P<0.01
∗∗∗ P<0.001. Black lines in B & D denote mean ± SEM, grey points & lines show
trajectories for individual cells. Error bars in E = SEM.
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3.4.3 Chemerin attenuates monosynaptic C-fibre input to a subset of
lamina I neurokinin 1 receptor expressing neurons in
inflammatory pain
To evaluate the ability of chemerin to modulate monosynaptic C-fibre input to lamina
I NK1R+ neurons, in tissue isolated from control or CFA treated rats, C-fibre eEPSCs
were recorded before and during the application of chemerin or vehicle. In neurons
from control tissue, there was a significant change in eEPSC amplitude over time
(P=0.013, 2-way repeated measures ANOVA, figure 3.5A), but chemerin was without
effect (P=0.502, 2-way repeated measures ANOVA) and there was no interaction
between time and chemerin (P=0.251, 2-way repeated measures ANOVA). Similarly,
in neurons from tissue isolated from CFA treated rats, eEPSC peak amplitude
significantly declined over time (P<0.0001, 2-way repeated measures ANOVA, 3.5B),
but there was no difference between chemerin and vehicle groups (P=0.152, 2-way
repeated measures ANOVA). There was however a significant interaction between
time and chemerin (P=0.0006, 2-way repeated measures ANOVA) indicating that the
significant decline in amplitude that occurred was influenced by chemerin, which
could be consistent with an effect in a subset of neurons. Figure 3.5C reveals that the
change in eEPSC amplitude between baseline and chemerin was not significantly
altered by chemerin (P=0.156, 2-way repeated measures ANOVA), CFA inflammation
did not alter the response and there was no interaction between chemerin and CFA
(P=0.931 & P=0.434, respectively, 2-way repeated measures ANOVA).
It was hypothesised that chemerin would attenuate primary afferent input to a subset
of lamina I NK1R+ neurons, as ChemR23 is only expressed on a subset of TRPV1+
and a subset of SP containing afferents (Xu et al. 2010), with these neurons being
known to be targeted by TRPV1+ (Hwang et al. 2003, Labrakakis & MacDermott
2003, Tong & MacDermott 2006) and SP containing (Hwang et al. 2003, Todd et al.
2002) primary afferents. To identify this subset, linear regression analysis was
performed on vehicle data to calculate 95% prediction bands. Neurons were classified
as responders if the peak eEPSC amplitude fell below the lower 95% prediction band
for at least the final 5 minutes of chemerin treatment. Neurons where this did not
occur were classified as non-responders. Figure 3.6A shows an example of a
non-responder recorded in CFA tissue, where the peak amplitude of the C-fibre
eEPSC largely remains within the 95% prediction bands. Figure 3.6B shows an
example of a chemerin responder recorded in CFA treated tissue, where the peak
amplitude of the response clearly falls below the lower 95% prediction band during
the final 5 minutes of chemerin application. Using this criteria it was discovered that















































































Figure 3.5: Chemerin does not alter the peak amplitude of monosynaptic C-fibre
eEPSCs in the overall lamina I NK1R+ neuron population. A In control tissue, chemerin
did not alter the C-fibre eEPSC peak amplitude (P=0.502, chemerin n=7, vehicle n=8). B
In CFA inflammation, no differences in peak eEPSC amplitude were detected between
chemerin and vehicle groups (P=0.152, chemerin n=16, vehicle n=7), while amplitude
significantly declined over time (P<0.0001). There was a significant interaction between
time and chemerin (P=0.0006), indicating that the reduction in amplitude was dependent
on chemerin. C Both chemerin (P=0.156) and CFA inflammation (P=0.931) was without
effect on the amplitude change and there was no interaction between these factors
(P=0.434). A & B: 2-way repeated measures ANOVA, C: 2-way ANOVA. Error bars =
SEM.
in C-fibre eEPSCs recorded in tissue isolated from CFA treated rats, 7/16 neurons
were classified as responders, while 9/16 were non-responders. In recordings from
control tissue, 1/7 neurons were classified as responder, while 6/7 were
non-responders.
To assess the validity of this classification criteria and ensure that responders and
non-responders were distinct populations, frequency histograms of the mean
amplitude during the final 5 minutes of chemerin / vehicle application recorded in
CFA tissue were produced. As shown in figure 3.6C, there was a significant
difference between the amplitude distribution of vehicle, chemerin responder and
chemerin non-responder groups (P<0.0001, 1-way ANOVA). The distribution of
chemerin responders was significantly different from chemerin non-responders and
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vehicle (both P<0.0001, 1-way ANOVA, Bonferroni post-tests), while there were no
differences between the vehicle and non-responder groups (P>0.999, 1-way ANOVA,
Bonferroni post-tests).
To assess whether the initial amplitude of C-fibre eEPSCs was predictive of the degree
to which chemerin reduced the amplitude of C-fibre responses, correlation between
the initial amplitude, recorded in minute 2 and the amplitude change recorded in the
final 5 minutes was assessed in chemerin treated neurons from CFA tissue only.
Figure 3.6E demonstrates that there was no significant correlation between initial
amplitude and amplitude change (P=0.886, Pearson’s r test). Therefore, chemerin
effects were independent of the initial peak amplitude of C-fibre eEPSCs.
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Figure 3.6: Dissecting a subpopulation of chemerin responders. A Example of a
chemerin non-responder demonstrates the peak amplitude of the C-fibre eEPSCs largely
fall within the 95% prediction bands (designated by the upper and lower grey lines). B An
example of a chemerin responder, where the peak amplitude of the C-fibre eEPSCs
clearly falls below the lower 95% prediction band for at least the final 5 minutes of
chemerin treatment. C Frequency histogram of the mean peak eEPSC amplitude during
the final 5 minutes, shows a significant difference in the frequency distribution of vehicle,
chemerin responder and chemerin non-responder groups (P<0.0001, 1-way ANOVA)
and post-tests revealed that chemerin responders were significantly different from
chemerin non-responders and vehicle (both P<0.0001, 1-way ANOVA, Bonferroni
post-tests), while there was no significant difference between vehicle and
non-responders (P>0.999, 1-way ANOVA, Bonferroni post-tests). D To assess whether
the initial amplitude (minute 2) was predictive of the amplitude change that resulted from
chemerin (measured in the final 5 minutes) Pearson’s r test for correlation was performed
on chemerin data from CFA tissue only (responders and non-responders were combined)
and revealed no significant correlation, P=0.886. Vehicle n=7, chemerin responders n=7,
chemerin non-responders n=9. Examples in A & B recorded in CFA tissue.
Representative traces of C-fibre eEPSCs recorded pre-chemerin and during chemerin,
in neurons classified as non-responders and responders are shown in figures 3.7B &
D, respectively. In the subgroup of neurons classified as non-responders, chemerin
had no significant effect on peak amplitude when compared to vehicle (P=0.802,
2-way repeated measures ANOVA, figure 3.7A), there was no change in amplitude
over time (P=0.172, 2-way repeated measures ANOVA) and no interaction between
these factors (P=0.705, 2-way repeated measures ANOVA). In chemerin responders,
peak amplitude significantly declined over time (P<0.0001, 2-way repeated measures
ANOVA, figure 3.7C) and chemerin significantly attenuated C-fibre eEPSC peak
CHAPTER 3: CHEMERIN MODULATION OF INPUT TO NK1R+ NEURONS 113
amplitude (P=0.001, 2-way repeated measures ANOVA), with this effect being
influenced by time (P<0.0001, 2-way repeated measures ANOVA). Post-hoc testing
revealed chemerin significantly reduced eEPSC amplitude in this subset of neurons
from 16 to 25 minutes (P<0.05 to <0.001, 2-way ANOVA, Bonferroni post-tests).
Analysis of the amplitude change in vehicle, chemerin responders and chemerin
non-responders revealed there to be a significant difference between these groups
(P<0.0001, 2-way repeated measures ANOVA). Post-hoc tests found that chemerin
responders showed a significantly greater change in amplitude than vehicle and
non-responders (P=0.0003 & P=0.0002, respectively, 2-way ANOVA, Bonferroni
post-tests, figure 3.7E), while there was no significant difference between vehicle and
chemerin non-responders (P=0.996, 2-way ANOVA, Bonferroni post-tests).







































































































Figure 3.7: Chemerin attenuates C-fibre eEPSC peak amplitude in a subset of lamina I
NK1R+ neurons in CFA inflammation. A Chemerin did not significantly alter C-fibre
eEPSC peak amplitude in chemerin non-responders (P=0.802, 2-way repeated
measures ANOVA), representative traces shown in B. C In the subgroup of chemerin
responders, chemerin significantly attenuated C-fibre eEPSC amplitude (P=0.001, 2-way
repeated measures ANOVA), example traces shown in D. E The amplitude change was
significantly different between groups (P<0.001, 1-way ANOVA) and Bonferroni
post-tests revealed that the amplitude change was significantly greater in chemerin
responders compared to vehicle and chemerin non-responders (P=0.0003 & P=0.0002,
respectively), there was no difference between vehicle and chemerin non-responders
(P=0.996). ∗P<0.05, ∗∗P<0.01, ∗∗∗P<0.001. Example traces = average of 3 sweeps,
baseline and chemerin traces recorded at points ‘a.’ and ‘b.’, respectively, denoted by
arrows on relevant graphs. Vehicle n=7, chemerin responders n=7, chemerin
non-responders n=9. Error bars = SEM.
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To determine whether the chemerin attenuation of monosynaptic C-fibre input to a
subset of lamina I NK1R+ neurons was pre- or post-synaptically mediated, C-fibre
evoked paired-pulse recordings were performed. Figure 3.8A shows example traces
of paired-pulse recordings before (‘pre-chemerin’) and during chemerin (‘chemerin’)
application. These traces demonstrate that in this neuron, paired-pulse stimulation
resulted in paired-pulse depression (PPD) of C-fibre eEPSCs and that chemerin
increased the PPR / decreased PPD. Overall, there were no significant effects of
chemerin or whether a neuron was classified as a responder or not (P=0.069 &
P=0.699, respectively, 2-way repeated measures ANOVA), however there was a
significant interaction between these factors (P=0.044, 2-way repeated measures
ANOVA, figure 3.8B). Post-tests revealed that in the subgroup of neurons classified as
chemerin responders, chemerin significantly increased the PPR / decreased PPD
(P=0.031, 2-way repeated measures ANOVA, Bonferroni post-tests). This indicates
that chemerin presynaptically attenuates C-fibre input to a subset of lamina I NK1R+
neurons in CFA inflammation.








































Figure 3.8: Chemerin presynaptically attenuates C-fibre eEPSC peak amplitude to a
subset of lamina I NK1R+ neurons. A Representative traces of C-fibre paired-pulse
stimulation in a chemerin responder recorded before (left, grey trace) and during (right,
black trace) chemerin application (average of 6 sweeps shown), where chemerin has
increased the paired-pulse ratio / decreased paired-pulse depression. B Paired-pulse
ratio was unaltered by chemerin or whether neurons were classified as responders or not
(P=0.069 & P=0.699, respectively), however there was a significant interaction between
these factors (P=0.044). Post-tests revealed that in neurons classified as responders
chemerin significantly increased the paired-pulse ratio / decreased paired-pulse
depression (P=0.031). 2-way repeated measures ANOVA followed by Bonferroni
post-tests, ∗P<0.05, responders n=5, non-responders n=6. Error bars = SEM.
3.4.4 Chemerin does not alter monosynaptic Aδ-fibre input to lamina I
neurokinin 1 receptor expressing neurons
To assess whether ChemR23 activation modulated monosynaptic Aδ-fibre input to
lamina I NK1R+ neurons under control or inflamed conditions, Aδ-fibre eEPSCs
were recorded in the presence of chemerin or vehicle. In control tissue, there was a
significant change in peak eEPSC amplitude over time (P=0.040, 2-way repeat
measures ANOVA, figure 3.9A), which was independent of chemerin (P=0.309,
2-way repeat measures ANOVA). Overall there was no difference between chemerin
and vehicle groups (P=0.194, 2-way repeat measures ANOVA). In tissue isolated
from CFA treated rats, chemerin was without effect on eEPSC peak amplitude
(P=0.550, 2-way repeat measures ANOVA, figure 3.9B), there was no significant
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effect of time and no interaction between these factors (P=0.891 & P=0.541,
respectively, 2-way repeat measures ANOVA). The change in Aδ-fibre eEPSC
amplitude was not altered by CFA inflammation or chemerin and there was no
significant interaction between these factors (P=0.357, P=0.528 & P=0.225,
respectively, 2-way repeat measures ANOVA, figure 3.9C). When the criteria used to
categorise neurons as chemerin responders or non-responders was applied (as detailed






















































































Figure 3.9: Chemerin does not alter monosynaptic Aδ-fibre input to lamina I NK1R+
neurons. A In control tissue there was no significant difference in eEPSC peak amplitude
between neurons which had been treated with chemerin and those treated with vehicle
(P=0.194, chemerin n=6, vehicle n=5). B Chemerin did not alter the peak amplitude of
the Aδ-fibre eEPSC response in tissue isolated from CFA treated rats (P=0.550,
chemerin n=6, vehicle n=6). C The amplitude change was not significantly unaltered by
chemerin (P=0.528), CFA inflammation (P=0.357) and there was no interaction between
chemerin and CFA inflammation (P=0.225). All statistics: 2-way repeated measures
ANOVA. Error bars = SEM.
3.4.5 Summary
A summary of the findings of the mEPSC experiments reported in this chapter are
presented in table 3.3. In those experiments where mEPSCs were recorded, chemerin
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Frequency Amplitude Capsaicin vs. Chemerin & Capsaicin
Chemerin no change no change Frequency Amplitude
Capsaicin increase increase
reduce no changeChemerin &
increase no change
Capsaicin
Table 3.3: Summary table of results from capsaicin potentiation mEPSC experiments.







CFA non-responder no effect
Table 3.4: Summary table of results from chemerin eEPSC experiments.
alone was found to be without effect on mEPSC frequency or amplitude in lamina I
NK1R+ neurons. When the capsaicin potentiation of mEPSCs and the influence of
chemerin upon this potentiation was assessed, it was discovered that while capsaicin
applied in the presence and absence of chemerin resulted in a significant increase in
mEPSC frequency, when the response in these two groups was compared it was found
that chemerin significantly attenuated the capsaicin potentiation. The amplitude of
mEPSCs was significantly increased following application of capsaicin alone, but was
unaltered when capsaicin was applied in the presence of chemerin. When these
effects were compared between groups it was found that chemerin did not
significantly attenuate the capsaicin potentiation of mEPSC amplitude.
The findings of eEPSC experiments in which the effects of chemerin on
monosynaptic Aδ- and C-fibre input to lamina I NK1R+ neurons, in control and CFA
inflammation was investigated, are summarised in table 3.4. In both control and CFA,
chemerin did not alter the peak amplitude of monosynaptic Aδ-fibre eEPSCs.
Likewise, chemerin was without effect upon the monosynaptic C-fibre input to these
neurons in control conditions. In CFA inflammation, chemerin was found to
significantly attenuate monosynaptic C-fibre input to a subset of lamina I NK1R+
neurons that were classified as ‘responders’ and which accounted for 44% of all
neurons recorded from. Furthermore, the PPR in those neurons classified as
responders was significantly increased following the application of chemerin,
indicating the chemerin reduction of eEPSC amplitude resulted from a presynaptic
inhibition of monosynaptic C-fibre input. Chemerin did not alter monosynaptic
C-fibre eEPSCs or PPR in those neurons classified as ‘non-responders’.
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3.5 Discussion
3.5.1 Chemerin is without effect in non-potentiated conditions
It has previously been established that activation of ChemR23 does not alter acute
pain sensitivity and has no effect on the frequency or amplitude of sEPSCs in
unidentified lamina II neurons in non-potentiated conditions (Xu et al. 2010). The
data presented here expand on these previous findings and novelly show that the
ChemR23 agonist, chemerin, does not alter mEPSC frequency or amplitude in lamina
I NK1R+ neurons in basal conditions (figure 3.2). In addition, chemerin does not alter
monosynaptic C- or monosynaptic Aδ-fibre inputs to these neurons in tissue isolated
from control rats (figures 3.5 & 3.9). It is proposed that activation of ChemR23
reduces inflammatory pain hypersensitivity by a mechanism that involves the
normalisation of potentiated spinal cord responses as opposed to a general reduction
in sensory transmission (Ji et al. 2011, Xu et al. 2010). The findings presented here
can be considered to support this.
3.5.2 Chemerin attenuates the capsaicin potentiation of primary
afferent input to lamina I neurokinin 1 receptor expressing
neurons
It has previously been established that chemerin prevents the capsaicin mediated
potentiation of sEPSC frequency in random lamina II neurons (Xu et al. 2010).
Because Xu et al. (2010) recorded sEPSCs in unidentified lamina II neurons it is not
clear where in the spinal cord network or upon which neuronal subtypes that the
effects of ChemR23 agonists are mediated. The experiments in this thesis improves
on these previous findings in that recordings were made from pre-identified lamina I
NK1R+ neurons and that mEPSCs were recorded, in which network activity is
blocked by application of TTX, which enables the effects upon direct excitatory
inputs to be observed. The results presented here demonstrate that application of
chemerin significantly attenuates the capsaicin potentiation of mEPSC frequency in
lamina I NK1R+ neurons (figure 3.3).
It was previously reported that activation of ChemR23 with chemerin (100ng/ml) or
RvE1 (1ng/ml) blocks the capsaicin potentiation of primary afferent input (Xu et al.
2010), however in the data presented here the potentiation is attenuated rather than
abolished. This difference could be accounted for by the fact that the capsaicin dose
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used here (1µM) was 10 times greater than that used by Xu et al. (2010) and this
higher concentration may override the effect of chemerin. This increased dose
undoubtably resulted in a greater potentiation, with a ∼44-fold increase reported here
versus a 2-fold increase (Xu et al. 2010). Using a lower capsaicin concentration of
100nM was investigated, however this did not reliably potentiate primary afferent
input to lamina I NK1R+ neurons, as only 1 out of 5 neurons showed a significant
change in the inter-event interval distribution and overall 100nM capsaicin did not
significantly alter mEPSC frequency (P=0.625, Wilcoxon, data not shown).
Although it is not explicitly stated by Xu et al. (2010), the data presentation would
suggest that 100nM capsaicin resulted in potentiation in all recorded neurons.
However, as Xu et al. (2010) recorded sEPSCs, where network activity is not blocked,
as opposed to mEPSCs in this study, so capsaicin could have had more of a
widespread effect. Other groups have demonstrated that 100nM capsaicin can
potentiate mEPSC frequency in unidentified lamina I/II neurons (Baccei et al. 2003,
Spicarova & Palecek 2009), so it is questionable as to whether the effects of 100nM
capsaicin are only detectable in conditions were network activity is not blocked.
Another key difference between this study and that of Xu et al. (2010) is that the
recordings presented here were made from a defined neuronal subset, as opposed to
unidentified neurons. Interestingly, potentiation of mEPSC frequency in lamina I
NK1R+ neurons has only been demonstrated at concentrations of 1µM (Labrakakis &
MacDermott 2003).
In this study mouse chemerin was used to activate ChemR23 receptors. As these
experiments were performed in rat tissue, ideally rat chemerin would have been used,
however rat chemerin is not commercially available. While there is a high level of
homology between rat and mouse chemerin and evidence for cross-species activity
(Busmann et al. 2004) it is possible that the effects of chemerin were not optimal due
to species differences. The fact that chemerin did not abolish the capsaicin
potentiation of mEPSC frequency could be a reflection of these species differences.
However, chemerin significantly reduced this capsaicin potentiation and attenuated
C-fibre eEPSCs in a subset of lamina I NK1R+ neurons in subsequent experiments.
Therefore, these results clearly show mouse chemerin is active in rat tissue.
It is possible that not every neuron recorded from received ChemR23 expressing
(ChemR23+) primary afferent input, which could account for the result that chemerin
attenuated rather than abolished the capsaicin potentiation of mEPSC frequency.
Most lamina I NK1R+ neurons in this study received input from TRPV1+ afferents,
as evidenced by the significant leftward shifts in inter-event interval distributions in
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83% of neurons, which confirms previous findings (Labrakakis & MacDermott 2003).
While TRPV1 is co-expressed with ChemR23, expression of the former does not
assure expression of the latter, as only 61% of TRPV1+ neurons co-express ChemR23
(Xu et al. 2010). The premise that not all lamina I NK1R+ neurons receive
ChemR23+ input is supported by additional results reported here, that show chemerin
only attenuates monosynaptic C-fibre input to a subset (44%) of lamina I NK1R+
neurons in inflammation (figure 3.7). One way in which a similar subset of chemerin
responsive neurons could have been identified in these capsaicin potentiation studies
would have been to apply both capsaicin alone and chemerin & capsaicin in
individual neurons. However, this approach was not possible due to the fact that
mEPSC frequency did not reliably return to baseline after capsaicin application, even
following long wash periods (data not shown), as has been described elsewhere
(Baccei et al. 2003). Another concern is that capsaicin treatment is known to
desensitise nociceptors (O’Neill et al. 2012), which may involve TRPV1 inactivation
and/or downregulation (Sanz-Salvador et al. 2012, Szallasi & Blumberg 1999).
Furthermore, repeated capsaicin application results in a progressive reduction in the
capsaicin mediated increase in mEPSC frequency (Baccei et al. 2003, Sikand &
Premkumar 2007). Therefore, this approach would have required careful
differentiation of the chemerin effect from the general run-down in the capsaicin
response.
This study has for the first time demonstrated that capsaicin alone significantly
increases mEPSC amplitude in lamina I NK1R+ neurons, as has been reported in
other spinal cord neurons (Baccei et al. 2003, Wrigley et al. 2009). Altered mEPSC
amplitude typically indicates a change in the postsynaptic response to
neurotransmitters (Engelman & MacDermott 2004). However, as the capsaicin
receptor, TRPV1, is likely to be expressed only on primary afferent terminals in the
spinal cord (Caterina et al. 1997, Cavanaugh et al. 2011, Tominaga et al. 1998) this
effect is most likely to be presynaptic, although this is disputed by Kim et al. (2012)
(discussed below). Other groups have reported this dual increase in mEPSC
frequency and amplitude in spinal cord neurons as a result of capsaicin applied at
≥1µM (Baccei et al. 2003, Wrigley et al. 2009). It has been argued that this apparent
increase in amplitude is as a result of the summation of high frequency events (Baccei
et al. 2003, Wrigley et al. 2009). The fact that a significant increase in mEPSC
amplitude was seen following the application of capsaicin alone, but not capsaicin &
chemerin, where the overall mEPSC frequency was lower, could be considered to
support this postulate. To study the effects of capsaicin on mEPSC amplitude in
isolation from the summation of high frequency events other groups have used a
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lower capsaicin concentration of 100nM, which significantly increases mEPSC
frequency, but not amplitude (Baccei et al. 2003). However, when capsaicin was
applied at a dose of 100nM it did not reliably evoke an increase in mEPSC frequency,
as discussed previously (data not shown).
TRPV1 channels are considered to be only expressed on primary afferent terminals in
the dorsal horn of the spinal cord (Caterina et al. 1997, Cavanaugh et al. 2011,
Tominaga et al. 1998). The strongest evidence for this comes from Cavanaugh et al.
(2011) who demonstrated, using a transgenic TRPV1 reporter mouse, that TRPV1
expression in the dorsal horn is unequivocally restricted to the central terminals of
primary afferents. Therefore, applying the TRPV1 agonist, capsaicin, can be
considered to presynaptically potentiate primary afferent input to dorsal horn neurons
(Baccei et al. 2003, Wrigley et al. 2009). Recent evidence has suggested that TRPV1
may also be expressed in a subpopulation of GABAergic interneurons in lamina II
(Kim et al. 2012), although this finding conflicts with previous studies (Caterina et al.
1997, Cavanaugh et al. 2011, Tominaga et al. 1998) and has yet to be replicated. The
expression of TRPV1 channels on this interneuron population are proposed to be
involved in spinal cord disinhibition by mediating long-term depression (LTD) of
these inhibitory interneurons (Kim et al. 2012). However, in the experiments reported
here, TRPV1 channels if expressed on this subpopulation of inhibitory interneuron
would have had a limited effect on the results of capsaicin application. TTX was
applied to block action-potential dependent events and inhibition was blocked by
holding neurons at Eanion and bath applying bicuculline and strychnine. As such, any
potential TRPV1 mediated changes in inhibitory tone within the wider spinal cord
network or directly upon inhibitory inputs to lamina I NK1R+ neurons would not
affect the mEPSCs recorded here.
In this study only a single dose of chemerin (100ng/ml) was used, in both mEPSC and
eEPSC experiments. Xu et al. (2010) demonstrated that i.t. administration of
chemerin at doses ranging from 0.45ng to 100ng resulted in a dose-dependent
inhibition of the second phase of the formalin test. Similarly, i.t. injection of RvE1 at
various concentrations resulted in a dose-dependent attenuation of heat hyperalgesia
and mechanical allodynia resulting from CFA injection. However, in their
electrophysiological studies, only a single concentration of chemerin (100ng/ml) and
RvE1 (1ng/ml) was used, therefore as 100ng/ml of chemerin was previously found to
effectively attenuate potentiated spinal cord responses, it was decided that this was an
appropriate dose to use. While it would have been interesting to have investigated
using different doses of chemerin, time limitations prevented this. Had higher doses
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been investigated it may have been possible to identify a concentration that abolished
the capsaicin potentiation of mEPSCs, in the manner that Xu et al. (2010)
demonstrated 100ng/ml could prevent the capsaicin (100nM) potentiation of sEPSC
frequency. Likewise, it would have been of interest in the eEPSC studies to determine
whether increased chemerin concentrations result in a greater inhibition of
monosynaptic C-fibre input to lamina I NK1R+ neurons and/or a greater proportion of
neurons being classified as chemerin responders.
As with different doses of chemerin, it would have been interesting to have studied
the effect of applying chemerin for varying lengths of time, particularly as the
chemerin attenuation of monosynaptic C-fibre eEPSCs in CFA inflammation, as seen
in figure 3.7C, does not appear to have peaked. Xu et al. (2010) fail to state the
duration of chemerin / RvE1 application used in each of their electrophysiological
experiments. However, from the figure showing example traces recorded during the
PTX inhibition of the RvE1 attenuation of capsaicin potentiation it was possible to
determine that RvE1 was applied for 8 minutes, with capsaicin applied for 4 minutes
of that time, therefore, it seems reasonable to assume that these durations were used
across all their experiments. In the mEPSC and eEPSC studies presented here,
chemerin was applied for a total of 15 minutes, with, in the case of the mEPSC
experiments, capsaicin applied for 5 minutes of that time. While applying chemerin
for this duration did significantly attenuate the capsaicin potentiation of mEPSC
frequency and the amplitude of monosynaptic C-fibre eEPSCs, in a subset of neurons,
future studies could investigate whether altering the duration of application impacts
upon the efficacy of chemerin.
3.5.3 Chemerin presynaptically attenuates monosynaptic C-fibre input
to a subset of lamina I neurokinin 1 receptor expressing neurons
in inflammation
This study presents new evidence that ChemR23 is likely functionally expressed on a
subset of monosynaptic C-fibre input to lamina I NK1R+ neurons and that chemerin,
presumably by acting upon these receptors can attenuate this monosynaptic C-fibre
input in inflammatory pain.
While the data presented here strongly suggests that there is functional expression of
ChemR23 on a subset of C-fibres, this cannot be considered conclusive. To confirm
that these chemerin effects are mediated via ChemR23, ideally it would have been
demonstrated that these effects could be blocked by a ChemR23 antagonist, however
CHAPTER 3: CHEMERIN MODULATION OF INPUT TO NK1R+ NEURONS 124
no such ligand is commercially available. PTX, an inhibitor of Gαi coupled GPCRs,
the receptor family to which ChemR23 belongs, has been used by others to inhibit the
RvE1 attenuation of capsaicin potentiated input to lamina II neurons (Xu et al. 2010).
While this approach could have been used to provide additional confirmation that the
actions of chemerin were mediated by ChemR23, PTX inhibition of the chemerin
response would only indicate that chemerin acted via a Gαi coupled GPCR and not
ChemR23 specifically.
Chemerin has also been shown to bind to chemokine (C-C motif) receptor-like 2
(CCRL2), but the current evidence suggests that this receptor is not involved in cell
signalling and may play a functional role in presenting chemerin to ChemR23
(Bondue et al. 2011, Yoshimura & Oppenheim 2010, Zabel et al. 2008). It is therefore
possible that altered CCRL2 expression in inflammation could play a role in the
chemerin effects reported here. It could be speculated that inflammation induced
up-regulation of this receptor in C-fibres could result in a greater accumulation and
more efficient presentation of chemerin to ChemR23 that drives an enhanced
chemerin response. While it would have been interesting to investigate the role of
CCRL2 in the chemerin response, this was not possible due to the lack of
commercially available antagonists. There is currently no evidence that CCRL2 is
expressed in DRG neurons and while CCRL2 is known to be expressed in the spinal
cord and central nervous system (CNS), this is predominantly on microglia (Brouwer
et al. 2004) and possibly astrocytes (Hamby et al. 2012). However, it is worth noting
that Brouwer et al. (2004) demonstrated spinal cord expression of CCRL2 in cells
which did not express the glial marker, glial fibrillary acidic protein (GFAP). It would
therefore be important to establish the expression of this receptor in pain pathways
before further investigating its role in or its potential as a novel target for the
treatment of inflammatory pain.
Chemerin has also been shown to bind to a third receptor, the G protein-coupled
receptor 1 (GPR1). Unlike CCRL2, binding of chemerin to GPR1 does result in
internalisation and signalling, however signalling is weak (Barnea et al. 2008) and it
has been speculated that GPR1 may act as a decoy receptor (Bondue et al. 2011). This
raises the prospect that the chemerin response in this study was influenced by this
receptor, either directly by cell signalling or indirectly by acting as a decoy to alter
chemerin availability to ChemR23. While there is also no evidence for in vivo GPR1
mediated activity (Bondue et al. 2011), it was not possible to investigate the role of
this receptor in the chemerin responses described here as there are no selective
agonists or antagonists available. There is evidence that GPR1 is expressed in the
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CNS (Croitoru-Lamoury et al. 2003, Marchese et al. 1994a, Marchese et al. 1994b,
Shimizu et al. 1999), however spinal cord and DRG expression has not been
investigated. Therefore, as with CCRL2, it would be useful to establish whether
GPR1 is expressed in pain pathways before a more comprehensive study into its
possible role in modulating C-fibre input to lamina I NK1R+ neurons.
There is some evidence that ChemR23 is expressed on microglia (Connor et al. 2007),
however this has not been confirmed in the spinal cord. The activation of spinal
microglia is known to be a key feature of neuropathic pain (Coull et al. 2005, Tsuda
et al. 2013, 2005) and is also implicated in inflammatory pain (Cao & Zhang 2008,
McMahon & Malcangio 2009). It has been argued that ChemR23 agonists acting
upon ChemR23 on microglia could prevent their activation and and thus reduce pain
(Ji et al. 2011). Interestingly, Xu et al. (2013) have recently demonstrated that
pretreatment with RvE1 (100ng for 3 days, delivered i.t.) attenuates chronic
constriction injury (CCI)-induced mechanical allodynia, but not heat hyperalgesia, in
mice. CCI produced a corresponding increase in the levels of mRNA for the
microglial marker, ionized calcium binding adaptor molecule 1 (IBA-1) and the
expression of TNF-α, in the dorsal horn, with both IBA-1 and TNF-α expression
being reduced in RvE1 treated animals. Furthermore, in microglial cultures, RvE1
dose-dependently reduced the number of activated microglia and the microglial
release of TNF-α in response to lipopolisaccharide application. These findings
suggest that ChemR23 agonists reduce neuropathic pain by an attenuation of
microglial activation and signalling. Therefore, it is possible that the RvE1 / chemerin
mediated reduction in inflammatory pain hypersensitivity and/or potentiated spinal
cord activity may in part be due to an attenuation of microglial activity.
Activation of ChemR23 is proposed to reduce inflammatory pain in part by
normalising potentiated spinal cord responses (Ji et al. 2011, Xu et al. 2010).
Monosynaptic C-fibre input to a subset of lamina I NK1R+ neurons may be
potentiated in inflammatory pain (Ikeda et al. 2006). Therefore, it could be
hypothesised that those neurons in this study that were classified as responders
belonged to a subgroup that received potentiated input. To test whether this was the
case, analysis was performed to ascertain whether there was any correlation between
initial C-fibre eEPSC amplitude and the amplitude change resulting from chemerin. If
chemerin was acting specifically on potentiated inputs, it could be expected that those
neurons with greater initial eEPSC amplitudes (possibly indicating potentiated inputs)
would exhibit an enhanced chemerin response and thus there would be a positive
correlation between increasing initial amplitude and increasing chemerin response.
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However, this was not the case as there was no significant correlation between initial
amplitude and the chemerin response (figure 3.6E). The data presented here cannot
confirm or refute the hypothesis that chemerin acts only on potentiated inputs. While
no potentiation of C-fibre eEPSC amplitude as a result of CFA inflammation was
reported here (figure 2.15B), it is impossible to know whether inputs to individual
neurons in CFA tissue were potentiated relative to the same inputs in control tissue. It
is difficult in comparative population recordings, as used here, to ascertain whether a
particular subgroup exhibits potentiation without the means to identify the subgroup
in both control and CFA tissue.
3.5.4 Chemerin has no effect on monosynaptic Aδ-fibre input to lamina
I neurokinin 1 receptor expressing neurons
The data presented here provide new evidence that chemerin does not effect
monosynaptic Aδ-fibre input to lamina I NK1R+ neurons in tissue isolated from
control or CFA treated rats. RvE1 was previously shown to attenuate mechanical
hypersensitivity associated with CFA inflammation (Xu et al. 2010). Given that
Aδ-fibres are known to mediate mechanical hypersensitivity (Fuchs et al. 2000,
Magerl et al. 2001, Ziegler et al. 1999) it could be expected that chemerin would
exhibit some activity upon Aδ-fibre eEPSCs, particularly in inflammatory conditions,
however this is not supported by the data presented here.
One explanation for this apparent lack of effect on Aδ-fibres could be that these
inputs do not express ChemR23. As discussed, ChemR23 is expressed on TRPV1+
and SP containing afferents (Xu et al. 2010). Only a small proportion of Aδ-fibres
express TRPV1 (Amaya et al. 2003, Kobayashi et al. 2005, Michael & Priestley 1999,
Yu et al. 2008) or contain SP (Lawson et al. 1997, 1993, McCarthy & Lawson 1989)
which could suggest that ChemR23 expression is limited in these afferents. However,
less than half of ChemR23+ DRG neurons co-express TRPV1 and expression of
ChemR23 on SP containing afferents has not been quantified (Xu et al. 2010), so a
lack of TRPV1 and/or SP expression does not preclude ChemR23 expression on
Aδ-fibres. To date no study has investigated the co-expression of ChemR23 with
neurofilament 200 (NF200), a typical marker of both Aβ-fibre and Aδ-fibres, with
large and small diameter NF200+ fibres typically signifying the former and latter,
respectively (Perry et al. 1991), therefore the degree to which ChemR23 is expressed
on Aδ-fibres is unclear. This question could be answered by future anatomical studies
whereby co-expression of ChemR23 and NF200 in small diameter DRG neurons is
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quantified.
Activation of ChemR23 by the agonists RvE1 or chemerin has been proposed to
attenuate inflammatory pain hypersensitivity by a mechanism involving the
normalising of potentiated spinal cord responses (Ji et al. 2011, Xu et al. 2010). While
there is evidence that Aδ-fibre input to lamina I NK1R+ neurons may be potentiated
in a subset of neurons in CFA inflammation (Torsney 2011), this was not found to be
the case in the present studies (figure 2.15B). Therefore, the lack of chemerin effect
on monosynaptic Aδ-fibre input reported here, particularly in recordings from tissue
isolated from CFA treated rats, could simply reflect that none of these inputs were
potentiated. However, despite finding no evidence for the CFA potentiation of
monosynaptic C-fibre input to lamina I NK1R+ neurons (figure 2.15B), chemerin did
significantly reduce C-fibre input to a subset of these neurons.
The lack of chemerin effect on Aδ-fibre inputs to lamina I NK1R+ neurons could also
be a reflection that the sample size of the Aδ-fibre groups was insufficient to detect
any effects. When the criteria used to classify neurons as responders was applied, 1
CFA and 2 control neurons were classified as responders. If the sample size was
larger this could have lead to a greater proportion of responders that would have
enabled the analysis of subgroups of responders and non-responders, as was done for
neurons receiving monosynaptic C-fibre input. Therefore, to fully ascertain whether
chemerin alters monosynaptic Aδ-fibre input to these neurons, a larger sample size
would be advantageous.
3.5.5 Chemerin receptor 23 agonists as future inflammatory pain
treatments
While the evidence presented here and elsewhere (Xu et al. 2010) suggests that drugs
which target ChemR23 may be effective in the treatment of inflammatory pain, it is
worth stating that chemerin or RvE1 may have limited therapeutic potential given that
they are not metabolically stable and are rapidly inactivated in vivo (Arita et al. 2006,
Shimamura et al. 2009). Interestingly, a stable analogue of RvE1,
19-(p-fluorophenoxy)-RvE1 (19-pf-RvE1), has been shown to effectively reduce
thermal hypersensitivity in the CFA inflammatory pain model for an extended time
period compared to RvE1 (Xu et al. 2010). Stable chemerin analogues have been
developed (Shimamura et al. 2009), however these have not been investigated in
models of inflammatory pain. Further research into the use of these or new stable
analogues that target ChemR23 could provide additional evidence for the potential
CHAPTER 3: CHEMERIN MODULATION OF INPUT TO NK1R+ NEURONS 128
that ChemR23 has as a target for the treatment of inflammatory pain.
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3.6 Conclusions
The results presented here have novelly demonstrated that application of the
ChemR23 agonist, chemerin, in non-potentiated conditions does not alter primary
afferent input, specifically monosynaptic Aδ- and monosynaptic C-fibre input to
lamina I NK1R+ neurons (figures 3.2, 3.5 & 3.9). This supports the premise that
targeting this receptor with chemerin or RvE1 does not alter basal synaptic
transmission in the spinal cord and that the ChemR23-mediated reduction in
inflammatory pain is as a result of an anti-hyperalgesic mechanism of action, whereby
potentiated spinal cord responses are normalised (Ji et al. 2011, Xu et al. 2010). This
lack of effect on normal pain processing and particularly in pain pathways involving
these key spinal cord output neurons (Nichols et al. 1999), adds to the evidence that
new treatment strategies that target this receptor will have the advantage that the acute
protective pain responses are left intact (Ji et al. 2011, Xu et al. 2010).
The data shown here supports previous studies that report ChemR23 activation can
attenuate the capsaicin potentiation of spinal cord responses (Xu et al. 2010). In
addition, it has been established for the first time that chemerin can specifically
attenuate the capsaicin potentiation of primary afferent input onto lamina I NK1R+
neurons (figure 3.3). It is known that TRPV1 channels can be sensitised by a number
of inflammatory mediators, which can contribute to the development and maintenance
of inflammatory pain hypersensitivity (Basbaum et al. 2009, Palazzo et al. 2012,
Pingle et al. 2007). Therefore, the finding that chemerin can attenuate the capsaicin
potentiation of primary afferent input to lamina I NK1R+ neurons, that are essential
for inflammatory pain (Nichols et al. 1999), strongly suggests that the development of
drugs directed towards the ChemR23 receptor could provide new inflammatory pain
treatments.
This thesis has presented novel data that strongly suggest ChemR23 is functionally
expressed on a subset of monosynaptic C-fibre inputs onto lamina I NK1R+ neurons
and that activation of these receptors with chemerin can presynaptically attenuate this
C-fibre input in inflammatory pain conditions (figures 3.7 & 3.8). Lamina I NK1R+
neurons are crucial for the manifestation of inflammatory pain (Nichols et al. 1999),
which is known to be driven by C-fibre activity (Abrahamsen et al. 2008). Therefore,
these data can be considered to lend support to suggestions that agents that target
ChemR23, such as RvE1, represent a promising new class of analgesics for the
treatment of inflammatory pain (Ji et al. 2011, Lee 2012, Xu et al. 2010).
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The findings described here have shown for the first time that chemerin does not alter
monosynaptic Aδ-fibre input to lamina I NK1R+ neurons in inflammatory pain
(figure 3.9). Mechanical hyperalgesia is know to be mediated by Aδ-fibres (Fuchs
et al. 2000, Magerl et al. 2001, Ziegler et al. 1999), therefore treatment strategies that
target ChemR23 may be of limited efficacy in combating mechanical hypersensitivity
associated with inflammatory pain. However, animal studies show that RvE1 can
reduce mechanical hypersensitivity, although with reduced potency compared to its
actions against thermal hypersensitivity, in that higher doses are required to produce
an effect (Xu et al. 2010). This suggests that the actions of ChemR23 agonists against
mechanical hypersensitivity may be mediated elsewhere within pain circuits and






Repetitive firing of C-fibres is known to drive central sensitisation (Latremoliere &
Woolf 2009, Woolf 1983) and inflammatory pain hypersensitivity has been
established to be mediated by C-fibre nociceptors (Abrahamsen et al. 2008).
Interestingly, C-fibres display a phenomenon called activity-dependent slowing
(ADS), whereby repetitive electrical stimulation at frequencies of 1Hz or above,
results in a progressive slowing of action potential conduction velocity, which
manifests as a progressive increase in response latency (Gee et al. 1996, Serra et al.
1999, Thalhammer et al. 1994, Weidner et al. 1999). ADS has been demonstrated in
unmyelinated fibres from a number of species including; human (Grafe et al. 1997,
Hilliges et al. 2002, Jørum et al. 2007, Ørstavik et al. 2003, Schmelz et al. 2000, Serra
et al. 1999, Shim et al. 2007, Weidner et al. 1999), rat (de Col et al. 2008, 2012, Gee
et al. 1996, Grafe et al. 1997, Nakatsuka et al. 2000, Raymond et al. 1990, Takigawa
et al. 1998, Thalhammer et al. 1994), mouse (Mazo et al. 2013, Shim et al. 2007), pig
(Obreja et al. 2011a, 2011b), monkey (Ringkamp et al. 2010), rabbit (Zhu et al. 2009)
and tortoise (Bliss & Rosenberg 1979). While much of the research describing ADS
has investigated this phenomenon in primary sensory neurons (de Col et al. 2008,
2012, Gee et al. 1996, Nakatsuka et al. 2000, Takigawa et al. 1998, Thalhammer et al.
1994, Zhu et al. 2009), ADS has also been reported in unmyelinated axons in the
hippocampus (Soleng et al. 2003), olfactory nerve (Bliss & Rosenberg 1979) and
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vagus nerve (Grafe et al. 1997, Takigawa et al. 1998).
The underlying physiological role of ADS is unclear. ADS has been proposed to
represent a form of self inhibition, that could act to limit nociceptive input to the
dorsal horn and therefore could regulate central sensitisation (de Col et al. 2012,
Mazo et al. 2013). Interestingly, ADS has been shown to occur in response to natural
heat and cold stimuli (Thalhammer et al. 1994), which demonstrates that ADS results
from natural stimuli as well as artificial electrical stimulation, which further suggests
a physiological role for this phenomenon. The progressive slowing of conduction
velocity that arises from ADS can be considered to alter the timing of nociceptive
inputs being relayed from peripheral nerves to the spinal cord and could potentially
alter spinal pain processing. However, to date there has been no investigation into the
influence of ADS on central nociceptive processing. Therefore, this chapter will aim
to establish whether ADS is present in monosynaptic C-fibre input to neurokinin 1
receptor expressing (NK1R+) neurons that reside in the lamina I region of the spinal
cord. These NK1R+ neurons are essential for the development of inflammatory pain
(Nichols et al. 1999), which is mediated by C-fibres (Abrahamsen et al. 2008). It is
important to determine if ADS is present in the monosynaptic C-fibre input to these
neurons, whether it is regulated in inflammatory pain and whether this ADS provides
a novel target with which to modulate the nociceptive input to these key spinal cord
neurons.
ADS has been described using electrophysiological recordings, both intracellular and
extracellular, from individual sensory neurons only (de Col et al. 2008, 2012, Gee
et al. 1996, Grafe et al. 1997, Nakatsuka et al. 2000, Raymond et al. 1990, Takigawa
et al. 1998, Thalhammer et al. 1994). The studies presented here will examine
whether ADS can be detected using extracellular population recordings from isolated
rat dorsal roots. These dorsal root recordings are technically simpler than the methods
that will be used to examine ADS in the monosynaptic primary afferent input to
lamina I NK1R+ neurons. As such, the ability to detect ADS in primary afferent
fibres in these dorsal root recordings will offer a simple means to characterise ADS
and to investigate the potential modulation in inflammatory pain and pharmacological
manipulations of ADS and ultimately inform the more technically challenging
patch-clamp recordings from lamina I NK1R+ neurons.
A number of physiological properties of C-fibres, which could act to modulate the
transmission of nociceptive input from peripheral nerves to the spinal cord, have been
shown to be correlated with ADS. Increased ADS is known to correspond with higher
mechanical activation thresholds (de Col et al. 2012). The ADS that results from
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mechanical stimulation is greater in C-fibres that responded with increased magnitude
(number of spikes) and peak discharge of spikes (Taguchi et al. 2010). Following
repetitive electrical stimulation, in a manner known to evoke ADS, C-fibres have been
shown to display a persistent altered response to natural stimuli, in that they fire less
action potentials and exhibit longer interspike intervals in response to cold and heat
stimuli (Thalhammer et al. 1994). It has also been demonstrated that greater ADS is
linked with an increase in the probability that conduction failure will occur
(Nakatsuka et al. 2000, Obreja et al. 2011a, Raymond et al. 1990, Zhu et al. 2009).
Clearly, failures in the monosynaptic C-fibre input to lamina I NK1R+ neurons, in
addition to ADS, will influence the pattern of nociceptive input being relayed to these
key spinal cord output neurons and potentially impact upon spinal pain processing.
Therefore, failures in the monosynaptic C-fibre input to lamina I NK1R+ neurons
during repetitive stimulation and whether this is altered in inflammatory pain, will be
quantified.
In addition to C-fibres, there is limited evidence that ADS occurs in A-fibres.
Aβ-fibres have been shown to exhibit negligible ADS at frequencies of ≤25Hz, but
display some ADS when stimulated at frequencies of ≥50Hz (Shin et al. 1997).
While some authors report that ADS occurs in C- but not Aδ-fibres (Mazo et al. 2013,
Nakatsuka et al. 2000), others provide clear evidence that Aδ-fibres display ADS,
although typically in response to higher stimulation frequencies than C-fibres
(Raymond et al. 1990, Thalhammer et al. 1994, Won et al. 1997). Aδ-fibres are
known to mediate mechanical hyperalgesia (Fuchs et al. 2000, Magerl et al. 2001,
Ziegler et al. 1999) and it is widely considered that Aβ-fibres mediate allodynia
(Latremoliere & Woolf 2009, Treede & Magerl 2000). It is important to establish the
presence of ADS in A-fibres and whether this is altered in inflammatory pain, as this
could offer insight into whether ADS represents a novel target for the treatment of
inflammatory pain. Therefore, this chapter will also aim to characterise ADS in
A-fibres in isolated dorsal roots and in monosynaptic Aδ-fibre input to lamina I
NK1R+ neurons. ADS in monosynaptic Aβ-fibre input to lamina I NK1R+ neurons
will not be investigated, as these neurons have very limited monosynaptic Aβ-fibre
input (Torsney 2011, Torsney & MacDermott 2006) (figure 2.14)
It is well established using in vivo recordings in a number of species including;
human (Obreja et al. 2010, Serra et al. 1999, Weidner et al. 1999), rat (Gee et al.
1996, Raymond et al. 1990, Thalhammer et al. 1994), pig (Obreja et al. 2010) and
monkey (Ringkamp et al. 2010), that the ADS profile that results from repetitive
electrical stimulation of primary afferent fibres can be used to functionally classify
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C-fibres. It has widely been shown that mechano-insensitive C-fibres demonstrate the
greatest magnitude of ADS in response to repetitive electrical stimulation while
mechano-sensitive C-fibres display minimal ADS (Gee et al. 1996, Obreja et al. 2010,
Serra et al. 1999, Weidner et al. 1999). Although these different levels of ADS have
been used to identify different functional classes of C-fibres in in vivo recordings
(George et al. 2007, Hilliges et al. 2002, Jørum et al. 2007, Schmelz et al. 2000), the
possibility of using ADS profiles to classify C-fibres of different sensory modalities in
ex vivo tissue preparations has not been explored. This chapter will therefore aim to
establish whether monosynaptic C-fibre input to lamina I NK1R+ neurons can be
grouped according to distinct ADS profiles, which could potentially be indicative of
mechano-insensitive / mechano-sensitive inputs, as this could provide a way to enable
the study of these different sensory modalities in the ex vivo spinal cord slice
preparation.
The relationship between the initial conduction velocity / latency of C-fibre responses
and the magnitude of ADS is unclear. While slower initial conduction velocities /
greater initial latencies have been shown to be correlated with greater levels of ADS
(Ringkamp et al. 2010, Shim et al. 2007, Swadlow & Waxman 1976, Weidner et al.
1999, Zhu et al. 2009), this is not supported by other groups who report there is no
correlation between initial latency and ADS magnitude (Gee et al. 1996, Serra et al.
1999, Taguchi et al. 2010, Thalhammer et al. 1994). Shim et al. (2007), who report
that C-fibres with greater initial latency display greater ADS, found that this
relationship was not altered following nerve injury, however it is unknown whether
this correlation is altered in inflammatory pain. Therefore, whether the initial
response latency of monosynaptic C-fibre input to lamina I NK1R+ neurons is
predictive of the magnitude of ADS as a result of repetitive stimulation and whether
this relationship is altered in inflammatory pain conditions, will be investigated.
4.1.2 Injury-induced changes in activity-dependent slowing
To my knowledge, there have been no investigations into whether ADS in A- or
C-fibres is altered in inflammatory pain, however ADS may be altered in neuropathic
pain states in both humans (Kleggetveit et al. 2012, Ørstavik et al. 2006, 2003) and
animals (Mazo et al. 2013, Shim et al. 2007, Shin et al. 1997, Won et al. 1997).
Erythromelalgia patients exhibit significantly greater C-fibre ADS than control
subjects (Ørstavik et al. 2003). Patients with painful diabetic neuropathy display
enhanced recovery from C-fibre ADS when compared to non-painful diabetic
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neuropathy patients and healthy control (Ørstavik et al. 2006). Likewise,
polyneuropathy patients who suffer from pain show faster ADS recovery than those
without pain (Kleggetveit et al. 2012). In the spinal nerve ligation (SNL) neuropathic
pain model, where the L5 dorsal root is lesioned, C-fibre ADS is enhanced in the
uninjured L4 dorsal root compared to sham operated rats (Shim et al. 2007). Mazo
et al. (2013) have recently reported that C-fibre ADS is reduced following saphenous
nerve transection in mice, however they fail to show a direct comparison between
ADS in control and axotomised groups and no statistics are provided to support their
claim, so it cannot be considered conclusive. In the SNL neuropathic pain model,
Aδ-fibres, which display negligible ADS in control animals, show a significant
increase in ADS (Won et al. 1997). In Aβ-fibres, nerve injury novelly induces ADS
during stimulation at 5 - 25Hz and enhances ADS at ≥50Hz (Shin et al. 1997).
Application of nerve growth factor (NGF), which is a major mediator in inflammatory
pain (Cheng & Ji 2008, Pezet & McMahon 2006), reduces ADS in pig C-fibres
(Obreja et al. 2011a, 2011b). Interestingly, NGF can alter the expression and activity
of a number of ion channels, including voltage-gated sodium channels (Navs) (Diss
et al. 2008, Fang et al. 2005, Fjell et al. 1999, Gould et al. 2000), which have been
implicated in ADS (Baker & Waxman 2012, de Col et al. 2008, 2012, Obreja et al.
2012). It is therefore hypothesise that ADS could be reduced in inflammatory pain
conditions.
4.1.3 Underlying mechanisms of activity-dependent slowing
While the physiological mechanisms underlying ADS remain unclear, a number of
hypotheses have been proposed. Repetitive action potential firing is associated with
increased Na+-K+-ATPase activity, which drives axonal hyperpolarisation (Kobayashi
et al. 1997, Morita et al. 1993, Rang & Ritchie 1968) and this hyperpolarisation has
been proposed to account for ADS (Gee et al. 1996). However, direct or indirect
Na+-K+-ATPase inhibition, by ouabain or cyanide, respectively, results in facilitation
rather than attenuation of ADS (de Col et al. 2008).
It has been suggested that accumulation of intracellular Na+ could account for ADS,
whereby repetitive action potential firing drives a cumulative decrease in the Na+
Nernst potential (Bliss & Rosenberg 1979), which is known to result in conduction
velocity slowing (Hodgkin & Katz 1949). However, blocking Nav activity with
tetrodotoxin (TTX) to decrease Na+ entry into the neuron, presumably reducing the
intracellular accumulation of Na+, enhances rather than inhibits ADS (de Col et al.
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2008).
Further evidence suggests that the activity of hyperpolarization-activated cyclic
nucleotide-gated (HCN) (Grafe et al. 1997, Mazo et al. 2013, Takigawa et al. 1998,
Zhu et al. 2009) and/or Nav (Baker & Waxman 2012, de Col et al. 2008, 2012, Obreja
et al. 2012) channels may be involved in mediating ADS. These channels, are
regulated and play a crucial role in inflammatory pain (Amir et al. 2006, Cummins
et al. 2007, Dib-Hajj et al. 2010, Emery et al. 2012, Papp et al. 2010, Weng et al.
2012).
The role of voltage-gated sodium channels in activity-dependent slowing
One of the key physiological mechanisms underlying ADS that has recently been
proposed is an activity-dependent modulation of Nav channel availability (Baker &
Waxman 2012, de Col et al. 2008, 2012, Obreja et al. 2012). In recordings from
unmyelinated dural afferents, de Col et al. (2008) have shown that application of low
doses of the Nav blocker, TTX, enhances ADS and increases the initial response
latency in a dose dependent manner. They also demonstrated that application of the
local anaesthetic, lidocaine, and the anti-convulsant, carbamazepine, which both
stabilise the slow-inactivated state of Nav channels (Cardenas et al. 2006, Sandtner
et al. 2004), at low doses increased the initial response latency and enhanced ADS.
These findings lead the authors to propose that ADS is caused by an
activity-dependent reduction in operational Nav channel availability, driven by a
gradual increase in the number of Nav channels entering a slow-inactivated state. This
hypothesis is supported by findings that show Nav1.8 channels enter a
slow-inactivated state following repetitive activation, as evidenced by patch-clamp
recordings from C-fibre dorsal root ganglia (DRG) neurons that show repetitive
activation leads to a reduction in Na+ currents (Blair & Bean 2003, Choi et al. 2007)
and increased action potential induction time, relating to reduced action potential
currents (Snape et al. 2010). Furthermore, Nav1.8 channels have greater susceptibility
to activity-dependent inactivation than Nav1.7 (Chevrier et al. 2004) and in the SNL
neuropathic pain model, uninjured C-fibres axons show increased Nav1.8
immunoreactivity, resulting from the redistribution of Nav1.8 as opposed to an
upregulation of expression (Gold et al. 2003) and display greater ADS (Shim et al.
2007). However, it should be recognised that Obreja et al. (2012) have recently shown
that ADS was reduced, rather than increased, in pig C-fibres following the application
of lacosamide, which selectively enhances Nav slow-inactivation (Errington et al.
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2008) and the local anaesthetic, lidocaine, which stabilises the slow-inactivated state
of Nav channels (Sandtner et al. 2004). It is also worth noting that Nav
slow-inactivation may also be relevant for ADS in A-fibres, in that application of
lidocaine causes a profound increase in ADS in Aβ-fibres, which display negligible
ADS in control conditions (Huang et al. 1997).
In inflammatory pain conditions, the expression of Nav channels in primary sensory
neurons is known to be regulated (Amir et al. 2006, Black et al. 2004, Cummins et al.
2007, Dib-Hajj et al. 2010, Gould et al. 2004). Carrageenan inflammation
significantly upregulates Nav1.3, 1.7 and 1.8 mRNA and protein and enhances Na+
currents in small, presumably C-fibre, DRG neurons, while there is no change in the
expression of Nav1.1, 1.2, 1.6 or 1.9 (Black et al. 2004, Tanaka et al. 1998).
Expression of Nav1.6, 1.7, 1.8 and 1.9 has also been shown to be increased in the
complete Freund’s adjuvant (CFA) inflammatory pain (Gould et al. 2004, Yu et al.
2011) and joint pain models (Strickland et al. 2008), however this is disputed by
others (Okuse et al. 1997). Furthermore, Nav1.8 and 1.9 currents are known to be
enhanced in CFA inflammation (Yu et al. 2011). Given the key role that Nav channels
are purported to play in mediating ADS (Baker & Waxman 2012, de Col et al. 2008),
this inflammation induced regulation of Nav channels suggests that ADS could be
altered in inflammatory pain. This can be considered to provide support for the
hypothesis, that ADS could be altered in inflammatory pain.
The role of HCN channels in activity-dependent slowing
HCN channels, which mediate the hyperpolarisation-activated current (Ih), have also
been implicated in ADS (Grafe et al. 1997, Mazo et al. 2013, Takigawa et al. 1998,
Zhu et al. 2009). In addition to the hypothesis that ADS is mediated by an
activity-dependent reduction in the availability of operational Nav channels, it has
alternatively been suggested that ADS could arise due to prolonged
after-hyperpolarisation, mediated by Ca2+-dependent K+ currents, following repetitive
stimulation (Gee et al. 1996, Soleng et al. 2003). It has been suggested that this
prolonged after-hyperpolarisation could be counteracted by Ih, based on evidence that
blocking Ih with Cs or the non-selective HCN antagonist, ZD7288, enhances ADS in
isolated rat vagus (Grafe et al. 1997, Takigawa et al. 1998), human sural (Grafe et al.
1997), rabbit saphenous nerves (Zhu et al. 2009) and unmyelinated hippocampal
axons (Soleng et al. 2003), indicating that the activity of HCN channels constrains
ADS. Recently, Mazo et al. (2013) have showed that ZD7288 significantly increases
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ADS in a subpopulation of ZD7288-sensitive C-fibres and interestingly show that this
effect of ZD7288 is enhanced following nerve axotomy, with nerve injury being
known to result in increased expression of HCN channels and enhanced Ih (Chaplan
et al. 2003, Emery et al. 2012, Jiang et al. 2008).
In recent years a great deal of interest has been expressed in targeting HCN channels
for the treatment of inflammatory pain (Emery et al. 2012). HCN2 channels in
particular have been shown to play a crucial role in the development of inflammatory
pain (Emery et al. 2011). The behavioural hypersensitivity observed during the
second phase of the formalin test is significantly reduced by application of the
non-specific HCN antagonist, ZD7288, or in knockout mice in which HCN2 has been
deleted from Nav1.8 expressing nociceptors (Nav1.8-HCN2−/−) (Emery et al. 2011).
Similarly, thermal hypersensitivity in response to prostaglandin E2 (PGE2) or
carrageenan hindpaw injection and mechanical hypersensitivity in response to PGE2
application was abolished in Nav1.8-HCN2−/− mice, or by application of ZD7288 to
wild type mice (Emery et al. 2011). The enhancement of action potential firing in
DRG neurons in response to forskolin application, that acts to elevate intracellular
cyclic adenosine monophosphate (cAMP), which increases the activity of HCN
channels (Biel et al. 2002, Kaupp & Seifert 2001), has been shown to be abolished in
DRG neurons isolated from HCN2 global knockout mice (HCN2−/−) and by
application of ZD7288 (Emery et al. 2011).
Anatomical studies in rat and mouse have shown that HCN2 channels are expressed
on the central terminals of C-fibres in the lamina I/II region of the dorsal horn and that
these channels are largely expressed on peptidergic afferents (Antal et al. 2004,
Hughes et al. 2012). Further evidence reveals that HCN2 channels are expressed on
the central terminals of substance P (SP) containing afferents, which form contacts
with NK1R+ neurons in lamina I (Papp et al. 2010, 2006, Todd et al. 2002). The
expression of HCN2 in lamina I/II and specifically on SP containing afferents is
significantly increased during CFA inflammation (Papp et al. 2010). HCN1 and
HCN2 expression has also been shown to be increased in trigeminal ganglia (TG)
neurons following the application of CFA to the dura mater (Cho et al. 2009).
Furthermore, recent evidence has demonstrated that HCN2 is upregulated in C-, but
not Aδ-fibres, 7 days after CFA hindpaw injection (Weng et al. 2012). This finding is
contrasted by Acosta et al. (2012) in that while HCN2 expression was found to be
elevated 1 day following CFA injection in small and medium diameter DRG neurons,
presumably C- and Aδ-fibre, respectively, it returned to baseline levels by day 4.
Furthermore, CFA injection into the temporomandibular joint does not cause a change
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in the intensity of HCN1, 2, 3 or 4 immunoreactivity, or in the number of TG neurons
that express these channels (Hatch et al. 2013). Inflammation-induced changes in
HCN2 immunoreactivity in large diameter, presumably Aβ-fibre, DRG neurons
shows no increase in expression 1 day after, but a reduction 4 days after CFA
injection (Acosta et al. 2012). Interestingly, similar reductions in HCN channel
expression have been reported in L4/5 DRG neurons following nerve injury, where
expression of HCN2, as well as 1, but not 3 or 4, was reported to be reduced 7 days
post injury (Chaplan et al. 2003).
In addition to changes in the expression of HCN channels, recent evidence has also
shown that Ih is upregulated in primary afferents in both inflammatory (Cho et al.
2009, Weng et al. 2012) and neuropathic (Chaplan et al. 2003, Kitagawa et al. 2006,
Tsuboi et al. 2004, Yao et al. 2003) pain models. The increase in Ih in CFA
inflammation has been shown to mirror the changes in HCN2 expression, in that Ih is
increased in C-, but not Aδ-fibres (Weng et al. 2012). However, large diameter DRG
neurons in the SNL neuropathic pain model, in which HCN expression is reduced,
also show a potentiation in Ih, which is attributed to to an increase in the open channel
probability and possibly an increase in channel conductance (Chaplan et al. 2003).
Given the findings that HCN2 expression and Ih is specifically upregulated in C-fibres
following injection of CFA to the hindpaw, it is hypothesised that ADS in
monosynaptic C-fibre input to lamina I NK1R+ neurons could be modified in
inflammatory pain and that part of the mechanism underlying this change could
involve altered HCN channel activity / expression.
ZD7288 has also been shown to significantly increase the rate of synaptic response
failures in monosynaptic C-fibre evoked excitatory postsynaptic currents (eEPSCs)
recorded in unidentified lamina I/II neurons (Papp et al. 2006). Further evidence from
single unit recordings of C-fibre activity report that ZD7288 increases action potential
failures in a dose dependent manner (Zhu et al. 2009). As with ADS, changes in the
rate of action potential failures will alter the pattern of the transmission of nociceptive
inputs to the spinal cord. Therefore, in addition to investigating the role of HCN
channels in ADS, it is important to establish whether blocking Ih leads to a change in
the number of synaptic response failures in monosynaptic C-fibre input to lamina I
NK1R+ neurons, as changes in failure rate could clearly impact upon nociceptive
processing by these key spinal cord output neurons.
In unmyelinated cerebellar parallel fibres, ZD7288 has been shown to reduce the
amplitude of extracellular compound action potentials (CAPs), which the authors
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interpret as resulting from a reduction in the number of fibres contributing to the
response, due to a ZD7288-induced increase in conduction failures (Baginskas et al.
2009). Whether ZD7288 causes a similar reduction in response amplitude in C-fibre
CAP recordings from isolated dorsal roots will be investigated, which could aid the
interpretation of any ZD7288-induced changes in the synaptic response failure rate in
the monosynaptic C-fibre input to lamina I NK1R+ neurons, seen during eEPSC
recordings.
ZD7288 has been reported to significantly reduce the peak amplitude of
monosynaptic C-fibre eEPSCs in unidentified lamina II neurons, with the inhibitory
effect of ZD7288 being enhanced in tissue isolated from nerve injured animals
(Takasu et al. 2010). The authors also shown that ZD7288 significantly reduces
miniature excitatory postsynaptic current (mEPSC) frequency, but not amplitude, in
recordings from neuropathic mouse spinal cord slices, which they argue indicates that
ZD7288 results in a presynaptic inhibition of excitatory transmission, presumably due
to a reduction in the presynaptic release of glutamate. It is unclear whether ZD7288
can similarly inhibit monosynaptic C-fibre input to lamina I NK1R+ neurons, or
whether this effect is altered in inflammatory pain. This study will therefore
investigate whether ZD7288 can modulate the amplitude of monosynaptic C-fibre
eEPSCs in lamina I NK1R+ neurons. Given that these neurons are crucial for the
manifestation of inflammatory pain (Nichols et al. 1999), which is mediated by
C-fibre nociceptors (Abrahamsen et al. 2008), the ability of ZD7288 to attenuate the
monosynaptic C-fibre input to these neurons could provide additional evidence to
support the targeting of HCN channels as a novel approach for the alleviation of
inflammatory pain (Emery et al. 2012).
Some recent evidence has suggested that ZD7288 acts as an antagonist of Nav
channels, in addition to its known ability to block HCN channels (Wu et al. 2012b).
ZD7288, at a concentration of 10µM, has been shown to significantly reduce the
conduction velocity / increase the initial latency of Aβ-, but not Aδ- or C-fibre DRG
neurons (Hogan & Poroli 2008). Similarly, 20µM ZD7288 has been shown to reduce
the conduction velocity of unmyelinated cerebellar parallel fibres (Baginskas et al.
2009). Interestingly, an increase in the initial latency of C-fibre responses can also
arise following application of the Nav channel antagonists; TTX, lidocaine or
carbamazepine (de Col et al. 2008, Pinto et al. 2008). Given the key role played by
Nav channels in action potential propagation (Gold & Gebhart 2010, Liu & Wood
2011), the finding that ZD7288 can modulate conduction velocity could be considered
to support the finding that ZD7288 acts as an antagonist of Nav channels. However,
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this effect of ZD7288 upon the initial latency / conduction velocity is disputed by
others who report that ZD7288 (10µM) does not alter the initial latency of C-fibre
responses (Takigawa et al. 1998) and while not explicitly stated, Mazo et al. (2013)
imply that the initial response latency is not altered at concentrations as high as
100µM. Therefore, in this study the effect of ZD7288 upon the initial latency of
C-fibre responses will be examined, which could give an indication as to whether any
ZD7288-induced changes in ADS could involve the modulation of Nav channels, as
well as HCN channels.
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4.2 Chapter aims and hypotheses
This chapter has investigated the phenomenon of ADS and sought to determine
whether ADS is altered in inflammatory pain. Furthermore, this chapter provides a
preliminary investigation into the role of HCN channels in mediating ADS in control
and CFA inflammation. The specific aims and hypotheses are presented below.
Aims
1. Investigate whether ADS in Aβ-, Aδ- and C-fibres can be detected in
extracellular electrophysiological recordings from isolated rat dorsal roots and
if this ADS is altered in inflammatory pain.
2. Determine whether ADS is present in monosynaptic Aδ- and/or monosynaptic
C-fibre input to lamina I NK1R+ neurons and ascertain if this ADS is modified
in inflammatory pain.
3. Using the repetitive stimulation protocols that are used to elicit ADS, quantify
the failure rate of monosynaptic C-fibre activation of lamina I NK1R+ neurons,
which is likely to reflect C-fibre conduction failures, that is correlated with
ADS, and investigate whether the incidence of failures is altered in
inflammatory pain.
4. Investigate whether monosynaptic C-fibre input to lamina I NK1R+ neurons
can be categorised into distinct groups based on ADS profile.
5. Undertake a preliminary investigation into the role of HCN channels in C-fibre
ADS to establish:
(a) Whether application of the non-specific HCN antagonist, ZD7288, alters
ADS.
(b) If the effect of ZD7288 on ADS is influenced by inflammatory pain.
(c) Whether ZD7288 alters the rate of failures in monosynaptic C-fibre input
to lamina I NK1R+ neurons.
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Hypotheses
1. ADS will be detectable using extracellular recordings from isolated dorsal
roots, with ADS being present in the C-fibre, but not Aδ- or Aβ-fibre
components and that this C-fibre ADS will be altered in CFA inflammation.
2. ADS will be present in the monosynaptic C-fibre, but not monosynaptic
Aδ-fibre input to lamina I NK1R+ neurons and that this C-fibre ADS will be
altered in CFA inflammation.
3. Increasing stimulation frequency will result in a greater number of synaptic
response failures in monosynaptic C-fibre input to lamina I NK1R+ neurons,
which may also be influenced by CFA inflammation.
4. Monosynaptic C-fibre input to lamina I NK1R+ neurons will fall into distinct
groups based on their ADS profile, which could be indicative of inputs that
detect and convey specific sensory modalities.
5. The non-specific HCN antagonist, ZD7288, will increase C-fibre ADS, with the
effect of ZD7288 being enhanced in inflammatory pain.
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4.3 Methods
4.3.1 Animals
As described in section 2.3.1.
4.3.2 Complete Freunds’s adjuvant inflammation
As described in section 2.3.2.
4.3.3 Activity-dependent slowing in isolated rat dorsal roots
Tissue preparation
Dorsal roots were isolated from control and CFA treated rats as described in
section 2.3.3
Compound action potential, activity-dependent slowing recordings
CAP recordings were carried out in the manner described in section 2.3.3. To
investigate ADS, isolated dorsal roots were stimulated 16 times at frequencies of 1
and 2Hz, at a stimulation intensity of 500µA and stimulus duration of 0.1ms. An
interval of 3 minutes was left between periods of stimulation to allow the fibres to
recover from ADS (Shim et al. 2007, Weidner et al. 1999). These stimulation
frequencies were chosen as they mimic the spontaneous firing rate of C-fibres
observed in inflammatory pain (Djouhri et al. 2006, Puig & Sorkin 1996, Xiao &
Bennett 2007). Aβ-, Aδ- and C-fibre components were identified on the basis of
activation threshold and conduction velocity, as described previously in section 2.3.3.
The latency of the Aβ-, Aδ- and C-fibre responses were measured as the latency
between the stimulus artefact and the negative peak of the triphasic response, as
shown in figure 4.1A. To assess ADS, these latency values were normalised to the
value obtained at stimulus 1, by calculating the latency change between stimulus 1
and all other subsequent stimuli. In addition, the area under the curve (AUC) of
latency change was calculated, as described in figure 4.1B. To confirm that the dorsal
roots included in control and CFA groups were of comparable length, dorsal root
length was measured as the distance between the recording and stimulating electrodes.
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In some cases, when the absolute latency values obtained during repetitive stimulation
were analysed using linear regression (as described in section 4.3.6), the intercepts of
the line of best fit were found to be significantly different, which was suggestive of a
CFA effect upon the initial latency / conduction velocity, which was contradictory to
the results in chapter 2 (figures 2.9C & 2.15D) and published studies (Baba et al.
1999, Djouhri & Lawson 2001, Nakatsuka et al. 1999, Torsney 2011). The intercept
of the line of best fit is an extrapolated value, which is influenced by the response to
repetitive stimulation (i.e. the slope of the line of best fit) and as such is not an
independent measure of initial latency / conduction velocity. Therefore, to further
investigate this potential CFA effect, the actual initial latency, recorded during
stimulus 1 of the Aβ-, Aδ- and C-fibre responses, was compared between control and
CFA groups. Only the initial latency recorded during 1Hz stimulation was compared,
to avoid any potential influence from repetitive stimulation.


































Figure 4.1: Compound action potential recording of activity-dependent slowing. A Trace
demonstrates the responses to repetitive stimulation of a control dorsal root stimulated at
C-fibre strength at a frequency of 2Hz. Trace is colour coded to match the stimulus train
shown above. The latency of C-fibre responses was measured as the time between the
stimulus artefact and the negative peak of the response, as indicated by the arrows and
broken lines. B The area under the curve of latency change recorded during repetitive
stimulation was calculated as the grey shaded area, for the dorsal root shown in A.
4.3.4 Activity-dependent slowing in monosynaptic primary afferent
input to lamina I neurokinin 1 receptor expressing neurons
To investigate ADS in monosynaptic Aδ- and monosynaptic C-fibre input to lamina I
NK1R+ neurons, patch-clamp electrophysiology was used to record eEPSCs from
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TMR-SP labelled (TMR-SP+) / NK1R+ neurons while the dorsal root was electrically
stimulated to activate these inputs. ADS in monosynaptic Aβ-fibre input was not
assessed as there is minimal monosynaptic Aβ-fibre input to these neurons (Torsney
2011, Torsney & MacDermott 2006) (figure 2.14).
Spinal cord slice preparation
Spinal cord slices with dorsal roots attached were prepared from tissue isolated from
control and CFA treated rats, as described in section 2.3.4.
Patch-clamp activity-dependent slowing recordings
Monosynaptic Aδ- and monosynaptic C-fibre input to lamina I NK1R+ neurons was
identified in the manner described in section 2.3.5. To assess ADS in monosynaptic
Aδ- and monosynaptic C-fibre input to lamina I NK1R+ neurons, eEPSCs were
recorded in response to dorsal root stimulation. Monosynaptic Aδ-fibre inputs were
stimulated 16 times at 2Hz, with a subset also being stimulated at 1 and/or 10Hz, at a
stimulus intensity of 100µA and a stimulus duration of 0.1ms. Monosynaptic C-fibre
inputs were stimulated 16 times at 1Hz, a subset of which were also stimulated at
2Hz, at an intensity of 500µA and a stimulus duration of 0.1ms. These frequencies
were chosen to mimic the spontaneous C-fibre firing rate observed during
inflammation (Djouhri et al. 2006, Puig & Sorkin 1996, Xiao & Bennett 2007). To
assess C-fibre ADS in response to higher stimulation frequencies, that more closely
match the C-fibre evoked firing rate (Thalhammer et al. 1994, Yeomans & Proudfit
1996), combined with longer stimulation trains, the monosynaptic C-fibre input to a
subset of lamina I NK1R+ neurons was also stimulated 40 times at frequencies of 2, 5
and 10Hz, at an intensity of 500µA with a stimulus duration of 0.1ms. In an
individual lamina I NK1R+ neuron, between periods of repetitive dorsal root
stimulation, intervals of 3 minutes, following 16 stimuli and 5 minutes, following 40
stimuli, were left to allow the fibres to recover from ADS (Shim et al. 2007, Weidner
et al. 1999). The latency of monosynaptic Aδ- and monosynaptic C-fibre responses
were measured as the time between the stimulus artefact and the onset of the
monosynaptic response, examples shown in figures 4.8 and 4.11. The data were
normalised to the latency recorded at stimulus 1, by calculating the latency change
between stimulus 1 and all other subsequent stimuli. Furthermore, the area under the
curve of latency change was calculated, as described for the CAP recordings in
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figure 4.1B. The dorsal root length in spinal cord slices was measured as the distance
between the stimulating electrode and the point at where the dorsal root entered the
dorsal horn and compared to confirm that comparable lengths of dorsal root were
used in each group, to ensure any ADS differences between groups were not
influenced by differences in root length. This method of measuring can only provide a
rough estimate of the distance of the conduction pathway, as it cannot account for the
section within the spinal cord, however it is still informative.
It is widely reported that C-fibres which convey information relating to different
sensory modalities exhibit different ADS profiles, specifically that
mechano-insensitive C-fibres display a high level of ADS, while mechano-sensitive
C-fibres display minimal ADS (Gee et al. 1996, Obreja et al. 2010, Serra et al. 1999,
Weidner et al. 1999). Therefore, for data obtained from C-fibre eEPSC recordings in
lamina I NK1R+ neurons, where 16 stimuli were used, frequency histograms of the
AUC of latency change were plotted to assess whether the distribution was bimodal
(Serra et al. 2004, 1999, Shim et al. 2007), which could be indicative of neurons that
receive mechano-sensitive or mechano-insensitive C-fibre input.
There is debate as to whether the initial C-fibre latency is correlated with the
magnitude of ADS that results from repetitive stimulation (Gee et al. 1996, Ringkamp
et al. 2010, Serra et al. 1999, Shim et al. 2007, Swadlow & Waxman 1976, Taguchi
et al. 2010, Thalhammer et al. 1994, Weidner et al. 1999, Zhu et al. 2009). Therefore,
to assess whether the initial latency of the monosynaptic C-fibre input to lamina I
NK1R+ neurons is predictive of the magnitude of ADS, correlation between the
initial C-fibre latency, measured during the first stimulus in the train and the AUC of
latency change was calculated.
As with the CAP experiments detailed in 4.3.3, when absolute latency values of the
monosynaptic Aδ-fibre / monosynaptic C-fibre responses recorded during repetitive
stimulation were analysed, some of the results showed significant differences in the
intercept of the lines of best fit between control and CFA groups, which was
suggestive of a CFA effect upon the initial latency / conduction velocity. However, as
the intercept is influenced by the slope and is an extrapolated value as opposed to an
actual value, this potential CFA effect was investigated further by comparing the
actual initial latency values obtained during the first stimulation of trains of 16 / 40
sweeps, at frequencies of 1, 2, 5 and 10Hz, in control and CFA tissue.
In the extended stimulation train experiments, the synaptic response failure rate was
analysed to ascertain whether CFA inflammation altered the degree of C-fibre
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conduction failures. A failure was determined as having occurred when a stimulus did
not result in a clear eEPSC, an example of which is shown in figure 4.2. The synaptic
response failure rate was determined per stimuli, during dorsal root stimulation at 2, 5
and 10Hz, with control and CFA groups being compared. Additionally, the total











Figure 4.2: Example of a monosynaptic C-fibre failure during repetitive stimulation.
Trace shows eEPSCs recorded in a lamina I NK1R+ neurons isolated from a CFA treated
rat, in response to C-fibre stimulation at 2Hz (40 stimuli). Stimuli 1 shown in green, while
stimuli 37 in orange demonstrates a failure in the monosynaptic C-fibre in which the
stimulus has not resulted in a clear eEPSC. Notably, no failure was present in the
monosynaptic Aδ-fibre component during this stimulus.
4.3.5 The role of HCN channels on activity-dependent slowing
Influence of HCN channels in activity-dependent slowing in C-fibres in
isolated rat dorsal roots
In these experiments, Ms Veny Lukito, a Physiological Society vacation student,
performed the electrophysiological recordings and conducted some analysis on the
resulting data.
To assess the role of HCN channels in constraining C-fibre ADS in isolated dorsal
roots and whether this is altered in CFA inflammation, CAP recordings of C-fibres
were made from dorsal roots isolated from control and CFA treated rats, as described
in sections 2.3.3 and 4.3.3. Dorsal roots were stimulated 40 times at a frequency of
2Hz, stimulation intensity of 500µA and a stimulus duration of 0.1ms, before
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(‘baseline’) and during bath application of the non-selective HCN antagonist,
ZD7288 (10µM, Sigma) or vehicle (Krebs only). These two stimulation periods were
separated by an interval of 10 minutes, during which ZD7288 was washed into the
recording bath. The C-fibre latency was measured for each stimulation as the time
between the stimulus artefact and the negative peak of the triphasic response
(figure 4.1A). The data were normalised, by calculating the latency change between
the response latency at stimulus 1 and all other subsequent stimuli. To assess the
degree of facilitation of ADS caused by ZD7288, the latency change recorded at
baseline was subtracted from the latency change recorded during ZD7288 application.
There is debate as to whether ZD7288 alters the initial latency of the C-fibre response
(Baginskas et al. 2009, Hogan & Poroli 2008, Mazo et al. 2013, Takigawa et al.
1998), which may be indicative of ZD7288s reported actions against Nav channels
(Wu et al. 2012b). Therefore, the effect of ZD7288 application on the initial C-fibre
response latency was investigated, by comparing the response latency measured
during the first stimuli during baseline and ZD7288 recordings.
ZD7288 has previously been shown to reduce the amplitude of CAPs in unmyelinated
cerebellar parallel fibres, which is suggested to indicate an increase in conduction
failures (Baginskas et al. 2009). Therefore, to aid interpretation of any ZD7288 effect
upon the synaptic response failure rate in monosynaptic C-fibre input to lamina I
NK1R+ neurons (detailed below), the effect of ZD7288 on the amplitude of the
C-fibre response was examined, by measuring the amplitude of the response, defined
as the difference between the positive and negative peak (as described previously in
section 2.3.3 and figure 2.6), during the first stimuli delivered during baseline and
ZD7288 recordings. Amplitude was only measured during the first stimuli so as to
study the effect of ZD7288 in isolation from the effect of repetitive stimulation.
Influence of HCN channels on activity-dependent slowing in
monosynaptic C-fibre input to lamina I neurokinin 1 receptor expressing
neurons
To investigate the capacity of HCN channels to constrain ADS in monosynaptic
C-fibre input to lamina I NK1R+ neurons in tissue isolated from control and CFA
treated rats, patch-clamp recordings were made from pre-labelled neurons in the
manner described above in section 4.3.4. Monosynaptic C-fibre input was stimulated
40 times at 2, 5 and 10Hz, at an intensity of 500µA, with a stimulus duration of
0.1ms, prior to (‘baseline’) and during application of 10µM ZD7288. ZD7288 was
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bath applied and a wash-in period of 10 minutes was allowed between baseline and
ZD7288 recordings. A 5 minute period was left between recordings using 2, 5 and
10Hz stimulation to allow the tissue to recover from ADS (de Col et al. 2008, 2012).
The latency of monosynaptic C-fibre responses was measured as the time between the
stimulus artefact and the onset of the eEPSC (figure 4.11). Data were normalised by
calculating the latency change from the first stimuli. To determine the degree of
ZD7288 facilitation, the baseline latency change was subtracted from the latency
change recorded during ZD7288 application. To determine whether ZD7288 altered
the initial latency of the C-fibre response, the latency measured during the first stimuli
during baseline and ZD7288 recordings were compared.
ZD7288 has previously been shown to increase the number of failures in saphenous
nerve recordings (Zhu et al. 2009) and in monosynaptic C-fibre input to unidentified
lamina I/II neurons (Papp et al. 2006). To investigate whether ZD7288 similarly alters
the number of synaptic response failures in monosynaptic C-fibre input, which is
likely indicative of C-fibre conduction failures, the failure rate in response to 2, 5 and
10Hz stimulation was recorded prior to and during ZD7288 application.
The eEPSC amplitude of monosynaptic C-fibre input to unidentified lamina II
neurons is known to be attenuated by ZD7288 (Takasu et al. 2010). To assess whether
ZD7288 application altered the amplitude of monosynaptic C-fibre input to lamina I
NK1R+ neurons, the peak amplitude of the C-fibre eEPSC during the first stimuli of
baseline and ZD7288 trains was measured, as described previously in section 2.3.5
and figure 2.15A. Only the first stimuli was measured to enable the study of the effect
of ZD7288 in isolation from any potential effects of repetitive stimulation.
4.3.6 Statistical analysis
To ascertain whether it was appropriate to use parametric or non-parametric statistical
tests, or whether data should be transformed prior to performing parametric tests, all
data were assessed for normality using D’Agostino & Pearson omnibus normality
tests, or Kolmogorov-Smirnov tests if sample sizes were insufficient to use the former.
In CAP recordings from isolated dorsal roots and in eEPSC recordings of
monosynaptic Aδ- and monosynaptic C-fibre input to lamina I NK1R+ neurons, the
effects of CFA inflammation on the the responses to repetitive stimulation were
analysed using linear regression. Lines of best fit were fitted to the absolute latency
data and to the normalised (‘latency change’) data. In the case of normalised data, the
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intercept was constrained to X = stimulus 1, Y = 0ms. To determine whether a
response was altered by repetitive stimulation and thus exhibited ADS, the slope of
the data was compared to a hypothetical slope of 0. To analyse whether CFA
inflammation altered the response, the slope of the control group was compared to the
slope of the CFA group. When the absolute latency data were plotted, in many cases
there appeared to be difference in the intercept of the line of best fit between control
and CFA groups, therefore the intercepts were compared in addition to the slopes. In
all cases slopes and intercepts were compared using a sum-of-squares F test. To
compare the effect of different stimulation frequencies and CFA inflammation on
ADS, the AUC of latency change was calculated. In CAP recordings, AUC of latency
change was statistically analysed using 2-way repeated measures ANOVA, while in
eEPSC data 2-way ANOVA was used. To determine whether the initial latency of
responses in CAP and eEPSC recordings was altered by CFA inflammation, the
latencies recorded during stimuli 1 were compared using 2-way ANOVA followed by
Bonferroni post-tests, in the case of CAP recordings a 2-way repeated measures
ANOVA was used. 2-way ANOVA or an unpaired t-test was used to determine
whether the length of dorsal root stimulated differed between groups. Linear
regression was used, as described above, to analyse the effects CFA inflammation on
the C-fibre failure rate during repetitive stimulation. The total C-fibre failure rates
during 2, 5 and 10Hz stimulation, in control and CFA groups were compared using
2-way ANOVA followed by Tukey post-tests. To assess whether the distribution of
the AUC of latency change was altered by CFA inflammation, a
Kolmogorov-Smirnov 2-sample test was used. Pearson’s r test was used to determine
whether the initial latency of monosynaptic C-fibre input to lamina I NK1R+ neurons
was correlated with the AUC of latency change.
In CAP and eEPSC recordings, the effect of ZD7288 (or vehicle in the case of CAP
recordings) application on C-fibre ADS was analysed using linear regression. Lines
of best fit were fitted to absolute and normalised (‘latency change’) data, in the case of
normalised data the intercept was constrained to X = stimulus 1, Y = 0ms. To
determine whether ADS was present, the slopes were compared to a hypothetical
slope of 0. To ascertain the effects of ZD7288 (or vehicle), the baseline slope was
compared to the ZD7288 slope. Where absolute latency data were analysed, the
intercepts of the slope were also compared. To compare the magnitude of ZD7288
facilitation in control and CFA inflammation groups, linear regression was used as
described above to compare the slopes of facilitation recorded in tissue isolated from
control and CFA treated rats. A sum-of-squares F test was used in all cases to
compare slopes and intercepts. 2-way repeated measures ANOVA followed by
CHAPTER 4: ACTIVITY-DEPENDENT SLOWING 153
Bonferroni post-tests was used to statistically analyse the effect of ZD7288 on the
initial response latency and on the C-fibre peak amplitude. The effect of ZD7288 on
the synaptic response failure rate in monosynaptic C-fibre input to lamina I NK1R+
neurons was assessed using 2-way repeated measures ANOVA followed by
Bonferroni post-tests.
All data are presented as mean ± standard error of the mean (SEM). All statistical
analysis was performed using Prism 6 (Graphpad Software).
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4.4 Results
4.4.1 Inflammatory pain attenuates activity-dependent slowing in C-,
but not A-fibres in isolated rat dorsal roots
Isolated dorsal roots were stimulated repetitively at frequencies of 1 and 2Hz to assess
whether ADS can be detected in extracellular electrophysiological population
recordings and whether CFA inflammation alters this phenomenon.
Representative traces of CAP recordings of the Aβ-fibre latency shift during
repetitive stimulation at 2Hz, in dorsal roots isolated from control and CFA treated
rats are shown in figure 4.3A. Analysis of the absolute latency of Aβ-fibre responses
demonstrated that 1 and 2Hz stimulation did not alter the latency, while CFA
inflammation did not alter the slope (P=0.953 & P=0.917, respectively, linear
regression, figure 4.3B & C, table 4.1) or the intercept (P=0.325 & P=0.172,
respectively, linear regression). When the data were normalised, it was shown that
repetitive stimulation at 1 and 2Hz caused a significant reduction in the response
latency, indicating ‘activity-dependent speeding’ (all P<0.0001, linear regression,
figure 4.3D & C, table 4.2). During 1Hz stimulation, no significant difference was
detected in the degree of latency change between control and CFA groups (P=0.445,
linear regression), however during 2Hz stimulation, there was significantly less
speeding in dorsal roots isolated from CFA treated rats (P=0.0002, linear regression,
figure 4.3E, table 4.1). When the AUC of latency change was compared, this
demonstrated that the Aβ-fibre response to repetitive stimulation was not influenced
by stimulation frequency (P=0.536, 2-way repeated measures ANOVA, figure 4.6A),
or CFA inflammation (P=0564. 2-way repeated measures ANOVA) and there was no
interaction between these factors (P=0.304, 2-way repeated measures ANOVA).
























































































































Figure 4.3: Aβ-fibres exhibit activity-dependent speeding. A Representative traces of
Aβ-fibre compound action potentials recorded in dorsal roots isolated from control (left)
and CFA (right) treated rats, during 2Hz stimulation. Large yellow box shows magnified
portion of the negative peak of the response, dotted lines intersect negative peak of the
response. B & C show absolute latency values recorded during 1 and 2Hz stimulation,
respectively. Stimulation at these frequencies did not significantly alter the absolute
latency, in control or CFA roots. CFA inflammation did not significantly alter the slope or
intercept of the data recorded during stimulation at 1 or 2Hz. When the data were
normalised, it was found that repetitive stimulation at 1 (D) and 2Hz (E) resulted in a
small but significant decrease in Aβ-fibre response latency (all P<0.0001). CFA
inflammation significantly attenuated the latency change seen during 2Hz (P=0.0002) but
not 1Hz stimulation (P=0.445). Statistics: linear regression. Slope, r2 and 95% CI values
for B/C & D/E are presented in tables 4.1 & 4.2, respectively. Control n=10, CFA n=12.
Legends in B apply to C, D & E. Error bars indicate SEM. Dashed lines represent line of
best fit. ∗∗∗P<0.001.
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Figure 4.4A shows representative traces of Aδ-fibre CAP recordings during repetitive
stimulation at 2Hz, in dorsal roots isolated from control and CFA treated rats. The
absolute latency of the Aδ-fibre response was not altered by repetitive stimulation at 1
or 2Hz and there was no difference in the slopes fitted to data obtained from control
and CFA groups (P=0.923 & P=0.356, respectively, linear regression, figure 4.4B &
C, table 4.1). In dorsal roots stimulated at 1 and 2Hz, the intercept was significantly
greater in the CFA group (P=0.0006 & P<0.0001, respectively, linear regression).
When the data were normalised, it was found that 1 and 2Hz stimulation resulted in a
small but significant progressive increase in response latency (all P<0.0001,
figure 4.4D & E, respectively, linear regression, table 4.2). CFA inflammation was
without effect during both 1Hz and 2Hz stimulation (P=0.075 & P=0.356,
respectively, linear regression). Analysis of the AUC of the latency change confirmed
that CFA inflammation did not alter ADS in Aδ-fibres (P=0.533, 2-way repeated
measures ANOVA, figure 4.6B) and showed that the magnitude of ADS was not
significantly altered by stimulation frequency (P=0.812, 2-way repeated measures
ANOVA) and there was no interaction between these variables (P=0.949, 2-way
repeated measures ANOVA).
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Figure 4.4: Aδ-fibre activity-dependent slowing. A Representative traces of Aδ-fibre
compound action potentials recorded in dorsal roots isolated from control (left) and CFA
(right) treated rats, during 2Hz stimulation. Dotted lines intersect negative peak of the
response during stimuli 1 and 16. The absolute latency of the Aδ-fibre response did not
significantly change during repetitive stimulation at 1 (B) or 2Hz (C). The intercept of the
slope was greater in CFA inflammation, during 1 and 2Hz stimulation (P=0.0006 &
P<0.0001, respectively), but CFA did not affect the slope. Analysis of normalised data
revealed that repetitive stimulation at 1 (D) and 2Hz (E) produced a significant
progressive increase in response latency (all P<0.0001), however CFA inflammation was
without effect (1Hz P=0.075, 2Hz P=0.356). Statistics: linear regression. Slope, r2 and
95% CI values for B/C & D/E are presented in tables 4.1 & 4.2, respectively. Control
n=11, CFA n=13. Legends in B apply to C, D & E. Error bars indicate SEM. Dashed lines
represent line of best fit. Control vs. CFA, intercept: ### P<0.001, #### P<0.0001.
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Representative traces of C-fibre CAP recordings, in dorsal roots isolated from control
and CFA treated rats, during repetitive stimulation at 2Hz are shown in figure 4.5A,
which clearly demonstrates the shift in latency that arises due to ADS. Analysis of the
absolute latency of the C-fibre response revealed that 2Hz, but not 1Hz, stimulation of
dorsal roots isolated from control treated rats resulted in a significant increase in
latency (P=0.038, linear regression, figure 4.5B, table 4.1), while no significant
differences were seen in CFA tissue. CFA inflammation did not alter the slope of the
data recorded during 1 or 2Hz stimulation (P=0.957 & P=0.628, respectively, linear
regression, figure 4.5A & B, table 4.1). In the CFA group, the intercept was
significantly less in data obtained during stimulation at 1 and 2Hz (both P<0.0001,
linear regression). Analysis of normalised data revealed that dorsal root stimulation at
1 and 2Hz resulted in a significant progressive increase in C-fibre response latency (all
P<0.0001, linear regression, figure 4.5D & E, respectively, table 4.2). Dorsal roots
isolated from CFA treated rats displayed significantly less ADS than control dorsal
roots during stimulation at 1 and 2Hz (both P<0.0001, linear regression). Comparison
of the AUC of latency change confirmed that CFA inflammation significantly reduced
C-fibre ADS (P=0.0006, 2-way repeated measures ANOVA, figure 4.6C) and revealed
that 2Hz stimulation resulted in significantly greater ADS than 1Hz (P=0.0009, 2-way
repeated measures ANOVA). There was no interaction between CFA inflammation
and stimulation frequency (P=0.719, 2-way repeated measures ANOVA).
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Figure 4.5: CFA inflammation attenuates activity-dependent slowing in C-fibres in
isolated dorsal roots. A Representative traces of C-fibre compound action potentials
recorded in dorsal roots isolated from control (left) and CFA (right) treated rats, during
2Hz stimulation, dotted lines transect the negative peak of the components. B & C The
absolute C-fibre latency was significantly increased in response to 2Hz stimulation, in
control dorsal roots only (P=0.038). CFA inflammation did not alter the slope of the fitted
line, but significantly reduced the intercept during 1 and 2Hz stimulation (both
P<0.0001). When the data were normalised, stimulation at 1 (D) and 2Hz (E) was found
to result in a significant increase in the C-fibre response latency (all P<0.0001), which
was significantly attenuated by CFA inflammation (both P<0.0001). Statistics: linear
regression. Slope, r2 and 95% CI values for B/C & D/E are presented in tables 4.1 & 4.2,
respectively. Control n=11, CFA n=13. Legends in B apply to C, D & E. Error bars
indicate SEM. Dashed lines represent line of best fit. Control vs. CFA, slope:





























Input Frequency Treatment Y Intercept Intercept Control Slope Slope Slope vs. Control r2
(Hz) 95% CI vs. CFA 95% CI Slope = 0 vs. CFA
Aβ
1
control 1.10 0.977 to 1.229
P=0.325
-0.002 -0.016 to 0.012 P=0.784
P=0.953
0.000
CFA 1.06 0.951 to 1.175 -0.003 -0.015 to 0.010 P=0.692 0.000
2
control 1.07 0.948 to 1.190
P=0.172
-0.002 -0.016 to 0.012 P=0.780
P=0.917
0.000
CFA 1.00 0.886 to 1.115 -0.001 -0.014 to 0.012 P=0.886 0.000
Aδ
1
control 5.14 4.605 to 5.678
P=0.0006
0.007 -0.055 to 0.067 P=0.837
P=0.923
0.000
CFA 5.86 5.348 to 6.369 0.002 -0.056 to 0.060 P=0.939 0.000
2
control 5.13 4.602 to 5.651
P<0.0001
0.030 -0.056 to 0.063 P=0.900
P=0.356
0.000
CFA 5.91 5.388 to 6.431 0.006 -0.053 to 0.065 P=0.840 0.000
C
1
control 19.19 18.41 to 19.96
P<0.0001
0.045 -0.025 to 0.150 P=0.164
P=0.957
0.011
CFA 17.27 16.54 to 18.00 0.020 -0.063 to 0.103 P=0.634 0.001
2
control 19.93 19.10 to 20.76
P<0.0001
0.048 0.006 to 0.196 P=0.038
P=0.628
0.025
CFA 17.47 16.66 to 18.27 0.068 -0.024 to 0.160 P=0.148 0.010





























Input Frequency (Hz) Treatment Slope r2 95% CI Slope vs. Slope = 0 Control vs. CFA
Aβ
1
control -0.003 0.036 -0.003 to -0.002 P<0.0001
P=0.445
CFA -0.003 0.080 -0.004 to -0.002 P<0.0001
2
control -0.003 0.021 -0.004 to -0.002 P<0.0001
P=0.0002
CFA -0.001 0.019 -0.002 to -0.001 P<0.0001
Aδ
1
control 0.008 0.021 0.005 to 0.011 P<0.0001
P=0.075
CFA 0.005 -0.005 0.003 to 0.007 P<0.0001
2
control 0.008 -0.012 0.006 to 0.010 P<0.0001
P=0.356
CFA 0.007 0.039 0.004 to 0.009 P<0.0001
C
1
control 0.074 0.258 0.004 to 0.082 P<0.0001
P<0.0001
CFA 0.016 0.089 0.011 to 0.020 P<0.0001
2
control 0.114 0.339 0.106 to 0.122 P<0.0001
P<0.0001
CFA 0.068 0.220 0.059 to 0.076 P<0.0001
Table 4.2: Comparison of the latency change in Aβ-, Aδ- and C-fibre CAP recordings.







































































Figure 4.6: Area under the curve analysis of activity-dependent slowing in isolated
dorsal roots. ADS was unaffected by CFA inflammation, stimulation frequency and there
was no interaction between these factors in Aβ- (A, P=0.564, P=0.536 & P=0.304
respectively) or Aδ-fibres (B, P=0.533, P=0.812 & P=0.949, respectively). C In C-fibres,
there was significantly greater ADS at 2Hz than 1Hz (P=0.0009), while CFA inflammation
significantly reduced the level of ADS (P=0.0006) irrespective of frequency (P=0.719). All
statistics: 2-way repeated measures ANOVA. Sample sizes indicated on bars. Legend in
A applies to all. Error bars indicate SEM. ∗∗∗P<0.001.
To confirm that the length of dorsal root stimulated was similar between control and
CFA groups, the length of dorsal root stimulated was compared. The length of
isolated dorsal roots used in these CAP studies did not significantly differ between
control and CFA groups (P=0.777, unpaired t-test, figure 4.7A) and so the
inflammation induced changes in ADS that were observed are unlikely to have
resulted due to differences in the length of dorsal root stimulated.
The initial response latency of the primary afferent components, recorded at stimuli 1
during 1Hz stimulation, was significantly altered by fibre type (P<0.0001, 2-way
repeated measures ANOVA, figure 4.7B). CFA inflammation did not alter the initial
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latency (P=0.458, 2-way repeated measures ANOVA) and there was no interaction
between these factors (P=0.108, 2-way repeated measures ANOVA). There is
evidence that primary afferents that display greater initial response latencies show
increased ADS (Ringkamp et al. 2010, Shim et al. 2007, Swadlow & Waxman 1976,
Weidner et al. 1999, Zhu et al. 2009), although this is disputed by others (Gee et al.
1996, Serra et al. 1999, Taguchi et al. 2010, Thalhammer et al. 1994). Therefore, the
changes in ADS seen during CFA inflammation reported here are unlikely to have
arisen due to alterations in initial latency. While these data do contradict the findings
in figures 4.4 and 4.5, that show significant differences in the intercept between
control and CFA groups for Aδ- and C-fibre responses, it should be noted that the
intercept is extrapolated from all data points and thus subject to influence from the
response to repetitive stimulation (i.e. the slope of the line of best fit). Therefore,
comparing the initial latency, which is not influenced by ADS, can be considered to










































Figure 4.7: Initial latency of Aβ-, Aδ- and C-fibre components in isolated dorsal roots. A
The dorsal root length in control and CFA groups was not significantly different (P=0.777,
unpaired t-test). B The initial latency of the responses was significantly different between
the different primary afferent components (P<0.0001, 2-way repeated measures
ANOVA), however CFA inflammation was without effect and there was no interaction
between these factors (P=0.458 & P=0.108, respectively, 2-way repeated measures
ANOVA). Sample size for A indicated on bars, B: Aδ & C; control n=11, CFA n=13, Aβ;
control n=10, CFA n=12. Error bars indicate SEM.
4.4.2 Activity-dependent slowing in monosynaptic Aδ-fibre input to
lamina I neurokinin 1 receptor expressing neurons
To investigate ADS in monosynaptic Aδ-fibre input to lamina I NK1R+ neurons,
Aδ-fibre eEPSCs were recorded while stimulating the dorsal root at frequencies of 1,
2 and 10Hz. Figure 4.8 shows representative traces of monosynaptic Aδ-fibre input to
lamina I NK1R+ neurons, in tissue isolated from control and CFA treated rats, during
repetitive stimulation at 2Hz, which demonstrates a negligible latency change. The
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absolute latency of monosynaptic Aδ-fibre input to lamina I NK1R+ neurons was not
altered by repetitive stimulation at 1, 2 or 10Hz. CFA inflammation did not alter the
slope fitted to the data recorded during any of these three stimulation frequencies
(P=0.935, P=0.995 & P=0.994, respectively, linear regression, figure 4.9A, B & C,
table 4.3). The intercept was significantly less in the CFA group during stimulation at
1 and 2Hz (P<0.0001 & P=0.006, respectively, linear regression), but not 10Hz
(P=0.239, linear regression). However, when the initial latency of the monosynaptic
Aδ-fibre response was compared this did not support the above data, in that the initial
Aδ-fibre latency was not altered by CFA inflammation (P=0.631, 2-way ANOVA on
rank transformed data, figure 4.9D) and did not differ between groups stimulated at 1,
2 or 10Hz (P=0.658, 2-way ANOVA on rank transformed data). There was no
significant interaction between these factors (P=0.600, 2-way ANOVA on rank
transformed data). The length of dorsal root stimulated did not differ between groups
(P=0.305, frequency P=0.497, interaction P=0.976, 2-way ANOVA, figure 4.9E).
Analysis of the normalised data demonstrated that stimulation of monosynaptic
Aδ-fibre input to lamina I NK1R+ neurons at frequencies of 1, 2 and 10Hz, in tissue
isolated from control and CFA treated rats, resulted in a small but significant
progressive increase in response latency (all P<0.0001, linear regression,
figure 4.10A, B & C, table 4.4). The degree of ADS elicited by 1 or 2Hz stimulation
was not affected by CFA inflammation (P=0.946 & P=0.277, respectively, linear
regression, figure 4.10A, & B, table 4.4). The ADS elicited by Aδ-fibre stimulation at
10Hz, was significantly reduced in tissue isolated from CFA treated rats (P=0.010,
linear regression, figure 4.10C, table 4.4). AUC analysis showed that the magnitude
of ADS was significantly altered by stimulation frequency (P=0.003, 2-way ANOVA,
figure 4.10D). CFA inflammation was without effect (P=0.465, 2-way ANOVA) and
there was no interaction between these variables (P=0.641, 2-way ANOVA).











































































Figure 4.8: Representative traces of Aδ-fibre activity-dependent slowing. Traces (left)
show Aδ-fibre eEPSCs recorded in tissue isolated from control (A) and CFA treated (B)
rats, during 2Hz stimulation. Latency was measured as the time between the stimulus
artefact and the monosynaptic response, indicated by the broken lines and arrows. The
latency change calculated from each example is shown to the right of the trace.
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Figure 4.9: A , B & C show the absolute latency of monosynaptic Aδ-fibre input to lamina
I NK1R+ neurons recorded during repetitive stimulation at 1, 2 and 10Hz, respectively. In
all cases the slope of absolute latency was unaltered by repetitive stimulation, while CFA
inflammation was also without effect (1Hz P=0.935, 2Hz P=0.995, 10Hz P=0.994). CFA
inflammation significantly reduced the intercept in the groups stimulated at 1 and 2Hz
(P<0.0001 & P=0.006, respectively), but not 10Hz (P=0.239). D The initial latency of the
Aδ-fibre responses did not differ between control and CFA groups (P=0.631) or between
stimulation frequencies (P=0.658) and there was no interaction between these factors
(P=0.600). E The length of dorsal root stimulated did not differ between control and CFA
groups (P=0.305) or between the different stimulation frequencies (P=0.497) and there
was no significant interaction (P=0.976). Statistics (A–C): linear regression. Slope, r2
and 95% CI values for A–C are presented in table 4.3. Statistics (D): 2-way ANOVA on
rank transformed data. Statistics (E): 2-way ANOVA. Sample sizes for A–D indicated on
bars in D. Sample sizes for E indicated on bars. Legend in A applies to B & C. Legend in
D applies to E. Error bars indicate SEM. Dashed lines represent line of best fit. Control
vs. CFA intercept: ## P<0.01, #### P<0.0001.
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Figure 4.10: Activity-dependent slowing in monosynaptic Aδ-fibre input to lamina I
NK1R+ neurons. Stimulation at 1 (A), 2Hz (B) and 10Hz (C) resulted in a small but
significant increase in response latency (all P<0.0001). CFA inflammation was without
effect when monosynaptic Aδ-fibre input to lamina I NK1R+ neurons was stimulated at 1
or 2Hz (P=0.945 & P=0.277, respectively). However, during 10Hz stimulation there was a
small but significant reduction in the latency change in the CFA inflammation group
(P=0.010). D Area under the curve analysis of latency change demonstrated that the
degree of ADS was significantly altered by stimulation frequency (P=0.003), but CFA
inflammation was without effect (P=0.465) and there was no interaction (P=0.641).
Statistics (A–C): linear regression. Slope, r2 and 95% CI values are presented in
table 4.4. Statistics (D): 2-way ANOVA. Sample sizes indicated on bars in D. Legend in A






























Frequency (Hz) Treatment Y Intercept Intercept Control Slope Slope Slope vs. Control r2
95% CI vs. CFA 95% CI Slope = 0 vs. CFA
1
control 9.577 7.459 to 11.69
P<0.0001
0.020 -0.220 to 0.261 P=0.867
P=0.935
0.000
CFA 6.138 5.163 to 7.114 0.011 -0.100 to 0.121 P=0.851 0.000
2
control 7.114 5.861 to 8.368
P=0.006
0.023 -0.119 to 0.165 P=0.752
P=0.995
0.000
CFA 6.081 5.306 to 6.857 0.023 -0.066 to 0.111 P=0.616 0.000
10
control 6.485 5.290 to 7.679
P=0.239
0.052 -0.086 to 0.189 P=0.464
P=0.994
0.003
CFA 6.029 5.160 to 6.897 0.051 -0.048 to 0.151 P=0.313 0.003
Table 4.3: Comparison of absolute latency in monosynaptic Aδ-fibre input to lamina I NK1R+ neurons during stimulation at 1, 2 and 10Hz.
Frequency (Hz) Treatment Slope r2 95% CI Slope vs. Slope = 0 Control vs. CFA
1
control 0.024 0.029 0.012 to 0.040 P<0.0001
P=0.946
CFA 0.024 -0.022 0.018 to 0.030 P<0.0001
2
control 0.046 -0.028 0.040 to 0.052 P<0.0001
P=0.277
CFA 0.042 -0.001 0.037 to 0.046 P<0.0001
10
control 0.821 0.028 0.069 to 0.095 P<0.0001
P=0.010
CFA 0.063 0.091 0.055 to 0.071 P<0.0001
Table 4.4: Comparison of latency change in monosynaptic Aδ-fibre input to lamina I NK1R+ neurons, during stimulation at 1, 2 and 10Hz.
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4.4.3 Activity-dependent slowing in monosynaptic C-fibre input to
lamina I neurokinin 1 receptor expressing neurons is reduced in
inflammatory pain
To assess ADS in monosynaptic C-fibre input to lamina I NK1R+ neurons, C-fibre
eEPSCs were recorded in response to dorsal root stimulation at 1 and 2Hz.
Representative traces of C-fibre eEPSCs recorded during 1Hz stimulation, in tissue
isolated from control and CFA treated rats, are shown in figure 4.11, which
demonstrates the progressive increase in response latency. The absolute latency of
monosynaptic C-fibre input to lamina I NK1R+ neurons, recorded in tissue isolated
from control rats, during stimulation at 1Hz, showed a significant progressive increase
(P=0.044, linear regression, figure 4.12A, table 4.5). The absolute latency was not
altered in CFA tissue during 1 or 2Hz stimulation, or in control tissue during 2Hz
stimulation. CFA inflammation did not alter the slope of the data (1Hz P=0.533, 2Hz
P=0.631, linear regression, figure 4.12A & B, table 4.5). The data recorded in tissue
isolated from CFA treated rats, during 1 and 2Hz stimulation, displayed a significantly
reduced intercept compared to control (both P<0.0001, linear regression). However,
this finding was not supported by the analysis of the initial C-fibre latency, where
CFA inflammation was found to be without effect (P=0.085, 2-way ANOVA,
figure 4.13A). The initial latency was significantly greater in those neurons stimulated
at 2Hz (P=0.020, 2-way ANOVA), without influence from CFA (P=0.590, 2-way
ANOVA). This was paralleled by the finding that the length of dorsal root stimulated
was significantly longer in the group stimulated at 2Hz (P=0.037, 2-way ANOVA,
figure 4.13B). No significant differences in root length were detected between control
and CFA inflammation groups (P=0.675, 2-way ANOVA) and there was no interaction
between stimulation frequency and CFA inflammation (P=0.475, 2-way ANOVA).
When the ADS latency data were normalised, it was found that repetitive stimulation
of monosynaptic C-fibre input to lamina I NK1R+ neurons, at frequencies of 1 and
2Hz resulted in a significant progressive increase in response latency, in both control
and CFA groups (all P<0.0001, linear regression, figure 4.12C & D, table 4.6). In
tissue isolated from CFA treated rats, the magnitude of ADS seen during 1 and 2Hz
C-fibre stimulation was significantly reduced (both P<0.0001, linear regression).
AUC analysis of latency change confirmed that CFA inflammation significantly
reduced ADS in monosynaptic C-fibre input to lamina I NK1R+ neurons (P<0.0001,
2-way ANOVA, figure 4.12E). There was a trend towards greater ADS during 2Hz
stimulation, however this was not significant (P=0.060, 2-way ANOVA). There was
no interaction between CFA inflammation and stimulation frequency (P=0.204, 2-way









































































Figure 4.11: Representative traces of C-fibre activity-dependent slowing. Traces (left)
show C-fibre eEPSCs recorded in tissue isolated from control (A) and CFA treated (B)
rats, during 1Hz stimulation. Latency was measured as the time between the stimulus
artefact and the onset of the response, indicated by the broken lines and arrows. The
latency change measured from the example traces are shown to the right. Traces in A &
B displayed with same X scale.
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Figure 4.12: Activity-dependent slowing in monosynaptic C-fibre input to lamina I
NK1R+ neurons is attenuated by CFA inflammation. C-fibre stimulation at 1 (A) or 2Hz
(B) did not alter the absolute latency of the response, except in the control group during
1Hz stimulation (P=0.044). CFA inflammation significantly reduced the intercept of the
line calculated from data obtained during 1 and 2Hz stimulation (both P<0.0001), but did
not alter the slope. When the data were normalised, stimulation at 1 (C) and 2Hz (D) was
shown to cause a significant progressive increase in response latency (all P<0.0001).
The latency change seen during stimulation at these frequencies was significantly
reduced by CFA inflammation (both P<0.0001). E Area under the curve analysis of
latency change confirmed that CFA inflammation significantly reduced ADS (P<0.0001).
There was a trend towards greater ADS at 2Hz, however this effect was not significant
(P=0.060). There was no interaction between CFA inflammation and stimulation
frequency (P=0.204). Statistics (A–D): linear regression. Slope, r2 and 95% CI values for
A/B and C/D are presented in tables 4.5 and 4.6, respectively. Statistics (E): 2-way
ANOVA. Sample sizes indicated on bars in E. Legend in A applies to B–D. Error bars
indicate SEM. Dashed lines represent line of best fit. Control vs. CFA slope:
∗∗∗∗P<0.0001, intercept: #### P<0.0001
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Figure 4.13: Dorsal root length and initial C-fibre eEPSC latency. A The initial latency in
the 2Hz stimulation group was significantly greater than in the 1Hz group (P=0.020),
however CFA was without effect (P=0.085) and there was no interaction between these
factors (P=0.590). B The length of dorsal root stimulated was significantly greater in the
group stimulated at 2Hz (P=0.037), but did not differ between control and CFA groups
(P=0.675) and there was no interaction (P=0.475). Statistics: 2-way ANOVA. Legend in





























Frequency (Hz) Treatment Y Intercept Intercept Control Slope Slope Slope vs. Control r2
95% CI vs. CFA 95% CI Slope = 0 vs. CFA
1
control 22.44 21.25 to 23.63
P<0.0001
0.139 0.005 to 0.275 P=0.044
P=0.533
0.006
CFA 20.57 19.67 to 21.47 0.086 -0.016 to 0.189 P=0.099 0.003
2
control 26.89 24.73 to 29.05
P<0.0001
0.176 -0.072 to 0.424 P=0.165
P=0.631
0.008
CFA 22.98 21.68 to 24.28 0.664 -0.042 to 0.258 P=0.158 0.004
Table 4.5: Comparison of absolute latency in monosynaptic C-fibre input to lamina I NK1R+ neurons, during stimulation at 1 and 2Hz.
Frequency (Hz) Treatment Slope r2 95% CI Slope vs. Slope = 0 Control vs. CFA
1
control 0.164 0.173 0.153 to 0.176 P<0.0001
P<0.0001
CFA 0.93 0.148 0.087 to 0.100 P<0.0001
2
control 0.229 0.106 0.196 to 0.262 P<0.0001
P<0.0001
CFA 0.113 0.138 0.100 to 0.126 P<0.0001
Table 4.6: Comparison of latency change in monosynaptic C-fibre input to lamina I NK1R+ neurons, during stimulation at 1 and 2Hz.
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Monosynaptic C-fibre input to lamina I neurokinin 1 receptor expressing
neurons cannot be classified on the basis of activity-dependent slowing
profiles
It has previously been established that C-fibres which convey different sensory
modalities display different levels of ADS, namely that mechano-insensitive C-fibres
exhibit a large degree of ADS, while mechano-sensitive C-fibres display minimal
ADS (Gee et al. 1996, Obreja et al. 2010, Serra et al. 1999, Weidner et al. 1999). To
assess whether it was possible to detect two distinct populations of neurons that
displayed high or low levels of ADS, which may be indicative of those receiving input
from mechano-insensitive or mechano-sensitive C-fibres, respectively, frequency
histograms of the AUC of latency change were plotted. The AUC of latency change
recorded during 1 and 2Hz stimulation, in tissue isolated from control and CFA
treated rats, displayed a unimodal distribution in all cases. CFA inflammation caused
a significant leftwards shift in the distribution, indicating less ADS, during 1 and 2Hz
stimulation (P=0.012 & P=0.025, respectively, figure 4.14A & B,
Kolmogorov-Smirnov 2-sample test).
Correlation between the initial latency of monosynaptic C-fibre input to
lamina I neurokinin 1 receptor expressing neurons and the magnitude of
activity-dependent slowing
To determine whether the initial latency of the C-fibre eEPSC was predictive of the
magnitude of ADS exhibited in monosynaptic C-fibre input to lamina I NK1R+
neurons, correlation between the initial C-fibre latency, recorded during stimulus 1,
and the AUC of the latency change was assessed. During 1Hz stimulation, in tissue
isolated from control and CFA treated rats, there was no significant correlation
between initial latency and the AUC of the latency change (P=0.107 & P=0.358,
respectively, figure 4.14C, Pearson’s r test). During 2Hz stimulation, there was a
significant positive correlation between the initial C-fibre latency and the AUC of
latency change in tissue isolated from CFA treated (P=0.013, Pearson’s r test,
figure 4.14D), but not control rats (P=0.655, Pearson’s r test).
CHAPTER 4: ACTIVITY-DEPENDENT SLOWING 175









































































































Figure 4.14: Distribution of the magnitude of activity-dependent slowing and its
correlation with initial latency. The distribution of the AUC of latency change between
control and CFA groups, obtained during C-fibre stimulation at 1 (A) and 2Hz (B), was
significantly different (P=0.012 & P=0.025, Kolmogorov-Smirnov 2-sample test).
Correlation between the initial latency and the AUC of latency change was calculated to
determine whether the initial C-fibre latency was predictive of the magnitude of ADS that
would be observed in monosynaptic C-fibre input to lamina I NK1R+ neurons. C There
was no significant correlation between the initial C-fibre latency and the AUC of latency
change during 1Hz stimulation, recorded in tissue isolated from control or CFA treated
rats (P=0.107 & P=0.358, respectively, Pearson’s r test). D In the CFA group, during 2Hz
stimulation, there was a significant positive correlation between initial C-fibre latency and
the resulting AUC of latency change (P=0.013, Pearson’s r test), while no such
correlation was seen in the control group (P=0.655, Pearson’s r test). Legend in A
applies to B . Lines in C & D indicate line of best fit. Legend in C applies to D . Control:
1Hz n=43, 2Hz n=16. CFA: 1Hz n=65, 2Hz n=34.
Activity-dependent slowing in monosynaptic C-fibre input to lamina I
neurokin 1 receptor expressing neurons, in response to longer and
higher frequency stimulus trains, is attenuated in inflammatory pain
To determine the effect of higher stimulation frequencies combined with longer
stimulus trains on ADS in monosynaptic C-fibre inputs to lamina I NK1R+ neurons,
C-fibre eEPSCs were recorded in response to trains of 40 stimuli at 2, 5 and 10Hz.
C-fibre stimulation at 2Hz resulted in a significant increase in the absolute latency of
the eEPSC, in tissue isolated from control and CFA treated rats (P=0.009 &
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P=0.0003, respectively, linear regression, figure 4.15A, table 4.7). CFA inflammation
did not alter the slope (P=0.415, linear regression), but the intercept in the CFA group
was significantly reduced (P<0.0001, linear regression). During 5Hz and 10Hz
stimulation, a significant increase in the absolute latency was found in the CFA group
(P=0.0002 & P=0.002, respectively, linear regression, figure 4.15B & C, table 4.7),
while in the control group latency was not significantly altered (P=0.209 & P=0.673,
respectively, linear regression). The intercept of the data obtained during 5 and 10Hz
stimulation was significantly lower in the CFA group (both P<0.0001, linear
regression), while the slope was unaffected (P=0.788 & P=0.404, respectively, linear
regression). The data demonstrating the reduction in the intercept of the line of best fit
in CFA inflammation was not supported by the finding that the initial latency of
monosynaptic C-fibre input to lamina I NK1R+ neurons, measured from the first
stimuli during 2Hz stimulation trains, was not significantly altered by CFA
inflammation (P=0.102, unpaired t-test, figure 4.15D). The length of dorsal root
stimulated was significantly shorter in the CFA groups (P=0.009, unpaired t-test,
figure 4.15E).
Analysis of normalised data revealed that repetitive stimulation of monosynaptic
C-fibre input to lamina I NK1R+ neurons at 2, 5 and 10Hz resulted in a significant
progressive increase in response latency (all P<0.0001, linear regression,
figure 4.16A, B & C, table 4.8). Consistent with the results presented in the previous
section, CFA inflammation significantly reduced ADS at all stimulation frequencies
(all P<0.0001, linear regression). AUC analysis confirmed that CFA inflammation
significantly reduced the ADS evoked by 2, 5 and 10Hz stimulation of C-fibres
(P=0.015, 2-way ANOVA, figure 4.16D), while the magnitude of ADS was
unaffected by stimulation frequency and there was no interaction between these
factors (P=0.267 & P=0.759, respectively, 2-way ANOVA).
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Figure 4.15: C-fibre eEPSC absolute latency in response to increased stimulation
frequency / longer stimulus trains. A 40 stimuli delivered at 2Hz resulted in a significant
increase in latency in both control and CFA groups (P=0.009 & P=0.0003, respectively).
The intercept of the line of best fit in the CFA group was significantly less that the control
(P<0.0001), but there was no difference in the slopes (P=0.415). Stimulation at 5 (B)
and 10Hz (C) resulted in a significant progressive increase in latency in CFA groups only
(5Hz P=0.0002, 10Hz P=0.002, Control: 5Hz P=0.209, 10Hz P=0.673). CFA
inflammation significantly reduced the intercept of the line fitted to data recorded during 5
and 10Hz stimulation (both P<0.0001), but did not alter the slope (P=0.742 & P=0.404,
respectively). D The initial latency of the C-fibre response, recorded during stimuli 1 of
2Hz stimulation trains, was not altered by CFA inflammation (P=0.102). E The length of
dorsal root stimulated was significantly less in the CFA inflammation group (P=0.009).
Statistics (A–C): linear regression. Slope, r2 and 95% CI values are presented in
table 4.7. D & E analysed using unpaired t-test. Samples sizes for A-C, both control &
CFA; 2Hz n=10, 5 & 10Hz n=9. Sample sizes for D & E indicated on bars. Legend in A
applies to B & C. Error bars indicate SEM. Dashed lines represent line of best fit. Control
vs. CFA slope: ∗P<0.05, ∗∗∗∗P<0.0001; intercept: #### P<0.0001.











































































































Figure 4.16: Activity-dependent slowing in monosynaptic C-fibre input to lamina I
NK1R+ neurons in response to increased stimulus frequency and longer stimulus trains.
Extended periods of repetitive stimulation of monosynaptic C-fibre input to lamina I
NK1R+ neurons at frequencies of 2 (A), 5 (B) and 10Hz (C) resulted in a significant
increase in response latency (all P<0.0001). In all cases, CFA inflammation significantly
reduced the degree of the latency increase (all P<0.0001). D Area under the curve
analysis of latency change confirms that CFA inflammation significantly reduced ADS in
C-fibre input to lamina I NK1R+ neurons (P=0.015) and demonstrates that ADS was not
influenced by stimulation frequency (P=0.267). There was no interaction between these
factors (P=0.759). Statistics (A–C): linear regression. Slope, r2 and 95% CI values are
presented in table 4.8. Statistics (D) 2-way ANOVA. Sample sizes indicated on bars in D
. Legend in A applies to B & C. Error bars indicate SEM. Dashed lines represent line of





























Frequency (Hz) Treatment Y Intercept Intercept Control Slope Slope Slope vs. Control r2
95% CI vs. CFA 95% CI Slope = 0 vs. CFA
2
control 25.87 23.90 to 27.85
P<0.0001
0.117 0.030 to 0.205 P=0.009
P=0.415
0.017
CFA 20.32 19.40 to 21.23 0.076 0.035 to 0.117 P=0.0003 0.034
5
control 27.65 25.22 to 30.08
P<0.0001
0.072 -0.040 to 0.184 P=0.209
P=0.742
0.005
CFA 21.23 20.21 to 22.26 0.092 0.045 to 0.139 P=0.0002 0.044
10
control 28.29 25.48 to 31.10
P<0.0001
0.028 -0.102 to 0.159 P=0.673
P=0.404
0.001
CFA 22.49 21.27 to 23.70 0.090 0.033 to 0.146 P=0.002 0.037
Table 4.7: Comparison of absolute latency in monosynaptic C-fibre inputs to lamina I NK1R+ neurons during increased stimulation frequency /
longer stimulus trains.
Frequency (Hz) Treatment Slope r2 95% CI Slope vs. Slope = 0 Control vs. CFA
2
control 0.128 0.269 0.119 to 0.137 P<0.0001
P<0.0001
CFA 0.078 0.182 0.072 to 0.085 P<0.0001
5
control 0.165 0.064 0.151 to 0.179 P<0.0001
P<0.0001
CFA 0.093 0.223 0.085 to 0.102 P<0.0001
10
control 0.181 0.015 0.161 to 0.201 P<0.0001
P<0.0001
CFA 0.094 0.067 0.079 to 0.108 P<0.0001
Table 4.8: Comparison of latency change in monosynaptic C-fibre inputs to lamina I NK1R+ neurons during increased stimulation frequency / longer
stimulus trains.
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Synaptic response failure rate in monosynaptic C-fibre input to lamina I
neurokinin 1 receptor expressing neurons
To determine whether CFA inflammation potentially alters the synaptic response
failure rate in monosynaptic C-fibre input to lamina I NK1R+ neurons, when
stimulated at frequencies of 2Hz or above, the rate of synaptic response failures
during repetitive stimulation was analysed. C-fibre stimulation at 2, 5 and 10Hz
resulted in a progressive increase in synaptic response failures (all P<0.0001, except
2Hz control P=0.005, linear regression, figure 4.17A, B & C, table 4.9). During 2Hz
stimulation, tissue isolated from CFA treated rats exhibited a significantly greater
degree of failures (P<0.0001, linear regression, figure 4.17A table 4.9), while CFA
inflammation was without effect during 5 and 10Hz stimulation (P=0.303 & P=0.604,
respectively, linear regression, figure 4.17 B & C, table 4.9). Analysis of the total
failure rate revealed that CFA inflammation did not significantly alter the synaptic
response failure rate in monosynaptic C-fibre input to lamina I NK1R+ neurons
(P=0.733, 2-way ANOVA, figure 4.17D). Stimulation frequency significantly affected
the total failure rate (P=0.0002, 2-way ANOVA), but there was no interaction between
CFA inflammation and stimulation frequency (P=0.855, 2-way ANOVA). Post-hoc
analysis showed that there was significantly more failures during 10Hz stimulation
than 2Hz (P=0.002, 2-way ANOVA followed by Tukey post-tests). There was a trend
towards a greater failure rate during 10Hz stimulation than 5Hz, however this was not
significant (P=0.058, 2-way ANOVA followed by Tukey post-tests), while there was
no difference in the failure rate between 2 and 5Hz stimulation (P=0.428, 2-way
ANOVA followed by Tukey post-tests).














































































Figure 4.17: Failures in monosynaptic C-fibre input to lamina I NK1R+ neurons during
repetitive stimulation. A, B and C show the percentage of failures that occur for each
stimuli at 2, 5 and 10Hz, respectively. In all cases the failure rate significantly increased
with increasing stimulus number (all P<0.0001, except 2Hz control where P=0.005). CFA
inflammation significantly increased the failure rate when monosynaptic C-fibre input was
stimulated at 2Hz (P<0.0001), but was without effect when stimulated at 5 or 10Hz
(P=0.303 & P=0.604, respectively). D Analysis of the total percentage of failures
demonstrates that failures in monosynaptic C-fibre input to lamina I NK1R+ neurons is
not influenced by CFA inflammation (P=0.733), but that increased stimulation frequency
results in a greater level of failures (P=0.002), although there were no interactions
between these factors (P=0.855). Post-hoc analysis revealed that 10Hz stimulation
resulted in significantly more failures that 2Hz (P=0.002). Statistics (A–C): linear
regression. Slope, r2 and 95% CI values are presented in table 4.9. Statistics (D): 2-way
ANOVA, followed by Tukey post-tests. Legend in A applies to B & C . Error bars indicate





























Frequency (Hz) Treatment Slope r2 95% CI Slope vs. Slope = 0 Control vs. CFA
2
control 0.073 0.038 0.023 to 0.123 P=0.005
P<0.0001
CFA 0.354 0.462 0.282 to 0.426 P<0.0001
5
control 0.054 0.484 0.534 to 0.781 P<0.0001
P=0.303
CFA 0.073 0.313 0.431 to 0.726 P<0.0001
10
control 0.079 0.336 1.068 to 1.389 P<0.0001
P=0.604
CFA 0.125 0.025 1.053 to 1.557 P<0.0001
Table 4.9: Comparison of failures in monosynaptic C-fibre eepsc recorded in lamina I NK1R+ neurons during stimulation at 2, 5 and 10Hz.
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4.4.4 The role of HCN channels in C-fibre activity-dependent slowing
ZD7288 enhances activity-dependent slowing in C-fibres in isolated
dorsal roots
The data presented in this section were collected by and some analysis was performed
by Ms Veny Lukito, a Physiological Society vacation student.
To investigate the role of HCN channels in constraining C-fibre ADS, CAPs were
recorded from dorsal roots isolated from control and CFA treated rats, in the absence
and presence of the non-selective HCN channel antagonist ZD7288 or vehicle.
Representative traces of C-fibre CAP recordings conducted prior to (‘baseline’) and
during application of ZD7288, from dorsal roots isolated from control and CFA
treated rats are shown in figure 4.18A and B, respectively. The slope fitted to the
absolute latency of C-fibre responses recorded during 2Hz stimulation was not altered
by application of ZD7288 or vehicle, in either control or CFA groups (figure 4.19A &
B, table 4.10). In the CFA group, ZD7288 resulted in a small but significant increase
in the intercept of the line of best fit (P=0.003, linear regression), while in control
tissue there was a trend towards an increased intercept, which was not significant
(P=0.058, linear regression). Vehicle application did not significantly alter the
intercept in control or CFA groups (P=0.431 & P=0.860, respectively, linear
regression).
When these data were normalised, it was found that in control and CFA groups,
ZD7288 significantly enhanced ADS (both P<0.0001, linear regression,
figures 4.20A & B, table 4.11), however vehicle was without effect (P=0.952 &
P=0.231, respectively, linear regression). To determine the extent to which ZD7288
enhanced ADS, the latency change measured at baseline was subtracted from the
latency change in the presence of ZD7288 / vehicle. This analysis revealed that the
facilitatory effect of ZD7288 was significantly greater in tissue isolated from CFA
treated rats (P<0.0001, linear regression, figure 4.20C (left), table 4.12). Vehicle
caused no facilitation of C-fibre ADS in dorsal roots isolated from control treated rats
(P=0.318, linear regression, figure 4.20C (right), table 4.12). In dorsal roots isolated
from CFA treated rats, vehicle had no significant effect upon ADS (P=0.231, linear
regression), however when the baseline subtracted values were compared, there was a
significant difference between control and CFA, with a small but significant
depression of ADS in the CFA group (P<0.0001, linear regression).










































































Figure 4.18: Representative traces of C-fibre activity-dependent slowing in the presence
of ZD7288, in dorsal roots isolated from control (A) and CFA (B) treated rats. Traces
demonstrate ADS in response to 40 stimuli delivered at 2Hz, prior to (‘baseline’, top left)
and during 10µM ZD7288 application (bottom left). Response latency was measured as
the difference between the stimulus artefact and the negative peak of the C-fibre
component (indicated by broken lines). The top right insert shows baseline sweep 1 and
ZD7288 sweep 1 overlaid, bottom right shows the baseline sweep 40 and ZD7288 sweep
40 traces overlaid. Inserts taken from area on main traces indicated by yellow box.

































































































Figure 4.19: Effect of ZD7288 application on the absolute latency of C-fibre responses
during repetitive stimulation of isolated dorsal roots. A In dorsal roots isolated from
control rats, application of 10µM ZD7288 (left) or vehicle (right) did not alter the slope
(P=0.919 & P=0.985, respectively) or intercept (P=0.058 & P=0.431, respectively) of the
C-fibre response latency recorded during stimulation at 2Hz . B In CAP recordings from
dorsal roots isolated from CFA treated rats, application of ZD7288 (left) or vehicle (right)
had no effect on the slope of the C-fibre response latency (P=0.313 & P=0.919,
respectively), however ZD7288 caused a small but significant increase in the intercept
(P=0.003). Statistics: linear regression. Slope, R2 and 95% CI values are presented in
table 4.10. Control: ZD7288 n=5, vehicle n=6. CFA: ZD7288 n=6, vehicle n=5. Error bars
indicate SEM. Dashed lines represent line of best fit. Control vs. CFA intercept: ##
P<0.01.
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Figure 4.20: ZD7288 enhances C-fibre activity-dependent slowing in isolated rat dorsal
roots. A In dorsal roots isolated from control rats, 2Hz stimulation prior to (‘baseline’) and
during application of 10µM ZD7288 (left) or vehicle (right) resulted in a significant
increase in the latency change (all P<0.0001). ZD7288 significantly enhanced this
latency change (P<0.0001), while vehicle was without effect (P=0.952). B Stimulation of
dorsal roots isolated from CFA treated rats resulted in a significant increase in response
latency in all conditions (all P<0.0001). ZD7288 application significantly elevated this
latency increase (P<0.0001, left), while vehicle had no effect (P=0.231, right). To
determine whether the ZD7288 facilitation of ADS was altered in CFA inflammation, the
latency change recorded at baseline was subtracted from that recorded during ZD7288 /
vehicle application. C The facilitatory effect of ZD7288 on ADS was significantly greater
in dorsal roots isolated from CFA treated rats (P<0.0001, left). When the baseline
subtracted values obtained during vehicle application were compared, it was found that
there was a small but significant depression of ADS in CFA tissue compared to control
(P<0.0001, right). Statistics: linear regression. Slope, r2 and 95% CI values for A/B & C
are presented in tables 4.11 & 4.12, respectively. Control: ZD7288 n=5, vehicle n=6.






























Treatment Recording Y Intercept Intercept Control Slope Slope Slope vs. Baseline r2
95% CI vs. CFA 95% CI Slope = 0 vs. ZD7288
Control
baseline 17.52 16.48 to 18.56
P=0.058
0.091 0.045 to 0.137 P=0.0001
P=0.920
0.071
ZD7288 18.36 17.19 to 19.53 0.088 0.036 to 0.140 P=0.001 0.054
baseline 12.67 12.27 to 13.08
P=0.431
0.034 0.016 to 0.052 P=0.0002
P=0.985
0.057
vehicle 12.79 12.40 to 13.17 0.196 0.017 to 0.052 P=0.0001 0.063
CFA
baseline 13.71 12.68 to 14.73
P=0.003
0.042 -0.003 to 0.087 P=0.067
P=0.313
0.014
ZD7288 14.21 13.09 to 15.33 0.077 0.027 to 0.126 P=0.003 0.038
baseline 15.40 13.87 to 16.92
P=0.860
0.059 -0.008 to 0.127 P=0.085
P=0.919
0.015
vehicle 15.39 13.89 to 16.90 0.054 -0.012 to 0.121 P=0.109 0.013
Table 4.10: Comparison of the effect of ZD7288 / vehicle on the absolute latency of C-fibre responses, during repetitive stimulation, in isolated
dorsal roots.
Treatment Drug Recording Slope r2 95% CI Slope vs. Slope = 0 Baseline vs. Drug
Control
ZD7288
baseline 0.105 0.615 0.100 to 0.110 P<0.0001
P<0.0001
drug 0.131 0.633 0.126 to 0.137 P<0.0001
Vehicle
baseline 0.043 0.446 0.040 to 0.045 P<0.0001
P=0.952
drug 0.043 0.526 0.040 to 0.045 P<0.0001
CFA
ZD7288
baseline 0.045 0.117 0.037 to 0.052 P<0.0001
P<0.0001
drug 0.091 0.310 0.083 to 0.098 P<0.0001
Vehicle
baseline 0.062 0.308 0.056 to 0.069 P<0.0001
P=0.231
drug 0.057 0.323 0.052 to 0.063 P<0.0001





























Drug Treatment Slope r2 95% CI Slope vs. Slope = 0 Control vs. CFA
ZD7288
control 0.028 -0.021 0.022 to 0.033 P<0.0001
P<0.0001
CFA 0.046 0.134 0.041 to 0.051 P<0.0001
Vehicle
control 0.001 0.003 -0.001 to 0.002 P=0.381
P<0.0001
CFA -0.005 0.034 -0.007 to -0.003 P<0.0001
Table 4.12: Comparison of the degree of ZD7288 / vehicle modulation of C-fibre ADS in isolated dorsal roots.
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The length of dorsal roots recorded from did not differ between control and CFA
groups (P=0.787, 2-way ANOVA, figure 4.21A) or between those treated with
ZD7288 or vehicle (P=0.312, 2-way ANOVA) and there was no interaction between
these factors (P=0.206, 2-way ANOVA). The initial latency, recorded during the first
stimuli of ZD7288 baseline or vehicle baseline, did not differ between groups treated
with ZD7288 or vehicle (P=0.362, 2-way ANOVA, figure 4.21B) or between dorsal
roots isolated from control or CFA treated rats (P=0.841, 2-way ANOVA). There were
no interactions between these variables (P=0.064, 2-way ANOVA). Application of
ZD7288 or vehicle did not significantly alter the initial C-fibre latency (P=0.295 &
P=0.210, respectively, 2-way repeated measures ANOVA, figure 4.21C & D). In both
cases CFA inflammation was without effect (P=0.162 & P=0.268, respectively, 2-way
repeated measures ANOVA) and there was no interaction between ZD7288 / vehicle
application and CFA inflammation (P=0.835 & P=0.232, respectively, 2-way repeated
measures ANOVA). When the change in initial latency, calculated by subtracting the
baseline initial latency from the initial latency recorded during ZD7288 / vehicle
application, was compared, it was discovered that there was no difference in the
change in initial latency between ZD7288 and vehicle groups (P=0.473, 2-way
ANOVA, figure 4.21E). CFA inflammation did not alter the change in initial latency
(P=0.601, 2-way ANOVA) and there was no interaction between these factors
(P=0.908).













































































































Figure 4.21: ZD7288 does not alter the initial latency of the C-fibre response in
compound action potential recordings from isolated dorsal roots. A The length of isolated
dorsal roots used in these experiments did not significantly differ between groups (CFA
vs. control P=0.787, ZD7388 / vehicle P=0.312, interaction P=0.206). B The initial
C-fibre response latency, in CAP recordings from isolated dorsal roots, prior to ZD7288
(10µM, ‘baseline’) or vehicle (‘vehicle baseline’), was no different between these groups
(P=0.362) and was unaltered by CFA inflammation (P=0.841). There was no significant
interaction between these factors (P=0.064). C Application of ZD7288 did not
significantly change the initial C-fibre latency (P=0.295), while CFA inflammation was
without effect (P=0.162) and there was no interaction (P=0.835). D Similarly, vehicle
application did not alter the initial latency (P=0.210) and there was no effect of CFA
(P=0.268) and no interaction (P=0.232). E When the change in initial latency that
resulted from ZD7288 / vehicle application was compared, it was found that the change
in initial response latency was not significantly affected by CFA inflammation (P=0.601)
and did not differ between application of ZD7288 or vehicle (P=0.473). There was no
interaction between these factors (P=0.908). Statistics: A, B & E 2-way ANOVA; C & D ,
2-way repeated measures ANOVA. Samples sizes indicated on bars, except E , where
sample sizes are shown on A. Error bars indicate SEM.
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Application of ZD7288 significantly reduced the peak amplitude of the C-fibre
response (P=0.006, 2-way repeated measures ANOVA, figure 4.22A), while CFA
inflammation was without effect (P=0.994, 2-way repeated measures ANOVA) and
there was no interaction between these factors (P=0.720, 2-way repeated measures
ANOVA). Application of vehicle did not alter the peak amplitude of the C-fibre
response (P=0.228, 2-way repeated measures ANOVA, figure 4.22B). CFA
inflammation did not alter the peak amplitude of the C-fibre response in the vehicle
group (P=0.876, 2-way repeated measures ANOVA) and there was no interaction
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Figure 4.22: ZD7288 reduces C-fibre amplitude in isolated rat dorsal roots. A In
compound action potential recordings from isolated rat dorsal roots, 10µM ZD7288
significantly reduced the peak amplitude of the C-fibre response (P=0.006), while CFA
inflammation was without effect (P=0.994) and there was no interaction between these
factors (P=0.720). B The peak amplitude of the C-fibre response was unaffected by
vehicle application (P=0.228), CFA inflammation (P=0.876) and there was no interaction
between these variables (P=0.677). Statistics: 2-way repeated measures ANOVA.
Sample sizes indicated on bars. Error bars indicate SEM. ∗∗P<0.01.
ZD7288 enhances activity-dependent slowing in monosynaptic C-fibre
input to lamina I neurokinin 1 receptor expressing neurons
A preliminary investigation into the role of HCN channels in limiting ADS in
monosynaptic C-fibre input to lamina I NK1R+ neurons was conducted by recording
C-fibre eEPSCs in response to dorsal root stimulation at 2, 5 and 10Hz, prior to
(‘baseline’) and during application of 10µM ZD7288. In control tissue, ZD7288 did
not alter the slope or intercept of lines fitted to the absolute latency data obtained
during C-fibre stimulation at 2, 5 or 10Hz (figure 4.23A, B & C, respectively,
table 4.13). In CFA inflammation, the effect of ZD7288 upon the absolute latency of
C-fibre eEPSCs was dependent upon the stimulation frequency used. During
stimulation at 2 and 5Hz, ZD7288 significantly increased the intercept (P=0.037 &
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P=0.0008, respectively, linear regression, 4.23A & B, table 4.13), but did not alter the
slope of the line fitted to the absolute latency data (P=0.243 & P=0.569, linear
regression). Conversely, during 10Hz stimulation, ZD7288 was found to alter the
slope of the line fitted to the data (P=0.003, linear regression, 4.23C, table 4.13),
however because the slopes were significantly different it was not possible to
accurately compare intercepts.
When the data assessing the effect of ZD7288 on ADS in monosynaptic C-fibre input
to lamina I NK1R+ neurons was normalised, the result of ZD7288 application was
found to be inconsistent, with responses differing depending upon the stimulation
frequency used and/or whether the tissue was isolated from control or CFA treated
rats. In both control and CFA treated rats during 2Hz stimulation, ZD7288
significantly enhanced ADS (both P<0.0001, linear regression, figure 4.24A & B,
table 4.14). When the facilitatory effect of ZD7288 was compared between these
control and CFA groups, it was found that the ZD7288 enhancement of ADS was not
influenced by CFA inflammation (P=0.125, linear regression, figure 4.24C,
table 4.15). Unlike 2Hz stimulation, the ADS elicited by 5 and 10Hz stimulation in
control tissue was unaffected by ZD7288 (P=0.849 & P=0.137, respectively, linear
regression, figures 4.25A & 4.26A, table 4.14). However, ZD7288 significantly
increased ADS in monosynaptic C-fibre input to lamina I NK1R+ neurons in CFA
tissue during both 5 and 10Hz stimulation (both P<0.0001, linear regression,
figures 4.25B & 4.26B, table 4.14). In contrast to the results obtained during 2Hz
stimulation, the facilitatory effect of ZD7288 upon ADS recorded during both 5 and
10Hz was found to be significantly greater in CFA inflammation (P=0.001 &
P<0.0001, respectively, linear regression, figures 4.25C & 4.26C, table 4.15).
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Figure 4.23: Effect of ZD7288 on the absolute latency of monosynaptic C-fibre input to
lamina I neurokinin 1 receptor expressing neurons, during stimulation at 2, 5 and 10Hz.
In eEPSC recordings from control tissue, application of 10µM ZD7288 during stimulation
at 2 (A), 5 (B) or 10Hz (C) did not alter the absolute latency of the C-fibre response. In
tissue isolated from CFA treated rats, ZD7288 caused a small but significant increase in
the intercept of the line fitted to data recorded during stimulation at 2 and 5Hz (P=0.037
& P=0.0008, respectively), but did not alter the slope (P=0.243 & P=0.569, respectively).
During 10Hz stimulation, ZD7288 significantly increased the latency of monosynaptic
C-fibre input to lamina I NK1R+ neurons (P=0.003), because the slopes were
significantly different it was not possible to test for differences in intercepts. Statistics:
linear regression. Slope, r2 and 95% CI values are presented in table 4.13. Control: 2Hz
n=4, 5 & 10Hz n=3. CFA: all n=3. Legend in A applies to all. Error bars indicate SEM.
Dashed lines represent line of best fit. Baseline vs. ZD7288 slope: ∗∗P<0.01; intercept:





























Frequency Treatment Recording Y Intercept Intercept Control Slope Slope Slope vs. Baseline r2
(Hz) 95% CI vs. CFA 95% CI Slope = 0 vs. ZD7288
2
control
baseline 28.55 25.53 to 31.57
P=0.105
0.068 0.011 to 0.278 P=0.036
P=0.709
0.028
ZD7288 29.76 26.41 to 33.11 0.183 0.032 to 0.333 P=0.019 0.038
CFA
baseline 17.09 14.82 to 19.36
P=0.037
0.052 -0.017 to 0.187 P=0.103
P=0.243
0.023
ZD7288 17.25 14.73 to 19.77 0.176 0.059 to 0.293 P=0.004 0.077
5
control
baseline 31.45 26.71 to 36.18
P=0.468
0.109 -0.112 to 0.329 P=0.330
P=0.994
0.009
ZD7288 32.91 27.19 to 38.63 0.108 -0.164 to 0.379 P=0.433 0.007
CFA
baseline 17.69 15.25 to 20.13
P=0.0008
0.139 0.026 to 0.253 P=0.017
P=0.569
0.054
ZD7288 20.30 17.21 to 23.39 0.191 0.047 to 0.336 P=0.010 0.078
10
control
baseline 24.74 20.21 to 29.26
P=0.711
-0.050 -0.261 to 0.160 P=0.633
P=0.751
0.004
ZD7288 24.88 21.86 to 27.90 -0.092 -0.234 to 0.050 P=0.200 0.033
CFA
baseline 19.31 16.24 to 22.39
n/a
0.159 0.006 to 0.313 P=0.042
P=0.003
0.055
ZD7288 19.21 15.73 to 22.69 0.565 0.346 to 0.784 P<0.0001 0.411
Table 4.13: Comparison of the effect of ZD7288 application on the absolute latency of monosynaptic C-fibre input to lamina I NK1R+ neurons,
during stimulation at 2, 5 and 10Hz.
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Figure 4.24: ZD7288 enhances activity-dependent slowing, in response to stimulation at
2Hz, in monosynaptic C-fibre input to lamina I NK1R+ neurons. Application of 10µM
ZD7288 significantly enhanced the progressive increase in C-fibre response latency
during 2Hz stimulation, in tissue isolated from control (A, P<0.0001) and CFA treated
rats (B, P<0.0001). To assess whether the facilitatory effect of ZD7288 was different
between control and CFA groups, the baseline latency change was subtracted from that
recorded in the presence of ZD7288. C The ZD7288 enhancement of latency change in
response to 2Hz stimulation was not altered by CFA inflammation (P=0.125). Statistics:
linear regression. Slope, R2 and 95% CI values for A/B & C are presented in tables 4.14
& 4.15, respectively. Control n=4, CFA n=3. Error bars indicate SEM. Dashed lines
represent line of best fit. ∗∗∗∗P<0.0001.
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Figure 4.25: ZD7288 enhances activity-dependent slowing, in response to stimulation at
5Hz, in monosynaptic C-fibre input to lamina I NK1R+ neurons. A In tissue isolated from
control treated rats, ZD7288 (10µM) did not significantly influence the latency change
during 2Hz stimulation (P=0.849). B ZD7288 significantly facilitated the progressive
latency increase in monosynaptic C-fibre seen during 5Hz stimulation, in the CFA group
(P<0.0001). C When the ability of ZD7288 to enhance ADS was compared between
control and CFA, it was revealed that ZD7288 had a significantly greater effect during
CFA inflammation (P=0.001). Statistics: linear regression. Slope, R2 and 95% CI values
for A/B & C are presented in tables 4.14 & 4.15, respectively. Control n=3, CFA n=3.
Error bars indicate SEM. Dashed lines represent line of best fit. ∗∗P<0.01,
∗∗∗∗P<0.0001.
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Figure 4.26: ZD7288 enhances activity-dependent slowing, in response to stimulation at
10Hz, in monosynaptic C-fibre input to lamina I NK1R+ neurons. A 10µM ZD7288 had
no effect on the progressive latency increase in control tissue, during 10Hz stimulation
(P=0.137). B In tissue isolated from CFA treated rats, ZD7288 significantly enhanced the
progressive increase in C-fibre response latency (P<0.0001). C The facilitatory effect of
ZD7288 was significantly greater in CFA inflammation conditions (P<0.0001). Statistics:
linear regression. Slope, R2 and 95% CI values for A/B & C are presented in tables 4.14
& 4.15, respectively. Control n=3, CFA n=2. Error bars indicate SEM. Dashed lines





























Frequency (Hz) Treatment Recording Slope r2 95% CI Slope vs. Slope = 0 Baseline vs. ZD7288
2
control
baseline 0.149 0.330 0.136 to 0.161 P<0.0001
P<0.0001
ZD7288 0.219 0.434 0.200 to 0.238 P<0.0001
CFA
baseline 0.073 0.234 0.061 to 0.086 P<0.0001
P<0.0001
ZD7288 0.152 0.273 0.129 to 0.175 P<0.0001
5
control
baseline 0.212 -0.030 0.185 to 0.239 P<0.0001
P=0.849
ZD7288 0.208 0.219 0.180 to 0.236 P<0.0001
CFA
baseline 0.102 0.365 0.087 to 0.117 P<0.0001
P<0.0001
ZD7288 0.191 0.246 0.159 to 0.223 P<0.0001
10
control
baseline 0.112 -0.077 0.088 to 0.135 P<0.0001
P=0.137
ZD7288 0.147 -0.159 0.109 to 0.185 P<0.0001
CFA
baseline 0.103 0.155 0.072 to 0.133 P<0.0001
P<0.0001
ZD7288 0.409 0.655 0.355 to 0.462 P<0.0001
Table 4.14: Comparison of the ZD7288 enhancement of ADS in monosynaptic C-fibre input to lamina I NK1R+ neurons.
Frequency (Hz) Treatment Slope r2 95% CI Slope vs. Slope = 0 Control vs. CFA
2
control 0.063 0.178 0.052 to 0.075 P<0.0001
P=0.125
CFA 0.077 0.231 0.064 to 0.089 P<0.0001
5
control 0.035 0.098 0.016 to 0.054 P=0.0004
P=0.001
CFA 0.083 0.017 0.060 to 0.107 P<0.0001
10
control 0.016 0.077 0.000 to 0.032 P=0.045
P<0.0001
CFA 0.275 0.450 0.223 to 0.327 P<0.0001
Table 4.15: Comparison of the magnitude of ZD7288 facilitation of ADS in monosynaptic C-fibre input to lamina I NK1R+ neurons.
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The initial latency of monosynaptic C-fibre eEPSCs, recorded in lamina I NK1R+
neurons was significantly shorter in tissue isolated from CFA treated rats (P=0.018,
2-way ANOVA on rank transformed data, figure 4.27A), although the initial latency
did not differ between recordings employing 2, 5 or 10Hz stimulation (P=0.888,
2-way ANOVA on rank transformed data). There was no significant interaction
between CFA inflammation and stimulation frequency (P=0.696, 2-way ANOVA on
rank transformed data). Similarly, the length of dorsal root stimulated in C-fibre
eEPSC ZD7288 recordings was significantly shorter in CFA groups (P<0.0001,
2-way ANOVA on rank transformed data, figure 4.27B), but did not differ between
stimulation frequencies (P=0.911, 2-way ANOVA on rank transformed data) and
there was no interaction (P=0.911, 2-way ANOVA on rank transformed data). The
effect of ZD7288 on the initial latency of monosynaptic C-fibre input to lamina I
NK1R+ neurons was assessed by comparing the initial latency recorded during
baseline recordings with the initial latency during ZD7288 recordings. In tissue
isolated from control rats, ZD7288 caused a small but significant increase in the
initial latency of the C-fibre response (P=0.0004, 2-way repeated measures ANOVA,
on rank transformed data, figure 4.27C), while stimulation frequency was without
effect (P=0.924, 2-way repeated measures ANOVA, on rank transformed data) and
there was no interaction (P=0.149, 2-way repeated measures ANOVA, on rank
transformed data). However, in tissue isolated from CFA treated rats, ZD7288 had no
effect on the initial C-fibre latency (P=0.431, 2-way repeated measures ANOVA, on
rank transformed data, figure 4.27D). Stimulation frequency was also without effect
(P=0.552, 2-way repeated measures ANOVA, on rank transformed data) and there
was no interaction between these factors (P=0939, 2-way repeated measures ANOVA,
on rank transformed data). The change in the initial latency produced by ZD7288
application was calculated by subtracting the baseline initial latency from the ZD7288
initial latency. It was found that ZD7288 caused a significantly greater change in
initial latency in tissue isolated from control rats (P=0.003, 2-way ANOVA, on rank
transformed data, figure 4.27E), while stimulation frequency had no significant effect
(P=0.293, 2-way ANOVA, on rank transformed data) and there was no interaction
between these variables (P=0.810, 2-way ANOVA, on rank transformed data).
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Figure 4.27: ZD7288 increases the initial latency of monosynaptic C-fibre input to lamina
I neurokinin 1 receptor expressing neurons. A The initial latency of monosynaptic C-fibre
input to lamina I NK1R+ neurons was significantly shorter in tissue isolated from CFA
treated rats (P=0.018), however stimulation frequency was without effect (P=0.888) and
there was no interaction between these variables (P=0.696). B The length of dorsal root
stimulated was significantly different between control and CFA groups (P<0.0001), but
did not differ between stimulation frequencies (P=0.911) and there was no interaction
(P=0.911). C In control tissue, application of 10µM ZD7288 produced a small but
significant increase in the initial latency of C-fibre eEPSCs (P=0.0004), while stimulation
frequency was without effect (P=0.924) and there was no interaction (P=0.149). D In the
CFA group, ZD7288 did not alter the initial C-fibre latency (P=0.431) and there was no
effect of stimulation frequency (P=0.552) and no interaction (P=0.939). E When the
change in the initial C-fibre response latency was compared between control and CFA
groups, it was discovered that ZD7288 resulted in a significant increase in initial latency
in tissue isolated from control rats (P=0.003). Stimulation frequency did not alter the
ZD7288 change in initial latency (P=0.293) and there was no significant interaction
between these variables (P=0.810). Statistics (A, B & E): 2-way ANOVA on rank
transformed data. Statistics (C & D): 2-way repeated measures ANOVA on rank
transformed data. Sample sizes indicated on graphs, except E , where sample sizes are
the same as A. Legend in A applies to B. Legend in C applies to D. Error bars indicate
SEM. ∗P<0.05, ∗∗P<0.01, ∗∗∗P<0.001.
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To determine whether application of ZD7288 altered the number of synaptic response
failures in monosynaptic C-fibre input to lamina I NK1R+ neurons, a preliminary
investigation into the synaptic response failure rate during repetitive stimulation in the
absence and presence of ZD7288 was conducted. During 2Hz stimulation, the
synaptic response failure rate was not altered by ZD7288, CFA inflammation and
there was no interaction between these factors (P=0.238, P=0.826 & P=0.900,
respectively, 2-way repeated measures ANOVA, figure 4.28A). Similarly, ZD7288
and CFA inflammation was without effect during C-fibre stimulation at 5Hz and there
was no interaction between these variables (P=0.221, P=0.779 & P=0.642,
respectively, 2-way repeated measures ANOVA, figure 4.28B). During 10Hz
stimulation, ZD7288 significantly altered the monosynaptic C-fibre synaptic response
failure rate (P=0.016, 2-way repeated measures ANOVA, figure 4.28C). This effect
was influenced by CFA inflammation, but CFA alone had no effect (P=0.026 &
P=0.599 respectively, 2-way repeated measures ANOVA). Post-hoc analysis revealed
that ZD7288 significantly increased the synaptic response failure rate seen during
10Hz stimulation, in tissue isolated from CFA treated rats (P=0.011, 2-way ANOVA
followed by Bonferroni post-tests).
To examine whether ZD7288 altered the amplitude of monosynaptic C-fibre input to
lamina I NK1R+ neurons, the peak C-fibre amplitude recorded prior to and during
ZD7288 application, in tissue isolated from control and CFA treated tissue, was
compared. The results of this preliminary study showed that ZD7288 did not
significantly alter the peak amplitude of monosynaptic C-fibre input to lamina I
NK1R+ neurons (P=0.944, 2-way repeated measures ANOVA on rank transformed
data, figure 4.29). CFA inflammation was similarly without effect on C-fibre peak
amplitude (P>0.999, 2-way repeated measures ANOVA on rank transformed data)
and there was no interaction between these factors (P=0.220, 2-way repeated
measures ANOVA on rank transformed data).























































Figure 4.28: Synaptic response failures in monosynaptic C-fibre input to lamina I NK1R+
neurons during ZD7288 application. Although application of ZD7288 typically resulted in
a greater number of failures in monosynaptic C-fibre input to lamina I NK1R+ neurons
during stimulation at frequencies of 2 and 5Hz (A & B , respectively), this effect was not
significant (P=0.238 & P=0.221, respectively). CFA inflammation was also without effect
(P=0.826 & P=0.779, respectively) and there was no interaction between these factors
(P=0.900 & P=0.642, respectively). C During 10Hz stimulation, ZD7288 significantly
altered the failure rate (P=0.016) and this effect was influenced by CFA inflammation
(P=0.026). CFA inflammation by itself was without effect (P=0.599). However, post-tests
revealed that ZD7288 significantly increased synaptic response failures in CFA
inflammation (P=0.011). All statistics: 2-way repeated measures ANOVA followed by
Bonferroni post-tests. Legend in A applies to all. Error bars indicate SEM. Control: 2Hz
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Figure 4.29: ZD7288 does not alter the peak amplitude of monosynaptic C-fibre input to
lamina I neurokinin 1 receptor expressing neurons. Application of ZD7288 did not alter
the peak amplitude of monosynaptic C-fibre input to lamina I NK1R+ neurons (P=0.944).
CFA inflammation was similarly without effect (P>0.999) and there was no interaction
between these factors (P=0.220). Statistics: 2-way repeated measures ANOVA on rank
transformed data. Sample sizes indicated on graph. Error bars indicate SEM.
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4.4.5 Summary
A summary of the key findings from this chapter, based on the analysis performed on
normalised data, are presented in tables 4.16, 4.17 and 4.18. C-fibre ADS in CAP
recordings from isolated dorsal roots and in monosynaptic C-fibre input to lamina I
NK1R+ neurons, elicited by repetitive stimulation at frequencies of 1, 2, 5 or 10Hz,
using stimulus trains of either 16 or 40 stimuli, was in all cases found to be
significantly reduced in CFA inflammation (table 4.16). Aδ-fibre ADS elicited by
stimulation at frequencies of 1 and 2Hz, in isolated dorsal roots or in the
monosynaptic Aδ-fibre input to lamina I NK1R+ neurons, was not altered in CFA
inflammation, however when monosynaptic Aδ-fibre input was stimulated at 10Hz,
the ADS recorded in CFA was found to be significantly reduced compared to control
(table 4.17). A preliminary investigation into the effect of ZD7288 on ADS was
conducted, where in almost all conditions it was found that ZD7288 significantly
enhanced ADS in CFA inflammation. In control tissue, ZD7288 increased ADS
during 2Hz stimulation, in both CAP and monosynaptic C-fibre eEPSC recordings,
but was without effect in eEPSC recordings when stimulated at 5 and 10Hz. In all
cases, except ADS elicited in monosynaptic C-fibre input during 2Hz stimulation, the
facilitatory effect of ZD7288 was significantly enhanced in tissue isolated from CFA
treated rats (table 4.18).








40 eEPSC ↓ ADS
5Hz 40 eEPSC ↓ ADS
10Hz 40 eEPSC ↓ ADS
Table 4.16: Summary of results from C-fibre ADS recordings.







10Hz 16 eEPSC ↓ ADS
Table 4.17: Summary of results from Aδ-fibre ADS recordings.
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Table 4.18: Summary of the effect of ZD7288 on C-fibre ADS recordings.
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4.5 Discussion
The findings of this chapter have confirmed the following:
1. C-fibres display a progressive slowing of conduction velocity / increase in
response latency, during repetitive stimulation at frequencies of 1Hz or above
(figures 4.5 & 4.6, table 4.2).
In addition these studies have revealed for the first time that:
1. ADS can be observed in extracellular population electrophysiological
recordings from isolated dorsal roots (figures 4.4 & 4.5).
2. Aβ-fibres, in isolated dorsal roots show a progressive reduction in response
latency during repetitive stimulation, which is altered by CFA inflammation at
2, but not 1Hz stimulation (figures 4.3 & 4.6, table 4.2).
3. Aδ-fibres in isolated dorsal roots and monosynaptic Aδ-fibre input to lamina I
NK1R+ neurons exhibit ADS, the latter of which which is reduced by CFA
inflammation, during stimulation at 10Hz (figures 4.4, 4.6 & 4.10, tables 4.2 &
4.4).
4. C-fibre ADS in isolated dorsal roots is significantly reduced in CFA
inflammation (figures 4.5 & 4.6, table 4.2).
5. Monosynaptic C-fibre input to lamina I NK1R+ neurons exhibits ADS in
response to repetitive stimulation, which is significantly attenuated in CFA
inflammation (figures 4.12 & 4.16, tables 4.6 & 4.8).
6. The non-selective HCN antagonist, ZD7288, significantly enhances C-fibre
ADS in isolated dorsal roots and monosynaptic C-fibre input to lamina I
NK1R+ neurons, where the facilitatory effect is significantly greater in tissue
isolated from CFA treated rats (figures 4.20, 4.24, 4.25 & 4.26, tables 4.11,
4.12, 4.14 & 4.15).
4.5.1 Aβ-fibres display ‘activity-dependent speeding’ in response to
repetitive stimulation
This study has shown that Aβ-fibres, in isolated rat dorsal roots, display a small but
significant reduction in response latency during stimulation at 1 and 2Hz, indicating
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an activity-dependent speeding rather than slowing (figures 4.3, 4.6 and table 4.2).
Furthermore, the speeding that occurred during 2Hz stimulation was significantly
reduced in dorsal roots isolated from CFA treated rats.
There is limited evidence that repetitive stimulation of Aβ-fibres results in an
activity-dependent change in conduction velocity / response latency. In vivo single
unit recordings from dorsal roots has shown that Aβ-fibres display minimal ADS at
stimulation frequencies of ≤25Hz, which is increased in a frequency dependent
manner at frequencies of ≥50Hz (Shin et al. 1997). This study examined changes in
Aβ-fibre response latency during a maximum stimulation frequency of 2Hz, while
Shin et al. (1997) employed frequencies up to 200Hz. It would therefore be of interest
to examine the changes in Aβ-fibres in response to increased stimulation frequencies
to determine whether Aβ-fibres display enhanced speeding or ADS.
The results presented here shown that the progressive reduction in Aβ-fibre response
latency observed during 2Hz stimulation is significantly attenuated by CFA
inflammation. Previous studies have shown that Aβ-fibre ADS is enhanced following
nerve injury (Shin et al. 1997), however this is the first evidence to suggest that the
activity-dependent changes in response latency of Aβ-fibres may be altered in
inflammatory pain.
The functional implications of Aβ-fibre activity-dependent speeding and its
subsequent attenuation in CFA inflammation, are unclear. Given that Aβ-fibres are
considered to mediate allodynia (Latremoliere & Woolf 2009, Treede & Magerl
2000), it could be speculated that any change in Aβ-fibre responses in inflammatory
pain conditions could have implications for the development / maintenance of
allodynia. However, the activity-dependent speeding reported here would lead a
reduction in the time between impulses arriving at the dorsal horn and arguably a
more efficient transmission of somatosensory information to the dorsal horn.
Whereas, the attenuation of this speeding in CFA inflammation would result in less
efficient transmission, so it is questionable whether this mechanism would play a
prominent role in inflammatory pain allodynia. As the CFA reduction in Aβ-fibre
speeding was seen at 2, but not 1Hz it may be more relevant to ascertain the influence
of inflammation upon activity-dependent speeding at higher frequencies, that are
more consistent with the evoked Aβ-fibre firing rate.
An important question with regards to these activity-dependent changes in Aβ-fibres,
is whether these changes in isolated dorsal roots are reflected in monosynaptic
Aβ-fibre input to lamina I NK1R+ neurons, which are crucial for the manifestation of
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inflammatory pain (Nichols et al. 1999). This was not explored in this current study
due to the fact that lamina I NK1R+ neurons receive limited monosynaptic Aβ-fibre
input (figure 2.14) (Torsney 2011, Torsney & MacDermott 2006). This thesis has
presented data that show a trend towards increased monosynaptic Aβ-fibre input to
lamina I NK1R+ neurons in CFA inflammation (figure 2.14), therefore it would be
important to establish whether this potential increase in the incidence of
monosynaptic Aβ-fibre input is likely to be accompanied by altered patterns of
Aβ-fibre input during inflammatory pain.
4.5.2 Aδ-fibres display activity-dependent slowing, which at higher
stimulation frequencies is attenuated in inflammatory pain
This study has established that Aδ-fibres in isolated dorsal roots (figures 4.4D & E,
4.6B, table 4.2) and monosynaptic Aδ-fibre input to lamina I NK1R+ neurons
(figure 4.10, table 4.4) exhibit small but significant levels of ADS in response to
repetitive stimulation at 1Hz or above. Furthermore, CFA inflammation significantly
attenuated the ADS in monosynaptic Aδ-fibre input to lamina I NK1R+ neurons,
elicited during 10Hz stimulation (figure 4.10C).
It has previously been reported that ADS in primary afferent fibres occurs in C-, but
not Aδ-fibres (Mazo et al. 2013, Nakatsuka et al. 2000), which the findings of this
study do not support. Although it should be recognised that several other studies do
provide evidence that Aδ-fibres exhibit ADS in response to repetitive stimulation
(Raymond et al. 1990, Thalhammer et al. 1994, Won et al. 1997). While Nakatsuka
et al. (2000) report that ADS does not occur in Aδ-fibres, it should be noted that they
use a maximum stimulation frequency of 10Hz, a frequency at which others report
minimal Aδ-fibre ADS (Won et al. 1997). This does raise the possibility that Aδ-fibre
ADS may only reveal itself during high-frequency stimulation, however this is
unlikely given that the findings of this study demonstrates Aδ-fibre ADS during
stimulation at 1Hz.
Aδ-fibre ADS has been shown to be frequency dependent, with increased stimulation
frequency being correlated with greater ADS (Raymond et al. 1990, Thalhammer
et al. 1994, Won et al. 1997). This is supported by the findings of the eEPSC
experiments reported here, where it was demonstrated that stimulation frequency
significantly alters the magnitude of monosynaptic Aδ-fibre ADS (figure 4.10D).
However, the Aδ-fibre ADS recorded in CAP studies did not display a frequency
dependence (figure 4.4B). This contradiction could suggest that while monosynaptic
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Aδ-fibre input to lamina I NK1R+ neurons displays frequency dependent ADS, not
all Aδ-fibres exhibit ADS and so any frequency dependent effect in the population
CAP recordings could be diluted. This hypothesis could be tested by comparing the
ADS profile of monosynaptic Aδ-fibre input to lamina I NK1R+ neurons with that of
other dorsal horn neurons that receive monosynaptic Aδ-fibre input.
This study has found that CFA inflammation significantly attenuates ADS in
monosynaptic Aδ-fibre input to lamina I NK1R+ neurons, during repetitive
stimulation at 10, but not 1 or 2Hz (figure 4.10, table 4.4). It has previously been
shown that Aδ-fibre ADS is enhanced in nerve injured animals, but only when dorsal
roots are stimulated at 5Hz or above (Won et al. 1997).
CFA was found to significantly alter the intercept of the line of best fit that was fitted
to the absolute latency of Aδ-fibre responses in CAP and eEPSC recordings during 1
and 2Hz stimulation. However, these results are contradictory, in that the CFA
inflammation group exhibited an increased intercept in CAP recordings (figure 4.4B
& C, table 4.1), but a decreased intercept in eEPSC recordings (figure 4.10A & B,
table 4.3). While these findings could suggest that the conduction velocity of
Aδ-fibres is altered in inflammatory pain conditions, this postulate is not supported by
other data. When the initial latencies of the Aδ-fibre responses were compared, no
significant differences were discovered between control and CFA groups, in CAP
(figure 4.7C) or eEPSC recordings (figure 4.9D). Arguably, comparing initial
latencies is a more accurate way to determine the effects of CFA inflammation upon
the initial latency of the Aδ-fibre response, as the intercept is influenced by the slope
of the line of best fit and is an extrapolated value, whereas the initial latency is an
actual measured value that is independent from the response to repetitive stimulation.
The results presented in chapter 2 also show that CFA inflammation does not alter the
conduction velocity of Aδ-fibres in isolated dorsal roots (figure 2.9C) or the estimated
conduction velocity of monosynaptic Aδ-fibre input to lamina I NK1R+ neurons
(figure 2.15D). Numerous other studies have also reported that CFA inflammation
does not significantly alter the conduction velocity of Aδ-fibres (Baba et al. 1999,
Nakatsuka et al. 1999, Torsney 2011) and importantly this has been shown to be the
case in monosynaptic Aδ-fibre input to lamina I NK1R+ neurons (Torsney 2011).
However, the conduction velocity of Aδ-fibre CAPs has been shown to be increased
in guinea pig dorsal roots following CFA inflammation (Djouhri & Lawson 2001).
There were no significant differences in the length of dorsal root stimulated between
control and CFA groups in CAP (figure 4.7A) or eEPSC studies (figure 4.9E), so this
is unlikely to account for the differences in the intercepts.
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The difference in intercept in the eEPSC data appears to be due to an increase in the
initial latency of the control group, in that the initial latency recorded in tissue
isolated from CFA treated rats remains comparable between different stimulation
frequencies, while in the control group the initial latency gradually declined between
1, 2 and 10Hz stimulation periods (figure 4.9). Furthermore, the intercepts of the
absolute latency recorded during 1, 2 and 10Hz stimulation were significantly
different in tissue isolated from control (P<0.0001, linear regression, data not
shown), but not CFA treated rats (P=0.821, linear regression, data not shown). In
these Aδ-fibre eEPSC studies, dorsal roots were stimulated at 1Hz followed by 2Hz
followed by 10Hz, although only a subset of Aδ-fibre inputs were stimulated at 1
and/or 10Hz. This raises the question of whether the reduction in Aδ-fibre latency, in
control tissue, between these different stimulation periods is an effect of the previous
stimulation train. It is possible that the period of time left between stimulus trains was
not sufficient to allow full recovery from ADS. However, if these monosynaptic
Aδ-fibre inputs had not fully recovered from the ADS elicited by the previous
stimulation train, you would expect the latency to increase, rather than decrease.
Future studies should therefore examine monosynaptic Aδ-fibre inputs to lamina I
NK1R+ neurons in the period following repetitive stimulation at 1Hz or above, to
determine the time course of recovery from ADS.
4.5.3 Activity-dependent slowing in C-fibres is altered in inflammatory
pain
The results of this study have novelly revealed that monosynaptic C-fibre input to
lamina I NK1R+ neurons display ADS in response to repetitive stimulation at 1Hz or
above (figures 4.12 & 4.16, tables 4.6 & 4.8). Furthermore, ADS in these C-fibre
inputs, as well as in isolated dorsal roots (figure 4.5, table 4.2), was significantly
reduced in tissue isolated from CFA treated rats.
It has been argued that ADS acts as a protective mechanism to limit nociceptive input
to the spinal cord and thus may act to regulate central sensitisation (de Col et al. 2012,
Mazo et al. 2013), which is known to arise from repetitive firing of C-fibres
(Latremoliere & Woolf 2009, Woolf 1983). Lamina I NK1R+ neurons are know to be
essential for the development of inflammatory pain (Nichols et al. 1999), which is
driven by activity in C-fibre nociceptors (Abrahamsen et al. 2008). Therefore, the
finding that ADS in monosynaptic C-fibre input to lamina I NK1R+ neurons is
significantly reduced in CFA inflammation suggests that the transmission of
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nociceptive information to these key spinal cord output neurons could be enhanced in
inflammatory pain conditions, which may drive inflammatory pain spinal plasticity.
This thesis has revealed that ADS in monosynaptic C-fibre input to lamina I NK1R+
neurons is significantly reduced in inflammatory pain conditions. This is consistent
with previous evidence that application of NGF, which is a key mediator in
inflammatory pain (Cheng & Ji 2008, Pezet & McMahon 2006), can modify ADS
(Obreja et al. 2011a, 2011b). Specifically, in vivo electrophysiological recordings
from pig saphenous nerve have shown that pre-treatment with NGF, 4–7 days or 3
weeks prior to recording, significantly reduces the degree of ADS seen in
mechano-insensitive C-fibre nociceptors, but not mechano-sensitive C-fibres or
sympathetic efferents (Obreja et al. 2011a, 2011b).
ADS in C-fibres has previously been shown to be altered in neuropathic pain states in
both humans (Kleggetveit et al. 2012, Ørstavik et al. 2006, 2003) and rats (Shim et al.
2007), although in these cases ADS was found to be enhanced. In the SNL
neuropathic pain model, electrophysiological recordings from isolated uninjured L4
dorsal roots demonstrated that ADS was elevated in nerve injured rats compared to
sham operated controls (Shim et al. 2007). While in humans, erythromyalgia patients
have been found to express greater ADS that controls (Ørstavik et al. 2003). Mazo
et al. (2013) report that following axotomy, ADS is reduced in mouse C-fibres,
however while ADS was shown to be reduced following nerve injury, the authors do
not present a direct comparison of ADS in control and axotomy groups and no
statistics are provided to support their claims. Therefore, it appears that inflammatory
and neuropathic pain may results in contrasting effects upon ADS.
The results presented here show a progressive increase in the latency of C-fibre, as
well as Aδ-fibre, eEPSCs that is considered to result from a gradual slowing of
conduction velocity. However, it should be recognised that this result could equally
arise from a gradual increase in the action potential initiation time. An underlying
mechanism of ADS that has been proposed is an activity-dependent reduction in the
availability of operational Nav channels, driven by an accumulation of Nav channels
entering the slow-inactivated state (Baker & Waxman 2012, de Col et al. 2008). In
patch-clamp recordings from C-fibre DRG neurons, slow-inactivation of Nav channels
driven by repetitive stimulation has been shown to lead to a progressive increase in
action potential initiation time (Snape et al. 2010). It is unclear whether the total
latency change reported in this thesis can be attributed solely to changes in action
potential initiation time. The change in action potential initiation time after 16 stimuli
at 2Hz was shown to be around 1 – 1.5ms (Snape et al. 2010), which is comparable
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with the latency change seen in C-fibre CAP recordings but approximately half of the
latency change seen in monosynaptic C-fibre inputs to lamina I NK1R+ expressing
neurons in this study. Furthermore, if the latency changes seen during repetitive
stimulation were entirely due to changes in action potential initiation duration, it
would be expected that the latency changes recorded would not be influenced by the
length of the conduction pathway. However, in eEPSC recordings, where a greater
proportion of the conduction pathways is stimulated, the degree of latency change is
larger than in CAP recordings, where the length of conduction pathway is shorter.
The contribution of changes in action potential initiation time to ADS could be
addressed by performing CAP recordings from isolated dorsal roots where two
recording electrodes are employed, rather than the single recording electrode used
here. This would enable the latency to be determined as the time taken for the
response to travel between the two recording electrodes, where action potential
initiation has already occurred and so enable the study of changes in conduction only.
In CAP recordings there are several possibilities that could account for the reduced
C-fibre ADS seen in CFA inflammation, as opposed to a simple reduction in ADS. It
has been established that there is a positive correlation between the probability of
conduction failure and the magnitude of ADS in C-fibres (Obreja et al. 2011a, Zhu
et al. 2009). Therefore, if CFA inflammation increased ADS in C-fibres in isolated
dorsal roots, an increase in the proportion of C-fibres that display conduction failures
would be expected. This could lead to a reduced contribution from those C-fibres that
display the greatest ADS in the extracellular population CAP recordings, which in
turn could lead to an apparent reduction in ADS. Interestingly, in eEPSC recordings
the progressive increase in synaptic response failure rate was significantly enhanced
in the CFA group during stimulation at 2Hz (figure 4.17A), although the overall
percentage of failures was not changed (figure 4.17D). The proposal that reduced
ADS is counterintuitively the result of increased ADS resulting in increased failures is
however unlikely, given that the CFA reduction in C-fibre ADS seen in CAP
recordings is mirrored in eEPSC recordings. If there was an increase in ADS / failures
in CFA inflammation, then arguably the criteria used to classify C-fibre input to
lamina I NK1R+ neurons as monosynaptic, a lack of failures when stimulated 20
times at 1Hz (section 2.3.5) (Nakatsuka et al. 2000, Torsney 2011, Torsney &
MacDermott 2006), could have unintentionally excluded those neurons that received
inputs displaying the highest levels of ADS / failures, as failures would have resulted
in misidentification as polysynaptic C-fibre input. However, this scenario is not
considered likely given that the incidence of monosynaptic C-fibre input reported here
(figure 2.14) and by others (Torsney 2011) is unaltered by CFA inflammation.
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Likewise, if monosynaptic C-fibre inputs were misidentified as polysynaptic in CFA
inflammation, a concurrent increase in the incidence of polysynaptic input would be
expected, but this is not the case (figure 2.14) (Torsney 2011).
Repetitive stimulation has previously been shown to increase activation thresholds in
response to natural stimulation (de Col et al. 2012, Thalhammer et al. 1994). As such,
an alternative explanation for the reduction in ADS seen in C-fibres in dorsal roots
isolated from CFA treated rats, could be that CFA increased ADS / electrical
activation thresholds, preventing action potential initiation in those fibres that
displayed high levels of ADS. If during CFA inflammation fibres displayed increased
ADS / activation threshold and were not activated by the stimulation intensity used in
CAP recordings, this could have lead to an apparent decrease in ADS. However,
results in chapter 2 demonstrate that the electrical activation thresholds of primary
afferent fibres are not altered by CFA inflammation (figure 2.9), a finding which is
supported by several published studies (Baba et al. 1999, Nakatsuka et al. 1999,
Torsney 2011). It is also worth noting that suprathreshold intensities were used to
activate primary afferents in this study. Furthermore, repetitive stimulation has been
shown to have no effect on the electrical activation threshold of C-fibres (Obreja et al.
2012).
Previous studies report that increasing stimulation frequencies are correlated with a
greater number of failures in the C-fibre response during repetitive stimulation
(Nakatsuka et al. 2000, Raymond et al. 1990, Zhu et al. 2009), however it was
unknown whether this is altered in inflammatory pain. While reduced ADS in
inflammatory pain has the potential to transform the temporal pattern of synaptic
input to lamina I NK1R+ neurons, an altered number of failures could clearly
fundamentally alter the synaptic drive to these neurons. To investigate this, the
number of synaptic response failures in the monosynaptic C-fibre input to lamina I
NK1R+ neurons was measured during repetitive stimulation at 2, 5 and 10Hz, in both
control and CFA tissue. In both control and CFA tissue, at all stimulation frequencies,
there was a progressive increase in the number of failures (figure 4.17A, B & C).
During 2Hz stimulation, it was discovered that there was significantly more failures in
the CFA group, however this was not supported by the findings obtained during 5 and
10Hz, where the number of failures was not altered by CFA inflammation. Likewise,
when the total percentage of failures was compared, it was found that CFA was
without effect (figure 4.17D). The total percentage of failures was however altered by
stimulation frequency, specifically 10Hz stimulation was found to result in
significantly more failures than 2Hz, which is consistent with previous data
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(Nakatsuka et al. 2000, Raymond et al. 1990, Zhu et al. 2009). Given that CFA
inflammation, in general, has no effect upon the number of failures in the
monosynaptic C-fibre input to lamina I NK1R+ neurons, it is unlikely that the pattern
of synaptic input to these neurons will be influenced by differing degrees of synaptic
response failures between control and inflammation conditions.
It has been established in numerous studies that different functional classes of C-fibres
display different ADS profiles, whereby mechano-insensitive C-fibres demonstrate
the greatest degree of ADS, while minimal ADS is seen in mechano-sensitive C-fibres
(Gee et al. 1996, Obreja et al. 2010, Serra et al. 1999, Weidner et al. 1999). With this
in mind, it could be argued that the significantly reduced C-fibre ADS seen in CFA
inflammation in the data presented here, could result from an expansion in
mechano-sensitive C-fibre input to lamina I NK1R+ neurons during inflammation,
which could manifest as an apparent reduction in ADS. To examine whether it was
possible to identify two distinct populations of lamina I NK1R+ neuron that received
monosynaptic C-fibre input that exhibited high or low levels of ADS, which could be
indicative of mechano-insensitive or mechano-sensitive input, respectively, frequency
histograms of the AUC of latency change, in response to 16 stimuli at 1 and 2Hz were
plotted. The results demonstrated that while CFA inflammation caused a significant
leftwards shift in the distribution of data obtained during 1 and 2Hz stimulation
(figure 4.14A & B), the distribution was unimodal and did not identify two distinct
populations of neuron based on ADS profile. However, had this analysis identified
two separate populations it should be recognised that the electrophysiological
recording techniques employed in these experiments do not enable the activation of
primary afferent inputs with natural stimulation, therefore further studies would have
been required to validate that the two populations did in fact consist of
mechano-sensitive and mechano-insensitive C-fibres.
There is conflicting evidence as to whether the initial C-fibre conduction velocity /
latency is related to the degree of ADS that is expressed in response to repetitive
stimulation. Recordings from rats (Gee et al. 1996, Taguchi et al. 2010, Thalhammer
et al. 1994) and humans (Serra et al. 1999) have found no correlation between initial
conduction velocity and ADS. However, others report that slower initial conduction
velocities / greater latencies are correlated with greater levels of ADS, in C-fibre
recordings from rat (Shim et al. 2007), human (Weidner et al. 1999), rabbit (Swadlow
& Waxman 1976, Zhu et al. 2009) and monkey (Ringkamp et al. 2010). While nerve
injury has been shown to have no effect on the correlation between initial conduction
velocity and ADS (Shim et al. 2007), it was not known whether inflammatory pain
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altered this relationship. To investigate this, the initial response latency of
monosynaptic C-fibre input to lamina I NK1R+ neurons was plotted against the
degree of ADS, as measured by the AUC of latency change. The results of this
analysis revealed that in the responses recorded during 1Hz stimulation, there was no
significant correlation between initial latency and ADS in either control or CFA
groups (figure 4.14C). During 2Hz stimulation there was no significant correlation in
the control group, however there was a significant positive correlation in the CFA
group (figure 4.14D), indicating that C-fibres which display a greater initial latency
display greater ADS.
C-fibre ADS in isolated dorsal roots demonstrated a frequency dependent effect,
whereby stimulation at 2Hz resulted in significantly greater ADS than 1Hz
(figure 4.6C). While in monosynaptic C-fibre input to lamina I NK1R+ neurons there
was a trend towards greater ADS at 2Hz than 1Hz, although this was not significant
(P=0.060, figure 4.12D). There is a precedent for the magnitude of ADS to be
frequency dependent. Electrophysiological recordings from isolated rat DRG neurons
(Nakatsuka et al. 2000) and in vivo single unit recordings in the rat (Raymond et al.
1990, Thalhammer et al. 1994) have shown that over a range of stimulation
frequencies, increasing frequency is correlated with an increase in the magnitude of
ADS.
In eEPSC studies, where monosynaptic C-fibre input to lamina I NK1R+ neurons was
stimulated 16 times at frequencies of 1 and 2Hz, the initial latency of the response was
significantly elevated at the onset of 2Hz stimulation compared to 1Hz (figure 4.13A).
However, this is likely to be accounted for by the fact that the dorsal root length in the
2Hz group is significantly greater (figure 4.13B). Incidentally, if the initial latency
values are converted into estimated conduction velocity, this significant difference
between 1 and 2Hz is no longer apparent (P=0.368, 2-way ANOVA, data not shown).
During monosynaptic C-fibre eEPSC recordings, the intercept of the line of best fit
was significantly reduced in the CFA group, during stimulation with 16 stimuli at 1
and 2Hz (figure 4.12) and 40 stimuli at 2, 5 and 10Hz (figure 4.15). These results
could be interpreted as showing that CFA inflammation significantly reduces the
conduction velocity of monosynaptic C-fibre input to lamina I NK1R+ neurons.
However, this is most likely not the case. As the intercept of the line of best fit is
extrapolated from all data points, it is influenced by the response to repetitive
stimulation. Comparing the actual initial latencies, which are recorded during the first
stimuli and as such are independent from any effect of repetitive stimulation, can
therefore be considered to be a more accurate way to evaluate the effect of CFA
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inflammation upon the initial C-fibre latency / conduction velocity. When the initial
latencies recored during these trains were compared, CFA was without effect. A
similar difference in intercept but not initial latency was found in Aδ- and C-fibre
CAP recordings (figures 4.4, 4.5 and 4.7) and Aδ-fibre eEPSC recordings (figure 4.9)
and can be explained by the same reasoning.
4.5.4 ZD7288 enhances C-fibre activity-dependent slowing
The results presented here demonstrate that the non-selective HCN antagonist,
ZD7288, significantly enhances C-fibre ADS in CAP recordings from isolated dorsal
roots (figure 4.20) and eEPSC recordings from lamina I NK1R+ neurons
(figures 4.24, 4.25 & 4.26), which suggests that HCN channels play a crucial role in
constraining ADS. This finding confirms previous reports that HCN channels are
involved in constraining ADS (Grafe et al. 1997, Mazo et al. 2013, Takigawa et al.
1998, Zhu et al. 2009).
An important point that should be considered when interpreting the data presented
here and elsewhere on the role of HCN channels in ADS, is the specificity of
ZD7288. While ZD7288 has long been considered a non-selective HCN antagonist, a
recent paper published by Wu et al. (2012b), following the completion of the ZD7288
recordings in this thesis, calls this into question. The authors provide evidence that
ZD7288, in addition to HCN channels, may act upon Nav channels, in that ZD7288
inhibited Na+ currents in DRG neurons (IC501.17µM) and in HEK cells expressing
Nav1.4, where 30µM ZD7288 virtually blocked the current (Wu et al. 2012b).
As discussed, Nav channels are thought to play a key role in mediating ADS (Baker &
Waxman 2012, de Col et al. 2008, 2012), so it is possible that the ZD7288
enhancement of ADS reported here and by others (Grafe et al. 1997, Mazo et al.
2013, Takigawa et al. 1998, Zhu et al. 2009) could be driven by an inhibition of Nav
channel activity. Mazo et al. (2013) report that the basal properties of C- and A-fibre
CAPs were unaffected by 100µM ZD7288, but that CAPs were blocked by 1µM
TTX, which they argue provides evidence that ZD7288 has no effect upon Nav
channels. If true, this could suggest that the Nav channel activity of ZD7288 in the
results presented here was potentially negligible, particularly given that this study
used ZD7288 at a concentration of 10µM. However, Mazo et al. (2013) do not show
their data, provide a limited description of what aspects of basal CAPs they measured
and give no details of statistical analysis to support their claims, so it is unclear how
robust these findings are.
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In CAP recordings from unmyelinated cerebellar parallel fibres, Baginskas et al.
(2009) have demonstrated that ZD7288 reduces conduction velocity. As Nav channels
play a crucial role in mediating action potential propagation (Gold & Gebhart 2010,
Liu & Wood 2011) and Nav channel antagonists have been shown to reduce
conduction velocity / increase response latency in C-fibres (de Col et al. 2008, Pinto
et al. 2008), the finding that ZD7288 modulates C-fibre conduction velocity could be
seen as supporting evidence for a ZD7288 effect upon Nav channels. However, the
results of the CAP recordings presented here found that ZD7288 (10µM) does not
alter the initial latency of C-fibre responses in either control or CFA tissue
(figure 4.21C). This finding is supported by previous studies which also show that
10µM ZD7288 does not alter the initial latency / conduction velocity of C-fibres
(Hogan & Poroli 2008, Takigawa et al. 1998).
In C-fibre eEPSC recordings, ZD7288 resulted in a small but significant increase in
the initial latency of monosynaptic C-fibre input to lamina I NK1R+ neurons in
control, but not CFA tissue (figure 4.27C & D), with the ZD7288 effect being
significantly greater in control than CFA (figure 4.27E). However, if these results are
due to ZD7288-altered Nav channel activity, then these findings can be considered
counterintuitive, given that the expression of Nav channels and Na+ currents are
known to be enhanced in inflammatory pain (Black et al. 2004, Dib-Hajj et al. 2010,
Tanaka et al. 1998) and in particular in the CFA inflammatory pain model (Gould
et al. 2004). Therefore, ZD7288 could be predicted to have a greater effect in CFA
inflammation. Although, if ZD7288 preferentially inhibits Nav1.1, 1.2, 1.6 or 1.9
channels, the expression of which has been shown to be unaltered in inflammatory
pain (Black et al. 2004, Tanaka et al. 1998), then the known upregulation of Nav1.3,
1.7 and 1.8 channels in inflammatory pain (Black et al. 2004, Gould et al. 2004,
Tanaka et al. 1998) may have compensated against a ZD7822-induced change in
initial latency.
In this study the facilitatory effect of ZD7288 on ADS was significantly greater in
tissue isolated from CFA treated rats. This could be considered to support previous
findings that report HCN2 expression and Ih is increased in C-fibres following CFA
inflammation (Weng et al. 2012). While the fact that the effect of ZD7288 on ADS in
monosynaptic C-fibre input to lamina I NK1R+ neurons was greater in CFA, arguably
could support previous data showing HCN2 channels are expressed on the central
terminals of SP containing afferents which form contacts with NK1R+ neurons in
lamina I (Papp et al. 2010, 2006) and that HCN2 expression is increased specifically
on SP containing afferents during CFA inflammation (Papp et al. 2010). However,
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given the questions over the specificity of ZD7288, with its reported activity against
Nav channels (Wu et al. 2012b), it is not possible to make these conclusions. Given
that the ZD7288 enhancement of ADS is greater in inflammatory pain conditions, this
could suggest that altered expression / activity of Nav channels is responsible for the
reduction in ADS seen in CFA inflammation. It is already known that Nav channels
are regulated in inflammatory pain and that expression of Nav1.3, 1.7 and 1.8
channels specifically are upregulated in inflammatory pain models (Amir et al. 2006,
Black et al. 2004, Cummins et al. 2007, Dib-Hajj et al. 2010, Gould et al. 2004). ADS
may be mediated by an activity-dependent reduction in the number of operational Nav
channels, resulting from an increase in the number of Nav channels entering a
slow-inactivated state (Baker & Waxman 2012, de Col et al. 2008, 2012, Obreja et al.
2012). Therefore, it is possible that the changes in Nav channel expression that occur
in inflammatory pain could impact upon ADS.
To overcome the limited pharmacological tools available to probe the role of HCN
channels in ADS, future studies could utilise genetic manipulation strategies. One
such way would be to investigate whether ADS and the impact of inflammation upon
ADS is altered in Nav1.8-HCN2−/− mice, which have been used in previous studies
into the importance of HCN channels in inflammatory pain (Emery et al. 2011). Not
only would such an approach negate the issues relating to the non-specificity of
ZD7288 (Wu et al. 2012b) it would provide insight into the specific role of HCN2
channels in ADS. If, for example, the inflammation-induced change in ADS was not
seen in these Nav1.8-HCN2−/− mice, then that would provide strong evidence that
the altered ADS in CFA inflammation that is described here, was mediated by altered
activity / expression of HCN2 channels. Given recent evidence suggesting a key role
for HCN2 channels in inflammatory pain (Emery et al. 2011, 2012, Weng et al. 2012),
such studies could provide additional evidence that HCN2 channels represent a
promising inflammatory pain target.
The data presented here show that ZD7288 application results in a significant increase
in synaptic response failures, that likely represent C-fibre action potential failures, in
monosynaptic C-fibre input to lamina I NK1R+ neurons, in tissue isolated from CFA
treated rats, when stimulated at 10Hz (figure 4.28). This finding is in agreement with
previous reports that ZD7288 increases action potential failures following C-fibre
stimulation at frequencies of 0.2 (Papp et al. 2006) and 20Hz (Zhu et al. 2009). While
Papp et al. (2006) report ZD7288 increased the failure rate in monosynaptic C-fibre
input to unidentified lamina I/II neurons, it is questionable as to whether these inputs
were actually monosynaptic. They report that in control conditions, during 0.2Hz
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stimulation there is a 34% failure rate, while other groups consider the presence of
failures when C-fibres are stimulated at 1Hz to indicate polysynaptic C-fibre input
(Nakatsuka et al. 2000, Torsney 2011, Torsney & MacDermott 2006). However, this
classification criteria is typically in response to 20 stimuli (Nakatsuka et al. 2000,
Torsney 2011, Torsney & MacDermott 2006), whereas the failure rate these authors
report was in response to 360 stimuli (Papp et al. 2006), which could account for the
discrepancy.
This study has demonstrated that application of ZD7288 significantly reduces the
amplitude of C-fibre CAP recordings (figure 4.22), which confirms previous reports
from population CAP recordings from unmyelinated hippocampal axons (Soleng et al.
2003) and unmyelinated cerebellar parallel fibres (Baginskas et al. 2009). Baginskas
et al. (2009) argue that this ZD7288-induced reduction in CAP amplitude most likely
arises due to an increase in the number of conduction failures, resulting in a reduction
in the number of fibres contributing to the response. Therefore, it is possible that the
reduction of C-fibre amplitude in the dorsal root recordings described here, results
from a ZD7288-driven increase in conduction failures. As such, this finding could be
seen to provide an explanation for the increase in synaptic response failures in
monosynaptic C-fibre input to lamina I NK1R+ neurons during 10Hz stimulation in
the presence of ZD7288, as discussed above. However, the ZD7288-induced increase
in failures in these eEPSC recordings was only seen in CFA tissue, while the CAP
amplitude effect was seen in both control and CFA groups. In the eEPSC recordings,
ZD7288 did produce more failures in the control and CFA group, when stimulated at
2 and 5Hz (and 10Hz in the control group), but this was not significant. Although, it
should be recognised that the sample sizes involved are small, ranging from n=2 to
n=4, so if these were increased a significant effect may become evident.
It has previously been shown that application of ZD7288 significantly attenuates the
eEPSC amplitude of monosynaptic C-fibre input to unidentified lamina II neurons,
with this effect being enhanced following nerve injury (Takasu et al. 2010). The
authors suggest that this ZD7288 reduction of eEPSC amplitude is a presynaptic
effect, given that ZD7288 reduced mEPSC frequency but not amplitude, although a
postsynaptic effect cannot be discounted as HCN channels are known to be expressed
on postsynaptic spinal cord neurons (Hughes et al. 2013, 2012, Milligan et al. 2006,
Santoro et al. 2000). In this chapter I conducted a preliminary investigation into
whether monosynaptic C-fibre input to lamina I NK1R+ neurons, with some of this
C-fibre input being known to express HCN channels (Papp et al. 2010, 2006), could
similarly be inhibited by ZD7288. The results presented demonstrate that ZD7288 did
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not alter the peak eEPSC amplitude of monosynaptic C-fibre input to lamina I NK1R+
neurons, in either control or CFA tissue (figure 4.29). However, small sample sizes,
n=3 and n=4, were used in this experiment so it cannot be considered conclusive.
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4.6 Conclusions
The results described in this chapter have novelly shown that monosynaptic C-fibre
input to lamina I NK1R+ neurons display ADS in response to repetitive stimulation
and that the magnitude of this ADS is significantly reduced in the CFA inflammatory
pain model (figures 4.12 & 4.16, tables 4.6 & 4.8). Lamina I NK1R+ neurons are
essential for the manifestation of inflammatory pain (Nichols et al. 1999) and C-fibres
have been established to drive inflammatory pain (Abrahamsen et al. 2008).
Therefore, it is possible that the altered C-fibre ADS during inflammation plays a role
in the development of inflammatory pain, by enhancing the transmission of
nociceptive signals from the periphery to these key spinal cord output neurons, which
could drive inflammatory pain spinal plasticity. Further investigation is required to
fully elucidate the functional impact of altered ADS in monosynaptic C-fibre input to
lamina I NK1R+ neurons. However, it is possible that novel treatment strategies that
restore the diminished ADS seen during inflammation, or which amplify ADS could
prove efficacious in the management of inflammatory pain.
It has been shown that monosynaptic Aδ-fibre input to lamina I NK1R+ neurons
displays a small but significant degree of ADS during repetitive stimulation, which
was frequency dependent (figure 4.10). Furthermore, for the fist time it has been
shown that Aδ-fibre ADS, elicited at 10, but not 1 or 2Hz, is significantly attenuated
in tissue isolated from CFA treated rats. As with C-fibre ADS, this suggests that
Aδ-fibre input to these key spinal cord output neurons could be intensified in
inflammatory pain conditions. Given the evidence that Aδ-fibres play a key role in
mediating mechanical hyperalgesia (Fuchs et al. 2000, Magerl et al. 2001, Ziegler
et al. 1999), this reduction of ADS could be involved in mechanical hyperalgesia
mechanisms, while treatments that restore or enhance Aδ-fibre ADS could represent a
novel approach to treat inflammatory hyperalgesia.
This study has demonstrated that application of the non-selective HCN antagonist,
ZD7288, significantly enhances C-fibre ADS in isolated dorsal roots and in
monosynaptic C-fibre input to lamina I NK1R+ neurons and that the facilitatory effect
of ZD7288 is significantly greater in CFA inflammation (figures 4.20, 4.24, 4.25 &
4.26, tables 4.11, 4.12, 4.14 & 4.15). This confirms previous studies that demonstrate
ZD7288 enhances C-fibre ADS and suggests a key role for HCN channels in
constraining ADS (Grafe et al. 1997, Mazo et al. 2013, Takigawa et al. 1998, Zhu
et al. 2009). The enhanced effect of ZD7288 in CFA provides support to published
studies that show expression of HCN channels are upregulated and Ih is increased in
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C-fibres in CFA inflammation (Papp et al. 2010, 2006, Weng et al. 2012). Given
recent evidence that HCN2 channels play a crucial role in inflammatory pain,
whereby pharmacological or genetic manipulation of these channels attenuates
inflammatory pain (Emery et al. 2011), it is possible that the mechanism by which
HCN channels regulate pain could involve an enhancement of ADS. However,
caution should be exercised in interpreting these results due to the likelihood that
ZD7288 also acts upon Nav channels (Wu et al. 2012b), which could equally explain
these results, given that a reduction in the availability of operational Nav channels is
also thought to play a key role in ADS (Baker & Waxman 2012, de Col et al. 2008),
while Nav channels are also critically implicated in inflammatory pain (Amir et al.
2006, Black et al. 2004, Cummins et al. 2007, Dib-Hajj et al. 2010, Gould et al.
2004). Therefore, future studies should investigate whether the altered ADS seen in
inflammatory pain are associated with altered Nav channel activity.
Chapter 5
Summary and conclusions
The aim of this thesis was to study inflammatory pain spinal plasticity mechanisms by
investigating the synaptic input to lamina I neurokinin 1 receptor expressing
(NK1R+) neurons, which are known to be essential for the manifestation of
inflammatory pain (Nichols et al. 1999). Inflammation-induced changes in and
pharmacological manipulation of the primary afferent drive to these lamina I NK1R+
neurons was assessed.
Findings presented in chapter 2 show that complete Freund’s adjuvant (CFA)
inflammation does not alter the relative distribution of the type of primary afferent
input that lamina I NK1R+ neurons receive. These results did not replicate previous
work from within my laboratory that showed the incidence of monosynaptic Aδ-fibre
input to lamina I NK1R+ neurons is significantly increased and that a subset of this
monosynaptic Aδ-fibre input is potentiated in CFA inflammation (Torsney 2011).
This previously reported facilitation of Aδ-fibre input is however consistent with
published functional-anatomical studies that show activation of Aδ-fibres, some of
which express substance P (SP) (Lawson et al. 1997), with noxious mechanical or
electrical stimuli, can drive the internalisation of neurokinin 1 receptors (NK1Rs) in
lamina I NK1R+ neurons, with the number of neurons displaying NK1R
internalisation being significantly increased following CFA inflammation (Abbadie
et al. 1997, Allen et al. 1999, Honor et al. 1999). The results in this chapter did
however report a trend towards an increase in the incidence of monosynaptic Aβ-fibre
input to lamina I NK1R+ neurons in CFA inflammation, although this did not reach
statistical significance. Given that Aβ-fibres are considered to mediate allodynia
(Latremoliere & Woolf 2009, Treede & Magerl 2000), an increase in Aβ-fibre input
to lamina I NK1R+ neurons in inflammatory pain conditions could play a role in the
development of allodynia, by recruiting low threshold / touch input to these
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nociceptive specific pathways. Further studies will need to be conducted to validate
this increase in Aβ-fibre input and to elucidate the potential mechanisms by which
these novel Aβ-fibre inputs are unmasked.
The peak amplitude of monosynaptic C-fibre input to lamina I NK1R+ neurons was
not altered following CFA inflammation. This finding confirms previous reports that
the long-lasting potentiation of monosynaptic C-fibre input to these neurons, as has
been elicited by electrical stimulation of these C-fibre inputs (Ikeda et al. 2003, 2006),
does not appear to be implicated in CFA inflammation (Torsney 2011).
The spontaneous excitatory drive to lamina I NK1R+ neurons and the influence of
inflammatory pain on this input had not previously been studied. Results presented
here demonstrate that CFA inflammation does not alter the frequency or amplitude of
spontaneous excitatory postsynaptic currents (sEPSCs) in lamina I NK1R+ neurons,
either in the entire population or when neuronal subpopulations that receive
monosynaptic input from Aδ- only, Aδ- & C- or C-fibre only are examined
independently. The sEPSC frequency was significantly elevated in those neurons that
received monosynaptic Aδ-fibre only input compared to neurons that received
monosynaptic C-fibre input only. This suggests that the previously reported increase
in the prevalence of monosynaptic Aδ-fibre input to lamina I NK1R+ neurons in
inflammatory pain (Torsney 2011) could be associated with an increase in the
spontaneous excitatory drive to these neurons. However, as the findings in this thesis
did not replicate the previously described increase in the incidence of monosynaptic
Aδ-fibre input to these neurons in inflammatory pain (Torsney 2011), the findings
presented here can neither confirm or refute this hypothesis.
Chapter 3 has presented an investigation into the capacity of chemerin, an agonist of
the chemerin receptor 23 (ChemR23), which is a potential new inflammatory pain
target (Ji et al. 2011, Xu et al. 2010), to pharmacologically modulate primary afferent
input to lamina I NK1R+ neurons. It was found that chemerin was without effect in
non-potentiated conditions, in that chemerin alone does not alter the frequency or
amplitude of miniature excitatory postsynaptic currents (mEPSCs) in lamina I
NK1R+ neurons and that chemerin does not affect the peak amplitude of
monosynaptic Aδ- or monosynaptic C-fibre evoked excitatory postsynaptic currents
(eEPSCs) in these neurons in control animals. However, chemerin significantly
reduces the capsaicin potentiation of excitatory input to lamina I NK1R+ neurons,
where chemerin attenuates the increase in mEPSC frequency resulting from capsaicin
application. Furthermore, the data presented here novelly show that chemerin
presynaptically attenuates monosynaptic C-fibre input to a subset of lamina I NK1R+
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neurons in inflammatory pain. Chemerin was observed to significantly reduce the
peak amplitude of monosynaptic C-fibre eEPSCs in a subset of neurons compared to
vehicle and significantly increased the paired-pulse ratio (PPR) / decreased
paired-pulse depression (PPD), indicating the chemerin effect was presynaptic, rather
than postsynaptic. The finding that chemerin acts only upon a subset of monosynaptic
C-fibre input to lamina I NK1R+ neurons is consistent with published expression data
that shows ChemR23 is expressed on a subset of transient receptor potential subtype
vanilloid 1 (TRPV1) expressing dorsal root ganglia (DRG) neurons and SP containing
primary afferent terminals in lamina I of the dorsal horn (Xu et al. 2010). Importantly,
lamina I NK1R+ neurons are known to receive inputs from both TRPV1 expressing
(Hwang et al. 2003, Labrakakis & MacDermott 2003, Tong & MacDermott 2006) and
SP containing afferents (Hwang et al. 2003, Todd et al. 2002).
The lack of chemerin effect in non-potentiated conditions supports previous findings
that ChemR23 agonists, such as chemerin and resolvin E1 (RvE1), do not impact
upon acute nociceptive processing (Xu et al. 2010), which suggests inflammatory pain
treatments that target ChemR23 will not alter protective acute pain responses.
Sensitisation of TRPV1 channels is known to contribute to inflammatory pain
hypersensitivity (Basbaum et al. 2009, Palazzo et al. 2012, Pingle et al. 2007), while
lamina I NK1R+ neurons are recognised to be essential for the manifestation of
inflammatory pain (Nichols et al. 1999), which is mediated by C-fibres (Abrahamsen
et al. 2008). Therefore, the ability of chemerin to reduce the capsaicin potentiation of
excitatory input to lamina I NK1R+ neurons and to presynaptically attenuate
monosynaptic C-fibre input to a subset of these neurons in inflammatory pain, adds to
the growing evidence that ChemR23 offers a promising target for the development of
novel inflammatory pain treatments (Ji et al. 2011, Lee 2012, Xu et al. 2010).
The phenomenon of activity-dependent slowing (ADS), whereby repetitive electrical
stimulation of C-fibres, at frequencies of 1Hz or above, results in a progressive
reduction in action potential conduction velocity, which manifests as a progressive
increase in response latency (Gee et al. 1996, Serra et al. 1999, Thalhammer et al.
1994, Weidner et al. 1999), was investigated in chapter 4. The data presented
demonstrate for the first time that C-fibre ADS can be observed in extracellular
population recordings from isolated dorsal roots during stimulation at 1 and 2Hz.
This C-fibre ADS was shown to be frequency dependent, with 2Hz stimulation
resulting in significantly greater ADS than 1Hz. Furthermore, the results novelly
show that the ADS elicited by dorsal root stimulation at 1 and 2Hz is significantly
reduced in tissue isolated from CFA treated rats.
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ADS in the monosynaptic C-fibre input to lamina I NK1R+ neurons was also
investigated. This thesis has novelly shown that ADS is present in monosynaptic
C-fibre input to lamina I NK1R+ neurons, as evidenced by a significant progressive
increase in response latency resulting from 16 stimuli delivered at 1 and 2Hz and 40
stimuli delivered at 2, 5 and 10Hz. There was a trend towards greater ADS during
2Hz stimulation in experiments where 16 stimuli were delivered, however this did not
reach significance. As with the results from the dorsal root recordings, CFA
inflammation was found to consistently result in a significantly reduction of ADS
during all stimulation protocols, compared to control.
The physiological role of ADS is unclear, however it has been argued that it
represents a form of self-inhibition that limits nociceptive input to the spinal cord,
which could reduce central sensitisation (de Col et al. 2012, Mazo et al. 2013). This
thesis has shown that altered ADS in CFA changes the timing of the transmission of
nociceptive input from peripheral C-fibres to lamina I NK1R+ neurons, which could
have implications for the temporal summation of nociceptive input to these neurons
and for spinal cord inflammatory pain plasticity. Importantly, excitatory postsynaptic
potentials (EPSPs) in these neurons have been shown to have a long duration (mean
duration 3.1s) (Cheunsuang et al. 2002), so there is ample scope for summation of
repetitive inputs. While the ADS reported here results in small latency changes
(∼1–7ms) in the timing of monosynaptic C-fibre input arriving at lamina I NK1R+
neurons, it should be noted that in these experiments only a small portion of the
conduction pathway was stimulated. With this in mind the sciatic nerve and its
peripheral and central branches were traced and measured in a number of rats to gain
an estimate of the total length of the conduction pathway. It was found that the total
estimated length of the conduction pathway, from the hindpaw to the dorsal root entry
zone, was 81.4 ± 2.0mm. In eEPSC ADS experiments the group mean length of
dorsal roots stimulated ranged between 5.5 – 6.0mm (data not shown), which
accounts for ∼7% of the estimated total conduction pathway. If the complete
conduction pathway is accounted for then the predicted latency changes would be
∼40–100ms, which arguably could limit the central summation of monosynaptic
C-fibre input, particularly during stimulation at frequencies that more closely mimic
the evoked C-fibre firing rate (∼5 – 40Hz) (Thalhammer et al. 1994, Yeomans &
Proudfit 1996), where for example the interstimulus interval during 10Hz stimulation
is only 100ms. Notably, CFA inflammation reduces ADS by ∼45% which could
promote the temporal summation of C-fibre input and drive action potential firing in
these neurons.
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To investigate whether the inflammation-reduced ADS impacts upon the function of
lamina I NK1R+ neurons, monosynaptic C-fibre evoked excitatory postsynaptic
potentials (eEPSPs) and action potential firing in these neurons could be recorded, in
current-clamp configuration, while the afferent input is electrically stimulated with
estimated stimulation trains, that consider ADS in the entire conduction path in
control and inflammatory pain conditions. Given that there are numerous factors that
could alter the activity of lamina I NK1R+ neurons in inflammatory pain
(Latremoliere & Woolf 2009) undertaking these studies in control tissue only would
enable the direct study of the effect of changes in ADS upon the function of these
neurons without confounding influences. However, it should be noted that the
suggested method of scaling up the latency changes lacks precision and does not take
into account the fact that conduction velocity (Waddell et al. 1989) and/or ADS (Won
et al. 1997) may be altered along the length of the conduction pathway. While the
main interest concerns ADS in monosynaptic C-fibre input to lamina I NK1R+
neurons, it would be technically demanding and perhaps not feasible to record
eEPSPs in lamina I NK1R+ neurons in spinal cord slices with the central and
peripheral branches of the nerve intact. However, it may be feasible to conduct
compound action potential (CAP) recordings from isolated nerves, with central and
peripheral branches intact, to provide insight into ADS along the entire conduction
path and improve the accuracy of the estimated stimulation trains.
Results in chapter 4 also demonstrate that monosynaptic Aδ-fibre input to lamina I
NK1R+ neurons exhibits a small, frequency dependent degree of ADS in response to
repetitive stimulation at frequencies of 1, 2 and 10Hz. Furthermore, the ADS elicited
in monosynaptic Aδ-fibre input to lamina I NK1R+ neurons during 10Hz, but not 1 or
2Hz, stimulation is significantly reduced in CFA inflammation. As with C-fibre ADS,
this Aδ-fibre ADS could act to limit nociceptive input to lamina I NK1R+ neurons,
with the inflammation-induced reduction in ADS facilitating nociceptive drive. The
incidence of monosynaptic Aδ-fibre input to lamina I NK1R+ neurons has previously
been show to be increased in CFA inflammation (Torsney 2011). The findings
presented here suggest that in inflammatory pain conditions, the timing of
monosynaptic Aδ-fibre input arriving at lamina I NK1R+ neurons may also be
altered, which could act to increase the excitability of these neurons and potentially
drive plasticity. Given that Aδ-fibres are known to mediate mechanical hyperalgesia
(Fuchs et al. 2000, Magerl et al. 2001, Ziegler et al. 1999), this reduced ADS could be
implicated in inflammatory hyperalgesia. As this inflammation induced change in
Aδ-fibre ADS only revels itself at higher stimulation frequencies, that more closely
relate to the Aδ-fibre evoked firing rate (Yeomans & Proudfit 1996), it may be
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relevant for future studies to investigate the effects of inflammation upon ADS in
response to stimulation at frequencies greater than 10Hz.
In summary, this thesis has investigated inflammatory pain spinal plasticity
mechanisms by studying the synaptic input to lamina I NK1R+ neurons and has
presented new evidence for ways in which this synaptic input may be altered and
pharmacologically manipulated in inflammatory pain. The spontaneous excitatory
drive to those lamina I NK1R+ neurons that receive monosynaptic input from
Aδ-fibres only was found to be elevated. Given previous evidence has shown that the
monosynaptic Aδ-fibre input to these neurons is increased in CFA inflammation
(Torsney 2011), this finding suggests there could be a corresponding increase in the
excitatory drive to these neurons in inflammatory pain. This thesis has investigated
the modulation of primary afferent input to lamina I NK1R+ neurons with chemerin,
an agonist of the novel inflammatory pain target, ChemR23 (Ji et al. 2011, Xu et al.
2010). Chemerin was shown to reduce the capsaicin potentiation of excitatory input
to lamina I NK1R+ neurons and presynaptically attenuate monosynaptic C-fibre input
to a subset of these neurons in CFA inflammation, but was without effect in control
conditions. These findings provide further evidence that ChemR23 offers a potential
target for the development of novel inflammatory pain treatments. The data presented
here have shown for the first time that ADS is present in monosynaptic C-fibre input
to lamina I NK1R+ neurons. Furthermore, C-fibre ADS was found to be significantly
reduced in CFA inflammation, in extracellular population recordings from isolated
dorsal roots and specifically in monosynaptic C-fibre input to lamina I NK1R+
neurons. While the physiological role of ADS is unclear, it is thought to limit
nociceptive input to the spinal cord and could thus act to regulate central sensitisation
(de Col et al. 2012, Mazo et al. 2013). Therefore the reduced ADS seen during
inflammation could facilitate nociceptive input to and significantly impact upon
nociceptive processing in these key spinal cord output neurons. This raises the
possibility that treatments which restore or enhance ADS could provide a novel
approach to the treatment of inflammatory pain.
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mechanical hyperalgesia: a MEG study’, European Journal of Pain 14(1), 64–70.
Mandadi, S. & Roufogalis, B. D. (2008), ‘ThermoTRP channels in nociceptors: taking a lead
from capsaicin receptor TRPV1’, Current Neuropharmacology 6(1), 21–38.
Maniadakis, N. & Gray, A. (2000), ‘The economic burden of back pain in the UK’, PAIN
84(1), 95–103.
Mantyh, P. W., DeMaster, E., Malhotra, A., Ghilardi, J. R., Rogers, S. D., Mantyh, C. R., Liu,
H., Basbaum, A. I., Vigna, S. R. & Maggio, J. E. (1995), ‘Receptor endocytosis and
dendrite reshaping in spinal neurons after somatosensory stimulation’, Science
268(5217), 1629–1632.
REFERENCES 248
Mantyh, P. W., Rogers, S. D., Honore, P., Allen, B. J., Ghilardi, J. R., Li, J., Daughters, R. S.,
Lappi, D. A., Wiley, R. G. & Simone, D. A. (1997), ‘Inhibition of hyperalgesia by ablation
of lamina I spinal neurons expressing the substance P receptor’, Science
278(5336), 275–279.
Marchese, A., Cheng, R., Lee, M. C., Porter, C. A., Heiber, M., Goodman, M., George, S. R.
& O’Dowd, B. F. (1994), ‘Mapping studies of two G protein-coupled receptor genes: an
amino acid difference may confer a functional variation between a human and rodent
receptor’, Biochemical and Biophysical Research Communications 205(3), 1952–1958.
Marchese, A., Docherty, J. M., Nguyen, T., Heiber, M., Cheng, R., Heng, H. H., Tsui, L. C.,
Shi, X., George, S. R. & O’Dowd, B. F. (1994), ‘Cloning of human genes encoding novel G
protein-coupled receptors’, Genomics 23(3), 609–618.
Maroon, J. C. & Bost, J. W. (2006), ‘ω-3 fatty acids (fish oil) as an anti-inflammatory: an
alternative to nonsteroidal anti-inflammatory drugs for discogenic pain’, Surgical
Neurology 65(4), 326–331.
Marshall, G. E., Shehab, S. A., Spike, R. C. & Todd, A. J. (1996), ‘Neurokinin-1 receptors on
lumbar spinothalamic neurons in the rat’, Neuroscience 72(1), 255–263.
Marvizón, J. C. G., Wang, X., Matsuka, Y., Neubert, J. K. & Spigelman, I. (2003),
‘Relationship between capsaicin-evoked substance P release and neurokinin 1 receptor
internalization in the rat spinal cord’, Neuroscience 118(2), 535–545.
Mattia, C. & Coluzzi, F. (2005), ‘Cox-2 inhibitors: pharmacological data and adverse effects’,
Minerva Anestesiologica 71(7-8), 461–470.
Maxwell, D. J., Belle, M. D., Cheunsuang, O., Stewart, A. & Morris, R. (2007), ‘Morphology
of inhibitory and excitatory interneurons in superficial laminae of the rat dorsal horn’, The
Journal of Physiology 584(Pt 2), 521–533.
Mayer, M. L., Westbrook, G. L. & Guthrie, P. B. (1984), ‘Voltage-dependent block by Mg2+
of NMDA responses in spinal cord neurones’, Nature 309(5965), 261–263.
Mazo, I., Rivera-Arconada, I. & Roza, C. (2013), ‘Axotomy-induced changes in
activity-dependent slowing in peripheral nerve fibres: Role of
hyperpolarization-activated/HCN channel current’, European Journal of Pain .
McCarson, K. E. & Krause, J. E. (1994), ‘NK-1 and NK-3 type tachykinin receptor mRNA
expression in the rat spinal cord dorsal horn is increased during adjuvant or
formalin-induced nociception’, The Journal of Neuroscience 14(2), 712–720.
McCarthy, P. W. & Lawson, S. N. (1989), ‘Cell type and conduction velocity of rat primary
sensory neurons with substance P-like immunoreactivity’, Neuroscience 28(3), 745–753.
McMahon, S. B. & Malcangio, M. (2009), ‘Current challenges in glia-pain biology’, Neuron
64(1), 46–54.
McMahon, S. B. & Wood, J. N. (2006), ‘Increasingly irritable and close to tears: TRPA1 in
inflammatory pain’, Cell 124(6), 1123–1125.
McNamara, C. R., Mandel-Brehm, J., Bautista, D. M., Siemens, J., Deranian, K. L., Zhao, M.,
Hayward, N. J., Chong, J. A., Julius, D., Moran, M. M. & Fanger, C. M. (2007), ‘TRPA1
REFERENCES 249
mediates formalin-induced pain’, Proceedings of the National Academy of Sciences of the
United States of America 104(33), 13525–13530.
Meder, W., Wendland, M., Busmann, A., Kutzleb, C., Spodsberg, N., John, H., Richter, R.,
Schleuder, D., Meyer, M. & Forssmann, W. G. (2003), ‘Characterization of human
circulating TIG2 as a ligand for the orphan receptor ChemR23’, FEBS Letters
555(3), 495–499.
Mesnage, B., Gaillard, S., Godin, A. G., Rodeau, J.-L., Hammer, M., Von Engelhardt, J.,
Wiseman, P. W., De Koninck, Y., Schlichter, R. & Cordero-Erausquin, M. (2011),
‘Morphological and functional characterization of cholinergic interneurons in the dorsal
horn of the mouse spinal cord’, The Journal of Comparative Neurology
519(16), 3139–3158.
Meyer, R. A., Ringkamp, M., Campbell, J. N. & Raja, S. N. (2005), Wall and Melzack’s
Textbook of Pain, 5 edn, Elsevier Health Sciences, chapter Peripheral mechanisms of
cutaneous nociception, pp. 3–34.
Michael, G. J. & Priestley, J. V. (1999), ‘Differential expression of the mRNA for the vanilloid
receptor subtype 1 in cells of the adult rat dorsal root and nodose ganglia and its
downregulation by axotomy’, The Journal of Neuroscience 19(5), 1844–1854.
Millan, M. J. (1999), ‘The induction of pain: an integrative review’, Progress in Neurobiology
57(1), 1–164.
Milligan, C. J., Edwards, I. J. & Deuchars, J. (2006), ‘HCN1 ion channel immunoreactivity in
spinal cord and medulla oblongata’, Brain Research 1081(1), 79–91.
Miura, S., Takahashi, K., Imagawa, T., Uchida, K., Saito, S., Tominaga, M. & Ohta, T. (2013),
‘Involvement of TRPA1 activation in acute pain induced by cadmium in mice’, Molecular
Pain 9, 7.
Mohr, C., Leyendecker, S., Mangels, I., Machner, B., Sander, T. & Helmchen, C. (2008),
‘Central representation of cold-evoked pain relief in capsaicin induced pain: an
event-related fMRI study’, PAIN 139(2), 416–430.
Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B. & Seeburg, P. H. (1994),
‘Developmental and regional expression in the rat brain and functional properties of four
NMDA receptors’, Neuron 12(3), 529–540.
Moore, K. A., Kohno, T., Karchewski, L. A., Scholz, J., Baba, H. & Woolf, C. J. (2002),
‘Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the
superficial dorsal horn of the spinal cord’, The Journal of Neuroscience 22(15), 6724–6731.
Morita, K., David, G., Barrett, J. N. & Barrett, E. F. (1993), ‘Posttetanic hyperpolarization
produced by electrogenic Na+-K+ pump in lizard axons impaled near their motor
terminals’, Journal of Neurophysiology 70(5), 1874–1884.
Moylan Governo, R. J., Morris, P. G., Prior, M. J. W., Marsden, C. A. & Chapman, V. (2006),
‘Capsaicin-evoked brain activation and central sensitization in anaesthetised rats: a
functional magnetic resonance imaging study’, PAIN 126(1-3), 35–45.
Mukherjee, D., Nissen, S. E. & Topol, E. J. (2001), ‘Risk of cardiovascular events associated
REFERENCES 250
with selective COX-2 inhibitors’, The Journal of the American Medical Association
286(8), 954–959.
Müller, F., Heinke, B. & Sandkühler, J. (2003), ‘Reduction of glycine receptor-mediated
miniature inhibitory postsynaptic currents in rat spinal lamina I neurons after peripheral
inflammation’, Neuroscience 122(3), 799–805.
Nagpal, S., Patel, S., Jacobe, H., DiSepio, D., Ghosn, C., Malhotra, M., Teng, M., Duvic, M.
& Chandraratna, R. A. (1997), ‘Tazarotene-induced gene 2 (TIG2), a novel
retinoid-responsive gene in skin’, The Journal of Investigative Dermatology 109(1), 91–95.
Nagy, G. G., Al-Ayyan, M., Andrew, D., Fukaya, M., Watanabe, M. & Todd, A. J. (2004),
‘Widespread expression of the AMPA receptor GluR2 subunit at glutamatergic synapses in
the rat spinal cord and phosphorylation of GluR1 in response to noxious stimulation
revealed with an antigen-unmasking method’, The Journal of Neuroscience
24(25), 5766–5777.
Nagy, G. G., Watanabe, M., Fukaya, M. & Todd, A. J. (2004), ‘Synaptic distribution of the
NR1, NR2A and NR2B subunits of the N-methyl-d-aspartate receptor in the rat lumbar
spinal cord revealed with an antigen-unmasking technique’, The European Journal of
Neuroscience 20(12), 3301–3312.
Naim, M. M., Shehab, S. A. & Todd, A. J. (1998), ‘Cells in laminae III and IV of the rat
spinal cord which possess the neurokinin-1 receptor receive monosynaptic input from
myelinated primary afferents’, The European Journal of Neuroscience 10(9), 3012–3019.
Naim, M., Spike, R. C., Watt, C., Shehab, S. A. & Todd, A. J. (1997), ‘Cells in laminae III and
IV of the rat spinal cord that possess the neurokinin-1 receptor and have dorsally directed
dendrites receive a major synaptic input from tachykinin-containing primary afferents’, The
Journal of Neuroscience 17(14), 5536–5548.
Nakanishi, S. (1992), ‘Molecular diversity of glutamate receptors and implications for brain
function’, Science 258(5082), 597–603.
Nakatsuka, T., Ataka, T., Kumamoto, E., Tamaki, T. & Yoshimura, M. (2000), ‘Alteration in
synaptic inputs through C-afferent fibers to substantia gelatinosa neurons of the rat spinal
dorsal horn during postnatal development’, Neuroscience 99(3), 549–556.
Nakatsuka, T., Park, J. S., Kumamoto, E., Tamaki, T. & Yoshimura, M. (1999), ‘Plastic
changes in sensory inputs to rat substantia gelatinosa neurons following peripheral
inflammation’, PAIN 82(1), 39–47.
Narikawa, K., Furue, H., Kumamoto, E. & Yoshimura, M. (2000), ‘In vivo patch-clamp
analysis of IPSCs evoked in rat substantia gelatinosa neurons by cutaneous mechanical
stimulation’, Journal of Neurophysiology 84(4), 2171–2174.
Nassar, M. A., Stirling, L. C., Forlani, G., Baker, M. D., Matthews, E. A., Dickenson, A. H. &
Wood, J. N. (2004), ‘Nociceptor-specific gene deletion reveals a major role for Nav1.7
(PN1) in acute and inflammatory pain’, Proceedings of the National Academy of Sciences
of the United States of America 101(34), 12706–12711.
Neugebauer, V. & Li, W. (2003), ‘Differential sensitization of amygdala neurons to afferent
REFERENCES 251
inputs in a model of arthritic pain’, Journal of Neurophysiology 89(2), 716–727.
Neugebauer, V., Li, W., Bird, G. C., Bhave, G. & Gereau, 4th, R. W. (2003), ‘Synaptic
plasticity in the amygdala in a model of arthritic pain: differential roles of metabotropic
glutamate receptors 1 and 5’, The Journal of Neuroscience 23(1), 52–63.
Neumann, S., Braz, J. M., Skinner, K., Llewellyn-Smith, I. J. & Basbaum, A. I. (2008),
‘Innocuous, not noxious, input activates PKCγ interneurons of the spinal dorsal horn via
myelinated afferent fibers’, The Journal of Neuroscience 28(32), 7936–7944.
Neumann, S., Doubell, T. P., Leslie, T. & Woolf, C. J. (1996), ‘Inflammatory pain
hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons’,
Nature 384(6607), 360–364.
Nichols, M. L., Allen, B. J., Rogers, S. D., Ghilardi, J. R., Honore, P., Luger, N. M., Finke,
M. P., Li, J., Lappi, D. A., Simone, D. A. & Mantyh, P. W. (1999), ‘Transmission of chronic
nociception by spinal neurons expressing the substance P receptor’, Science
286(5444), 1558–1561.
Nicol, G. D. & Vasko, M. R. (2007), ‘Unraveling the story of NGF-mediated sensitization of
nociceptive sensory neurons: ON or OFF the Trks?’, Molecular Interventions 7(1), 26–41.
Noble, M., Treadwell, J. R., Tregear, S. J., Coates, V. H., Wiffen, P. J., Akafomo, C. &
Schoelles, K. M. (2010), ‘Long-term opioid management for chronic noncancer pain’,
Cochrane Database of Systematic Reviews (1), CD006605.
Novakovic, S. D., Tzoumaka, E., McGivern, J. G., Haraguchi, M., Sangameswaran, L.,
Gogas, K. R., Eglen, R. M. & Hunter, J. C. (1998), ‘Distribution of the
tetrodotoxin-resistant sodium channel PN3 in rat sensory neurons in normal and
neuropathic conditions’, The Journal of Neuroscience 18(6), 2174–2187.
Nowak, A., Mathieson, H. R., Chapman, R. J., Janzsó, G., Yanagawa, Y., Obata, K., Szabo, G.
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Schäfer, M. K., Nohr, D., Krause, J. E. & Weihe, E. (1993), ‘Inflammation-induced
upregulation of NK1 receptor mRNA in dorsal horn neurones’, Neuroreport
4(8), 1007–1010.
Schmelz, M., Schmid, R., Handwerker, H. O. & Torebjörk, H. E. (2000), ‘Encoding of
burning pain from capsaicin-treated human skin in two categories of unmyelinated nerve
fibres’, Brain 123(3), 560–571.
Scholz, J., Broom, D. C., Youn, D.-H., Mills, C. D., Kohno, T., Suter, M. R., Moore, K. A.,
Decosterd, I., Coggeshall, R. E. & Woolf, C. J. (2005), ‘Blocking caspase activity prevents
transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn
after peripheral nerve injury’, The Journal of Neuroscience 25(32), 7317–7323.
Scholz, J. & Woolf, C. J. (2002), ‘Can we conquer pain?’, Nature Neuroscience 5
Suppl, 1062–1067.
Scholz, J. & Woolf, C. J. (2007), ‘The neuropathic pain triad: neurons, immune cells and
glia’, Nature Neuroscience 10(11), 1361–1368.
Schwab, J. M., Chiang, N., Arita, M. & Serhan, C. N. (2007), ‘Resolvin E1 and protectin D1
REFERENCES 257
activate inflammation-resolution programmes’, Nature 447(7146), 869–874.
Seal, R. P., Wang, X., Guan, Y., Raja, S. N., Woodbury, C. J., Basbaum, A. I. & Edwards,
R. H. (2009), ‘Injury-induced mechanical hypersensitivity requires C-low threshold
mechanoreceptors’, Nature 462(7273), 651–655.
Seeburg, P. H. & Hartner, J. (2003), ‘Regulation of ion channel/neurotransmitter receptor
function by RNA editing’, Current Opinion in Neurobiology 13(3), 279–283.
Serhan, C. N. (2010), ‘Novel lipid mediators and resolution mechanisms in acute
inflammation: to resolve or not?’, The American Journal of Pathology 177(4), 1576–1591.
Serhan, C. N. & Chiang, N. (2008), ‘Endogenous pro-resolving and anti-inflammatory lipid
mediators: a new pharmacologic genus’, British Journal of Pharmacology 153(Suppl
1), S200–215.
Serhan, C. N., Chiang, N. & Van Dyke, T. E. (2008), ‘Resolving inflammation: dual
anti-inflammatory and pro-resolution lipid mediators’, Nature Reviews Immunology
8(5), 349–361.
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G. &
Moussignac, R.-L. (2002), ‘Resolvins: a family of bioactive products of omega-3 fatty acid
transformation circuits initiated by aspirin treatment that counter proinflammation signals’,
The Journal of Experimental Medicine 196(8), 1025–1037.
Serra, J., Campero, M., Bostock, H. & Ochoa, J. (2004), ‘Two types of C nociceptors in
human skin and their behavior in areas of capsaicin-induced secondary hyperalgesia’,
Journal of Neurophysiology 91(6), 2770–2781.
Serra, J., Campero, M., Ochoa, J. & Bostock, H. (1999), ‘Activity-dependent slowing of
conduction differentiates functional subtypes of C fibres innervating human skin’, The
Journal of Physiology 515(3), 799–811.
Shehab, S. A. S., Spike, R. C. & Todd, A. J. (2003), ‘Evidence against cholera toxin B subunit
as a reliable tracer for sprouting of primary afferents following peripheral nerve injury’,
Brain Research 964(2), 218–227.
Sherman, S. E. & Loomis, C. W. (1996), ‘Strychnine-sensitive modulation is selective for
non-noxious somatosensory input in the spinal cord of the rat’, PAIN 66(2-3), 321–330.
Sherrington, C. S. (1906), ‘Observations on the scratch-reflex in the spinal dog’, The Journal
of Physiology 34(1-2), 1–50.
Shibata, T., Watanabe, M., Ichikawa, R., Inoue, Y. & Koyanagi, T. (1999), ‘Different
expressions of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid and
N-methyl-D-aspartate receptor subunit mRNAs between visceromotor and somatomotor
neurons of the rat lumbosacral spinal cord’, The Journal of Comparative Neurology
404(2), 172–182.
Shields, S. D., Ahn, H.-S., Yang, Y., Han, C., Seal, R. P., Wood, J. N., Waxman, S. G. &
Dib-Hajj, S. D. (2012), ‘Nav1.8 expression is not restricted to nociceptors in mouse
peripheral nervous system’, PAIN 153(10), 2017–2030.
Shih, Y.-Y. I., Chiang, Y.-C., Chen, J.-C., Huang, C.-H., Chen, Y.-Y., Liu, R.-S., Chang, C. &
REFERENCES 258
Jaw, F.-S. (2008), ‘Brain nociceptive imaging in rats using (18)f-fluorodeoxyglucose
small-animal positron emission tomography’, Neuroscience 155(4), 1221–1226.
Shim, B., Ringkamp, M., Lambrinos, G. L., Hartke, T. V., Griffin, J. W. & Meyer, R. A.
(2007), ‘Activity-dependent slowing of conduction velocity in uninjured L4 C fibers
increases after an L5 spinal nerve injury in the rat’, PAIN 128, 40–51.
Shimamura, K., Matsuda, M., Miyamoto, Y., Yoshimoto, R., Seo, T. & Tokita, S. (2009),
‘Identification of a stable chemerin analog with potent activity toward ChemR23’, Peptides
30(8), 1529–1538.
Shimizu, N., Soda, Y., Kanbe, K., Liu, H. Y., Jinno, A., Kitamura, T. & Hoshino, H. (1999),
‘An orphan G protein-coupled receptor, GPR1, acts as a coreceptor to allow replication of
human immunodeficiency virus types 1 and 2 in brain-derived cells’, Journal of Virology
73(6), 5231–5239.
Shin, H. C., Oh, S. J., Jung, S. C., Choi, Y. R., Won, C. K. & Leem, J. W. (1997),
‘Activity-dependent conduction latency changes in Aβ fibers of neuropathic rats’,
Neuroreport 8(12), 2813–2816.
Shiokawa, H., Kaftan, E. J., MacDermott, A. B. & Tong, C.-K. (2010), ‘NR2 subunits and
NMDA receptors on lamina II inhibitory and excitatory interneurons of the mouse dorsal
horn’, Molecular Pain 6, 26.
Sikand, P. & Premkumar, L. S. (2007), ‘Potentiation of glutamatergic synaptic transmission
by protein kinase C-mediated sensitization of TRPV1 at the first sensory synapse’, The
Journal of Physiology 581(2), 631–647.
Slack, S. E., Grist, J., Mac, Q., McMahon, S. B. & Pezet, S. (2005), ‘TrkB expression and
phospho-ERK activation by brain-derived neurotrophic factor in rat spinothalamic tract
neurons’, The Journal of Comparative Neurology 489(1), 59–68.
Slack, S. E., Pezet, S., McMahon, S. B., Thompson, S. W. N. & Malcangio, M. (2004),
‘Brain-derived neurotrophic factor induces NMDA receptor subunit one phosphorylation
via ERK and PKC in the rat spinal cord’, The European Journal of Neuroscience
20(7), 1769–1778.
Slugg, R. M. & Light, A. R. (1994), ‘Spinal cord and trigeminal projections to the pontine
parabrachial region in the rat as demonstrated with phaseolus vulgaris leucoagglutinin’,
The Journal of Comparative Neurology 339(1), 49–61.
Smith, E. S. J. & Lewin, G. R. (2009), ‘Nociceptors: a phylogenetic view’, Journal of
Comparative Physiology A 195(12), 1089–1106.
Snape, A., Pittaway, J. F. & Baker, M. D. (2010), ‘Excitability parameters and sensitivity to
anemone toxin ATX-II in rat small diameter primary sensory neurones discriminated by
Griffonia simplicifolia isolectin IB4’, The Journal of Physiology 588(1), 125–137.
Soleng, A. F., Chiu, K. & Raastad, M. (2003), ‘Unmyelinated axons in the rat hippocampus
hyperpolarize and activate an H current when spike frequency exceeds 1Hz’, The Journal
of Physiology 552(2), 459–470.
Sommer, B., Keinänen, K., Verdoorn, T. A., Wisden, W., Burnashev, N., Herb, A., Köhler, M.,
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Zabel, B. A., Nakae, S., Zúñiga, L., Kim, J.-Y., Ohyama, T., Alt, C., Pan, J., Suto, H., Soler,
D., Allen, S. J., Handel, T. M., Song, C. H., Galli, S. J. & Butcher, E. C. (2008), ‘Mast
cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal
induction of IgE-mediated passive cutaneous anaphylaxis’, The Journal of Experimental
Medicine 205(10), 2207–2220.
Zeilhofer, H. U., Studler, B., Arabadzisz, D., Schweizer, C., Ahmadi, S., Layh, B., Bösl, M. R.
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